
<html lang="en"     class="pb-page"  data-request-id="f0fa372d-6449-4fde-9a76-78bc241c48c8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm100509v;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-19;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Folate-Targeted Therapies for Cancer" /></meta><meta name="dc.Creator" content="Wei  Xia" /></meta><meta name="dc.Creator" content="Philip S.  Low" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 28, 2010" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100509v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100509v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100509v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100509v" /></link>
        
    
    

<title>Folate-Targeted Therapies for Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100509v" /></meta><meta property="og:title" content="Folate-Targeted Therapies for Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100509v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100509v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100509v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100509v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100509v&amp;href=/doi/10.1021/jm100509v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 6811-6824</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100189a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm901828c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Folate-Targeted Therapies for Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Xia">Wei Xia</a></span></span></li><span class="comma-separator">Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+S.++Low">Philip S. Low</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +1-765-494-5273. Fax: +1-765-494-5272. E-mail: <a href="/cdn-cgi/l/email-protection#a2d2cecdd5e2d2d7d0c6d7c78cc7c6d7"><span class="__cf_email__" data-cfemail="76061a19013606030412031358131203">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100509v&amp;href=/doi/10.1021%2Fjm100509v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 6811â6824</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 28, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 April 2010</li><li><span class="item_label"><b>Published</b> online</span>28 July 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 October 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100509v" title="DOI URL">https://doi.org/10.1021/jm100509v</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6811%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWei%2BXia%252C%2BPhilip%2BS.%2BLow%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D19%26contentID%3Djm100509v%26title%3DFolate-Targeted%2BTherapies%2Bfor%2BCancer%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6824%26publicationDate%3DOctober%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100509v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7908</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">331</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100509v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Folate-Targeted Therapies for Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Xia&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;S. Low&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;6811-6824&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100509v&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100509v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100509v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100509v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100509v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100509v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100509v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100509v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100509v&amp;href=/doi/10.1021/jm100509v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100509v" /></input><a href="/doi/pdf/10.1021/jm100509v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100509v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100509v%26sid%3Dliteratum%253Aachs%26pmid%3D20666486%26genre%3Darticle%26aulast%3DXia%26date%3D2010%26atitle%3DFolate-Targeted%2BTherapies%2Bfor%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D19%26spage%3D6811%26epage%3D6824%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292101" title="Nutrition">Nutrition</a>,</li><li><a href="/action/doSearch?ConceptID=292519" title="Cancer therapy">Cancer therapy</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jmcmar.2010.53.issue-19/production/jmcmar.2010.53.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2">1.1 General Strategies in the Design of Tumor Targeted Therapeutics</h3><div class="NLM_p">Todayâs quest for developing tumor-targeted therapies has naturally followed two nonoverlapping strategies. The first strategy involves pursuing agents that can selectively block novel pathways or proteins that emerge or become overexpressed in malignant cells. These pathways are generally critical for tumor cell survival but are either not present or not needed to a similar extent by normal cells. Examples of this type of targeted therapy include Gleevec (imatinib), a kinase inhibitor that targets the fusion protein bcr/abl, which arises solely from a chromosomal translocation during tumorigenesis,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> and Avastin (bevacizumab), a monoclonal antibody that suppresses neoangiogenesis required to nourish tumors for proliferation.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> The pharmaceutical industry is currently focusing its efforts almost exclusively on this type of targeted therapeutic agent.</div><div class="NLM_p last">The second strategy involves the use of a homing ligand that binds specifically to a receptor that is expressed primarily on malignant cells. When linked to a therapeutic drug, this ligand can be exploited to carry the nonselective drug specifically into the cancer cell. If the drug is released only after internalization by the diseased cell, unwanted collateral damage to receptor-negative tissues can be avoided. Thus, wherever appropriately specific ligands can be identified, they can be exploited to convert nonspecific cytotoxic drugs into finely tuned tumor-specific warheads. Ligands that have been exploited for this approach to tumor targeting include monoclonal antibodies<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> and low molecular weight receptor-binding molecules such as peptide hormones, receptor antagonists and agonists, oligosaccharides, oligopeptides, and vitamins.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13">(8-13)</a> This article will review the use of folic acid as a ligand to target therapeutic cargos of many sizes, shapes, and mechanisms of action to tumor cells both in vitro and in vivo. For reviews of the use of folic acid to deliver attached imaging agents to malignant masses, the reader is referred to other published articles.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.2 Pros and Cons of Ligand-Targeted Therapies</h3><div class="NLM_p">Ligand-targeted therapies offer several advantages over the aforementioned functionality-targeted therapies, the most notable being the formerâs remarkable flexibility and adaptability. Almost any potent drug can be targeted to a tumor tissue if it can be linked reversibly to a targeting ligand with specificity for a pathologic cell type. A second advantage is that a cognate imaging agent can almost always be synthesized using the same targeting ligand, and this targeted imaging agent can then be employed to select for patients whose tumors overexpress the ligandâs receptor.<a onclick="showRef(event, 'ref11 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref15">(11, 15)</a> Third, ligand-targeted therapies are generally preferred for delivery of membrane-impermeable drugs because a good targeting ligand can convey its attached cargo into the target cell by receptor-mediated endocytosis, rendering an otherwise membrane impermeable drug more efficacious.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> And finally, because overexpression of a receptor on cancer cells is usually a more common event than over-reliance on an enzyme unique to cancer cells (e.g., bcr/abl), more development potential may exist for ligand-targeted therapies than functionality-targeted therapies.</div><div class="NLM_p last">Development of ligand-targeted therapies also poses several challenges that are absent from functionality-targeted and nontargeted therapies. First, because most endocytic pathways transport relatively few molecules into a cell, the ligand-targeted drug must be effective at low concentrations. This can be problematic for diseases for which few highly potent drugs have been identified. Second, delivery to the correct site does not necessarily guarantee therapeutic efficacy; rather, the drug generally not only must be internalized by the cell but also must be released within the cell. Because only a few chemical functionalities allow for facile release of a covalently attached drug after targeted cell uptake, drugs must contain at least one of a limited number of chemical moieties (âSH, âCOOH, âOH, or âNH<sub>2</sub>) that can be adapted for intracellular release.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Third, an efficient drug release mechanism must be designed into the conjugate: one that is inert during transit to the pathologic lesion but is activated rapidly after target cell binding and internalization, enabling release of the therapeutic cargo only at the site of disease. Not all ligand-targeted conjugates lend themselves to such mechanisms. And finally, for some membrane-impermeable drugs, an endosome escape strategy must be designed. Thus, after receptor-mediated endocytosis, the drug will generally still need to pass through the endosomal membrane to reach its target within the pathologic cell. While much progress has been made in developing these endosomal escape mechanisms, more improvements are needed before the full potential of ligand-targeted macromolecular drugs (such as siRNAs,<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: CHEMS, cholesteryl hemisuccinate; CTL, cytotoxic T lymphocytes; DM1, maytansine; DOPE, dioleoylphosphatidylethanolamine; DSPE, distearoylphosphatidylethanolamine; EGFR, epidermal growth factor receptor; Fab, the antigen-binding fragment of an antibody; FITC, fluorescein; FR, folate receptor; FRET, fluorescence resonance energy transfer; HSV-1, herpes simplex virus type 1; LPD, liposome/protamine/DNA complex; MRI, magnetic resonance imaging; IC<sub>50</sub>, the half maximal inhibitory concentration; IFN-Î±, interferon-Î±; IgG, immunoglobulin G; IL-2, interleukin 2; ODN, oligodeoxynucleotide; PE, phosphatidylethanolamine; PEG, polyethylene glycol; PEI, polyethylenimine; PHSM, pH-sensitive polymeric mixed micelles; PLLA, poly-<span class="smallcaps smallerCapital">l</span>-lactic acid; pLys, poly-<span class="smallcaps smallerCapital">l</span>-lysine; RES, the reticuloendothelial system; scFv, the single chain variable fragment of an antibody; siRNA, small interfering RNA; TCR, T cell receptor, TK, thymidine kinase.</p></div> proteins, and nanoparticles) can be realized.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.3 Folate Receptor Expression Patterns</h3><div class="NLM_p">Folic acid is a vitamin that is essential for the proliferation and maintenance of all cells. Because most mammalian cells obtain their normal folate requirement via a low affinity reduced folate carrier<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> or proton-coupled folate transporter,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> accessible FRs are normally expressed in significant numbers only on cancer cells,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> activated macrophages,<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a> and the proximal tubule cells of the kidney.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Although folate conjugates display no affinity for the reduced folate carrier or proton-coupled folate transporter, they bind to folate receptors (FRs) on these cell types with high affinity (<i>K</i><sub>d</sub> â 10<sup>â9</sup> M) and enter FR-expressing cells by receptor-mediated endocytosis.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a></div><div class="NLM_p">Overexpression of FRs on cancer cells may have evolved as a consequence of their increased requirement for folic acid that is essential in the synthesis of nucleotide bases needed in cell proliferation. Because folate is often a limiting nutrient in human serum, up-regulation of a high affinity FR on cancer cells may enable malignant cells to compete more aggressively for the vitamin. Many, but not all, cancers express either the Î± or Î² isoform of FR.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Those cancers that most aggressively up-regulate the folate receptor include cancers of the ovary, lung, kidney, endometrium, breast, brain, colon, and myeloid cells of hematopoetic lineage (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). While other tumors, such as sarcomas, lymphomas, pancreatic cancer, testicular cancer, and cancers of the bladder, prostate, liver, head/neck, and skin, do not commonly up-regulate FR<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (and personal observations), these malignant FR-negative cells may, in contrast, up-regulate the reduced folate carrier or proton-coupled folate transporter to satisfy their heightened folate needs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Folate Receptor Expression in Selected Solid Tumors Determined by Either Immunohistochemistry or Imaging with EC20,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> a Folate-Targeted <sup>99m</sup>Tc-Based Radioimaging Agent<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (Personal Observations)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cancer</th><th class="colsep0 rowsep0" align="center" char=".">% FR<sup>+</sup></th><th class="colsep0 rowsep0" align="center" char=".">number of cases examined</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">488</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung (NSCLC: non-small-cell carcinoma)</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">511</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">endometrial</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">renal cell carcinoma (RCC)</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">colorectal</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">314</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nonfunctional pituitary adenoma (NFPA)</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thyroid</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cervical</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung metastases</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung (SCLC: small-cell lung carcinoma)</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mesothelioma</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr></tbody></table></div></div><div class="NLM_p">Expression of FR on nonmalignant hematopoietic cells (primarily the Î² isoform) appears to be limited to activated macrophages and their precursors.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a> Because activated macrophages accumulate at sites of inflammation, their uptake of folate conjugates is seen primarily in patients with inflammatory or autoimmune diseases.<a onclick="showRef(event, 'ref25 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref27">(25, 27)</a> Folateâs utility in diagnosing and treating these diseases has been reviewed elsewhere.<a onclick="showRef(event, 'ref11 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref11 ref32 ref33">(11, 32, 33)</a></div><div class="NLM_p">FR expression in the kidney is limited to the apical surface of the proximal tubule where the receptor captures the vitamin (or a folateâdrug conjugate) from the nascent urine and transcytoses it back across the kidney epithelium for release into the blood.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In this process, FR serves as a salvage receptor to prevent loss of folates in the urine. Because most folate conjugates are not retained in the kidneys, no renal toxicity has ever been observed in animals or humans treated with folate-chemotherapeutic agent conjugates.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a></div><div class="NLM_p">A few other normal epithelial cells may also express FR,<a onclick="showRef(event, 'ref29 ref37'); return false;" href="javascript:void(0);" class="ref ref29 ref37">(29, 37)</a> especially alveolar epithelial cells,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> but these FR are inaccessible to folate and folate conjugates because of their exclusive localization on the apical surfaces of polarized epithelia (i.e., the side facing the lumen or opening). Consequently, in healthy patients that do not have malignant masses or an inflammatory disease, measurable folate conjugate uptake is limited to the kidneys (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of [<sup>111</sup>In]DTPAâfolate uptake in a patient with stage III ovarian cancer (left) and a healthy volunteer (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">2 Folate-Targeted Cancer Therapeutics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Significant up-regulation of the folate receptor on tumor tissue has led us to hypothesize that folate-linked therapeutic agents might display reduced off-site toxicity and enhanced potency against tumor cells compared to nontargeted drugs.<a onclick="showRef(event, 'ref17 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref22">(17, 22)</a> The sections that follow describe the many applications of folic acid for targeting of a variety of therapeutic agents for treatment of malignant diseases. Although many types of folate conjugates have been evaluated in animal models of human cancers, only six folate-linked drugs have been tested in the clinic to date.<a onclick="showRef(event, 'ref15 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref15 ref39 ref40 ref41 ref42">(15, 39-42)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1 Folate-Targeted Protein Toxins</h3><div class="NLM_p last">Initial efforts to build folate-linked cytotoxic drugs focused on folate-linked protein toxins. A folateâ<i>Pseudomonas</i> exotoxin (folateâPE38) conjugate was found to kill FR<sup>+</sup> cancer cells with an IC<sub>50</sub> of â¼10<sup>â11</sup> M. Interestingly, folateâPE38 demonstrated 100-fold greater inhibition of protein synthesis and similarly increased cytotoxicity toward cancer cells compared to folateâmomordin, probably because of the former proteinâs built-in mechanism of endosomal escape following FR-mediated endocytosis.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> To confirm that this difference in potency was indeed a consequence of a difference in endosomal escape, the mechanism of endosomal escape was selectively inhibited in folateâPE38 by blocking a critical cysteine residue. The resulting folateâtoxin conjugate displayed a decrease in potency of 4 orders of magnitude, confirming the importance of endosomal release in the toxinâs mechanism of action.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Similar requirements for endosomal escape have been observed for other macromolecular folate conjugates (personal observations).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.2 Folate-Targeted Chemotherapeutic Agents</h3><div class="NLM_p">Because of its high affinity for FR, folate has often been observed to remain attached to FR as the receptor internalizes and then recycles back to the cell surface (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>); i.e., the oxidized form of the vitamin (folic acid) may not normally dissociate from the receptor during FR trafficking.<a onclick="showRef(event, 'ref31 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref31 ref45 ref46">(31, 45, 46)</a> A similar fate has been observed to compromise the potency of folate-targeted chemotherapeutic agents when the linker between the vitamin and its attached therapeutic warhead is not cleaved during FR recycling. Therefore, in an effort to ensure intracellular drug release, multiple strategies for unloading an attached therapeutic cargo within the target cell have been explored. The most prominent method to trigger intracellular drug release has exploited the large difference in reducing power between the extra- and intracellular environments. In this approach, a self-immolative disulfide bridge is introduced between the drug and folic acid with the anticipation that an unmodified drug will be discharged once the conjugate has entered a reducing endosome.<a onclick="showRef(event, 'ref31 ref43'); return false;" href="javascript:void(0);" class="ref ref31 ref43">(31, 43)</a> This approach was directly imaged by microscopy when folate was linked via a disulfide bond to two fluorescent dyes that engaged in fluorescence resonance energy transfer while covalently linked in the same folate conjugate<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Loss of fluorescence resonance energy transfer (FRET) without loss of the fluorescence of either dye was taken as evidence that the disulfide bond linking one of the dyes to folate had been reduced, allowing separation of the fluorescence donor and acceptor pair. Importantly, FRET was observed to decline immediately upon internalization of the conjugate by FR-mediated endocytosis, and energy transfer was seen to completely disappear before any folate conjugates could recycle to the cell surface.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> These data demonstrated that disulfide bond reduction begins early during endosomal trafficking and continues rapidly until all disulfide bonds are cleaved. Assuming that the released therapeutic cargo is membrane permeable, the discharged drug was hypothesized to rapidly diffuse out of the endosome and into the cytoplasm where it could perform its function. This hypothesis was supported by observations demonstrating that disulfide-linked drugs, such as folateâmaytansine DM1 and folateâcamptothecin,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> could kill a panel of FR<sup>+</sup> cancer cells with IC<sub>50</sub> values between 10<sup>â11</sup> and 10<sup>â10</sup> M, suggesting efficient drug release following FR endocytosis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. FR-mediated endocytosis of folateâdrug conjugates. Exogenously added folateâdrug conjugates bind specifically to FR with high affinity. The plasma membrane invaginates around the FR/folate conjugate complex to form an endosome. As the lumen of the maturing endosome acidifies, the receptor changes conformation and releases the conjugate, and the disulfide bond between folate and its drug cargo is reduced to release the parent drug cargo. Because the pH of FR-containing endosomes is only mildly acidic, acid-labile linkers do not release the attached drug as efficiently (see discussion in <a class="ref internalNav" href="#sec2_2" aria-label="section 2.2">section 2.2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The folateâFRET reporter changes fluorescence from red to green upon disulfide reduction. In the nonreduced folateâFRET reporter (upper), excitation of BODIPY (488 nm) leads to rhodamine (red, 595 nm) emission due to FRET from BODIPY to rhodamine. Upon disulfide reduction (lower), rhodamine is released from the folateâBODIPY backbone, leading to loss of FRET signal and concurrent recovery of BODIPY (green, 520 nm) fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The second approach to trigger endosomal release of an active drug from its folate conjugate was designed to exploit the more acidic pH values commonly encountered in late endosomes and lysosomes.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In an early study, a paclitaxel-7-polyethylene glycolâfolate conjugate was designed with a pH-sensitive ester connecting the taxane to the polyethylene glycolâfolate in the hope that the low endosomal pH experienced during intracellular trafficking would release the paclitaxel.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, the folate conjugate was found to be 50-fold less cytotoxic to FR<sup>+</sup> KB cells than the free paclitaxel despite the fact that the conjugate retained high affinity for the FR.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Subsequent experiments examined the cause of this unexpected inactivity as well as the poor potencies of other pH sensitive folateâdrug conjugates. Surprisingly, analyses of the pH in FR-containing endosomal compartments using folate-linked pH indicator dyes revealed that these endosomes never reached pH below 6.2, suggesting that the pH was never sufficiently acidic to rapidly hydrolyze ester bridges (<i>t</i><sub>1/2</sub> â 197 h).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> More detailed studies further revealed that monovalent folateâdrug conjugates recycle through endosomes with median pH of 6.8 and never encounter strongly acidic compartments (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In contrast, multivalent folate conjugates (e.g., liposomes with multiple folates attached) were found to traffic to lysosomes where median pH values were near pH 5.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Consequently, acid catalyzed drug release mechanisms will only be useful for delivery of multivalent folate-targeted constructs (e.g., nanoparticles and liposomes).</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of endosomal compartment pH values encountered by monovalent and multivalent folate conjugates following their uptake by folate receptor-mediated endocytosis. Multivalent conjugates (left) bind simultaneously to multiple FR and traffic to acidic lysosomes following endocytosis.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In contrast, monovalent conjugates traffic to a mildly acidic recycling center where disulfide-linked drugs are rapidly released by disulfide reduction.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The above differences between disulfide and pH-sensitive linkers have been confirmed on multiple folate conjugates designed to differ only in the chemistries of their linkers. One well studied example involves a matched pair of folateâdesacetylvinblastine monohydrazide conjugates: <b>1</b> (EC140) with an acylhydrazone (pH-sensitive) linker and <b>2</b> (EC145) with a disulfide linker (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). As anticipated, in vivo tests have demonstrated <b>2</b> to be dramatically more potent than <b>1</b>.<a onclick="showRef(event, 'ref39 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref39 ref51 ref52">(39, 51, 52)</a></div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of two folateâdesacetylvinblastine monohydrazide conjugates.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Optimization of linker design requires not only that the bridging chemistry allow facile release of an unmodified drug following uptake by its target cell but also that the folateâdrug conjugate remain intact during its brief transit in the vasculature from its site of injection to the tumor mass. Importantly, because the sizes of most folateâchemotherapeutic agents are small, they have been found to perfuse solid tissues very rapidly, leading to saturation of all FR in solid tumors in <5 min in mice<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and probably <15 min in humans following intravenous injection. Since clearance of water-soluble folate conjugates from the bloodstream is >99% complete in less than 20 min, the cleavable linker connecting folate to its attached drug need only be stable in the bloodstream for â¼15â20 min. Pharmacokinetic studies in both rodents and humans have revealed that this stability requirement is readily satisfied, at least for disulfide linked folate conjugates.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Considered together with the previously established efficient release of disulfide bridged conjugates in early endosomes, our lab has decided that future monovalent folate-targeted chemotherapeutic agents should be tethered via a disulfide rather than a pH labile linker to its targeting ligand. Moreover, all future folate-targeted drugs will be linked via the Î³-carboxyl rather than Î±-carboxyl because the former exhibits slightly higher affinity for FR than the latter.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Representative examples of such Î³-carboxyl derivatized disulfide-linked cytotoxic drugs (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) include <b>2</b> (IC<sub>50</sub> â 9 nM),<a onclick="showRef(event, 'ref39 ref52'); return false;" href="javascript:void(0);" class="ref ref39 ref52">(39, 52)</a> folateâmaytansine DM1 (EC131, IC<sub>50</sub> â 16â25 nM),<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> folateâtubulysin B (EC0305, IC<sub>50</sub> â 1â10 nM),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> folateâmitomycin C (EC72, IC<sub>50</sub> â 5 nM),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> folateâcamptothecin (IC<sub>50</sub> â 10 nM),<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and a dual warhead folateâmitomycin C/desacetylvinblastine conjugate (EC0225, IC<sub>50</sub> â 5.4 nM).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Because the tumor delivery capacity of the FR endocytic pathway is limited primarily by the number of FR expressed on the cancer cell (usually (1â3) Ã 10<sup>6</sup>/cell), only highly potent warheads have eventually succeeded as effective folate-targeted therapeutics. As noted in the cited articles, each of the aforementioned folate-targeted cytotoxic drugs has demonstrated remarkable activity in animal tumor models with greatly reduced off-target toxicity to healthy cells. <b>2</b> will soon be entering phase 3 clinical trials, whereas several other folateâdrug conjugates are currently undergoing testing in either phase 1 or phase 2 clinical trials.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structures of folateâÎ³-carboxyl derivatized disulfide-linked cytotoxic drugs.<a onclick="showRef(event, 'ref40 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref40 ref55 ref56 ref57">(40, 55-57)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.3 Folate-Targeted Immunotherapy</h3><div class="NLM_p">One problem with the effectiveness of traditional cancer treatments is that most tumors evolve mechanisms to evade their chemotherapies by selection of mutations that lead to drug resistance. Because most immunotherapies are designed to educate the immune system to recognize mutations that arise during tumor progression, activation of humoral and/or cellular immunities against tumor cells can result in tumor cell killing and extension of patient lifespan. As with chemotherapy strategies, immunotherapies can also be improved by targeting the immune stimulant to the folate receptor. To date, protocols for targeting immunotherapeutic agents to FR<sup>+</sup> cancers have included (1) administration of unconjugated or conjugated anti-FR antibodies (MOv18, MOv19),<a onclick="showRef(event, 'ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61 ref62">(59-62)</a> (2) the use of folate/anti-T cell receptor (anti-TCR IgG) bispecific antibodies,<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63-65)</a> (3) transduction of T lymphocytes with FR peptides for production of cellular anti-FR immunity,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and (4) administration of folate-targeted haptens to âpaintâ tumor cell surfaces with foreign/immunogenic molecules.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a></div><div class="NLM_p">Initial immunotherapy efforts focused on the use of two murine monoclonal antibodies, MOv18 (IgG1Îº) and MOv19 (IgG2aÎº), that exhibited high affinity for ovarian cancer cells (<i>K</i><sub>A</sub> = 10<sup>8</sup>â10<sup>9</sup> M<sup>â1</sup>).<a onclick="showRef(event, 'ref62 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref62 ref69 ref70">(62, 69, 70)</a> MOv18 was initially exploited to deliver the therapeutic radionuclide <sup>131</sup>I or to redirect the cytotoxicity of activated autologous immune cells to FR<sup>+</sup> ovarian carcinoma cells in vitro.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> Similarly, the single-chain Fv (scFv) of MOv19 was used to direct conjugated interleukin-2 (IL-2) to tumors with the hope that the IL-2 would stimulate activation of the immune system within the tumor.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Prolonged release of IL-2/MOv19 scFv protected 60% of mice from developing lung metastases caused by FR<sup>+</sup> tumors. Moreover, treatment with IL-2/MOv19 scFv (but not with nontargeted recombinant IL-2) significantly reduced the volume of subcutaneous FR<sup>+</sup> tumors in mice.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Although early human trials with these monoclonal antibodies failed, clinical trials using improved versions of antifolate receptor monoclonal antibodies are currently underway and the results are very promising.<a onclick="showRef(event, 'ref62 ref71'); return false;" href="javascript:void(0);" class="ref ref62 ref71">(62, 71)</a> In order to overcome potential tumor penetration barriers that were thought to compromise the potencies of the larger intact IgGs, completely humanized antibody fragments (Fabs) against FR have been assembled using phage display and epitope imprinting selection methodologies.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> For example, a smaller Fab dimer was demonstrated with high affinity for FR and significantly improved tumor-to-blood ratios. Future development of this antibody construct for clinical applications is apparently planned.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p">Instead of using an antifolate receptor antibody to deliver an attached cargo, Kranz et al.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> used a folate-derivatized antibody against the T cell receptor (anti-TCR IgG) to force T cells (recognized by anti-TCR IgG) to dock with FR<sup>+</sup> cancer cells (recognized by the folic acid). With an average of five folates per IgG, this folate conjugate effectively mediated lysis of FR<sup>+</sup> tumor cells at concentrations as low as 1 pM. Importantly, the extent of tumor cell lysis was found to correlate with its level of FR expression, and cell killing was found to be completely inhibited by free folic acid.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> For unknown reasons, this promising strategy has never been tested in the clinic. In a follow-up study, a âsmallerâ folate conjugate to a single-chain antibody fragment (scFv) of the anti-TCR IgG was constructed. Similar to IgGâfolate, the scFvâfolate was found to mediate lysis of FR<sup>+</sup> tumor cells by cytotoxic T lymphocytes (CTLs) (with EC<sub>50</sub> â 40 pM) in vitro.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> However, in vivo preclinical testing of the folateâantibody/scFv bispecific construct against human tumors was limited to immunodeficient mice that received the bispecific agent plus activated human effector T cells. Unfortunately, such a model does not accurately reflect a clinical scenario. Therefore, the same group developed a transgenic mouse model that would grow FR<sup>+</sup> human KB cell tumors and induced mobilization of endogenous CTLs with a synthetic antigenic peptide recognized by the CTLs.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Importantly, the transgenic mice rejected the human tumors after treatment with the activating peptide and the scFvâfolate. However, since the T cells in this model were derived from a single clone, it can be cogently argued that such an immunotherapy strategy would best be tested in a syngeneic mouse model with a normal heterogeneous immune system before advancing the methodology into the clinic.</div><div class="NLM_p">As an alternative to direct targeting of a CTL or inflammatory cytokine to a cancer, folate has also been exploited to deliver a highly immunogenic hapten to the surface of FR<sup>+</sup> tumors as a method of marking the tumor as âforeign.â This âimmunogenic flagâ was hypothesized to render a malignant mass that had somehow escaped recognition by the immune system highly visible to immune cells (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). To test this hypothesis, tumor-bearing mice were vaccinated against fluorescein before intraperitoneal implantation of FR<sup>+</sup> M109 tumor cells. After an adequate anti-FITC antibody titer had been induced, a combination of folateâFITC, IL-2, and interferon-Î± (IFN-Î±) was administered to simultaneously decorate the FR-expressing tumor cells with FITC and stimulate the immune system with the cytokines.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Healthy FR-negative cells were found to be spared from immune attack, whereas FR<sup>+</sup> malignant cells were observed to be rapidly destroyed by a massive influx of immune cells.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> More importantly, this folateâhapten therapy was seen to confer long-term immunity against the same cancer. Thus, when challenged with fresh tumor cells on multiple occasions at later dates, the same mice rejected the newly implanted cells without needing any further therapy.<a onclick="showRef(event, 'ref41 ref75'); return false;" href="javascript:void(0);" class="ref ref41 ref75">(41, 75)</a> Subsequent analysis of the mechanism of this immune memory demonstrated that the sustained memory resided in the T cell population. This cancer-specific immune memory probably constitutes the chief merit of folate-targeted hapten therapy, since it prevents recurrence of the disease in patients that would otherwise relapse. Given these encouraging results, the folate-targeted hapten therapy now is in early clinical trials.</div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Illustration of folateâhapten mediated immunotherapy. Mice previously immunized against a hapten (e.g., fluorescein) are treated with a folateâhapten conjugate (such as folateâfluorescein) that can bind to cell surface FR. After binding of antifluorescein antibodies induced during the immunization, the cancer cell is recognized by Fc receptor-expressing immune cells, leading to cancer cell destruction by antibody-dependent cell cytotoxicity (ADCC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.4 Folate-Targeted Gene Therapy</h3><div class="NLM_p">Although a few reports exist regarding FR-targeted viral vectors for gene therapy,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> obstacles including the immunogenicity of viral proteins and potential generation of infectious viral particles have redirected most of these efforts to folate-linked nonviral biocompatible polymeric gene carriers, such as cationic polymers, cationic peptides, cationic lipids, and so on.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> However, because nonviral formulations lack the transfection machinery inherent in many viral vectors, improved circulation times, strategies for endosomal escape, and methods for nuclear trafficking have had to be designed into the folate-targeted nonviral gene therapy vectors to render them efficacious.</div><div class="NLM_p">Cationic polymers have been utilized widely for folate-targeted gene delivery because of their (1) physiochemical versatility, (2) ease of manipulation, and (3) ability to condense DNA into compact complexes. Early efforts by Gottschalk et al.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> and Reddy et al.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> using folate-linked poly-<span class="smallcaps smallerCapital">l</span>-lysine (pLys) and pLys-polyethylene glycol (PEG) complexes, respectively, yielded only low levels of reporter activity despite good gene delivery to FR<sup>+</sup> cells. These early studies indicated that efficient DNA delivery and gene expression required an endosomal disruption mechanism to release that DNA from its intracellular compartment.</div><div class="NLM_p">Unlike pLys, polyethylenimine (PEI) was known to possess inherent endosomal lytic activity, serving as both a DNA-condensing agent and a proton sponge that could osmotically lyse its entrapping endosome;<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> however, PEI also suffers from nonspecific uptake in the lungs and liver that can lead to unwanted toxicity. Thus, to achieve targeted gene delivery with minimal collateral toxicity, Benns et al.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> linked folate to both ends of a monofunctionalized PEG and then grafted it to PEI (FPF-g-PEI). The complex of FPF-g-PEI and a luciferase reporter gene achieved transfection in FR<sup>+</sup> cancer cells in a FR-dependent manner.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> However, because the barriers to in vivo delivery are much greater than those encountered in vitro, it will now be important to prove the utility of these complexes in tumor-bearing mice in vivo.</div><div class="NLM_p">Several cationic liposomal formulations that incorporate a lipophilic folate derivative as a targeting moiety have also been studied. In pioneering studies, Hofland et al.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> performed the first in vivo folate-targeted gene transfer in a subcutaneous mouse tumor model using a folateâPEGâlipid/DNA complex. While a biodistribution analysis of the <sup>111</sup>In-labeled folate-targeted liposomes showed no improvement in tumor-specific accumulation over nontargeted PEGâlipid/DNA complexes, attachment of folateâPEG to the cationic lipid/chloramphenicol acetyl transferase (CAT) reporter gene complex was found to significantly increase gene transfer activity in FR<sup>+</sup> tumors while decreasing nonspecific expression in the lungs 50- to 100-fold.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Although nonspecific gene transfer needs to be minimized further to generate an ideal DNA delivery formulation, the approach nonetheless provided the first in vivo proof of concept of systemically targeted gene delivery to tumors.</div><div class="NLM_p">Novel liposome/protamine/DNA formulations (LPD) have also been linked to folate to improve tumor-specific gene transfer. In an in vivo ascites tumor model, Reddy et al.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> reported an 8- to 10-fold increase in tumor-associated gene transfer compared to a corresponding nontargeted LPD formulation.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Moreover, using an LPDâPEGâfolate formulation to deliver the herpes simplex virus type-1 (HSV-1) thymidine kinase (TK) gene into murine breast cancer cells, Bruckheimer et al.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> demonstrated a greater reduction in mean tumor volume compared to either nontargeted LPDâPEG/TK, the vehicle alone, or an untreated control group.</div><div class="NLM_p last">Significant efforts have also been devoted to optimizing folate-targeted constructs for improved gene delivery, from titrating the use of PEG, which can reduce nonspecific uptake and increase transfection efficiency, to minimization of vector size, which can improve  extravasation of the vector into the tumor. Continued efforts toward these objectives should yield improved folate-targeted gene therapy vectors, as should research into enhancement of the efficiencies of endosomal escape and gene trafficking to the nucleus.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.5 Folate-Targeted Antisense Oligodeoxyribonucleotides (ODN) and Small Interfering RNAs (siRNA)</h3><div class="NLM_p">Using ODN or siRNA to ablate or modulate gene expression shows great promise as a method to arrest tumor cell growth and induce apoptosis largely because of the potential specificity of oligonucleotides for their complementary target mRNAs. Unfortunately, nonspecific activation of the immune system,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> inadequate permeability of naked oligonucleotides to cell membranes,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> indiscriminate uptake of cationic complexes of oligonucleotides by nonpathologic cells,<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a> and insufficient release of oligonucleotide complexes from endosomal compartments following uptake by endocytosis<a onclick="showRef(event, 'ref88 ref90'); return false;" href="javascript:void(0);" class="ref ref88 ref90">(88, 90)</a> have all compromised the potential of this important therapeutic strategy. While encapsulating/complexing oligonucleotides into liposomes, dendrimers, micelles, or nanoparticles has improved their pharmacokinetic properties, the same nanocomplexes have generally been handicapped by reduced target cell binding and tumor specificity.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a> Thus, the major obstacle to developing antisense ODN and siRNA for use in therapeutic applications can be summarized as a problem in oligonucleotide delivery. As will be seen below, while attachment of folate as a targeting ligand can improve tumor-specific oligonucleotide delivery and associated gene knockdown, endosomal escape strategies will have to be improved to achieve the full potential of ODN and siRNA therapies.</div><div class="NLM_p">The simplest approach to folate-targeted delivery of siRNA and ODN to solid tumors has involved direct attachment of one strand of the oligonucleotide to the Î³-carboxyl of folic acid via some type of cleavable or releasable bridge. In one study, folate was covalently attached to a single stranded oligonucleotide that was complementary to a single-stranded overhang added to the end of the siRNA.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Upon base-pairing with the single stranded oligonucleotide extension, the folate-linked oligonucleotide was found to facilitate delivery of the attached siRNA into any cell expressing FR. The utility of this universal linker strategy was most clearly demonstrated in vitro by showing its ability to suppress expression of an Î±V integrin gene by 80% in an FR<sup>+</sup> cancer cell line.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><div class="NLM_p">In vivo demonstration of the ability of folate to target an attached oligonucleotide to solid tumors was achieved using a related but much simpler construct, where folate was attached to either the 3â²- or 5â²-end of the sense strand of an siRNA or ODN via a disulfide bond and the complementary antisense strand was labeled with a fluorescent dye (e.g., Dylight 647 or Cy5).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Four hours after injecting the naked oligonucleotide into the tail vein of KB tumor-bearing mice, the mice were imaged and found to contain the fluorescent marker almost exclusively in the solid tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Since the targeting ligand (i.e., folate) was not present on the strand labeled with the fluorescent dye, localization of fluorescence to the tumor demonstrated that the naked nucleotide duplex was delivered to the solid tumor intact.</div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Folate-mediated targeting of fluorescent oligonucleotides to solid tumors in vivo, as visualized using a Kodak imaging station.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The mouse on the left was injected with nontargeted Dylight 647-labeled siRNA, while the mouse on the right was injected with a folate-targeted version of the same siRNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More sophisticated efforts to target siRNA/ODN to tumors in vivo with folate have focused on the use a cationic polymer to condense the ODN or siRNA prior to folate-targeted delivery. Citro et al.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> covalently linked folate to a pLys chain and delivered c-myb sense and antisense ODNs to HL60 leukemia cells in vitro, reporting a down-regulation of c-myb expression and inhibition of proliferation in HL60 cells.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> In similar fashion, Kim et al.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> utilized a folate-targeted PEI-based cationic polymer for ODN/siRNA delivery, which demonstrated enhanced cell uptake and more efficient green fluorescent protein (GFP) expression inhibition in FR<sup>+</sup> KB cells than nontargeted PEI. Importantly, the inhibitory difference between PEIâPEGâfolate and nontargeted PEG-PEI disappeared when similar studies were performed in FR-negative A549 cells, suggesting an FR requirement for gene knockdown.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> More recently, with the optimization of polymer architecture, a novel hydrophilic-block-cationic copolymer conjugated to folate with improved stability in circulation as well as fewer nonspecific side effects has been developed.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> In vivo comparisons will obviously now be required to assess the full potentials of these and other copolymer blends for siRNA delivery.</div><div class="NLM_p">Cationic liposome-based formulations have also been investigated for improved tumor targeting via folate receptors. Initially, Wang et al.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> constructed a folateâPEGâliposome formulation to deliver an ODN against epidermal growth factor receptor (EGFR) into KB cells. The folateâPEGâliposome complex was found to eliminate EGFR expression, alter cell morphology, and halt tumor cell growth.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Rait et al.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> further showed that FR-targeted cationic liposomes (without PEG) were more efficient than the nonselective commercially available transfection reagent, Lipofectin, in delivering anti-HER2 ODN into breast cancer cells both in vitro and in vivo. Notably, treatment with folateâliposomeâODN resulted in chemosensitization of the tumor cells, and inhibition of tumor growth was sustained for >3 weeks after treatment.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> This important publication constituted the first report of in vivo efficacy against tumors using a folate-targeted liposome delivery system for systemic ODN/siRNA therapy. Using a folateâPEGâliposome formulation, Leamon et al.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> reported that nearly 100â000 ODN-loaded folate-targeted liposomes were taken up per KB cell in vitro during 1 h of incubation, and maximal FR loading was achieved with PEG linkers as low as 1000 Da. However, tumor-specific accumulation of the folate-targeted liposomes in vivo was unexpectedly no greater than that of their nontargeted counterparts.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p">Somewhat related folate-linked lipid-based nanoparticles complexed with DNA have also been shown to display efficient delivery of synthetic siRNAs to tumors.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> When HER2 siRNA was used as the test siRNA, the folate targeted formulation was found to inhibit KB tumor xenograft growth and selectively suppress HER2 protein expression significantly more than any comparable nontargeted formulation.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><div class="NLM_p">Folate-derivatized polyelectrolyte (PEC) micelles, whose assembly is driven by ionic interactions between a folateâPEGâODN and PEI, have also been used for delivery of ODN to tumors. Biodistribution studies have revealed that these micellar ODN also concentrate in FR<sup>+</sup> solid tumors following systemic administration. Although uptake was also high in several healthy tissues, probably due to macrophage scavenging, the data nonetheless suggest that folate-targeted micelles also exhibit potential for ODN delivery to cancer cells in vivo.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><div class="NLM_p last">Most platforms employed to deliver siRNA to tumors rely on some intrinsic ability of the internalized polymer/nanoparticle to escape its entrapping endosome and release its siRNA cargo into the cytoplasm. Although in vitro and in vivo studies with folate-targeted siRNAs have already demonstrated suppression of specific genes, the extent of gene knockdown to date has generally been modest compared to the knockdown achieved with similar quantities of siRNA complexed with a cell permeabilizing agent such as lipofectamine. This and related comparisons suggest that most internalized oligonucleotides do not escape their endosomal compartments and enter the cytoplasm where they must function. While it is possible that optimization of nanoparticle size, solubility, nonspecific adsorption, and particle shape could lead to enhanced oligonucleotide potency in vivo, we believe that the greatest improvement in gene suppression will eventually be achieved when an efficient endosomal escape strategy can be developed. In our opinion, this goal should be the primary focus of future efforts in formulating siRNA and ODN delivery vehicles.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.6 Design of Folate-Targeted Nanoparticles</h3><div class="NLM_p">Nanoparticles can also be developed into effective delivery vehicles for chemotherapeutic agents, in part because they can be designed to carry large quantities of therapeutic cargos in compartments characterized by a diversity of sizes, shapes, rheologic properties, and chemistries.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Moreover, since the vasculature is often incompletely/abnormally formed in solid tumors, often displaying large gaps of â¼300â800 nm between adjacent endothelial cells, nanoparticle extravasation and tumor accumulation can be greatly enhanced at these sites.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> This passive accumulation of nanoparticles in solid tumors, together with the poor drainage of the same particles via a commonly flawed lymphatic system, can lead to significant accumulation of nanoparticles at malignant sites.</div><div class="NLM_p">How then might folate targeting be exploited to improve intratumoral delivery of nanoparticles? In general, attachment of folate to nanoparticles, including liposomes, dendrimers, micelles, nanospheres, nanocapsules, nanowires, polyplexes, and lipoplexes, etc., cannot enhance entry of the particle into a solid tumor, since the density of tumor blood vessels, the porosity of the tumor vasculature, and the compactness of the extracellular matrix will largely control perfusion pharmacokinetics of nanoparticles into tumor masses. Indeed, âbinding site barrier effectsâ due to high affinity docking of the initial folate-labeled particles to exit a vasculature onto FR<sup>+</sup> cancer cells directly adjacent to the blood vessels can actually reduce penetration of subsequent folate-targeted particles to sites further from the vasculature.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> However, once a folate-linked nanoparticle arrives at an FR<sup>+</sup> tumor cell, ligation of the particle to folate can only enhance its therapeutic efficacy, since folate will not only increase retention of the nanoparticle in the tumor mass but also facilitate uptake of the particle by an FR-mediated endocytosis. A few examples of folate-targeted nanoparticle therapeutics will now be provided below to illustrate their potential.</div><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">2.6.1 Folate-Targeted Liposomes</h4><div class="NLM_p">Liposomes are unilamellar or multilamellar lipid assemblies that can entrap large quantities of hydrophilic molecules within their aqueous interiors or hydrophobic drugs within their hydrocarbon bilayers. Because of this diverse âcarrying capacityâ, as well as their desirable biocompatibility,<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> a number of liposomal drug formulations are in development, currently undergoing clinical trials, or already on the market. While no folate-targeted liposomes have yet achieved FDA approval, many have been employed successfully to deliver compounds to tumor cells in model systems with highly promising results.<a onclick="showRef(event, 'ref79 ref98 ref103 ref104 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref79 ref98 ref103 ref104 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref113 ref114">(79, 98, 103-114)</a></div><div class="NLM_p">The first folate-targeted liposome was prepared by attaching folate to the distal end of a PEG spacer that was in turn linked to the amino group of phosphatidylethanolamine (folateâPEGâPE) embedded in the liposome bilayer.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Initial binding studies with this formulation demonstrated that the length of the spacer between folate and the lipid anchor was critical, where a 250 Ã PEG<sub>3350</sub> spacer yielded â¼37 times greater uptake than similar liposomes with a 23 Ã maleiimidocaproylâlysineâSH spacer. Unfortunately, these relatively ânakedâ liposomal formulations were found to suffer from short circulation times in vivo due to their nonspecific uptake by the reticuloendothelial system (RES). Such nonspecific uptake, however, was subsequently overcome by incorporating 4% nontargeted PEGylated lipid into the folate-targeted liposomes to mimic the commercially successful âstealth liposomesâ.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Further improvements then emerged when it was observed that better tumor targeting could be achieved if the predominant PEGylated lipid comprising the âstealthâ coating contained a shorter PEG chain (e.g., PEG<sub>2000</sub>) than the folate-derivatized lipid (e.g., PEG<sub>3400</sub>, PEG<sub>5000</sub>).<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116, 117)</a> A mole fraction of 0.03â0.5% folateâPEGâDSPE was then found to be optimal for effective delivery of the targeted âstealthâ liposomes into FR<sup>+</sup> cells. In fact, increasing the density of the folate ligand on the liposome surface above this mole fraction was observed to reduce net uptake of the liposome by the target cell.<a onclick="showRef(event, 'ref84 ref103 ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref84 ref103 ref116 ref117">(84, 103, 116, 117)</a> Finally, in addition to folateâPEGâDSPE, two other lipophilic folate derivatives have been reported to facilitate good liposome targeting to FR<sup>+</sup> tumor cells both in vitro and in vivo. These are folateâPEGâcholesterol and folateâPEGâcholesteryl hemisuccinate (CHEMS).<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a></div><div class="NLM_p">As with siRNA delivery, one obstacle found to limit the potencies of some folate-targeted liposomal drug formulations has been the poor efficiency of drug unloading following receptor-mediated uptake into FR<sup>+</sup> cells. Because multivalent nanoparticles (in contrast to monovalent folateâdrug conjugates) encounter low pH endosomes during their intracellular trafficking,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> this problem has been addressed by exploring a number of pH-triggered liposome disrupting mechanisms. In one strategy, a pH sensitive membrane-destabilizing peptide has been entrapped together with the desired drug in a folate-targeted liposome.<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120, 121)</a> Since the encapsulated peptide is designed to become fusogenic only at the low pH found in intracellular endosomes, these liposomes have been observed to unload their cargos only following internalization and trafficking to an acidic intracellular compartment.</div><div class="NLM_p">A second endosomal unloading strategy has been based on the propensity of vinyl ethers to hydrolyze at the low pH characteristic of late endosomes and lysosomes. By using such linkages to connect the fatty acyl component of a phospholipid to its glycerol backbone, Rui et al.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> were able to generate diplasmenylcholine (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) that would hydrolyze to lysolipid detergents upon trafficking to lysosomes. Employing such lipids to encapsulate cytosine arabinoside was found to increase the potency of the corresponding folate-targeted liposomal preparation 60-fold compared to its pH-insensitive phosphatidylcholine counterpart.<a onclick="showRef(event, 'ref80 ref122'); return false;" href="javascript:void(0);" class="ref ref80 ref122">(80, 122)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structure of diplasmenylcholine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a third strategy, folate-linked liposomes were supplemented with <i>N</i>-citraconyldioleoylphosphatidylethanolamine (C-DOPE), which was shown to hydrolyze rapidly at pH 5 to yield the highly fusogenic lipid, DOPE. When incorporated with folateâPEGâDOPE into liposomes, the resulting formulation was found to remain stable at a neutral pH but become fusogenic at pH 5, releasing an encapsulated plasmid into the target cell cytoplasm, thereby improving expression of the plasmid.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Finally, to improve liposome stability in the bloodstream, a novel serum-resistant pH-sensitive liposome formulation comprising egg phosphatidylcholine, CHEMS, oleyl alcohol, and Tween-80 has been designed to deliver cytosine-b-<span class="smallcaps smallerCapital">d</span>-arabinofuranoside (Ara-C) to FR<sup>+</sup> KB cells. This interesting formulation has been reported to yield a 17-fold improvement in cancer cell death compared to its non-pH sensitive counterpart.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><div class="NLM_p last">Although each of the above mechanisms reports an improvement in endosomal drug release, the use of different therapeutic cargos, unrelated cell lines, and distinct therapeutic objectives has rendered a direct comparison of their efficacies impossible. Before considering any of these strategies for preclinical development, it will be important to compare their abilities to mediate each step of the delivery process directly in the same experimental system so that their relative strengths and weaknesses can be identified. Perhaps in this manner an optimal hybrid approach can eventually be designed that will efficiently deliver large quantities of therapeutic cargos into FR expressing cancer cells.</div></div><div id="sec2_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.6.2 Folate-Targeted Micelles</h4><div class="NLM_p">Over the past decade, polymeric micelles consisting of a hydrophilic shell and a hydrophobic core have become an attractive alternative delivery vehicle for hydrophobic molecules, including many anticancer drugs.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> While maintaining some similarities with liposomal delivery systems, polymeric micelles exhibit one distinct advantage over liposomes: their much smaller size. Typically less than 50 nm in diameter, polymeric micelles can both evade RES uptake and escape renal filtration while concurrently maintaining enhanced vascular permeability and improved tumor penetration. Not surprisingly, nontargeted micelles have been utilized extensively to deliver doxorubicin and paclitaxel to solid tumors through passive targeting,<a onclick="showRef(event, 'ref125 ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref125 ref126 ref127">(125-127)</a> but only recently have researchers explored the use of folate to improve the specificities of these formulations for tumor cells.</div><div class="NLM_p">Lee et al.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> prepared a novel pH-sensitive polymeric mixed micelle (PHSM) consisting of PEG<sub>2000</sub>-poly-<span class="smallcaps smallerCapital">l</span>-histidine (MW = 5K) and PEG<sub>2000</sub>-poly-<span class="smallcaps smallerCapital">l</span>-lactic acid (PLLA, MW = 3K) block copolymers with or without folate conjugation. When loaded with doxorubicin, the PHSMâfolate micelles showed >90% cytotoxicity to doxorubicin-resistant MCF-7 cells at 10 Î¼g/mL doxorubicin.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> In mice bearing subcutaneous doxorubicin-resistant MCF-7/doxorubicin xenografts, the accumulated doxorubicin level of PHSMâfolate in the solid tumors was 20 times higher than that of free doxorubicin and 3 times higher than nontargeted PHSM. Accordingly, the tumor volumes of mice treated with targeted PHSMâfolate were found to be significantly smaller than the volumes of either control group. On the basis of other observations, it was also suggested that FR-mediated internalization of the formulation by the tumor cell followed by polyhistidine-induced micelle destabilization and drug release endowed the drug carrier with the ability to bypass multidrug efflux pumps. Although biodistribution studies indicated that some PHSMâfolate also accumulated in the liver and spleen, the results nevertheless suggests that the PHSMâfolate formulation warrants further exploration as a possible means for treating drug-resistant FR<sup>+</sup> tumors.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><div class="NLM_p last">While the above studies augur well for the future of folate-targeted micelles, a number of studies suggest that in vivo stability problems must be addressed if the formulations are to eventually reach the clinic. FRET imaging studies of dual-labeled micelles comprising a block copolymer derivatized with a fluorescence donor and an entrapped fluorescent drug mimetic revealed a 50% decrease in FRET efficiency within 15 min of intravenous injection, implying that the micelleâs cargo is released quickly into the blood.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> A similar FRET study has similarly shown that another diblock copolymer micelle releases its hydrophobic cargo rapidly upon contact with the plasma membrane of KB cells, significantly reducing the amount of cargo that is eventually delivered inside the tumor cell.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> These studies raise the question of whether current micelle formulations can retain their cargos long enough for in vivo tumor delivery, and they suggest that future improvements to in vivo stability may be required to render such micellar drug carriers promising agents for targeted cancer therapies.</div></div><div id="sec2_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">2.6.3 Folate-Targeted Dendrimers</h4><div class="NLM_p">Dendrimers are synthetic, often biocompatible, nonimmunogenic, nanoscaled polymers that can be manufactured to specific sizes and reproducible surface characteristics. Because their surfaces can be densely functionalized, large amounts of diagnostic and/or therapeutic agents can be attached to these dendrimers, rendering them highly compact drug delivery vehicles.</div><div class="NLM_p">The first folate-targeted dendrimers described in the literature consisted of an ammonium-core polyamidoamine-core modified with folate as a targeting molecule and FITC as a fluorescent reporter. This targeted dendrimeric construct was then capped with succinic anhydride to render the remaining surface groups negatively charged to avoid nonspecific cell adsorption.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> When introduced to FR<sup>+</sup> erythroleukemia cells, the folateâdendrimer particle demonstrated biphasic uptake: rapid uptake within the first minutes (attributed to the dendrimerâs initial binding to empty cell surface FR), followed by slower internalization attributed to endocytosis and recycling of FR back to the cell surface. Redesign of this folateâdendrimer construct to deliver an MRI contrast agent (gadolinium) provided good MRI contrast both in vitro and in vivo in FR<sup>+</sup> tumor xenografts.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Quintana et al.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> then improved the folateâdendrimer design by capping the dendrimer surface amines with hydroxyl and acetamide groups, which enhanced projection of the targeting ligand away from the nanoparticle surface, permitting greater access to cell surface FR. These dendrimers demonstrated increased capture by KB cells and better drug delivery into the same cell type.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Importantly, neutralization of the dendrimerâs amine surface charge was found to be essential to prevent toxicity and nonspecific uptake of the drug conjugate.</div><div class="NLM_p last">Building on the above improvements, Kukowska-Latallo and co-workers<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> next evaluated the ability of folate-targeted, acetylated dendrimers to deliver anticancer therapeutics and imaging agents to human KB tumor xenografts in immune compromised mice.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> In contrast to the corresponding nontargeted polymer, folate-conjugated nanoparticles accumulated in the tumor and liver tissue over 4 days following intravenous administration. Additionally, folate-targeting was found to both increase methotrexateâs antitumor activity and reduce its off-site toxicity. As proof of tumor targeting, tumor uptake of the dendrimer was shown to be attenuated by prior intravenous injection of free folic acid.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> A later comparison of the release kinetics of a covalently conjugated methotrexate and a noncovalently complexed form of the same drug suggested that the former might be better suited for targeted drug delivery.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Despite their many positive properties (including improved in vivo stability over most polymeric micelles), these particles suffered the same shortcoming as previous nontargeted dendrimers, showing significant accumulation in the liver, spleen, and heart 4â7 days postinjection.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Perhaps some type of stealth coating can eventually be designed to reduce off-target uptake while retaining the desirable size and stability characteristics of these important nanomedicines.</div></div><div id="sec2_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.6.4 Other FolateâNanoparticle Drug Delivery Systems</h4><div class="NLM_p last">Folate has also been conjugated to a host of other nanoparticle platforms, including superparamagnetic nanoparticles,<a onclick="showRef(event, 'ref136 ref137'); return false;" href="javascript:void(0);" class="ref ref136 ref137">(136, 137)</a> gold nanoparticles,<a onclick="showRef(event, 'ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref138 ref139">(138, 139)</a> magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> carbon nanotubes,<a onclick="showRef(event, 'ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref141 ref142">(141, 142)</a> lipoprotein-based nanoplatforms,<a onclick="showRef(event, 'ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref143 ref144">(143, 144)</a> thermoresponsive microgels,<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> bovine serum albumin nanoparticles,<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> and virus capsid proteins.<a onclick="showRef(event, 'ref147 ref148'); return false;" href="javascript:void(0);" class="ref ref147 ref148">(147, 148)</a> Because little data are available on the in vivo properties of these nanomedicines,<a onclick="showRef(event, 'ref142 ref144 ref149'); return false;" href="javascript:void(0);" class="ref ref142 ref144 ref149">(142, 144, 149)</a> their potentials as novel drug carriers cannot be assessed at this juncture. However, in general, the design and application of such folate-targeted nanoparticles are similar to the folate-targeted nanomedicines described above in that the primary objective focuses on improved delivery of larger payloads and more hydrophobic drugs. Unfortunately, much like their better characterized counterparts, these particles may similarly suffer from compromised penetration into solid tumors and nonspecific uptake by macrophages in the liver, spleen, and other organs of the reticuloendothelial system. Use of PEGylation (or a related coating) to suppress macrophage recognition could conceivably reduce nonspecific uptake, but improvement of penetration into solid tumors will require creative strategies to digest or weaken the dense extracellular matrix that cements solid tumors together.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Further, because many nanoparticles carry their active components on their surfaces, an optimal ratio of PEG/PEGâfolate/drug must still be determined to ensure adequate water solubility, good folate presentation, and maximal RES evasion. And in cases where the drug molecules are enclosed within the nanoparticle, they must still be released following target cell entry but not during transit to the tumor mass. Clearly, while tumor targeted nanoparticles offer attractive solutions to many problems plaguing small molecule delivery, they simultaneously introduce new obstacles of their own that will require solutions before their full potentials can be realized.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">3 Conclusion and Future Directions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The use of folate-conjugated drugs and drug-laden nanoformulations to treat solid tumors is poised to affect the management of many malignant diseases. While monovalent folateâdrug conjugates will likely see clinical application in the very near future, similar targeting strategies may not prove successful for delivery of many biologic therapies, including peptides, siRNA, oligodeoxyribonucleotides, gene therapy vectors, and proteins. For efficient tumor targeting of these macromolecular medicines, nanoparticulate formulations may be required. However, for nanoformulations to reach their full potential, they may have to overcome problems associated with (1) poor tumor penetration, (2) unwanted accumulation in nontargeted tissues, and (3) inefficient release from endosomes. With improvements in these latter areas, use of folate to increase the selectivity and potency of nanoparticulate therapeutics can also rapidly become a reality.</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip S. Low</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ccbca0a3bb8cbcb9bea8b9a9e2a9a8b9"><span class="__cf_email__" data-cfemail="c7b7aba8b087b7b2b5a3b2a2e9a2a3b2">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Xia</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100509v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wei Xia</b> received her B.S. degree in Pharmacy from Fudan University, Shanghai, China. Her graduate studies were under the direction of Dr. Philip S. Low at Purdue University, IN, where she received her Ph.D. in Chemistry. Her research interests include the activities and targeting of activated immune cells in inflammatory diseases.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Philip S. Low</b> is the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University, IN, and Founder and Chief Science Officer of Endocyte Inc. Dr. Low has published over 300 refereed articles and has received both of Purdue Universityâs awards for outstanding research, an NIH Merit Award, and several national and international research awards. He currently serves on six editorial boards and several external advisory boards for major institutions. His research into receptor-targeted therapeutic and imaging agents has led to >35 U.S. patents/patents pending, and development of these patents has yielded six targeted drugs that are currently undergoing human clinical trials for various cancers. One additional targeted drug from his research is in late preclinical development for treatment of inflammatory and autoimmune diseases.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a grant from Endocyte Inc. <i>Conflict of Interest Statement</i>: Philip S. Low is the Founder and Chief Science Officer of Endocyte Inc., a biotechnology company dedicated to the clinical development of several of the described folate conjugates.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 150 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Pytel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwinski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poplawski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferriola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majsterek, I.</span><span> </span><span class="NLM_article-title">Tyrosine kinase blockers: new hope for successful cancer therapy</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">â</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=66-76&author=D.+Pytelauthor=T.+Sliwinskiauthor=T.+Poplawskiauthor=D.+Ferriolaauthor=I.+Majsterek&title=Tyrosine+kinase+blockers%3A+new+hope+for+successful+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPytel%26aufirst%3DD.%26aulast%3DSliwinski%26aufirst%3DT.%26aulast%3DPoplawski%26aufirst%3DT.%26aulast%3DFerriola%26aufirst%3DD.%26aulast%3DMajsterek%26aufirst%3DI.%26atitle%3DTyrosine%2520kinase%2520blockers%253A%2520new%2520hope%2520for%2520successful%2520cancer%2520therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D66%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span> </span><span class="NLM_article-title">Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">â</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fnm0596-561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=8616716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=561-566&author=B.+J.+Drukerauthor=S.+Tamuraauthor=E.+Buchdungerauthor=S.+Ohnoauthor=G.+M.+Segalauthor=S.+Fanningauthor=J.+Zimmermannauthor=N.+B.+Lydon&title=Effects+of+a+selective+inhibitor+of+the+Abl+tyrosine+kinase+on+the+growth+of+Bcr-Abl+positive+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells</span></div><div class="casAuthors">Druker, Brian J.; Tamura, Shu; Buchdunger, Elisabeth; Ohno, Sayuri; Segal, Gerald M.; Fanning, Shane; Zimmermann, Jurg; Lydon, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">The Bcr-Abl oncogene, present in 95% of patients with chronic myelogenous leukemia (CML), has been implicated as the cause of this disease.  A compd., designed to inhibit the Abl protein tyrosine kinase (CGP 57148), was evaluated for its effects on cells contg. the Bcr-Abl fusion protein.  Cellular proliferation and tumor formation by Bcr-Abl-expressing cells were specifically inhibited by this compd.  In colony-forming assays of peripheral blood or bone marrow from patients with CML, there was a 92-98% decrease in the no. of Bcr-Abl colonies formed but no inhibition of normal colony formation.  This compd. may be useful in the treatment of Bcr-Abl-pos. leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjzXj-25AHOrVg90H21EOLACvtfcHk0li0xS7j837CnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D&md5=1dc111cc883a1ed29964ae2c88c88cb9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnm0596-561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0596-561%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DSegal%26aufirst%3DG.%2BM.%26aulast%3DFanning%26aufirst%3DS.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26atitle%3DEffects%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Abl%2520tyrosine%2520kinase%2520on%2520the%2520growth%2520of%2520Bcr-Abl%2520positive%2520cells%26jtitle%3DNat.%2520Med.%26date%3D1996%26volume%3D2%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Heath, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicknell, R.</span><span> </span><span class="NLM_article-title">Anticancer strategies involving the vasculature</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">â</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fnrclinonc.2009.52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19424102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslKks78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=395-404&author=V.+L.+Heathauthor=R.+Bicknell&title=Anticancer+strategies+involving+the+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer strategies involving the vasculature</span></div><div class="casAuthors">Heath, Victoria L.; Bicknell, Roy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">395-404</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Understanding the process of tumor angiogenesis and ways to modify this is a key point in the fight against cancer.  This Review explores the current status of vascular-disrupting strategies, discusses how anti-VEGF-based anti-angiogenic therapies can be combined with conventional chemotherapy and radiotherapy, and highlights potential future targets for therapeutic intervention.  The growth and metastasis of solid tumors critically depends on their ability to develop their own blood supply, a process known as tumor angiogenesis.  Over the past decade much work has been performed to understand this process, and modifying this process provides a key point of therapeutic intervention in the fight against cancer.  This Review explores the development of anti-VEGF-based antiangiogenic therapies, of which there are currently three licensed for clin. use worldwide.  Although originally anticipated to inhibit the growth of tumor vessels, the induction of vascular normalization caused by these approved agents has provided a novel means of effective delivery of known chemotherapeutic agents.  The development of small mols. that target VEGF receptors has resulted in the generation of inhibitors with not only vascular activity but antitumor activity in certain cancers.  This Review will address the current status of vascular-disrupting strategies, such as therapies designed to induce tumor collapse by selectively destroying existing tumor vessels.  These therapies can be broadly divided into small-mol.-wt. vascular-disrupting agents and ligand-directed approaches.  We discuss the current status of development, drug mechanisms of actions, combination with conventional chemotherapy and radiotherapy, and potential future targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplD5MIHIdPorVg90H21EOLACvtfcHk0li0xS7j837CnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslKks78%253D&md5=6fb8683aa2e4261029e30f79a854e063</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2009.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2009.52%26sid%3Dliteratum%253Aachs%26aulast%3DHeath%26aufirst%3DV.%2BL.%26aulast%3DBicknell%26aufirst%3DR.%26atitle%3DAnticancer%2520strategies%2520involving%2520the%2520vasculature%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D6%26spage%3D395%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Finn, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A. X.</span><span> </span><span class="NLM_article-title">Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">â</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1586%2Fera.09.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19374603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKlsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=503-509&author=R.+S.+Finnauthor=A.+X.+Zhu&title=Targeting+angiogenesis+in+hepatocellular+carcinoma%3A+focus+on+VEGF+and+bevacizumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab</span></div><div class="casAuthors">Finn, Richard S.; Zhu, Andrew X.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">503-509</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and one of the few malignancies with an increasing incidence in the USA.  While the relationship between HCC and its inciting risk factors (e.g., hepatitis B, hepatitis C and alc. liver disease) is well defined, driving genetic alterations are still yet to be identified.  Clin., HCC tends to be hypervascular and, for that reason, transarterial chemoembolization has proven to be effective in managing many patients with localized disease.  More recently, angiogenesis has been targeted effectively with pharmacol. strategies, including monoclonal antibodies against VEGF and the VEGF receptor, as well as small-mol. kinase inhibitors of the VEGF receptor.  Targeting angiogenesis with these approaches has been validated in several different solid tumors since the initial approval of bevacizumab for advanced colon cancer in 2004.  In HCC, only sorafenib has been shown to extend survival in patients with advanced HCC and has opened the door for other anti-angiogenic strategies.  Here, we will review the data supporting the targeting of the VEGF axis in HCC and the preclin. and early clin. development of bevacizumab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI-lj8p3lprbVg90H21EOLACvtfcHk0li0xS7j837CnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKlsbc%253D&md5=e3fda6ba36821afd5104a1af84e8c051</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1586%2Fera.09.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.09.6%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DR.%2BS.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26atitle%3DTargeting%2520angiogenesis%2520in%2520hepatocellular%2520carcinoma%253A%2520focus%2520on%2520VEGF%2520and%2520bevacizumab%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D503%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lambert, J. M.</span><span> </span><span class="NLM_article-title">Drug-conjugated monoclonal antibodies for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">â</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.coph.2005.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16087399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvV2ltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=543-549&author=J.+M.+Lambert&title=Drug-conjugated+monoclonal+antibodies+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-conjugated monoclonal antibodies for the treatment of cancer</span></div><div class="casAuthors">Lambert, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">543-549</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Early clin. development in the field of targeted delivery of cytotoxic drugs to tumors was not successful because the limitations imposed by the pharmacokinetic and pharmacodynamic properties of monoclonal antibodies were not fully appreciated.  Recently, development of this concept has been reinvigorated by the approval of gemtuzumab ozogamicin for treatment of acute myeloid leukemia.  Other conjugates of calicheamicin and conjugates of potent tubulin poisons (maytansinoids, auristatins, and taxoids) are undergoing clin. evaluation or are in preclin. development.  What all of these drugs have in common is that their cytotoxic potencies are in the picomolar range.  Thirty years after the discovery of monoclonal antibodies, this new generation of highly potent compds. could yield targeted cytotoxic agents that are effective treatments for many cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqeCYpT56HHrVg90H21EOLACvtfcHk0lgsSAQ1vCn5jQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvV2ltLg%253D&md5=8e6b043acd6934ef5804f69e112d0277</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26atitle%3DDrug-conjugated%2520monoclonal%2520antibodies%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D543%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rao, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K.</span><span> </span><span class="NLM_article-title">Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults</span> <span class="citation_source-journal">Am. J. Geriatr. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.amjopharm.2007.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17996665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=247-262&author=A.+V.+Raoauthor=K.+Schmader&title=Monoclonal+antibodies+as+targeted+therapy+in+hematologic+malignancies+in+older+adults"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults</span></div><div class="casAuthors">Rao, Arati V.; Schmader, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-262</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1543-5946</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Biol. agents are proving to be increasingly useful and exciting addns. to the antineoplastic armamentarium, but many clinicians are unfamiliar with the properties of these types of agents.  Objectives: This review focuses on monoclonal antibodies (MAbs) that are used in the treatment of hematol. malignancies.  Our goal was to provide the reader with information on trials that led to US Food and Drug Administration (FDA) approval of commonly used MAbs in hematol. malignancies, including their mechanisms of action and pharmacokinetics, with specific emphasis on use in elderly patients; we also present data on toxicities and precautions to be aware of when administering these drugs.  Methods: Materials for this review were gathered based on a computerized literature search (English-language articles only) using the PubMed database covering the period Jan. 1998 to Dec. 2005.  Search terms used included the following: elderly, monoclonal antibodies, and neoplasms.  Results: Alemtuzumab is a recombinant DNA-derived, humanized MAb directed against the CD52 B-cell antigen.  It is indicated for the treatment of B-cell chronic lymphocytic leukemia (CLL) in patients who have been treated with alkylating agents and who have failed to respond to fludarabine therapy.  Gemtuzumab ozogamicin is an MAb conjugated with a cytotoxic antitumor antibiotic, calicheamicin.  It has been approved for use in patients with CD33-pos. acute myeloid leukemia (AML) in first relapse who are aged â¥60 years and who are not considered candidates for other cytotoxic chemotherapy.  Rituximab, one of the first MAbs approved by the FDA for use in human cancers, is an antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes.  It is extensively used in the treatment of B-cell malignancies, such as CLL, and non-Hodgkin's lymphomas (NHLs), such as follicular lymphoma and diffuse large B-cell lymphoma.  Conclusions: It is noteworthy that while there have been a no. of studies using these agents in the younger population, there continues to be a paucity of clin. trials targeting the elderly patient in particular; this continues to be an area of research interest.  More clin. studies of these agents-conducted specifically in elderly patients with CLL, NHL, AML, and other hematol. malignancies-are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_uDpFrh2o0rVg90H21EOLACvtfcHk0lgsSAQ1vCn5jQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtr7J&md5=9673e5a985f0b89458488cdf612e3a5e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2007.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2007.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DA.%2BV.%26aulast%3DSchmader%26aufirst%3DK.%26atitle%3DMonoclonal%2520antibodies%2520as%2520targeted%2520therapy%2520in%2520hematologic%2520malignancies%2520in%2520older%2520adults%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2007%26volume%3D5%26spage%3D247%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Modjtahedi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essapen, S.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">â</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=851-855&author=H.+Modjtahediauthor=S.+Essapen&title=Epidermal+growth+factor+receptor+inhibitors+in+cancer+treatment%3A+advances%2C+challenges+and+opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DModjtahedi%26aufirst%3DH.%26aulast%3DEssapen%26aufirst%3DS.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%2520in%2520cancer%2520treatment%253A%2520advances%252C%2520challenges%2520and%2520opportunities%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D851%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Garanger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boturyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumy, P.</span><span> </span><span class="NLM_article-title">Tumor targeting with RGD peptide ligandsâdesign of new molecular conjugates for imaging and therapy of cancers</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">â</span> <span class="NLM_lpage">558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=552-558&author=E.+Garangerauthor=D.+Boturynauthor=P.+Dumy&title=Tumor+targeting+with+RGD+peptide+ligands%E2%80%94design+of+new+molecular+conjugates+for+imaging+and+therapy+of+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaranger%26aufirst%3DE.%26aulast%3DBoturyn%26aufirst%3DD.%26aulast%3DDumy%26aufirst%3DP.%26atitle%3DTumor%2520targeting%2520with%2520RGD%2520peptide%2520ligands%25E2%2580%2594design%2520of%2520new%2520molecular%2520conjugates%2520for%2520imaging%2520and%2520therapy%2520of%2520cancers%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Irache, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamazo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espuelas, S.</span><span> </span><span class="NLM_article-title">Mannose-targeted systems for the delivery of therapeutics</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">â</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1517%2F17425247.5.6.703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18532925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslOrtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=703-724&author=J.+M.+Iracheauthor=H.+H.+Salmanauthor=C.+Gamazoauthor=S.+Espuelas&title=Mannose-targeted+systems+for+the+delivery+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mannose-targeted systems for the delivery of therapeutics</span></div><div class="casAuthors">Irache, Juan M.; Salman, Hesham H.; Gamazo, Carlos; Espuelas, Socorro</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">703-724</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The specific targeting of nanomedicines to mannose receptors, highly expressed in cells of the immune system, performs a useful strategy for improving the efficacy of vaccines and chemotherapy.  This review discusses the potential of mannose-targeted drug/antigen delivery systems for vaccination and treatment of diseases localized in macrophages and other antigen-presenting cells.  The first part of the review describes the characteristics, localization and functions of mannose receptors.  The following sections are devoted to the description of different methods used to deliver therapeutic agents, including mannose conjugates and mannosylated carriers or particulates (i.e., liposomes, nanoparticles and niosomes).  A general overview of published reports confirms the effectiveness of mannosylation strategies, although the optimization and full exploitation of mannose-targeted drug delivery systems would require a deeper understanding of the structure-activity relationship.  In the near future, these nanomedicines have the potential to treat a no. of diseases (including cancer) and improve the quality of life of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcTssJrIfvdLVg90H21EOLACvtfcHk0lgDPwJ7_WcL1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslOrtbs%253D&md5=cca8209381ae3b11d7e5eccb0a2fddc2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F17425247.5.6.703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.5.6.703%26sid%3Dliteratum%253Aachs%26aulast%3DIrache%26aufirst%3DJ.%2BM.%26aulast%3DSalman%26aufirst%3DH.%2BH.%26aulast%3DGamazo%26aufirst%3DC.%26aulast%3DEspuelas%26aufirst%3DS.%26atitle%3DMannose-targeted%2520systems%2520for%2520the%2520delivery%2520of%2520therapeutics%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2008%26volume%3D5%26spage%3D703%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gupta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S. K.</span><span> </span><span class="NLM_article-title">Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents</span> <span class="citation_source-journal">Crit. Rev. Ther. Drug Carrier Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1615%2FCritRevTherDrugCarrierSyst.v25.i4.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18540842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFegt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=347-379&author=Y.+Guptaauthor=D.+V.+Kohliauthor=S.+K.+Jain&title=Vitamin+B12-mediated+transport%3A+a+potential+tool+for+tumor+targeting+of+antineoplastic+drugs+and+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents</span></div><div class="casAuthors">Gupta, Yashwant; Kohli, Dharm Veer; Jain, Sanjay K.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Therapeutic Drug Carrier Systems</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-379</span>CODEN:
                <span class="NLM_cas:coden">CRTSEO</span>;
        ISSN:<span class="NLM_cas:issn">0743-4863</span>.
    
            (<span class="NLM_cas:orgname">Begell House, Inc.</span>)
        </div><div class="casAbstract">A review.  The uptake of vitamin B12 (cyanocobalamin, Cbl/VB12) in mammalian cells is mediated by specific, high-affinity receptors for the vitamin B12-binding protein, transcobalamin II, which is expressed on the plasma membrane.  The receptor for vitamin B12 is overexpressed on a no. of human tumors, including cancers of the ovary, kidney, uterus, testis, brain, colon, lung, and myelocytic blood cells.  Furthermore, the affinity of cyanocobalamin conjugates for cell surface transcobalamin II receptors seems to be high enough so that vitamin B12 derivatization with the cytotoxic agent or carriers bearing cytotoxic drugs allows the selective delivery of diagnostic and therapeutic agents to cancer cells.  Thus, conjugates of vitamin B12 enter receptor-expressing cancer cells via receptor-mediated endocytosis, and targeting may be accomplished by multiple mechanisms, depending on the drug-delivery strategy.  This review summarizes the applications of vitamin B12 as a targeting ligand and highlights the various methods being developed for delivery of therapeutic and imaging agents to cancer cells in vitro and in vivo.  This review reflects the potentiality of vitamin B12 for tumor targeting of chemotherapeutic and diagnostic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD608wqR5cVrVg90H21EOLACvtfcHk0lgDPwJ7_WcL1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFegt7g%253D&md5=2adb5e01cd3c0004229dd1dbf9bd7a2d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1615%2FCritRevTherDrugCarrierSyst.v25.i4.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevTherDrugCarrierSyst.v25.i4.20%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DY.%26aulast%3DKohli%26aufirst%3DD.%2BV.%26aulast%3DJain%26aufirst%3DS.%2BK.%26atitle%3DVitamin%2520B12-mediated%2520transport%253A%2520a%2520potential%2520tool%2520for%2520tumor%2520targeting%2520of%2520antineoplastic%2520drugs%2520and%2520imaging%2520agents%26jtitle%3DCrit.%2520Rev.%2520Ther.%2520Drug%2520Carrier%2520Syst.%26date%3D2008%26volume%3D25%26spage%3D347%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span> </span><span class="NLM_article-title">Folate-targeted therapeutic and imaging agents for cancer</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">â</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.cbpa.2009.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19419901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVWltbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=256-262&author=P.+S.+Lowauthor=S.+A.+Kularatne&title=Folate-targeted+therapeutic+and+imaging+agents+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted therapeutic and imaging agents for cancer</span></div><div class="casAuthors">Low, Philip Stewart; Kularatne, Sumith Anurasiri</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer therapies that exploit targeting ligands to deliver attached cytotoxic drugs selectively to malignant cells are currently receiving significant attention.  While antibody-targeted drugs have been the first to enter the clinic, recent studies demonstrate that the vitamin folic acid can also be used to deliver attached imaging and therapeutic agents selectively to malignant cells in both animal tumor models and human cancer patients.  Thus, folate conjugates bind to folate receptors that are overexpressed on â¼40% of human cancers and mediate internalization of their attached drugs by receptor-mediated endocytosis.  With the use of proper linkers, folate-targeted drugs can be released inside their target cells where they can perform their desired cytotoxic functions.  Based on this strategy, six folate-targeted drugs are currently in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp_l-sdKEElbVg90H21EOLACvtfcHk0lgDPwJ7_WcL1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVWltbY%253D&md5=c6b6b07b0df9d1355e99da7c471a2a4b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2009.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2009.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26atitle%3DFolate-targeted%2520therapeutic%2520and%2520imaging%2520agents%2520for%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D13%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Carpenter, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aina, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightstone, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurth, M. J.</span><span> </span><span class="NLM_article-title">Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">â</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800313f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=14-19&author=R.+D.+Carpenterauthor=M.+Andreiauthor=O.+H.+Ainaauthor=E.+Y.+Lauauthor=F.+C.+Lightstoneauthor=R.+Liuauthor=K.+S.+Lamauthor=M.+J.+Kurth&title=Selectively+targeting+T-+and+B-cell+lymphomas%3A+a+benzothiazole+antagonist+of+alpha4beta1+integrin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800313f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800313f%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DR.%2BD.%26aulast%3DAndrei%26aufirst%3DM.%26aulast%3DAina%26aufirst%3DO.%2BH.%26aulast%3DLau%26aufirst%3DE.%2BY.%26aulast%3DLightstone%26aufirst%3DF.%2BC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26atitle%3DSelectively%2520targeting%2520T-%2520and%2520B-cell%2520lymphomas%253A%2520a%2520benzothiazole%2520antagonist%2520of%2520alpha4beta1%2520integrin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D14%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhapuram, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">â</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp900069d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsF2hsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=780-789&author=S.+A.+Kularatneauthor=K.+Wangauthor=H.+K.+Santhapuramauthor=P.+S.+Low&title=Prostate-specific+membrane+antigen+targeted+imaging+and+therapy+of+prostate+cancer+using+a+PSMA+inhibitor+as+a+homing+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand</span></div><div class="casAuthors">Kularatne, Sumith A.; Wang, Kevin; Santhapuram, Hari-Krishna R.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate cancer (PCa) is a major cause of mortality and morbidity in Western society today.  Current methods for detecting PCa are limited, leaving most early malignancies undiagnosed and sites of metastasis in advanced disease undetected.  Major deficiencies also exist in the treatment of PCa, esp. metastatic disease.  In an effort to improve both detection and therapy of PCa, we have developed a PSMA-targeted ligand that delivers attached imaging and therapeutic agents selectively to PCa cells without targeting normal cells.  The PSMA-targeted radioimaging agent (DUPA-99mTc) was found to bind PSMA-pos. human PCa cells (LNCaP cell line) with nanomolar affinity (KD = 14 nM).  Imaging and biodistribution studies revealed that DUPA-99mTc localizes primarily to LNCaP cell tumor xenografts in nu/nu mice (% injected dose/g = 11.3 at 4 h postinjection; tumor-to-muscle ratio = 75:1).  Two PSMA-targeted optical imaging agents (DUPA-FITC and DUPA-rhodamine B) were also shown to efficiently label PCa cells and to internalize and traffic to intracellular endosomes.  A PSMA-targeted chemotherapeutic agent (DUPA-TubH) was demonstrated to kill PSMA-pos. LNCaP cells in culture (IC50 = 3 nM) and to eliminate established tumor xenografts in nu/nu mice with no detectable wt. loss.  Blockade of tumor targeting upon administration of excess PSMA inhibitor (PMPA) and the absence of targeting to PSMA-neg. tumors confirmed the specificity of each of the above targeted reagents for PSMA.  Tandem use of the imaging and therapeutic agents targeted to the same receptor could allow detection, staging, monitoring, and treatment of PCa with improved accuracy and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF7vaoehkEsrVg90H21EOLACvtfcHk0lgZNj5mUp2KIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsF2hsrw%253D&md5=2fba93274e7f4c4ff0910e2edef9e189</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fmp900069d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp900069d%26sid%3Dliteratum%253Aachs%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DSanthapuram%26aufirst%3DH.%2BK.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520targeted%2520imaging%2520and%2520therapy%2520of%2520prostate%2520cancer%2520using%2520a%2520PSMA%2520inhibitor%2520as%2520a%2520homing%2520ligand%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D780%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sega, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Tumor detection using folate receptor-targeted imaging agents</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs10555-008-9155-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18523731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCis7zF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=655-664&author=E.+I.+Segaauthor=P.+S.+Low&title=Tumor+detection+using+folate+receptor-targeted+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor detection using folate receptor-targeted imaging agents</span></div><div class="casAuthors">Sega, Emanuela I.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-664</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Folate receptors are up-regulated on a variety of human cancers, including cancers of the breast, ovaries, endometrium, lungs, kidneys, colon, brain, and myeloid cells of hematopoietic origin.  This over-expression of folate receptors (FR) on cancer tissues can be exploited to target folate-linked imaging and therapeutic agents specifically to FR-expressing tumors, thereby avoiding uptake by most healthy tissues that express few if any FR.  Four folate-targeted therapeutic drugs are currently undergoing clin. trials, and several folate-linked chemotherapeutic agents are in late stage preclin. development.  However, because not all cancers express FR, and because only FR-expressing cancers respond to FR-targeted therapies, FR-targeted imaging agents have been required to select patients with FR-expressing tumors likely to respond to folate-targeted therapies.  This review focuses on recent advances in the use of the vitamin folic acid to target PET agents, Î³-emitters, MRI contrast agents and fluorescent dyes to FR+ cancers for the purpose of diagnosing and imaging malignant masses with improved specificity and sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEDWzmWjsEhLVg90H21EOLACvtfcHk0lgZNj5mUp2KIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCis7zF&md5=d02bc9ceff50817dd01f51fbe66c1c9b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9155-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9155-6%26sid%3Dliteratum%253Aachs%26aulast%3DSega%26aufirst%3DE.%2BI.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DTumor%2520detection%2520using%2520folate%2520receptor-targeted%2520imaging%2520agents%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D655%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, N.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">â</span> <span class="NLM_lpage">1210</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0200430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlSms74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=1200-1210&author=C.+P.+Leamonauthor=M.+A.+Parkerauthor=I.+R.+Vlahovauthor=L.+C.+Xuauthor=J.+A.+Reddyauthor=M.+Vetzelauthor=N.+Douglas&title=Synthesis+and+biological+evaluation+of+EC20%3A+a+new+folate-derived%2C+%2899m%29Tc-based+radiopharmaceutical"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical</span></div><div class="casAuthors">Leamon, Christopher P.; Parker, Matthew A.; Vlahov, Iontcho R.; Xu, Le-Cun; Reddy, Joseph A.; Vetzel, Marilynn; Douglas, Nikki</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1200-1210</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new peptide deriv. of folic acid was designed to efficiently coordinate 99mTc.  This new chelate, referred to as EC20, was found to bind cultured folate receptor (FR)-pos. tumor cells in both time- and concn.-dependent manner with very high affinity (KD â¼ 3 nM).  Using an in vitro relative affinity assay, EC20 was also found to effectively compete with 3H-folic acid for cell binding when presented either alone or as a formulated metal chelate.  Following i.v. injection into Balb/c mice, 99mTc-EC20 was rapidly removed from circulation (plasma t1/2 â¼ 4 min) and excreted into the urine in a nonmetabolized form.  Data from Î³ scintigraphic and quant. biodistribution studies performed in M109 tumor-bearing Balb/c mice confirmed that 99mTc-EC20 predominantly accumulates in FR-pos. tumor and kidney tissues.  These results suggest that 99mTc-EC20 may be clin. useful as a noninvasive radiodiagnostic imaging agent for the detection of FR-pos. human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx1u2XPLpJqbVg90H21EOLACvtfcHk0ljZAkNzqSxeNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlSms74%253D&md5=9d1913e45db0e5aab3783301976d95fe</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbc0200430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0200430%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DParker%26aufirst%3DM.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DDouglas%26aufirst%3DN.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520EC20%253A%2520a%2520new%2520folate-derived%252C%2520%252899m%2529Tc-based%2520radiopharmaceutical%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26spage%3D1200%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1175</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1175&publication_year=2009&pages=32-39&author=M.+Thomasauthor=S.+A.+Kularatneauthor=L.+Qiauthor=P.+Kleindlauthor=C.+P.+Leamonauthor=M.+J.+Hansenauthor=P.+S.+Low&title=Ligand-targeted+delivery+of+small+interfering+RNAs+to+malignant+cells+and+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DKleindl%26aufirst%3DP.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DHansen%26aufirst%3DM.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DLigand-targeted%2520delivery%2520of%2520small%2520interfering%2520RNAs%2520to%2520malignant%2520cells%2520and%2520tissues%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2009%26volume%3D1175%26spage%3D32%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doorneweerd, D. D.</span><span> </span><span class="NLM_article-title">Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">â</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar7000815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=120-129&author=P.+S.+Lowauthor=W.+A.+Henneauthor=D.+D.+Doorneweerd&title=Discovery+and+development+of+folic-acid-based+receptor+targeting+for+imaging+and+therapy+of+cancer+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases</span></div><div class="casAuthors">Low, Philip S.; Henne, Walter A.; Doorneweerd, Derek D.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-129</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of folic-acid-targeted drug delivery has grown rapidly over the past decade, with several applications currently in human clin. trials.  Owing to the small size of the vitamin, its high affinity for the folate receptor (Kd = 10-10 M), the limited distribution of its receptor in normal tissues (primarily in kidney proximal tubules), the overexpression of its receptor in pathol. cells (upregulated in cancer cells and activated macrophages/monocytes), and its ease of conjugation to imaging and therapeutic agents, the use of folate as a targeting ligand for selective delivery of attached mols. to tumor tissues and sites of inflammation has attracted considerable interest.  This account reviews the discovery of folic acid as a targeting ligand and its current use in the selective targeting of drugs to malignant masses and sites of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM5t9sRmCOBbVg90H21EOLACvtfcHk0ljZAkNzqSxeNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D&md5=20620eb124d19634b10c27a48ed46849</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Far7000815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far7000815%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHenne%26aufirst%3DW.%2BA.%26aulast%3DDoorneweerd%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520folic-acid-based%2520receptor%2520targeting%2520for%2520imaging%2520and%2520therapy%2520of%2520cancer%2520and%2520inflammatory%2520diseases%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D120%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tranoy-Opalinski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papot, S.</span><span> </span><span class="NLM_article-title">Design of self-immolative linkers for tumour-activated prodrug therapy</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">â</span> <span class="NLM_lpage">637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=618-637&author=I.+Tranoy-Opalinskiauthor=A.+Fernandesauthor=M.+Thomasauthor=J.+P.+Gessonauthor=S.+Papot&title=Design+of+self-immolative+linkers+for+tumour-activated+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTranoy-Opalinski%26aufirst%3DI.%26aulast%3DFernandes%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DPapot%26aufirst%3DS.%26atitle%3DDesign%2520of%2520self-immolative%2520linkers%2520for%2520tumour-activated%2520prodrug%2520therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D618%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ojima, I.</span><span> </span><span class="NLM_article-title">Guided molecular missiles for tumor-targeting chemotherapyâcase studies using the second-generation taxoids as warheads</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">â</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700093f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=108-119&author=I.+Ojima&title=Guided+molecular+missiles+for+tumor-targeting+chemotherapy%E2%80%94case+studies+using+the+second-generation+taxoids+as+warheads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Far700093f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700093f%26sid%3Dliteratum%253Aachs%26aulast%3DOjima%26aufirst%3DI.%26atitle%3DGuided%2520molecular%2520missiles%2520for%2520tumor-targeting%2520chemotherapy%25E2%2580%2594case%2520studies%2520using%2520the%2520second-generation%2520taxoids%2520as%2520warheads%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D108%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Matherly, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span> </span><span class="NLM_article-title">Human reduced folate carrier: translation of basic biology to cancer etiology and therapy</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">â</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs10555-007-9046-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17334909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=111-128&author=L.+H.+Matherlyauthor=Z.+Houauthor=Y.+Deng&title=Human+reduced+folate+carrier%3A+translation+of+basic+biology+to+cancer+etiology+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human reduced folate carrier: Translation of basic biology to cancer etiology and therapy</span></div><div class="casAuthors">Matherly, Larry H.; Hou, Zhanjun; Deng, Yijun</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-128</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This review attempts to provide a comprehensive overview of the biol. of the physiol. and pharmacol. important transport system termed the "reduced folate carrier" (RFC).  The ubiquitously expressed RFC has unequivocally established itself as the major transport system in mammalian cells and tissues for a group of compds. including folate cofactors and classical antifolate therapeutics.  Loss of RFC expression or function may have potentially profound pathophysiol. consequences including cancer.  For chemotherapeutic antifolates used for cancer such as methotrexate or pemetrexed, synthesis of mutant RFCs or loss of RFC transcripts and proteins results in antifolate resistance due to incomplete inhibition of cellular enzyme targets and insufficient substrate for polyglutamate synthesis.  Since RFC was first cloned in 1994, tremendous advances have been made in understanding the complex transcriptional and posttranscriptional regulation of RFC, in identifying structurally and functionally important domains and amino acids in the RFC mol. as a prelude to establishing the mechanism of transport, and in characterizing the mol. defects in RFC assocd. with loss of transport in antifolate resistant cell line models. Many of the insights gained from lab. models of RFC portend opportunities for modulating carrier expression in drug resistant tumors, and for designing a new generation of agents with improved transport by RFC or substantially enhanced transport by other folate transporters over RFC.  Many of the advances in the basic biol. of RFC in cell line models are now being directly applied to human cancers in the clin. setting, most notably pediatric acute lymphoblastic leukemia and osteogenic sarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYdmMaSLKVPrVg90H21EOLACvtfcHk0lgQAai1Mty8nA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqtb4%253D&md5=ea3e6431ea2321cc851f61a65120c49e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9046-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9046-2%26sid%3Dliteratum%253Aachs%26aulast%3DMatherly%26aufirst%3DL.%2BH.%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DHuman%2520reduced%2520folate%2520carrier%253A%2520translation%2520of%2520basic%2520biology%2520to%2520cancer%2520etiology%2520and%2520therapy%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26spage%3D111%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, I. D.</span><span> </span><span class="NLM_article-title">A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">4267</span><span class="NLM_x">â</span> <span class="NLM_lpage">4274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=4267-4274&author=R.+Zhaoauthor=S.+H.+Minauthor=Y.+Wangauthor=E.+Campanellaauthor=P.+S.+Lowauthor=I.+D.+Goldman&title=A+role+for+the+proton-coupled+folate+transporter+%28PCFT-SLC46A1%29+in+folate+receptor-mediated+endocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DMin%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCampanella%26aufirst%3DE.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DGoldman%26aufirst%3DI.%2BD.%26atitle%3DA%2520role%2520for%2520the%2520proton-coupled%2520folate%2520transporter%2520%2528PCFT-SLC46A1%2529%2520in%2520folate%2520receptor-mediated%2520endocytosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D4267%26epage%3D4274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">â</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ab.2004.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15745749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVaqur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=284-293&author=N.+Parkerauthor=M.+J.+Turkauthor=E.+Westrickauthor=J.+D.+Lewisauthor=P.+S.+Lowauthor=C.+P.+Leamon&title=Folate+receptor+expression+in+carcinomas+and+normal+tissues+determined+by+a+quantitative+radioligand+binding+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay</span></div><div class="casAuthors">Parker, Nikki; Turk, Mary Jo; Westrick, Elaine; Lewis, Jeffrey D.; Low, Philip S.; Leamon, Christopher P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The folate receptor (FR) is a valuable therapeutic target that is highly expressed on a variety of cancers.  The current development of folate-targeted cancer therapies has created the need for quantitating functional FRs in clin. specimens.  In this article, we report on the creation of a highly sensitive radioactive binding method for quant. measuring FR expression in frozen tissue homogenates.  Expression was pos. in approx. 89% of human ovarian carcinomas but was negligible in both mucinous ovarian carcinomas and normal ovary.  Expression was also significant in carcinomas of the kidney, endometrium, lung, breast, bladder, and pancreas.  Normal tissues from humans and six different lab. species were also analyzed; surprisingly, some interspecies variability in FR expression (esp. in kidney, spleen, and lung tissue) was found.  Interestingly, normal human lung tissue displayed high expression levels, whereas expression in normal lung of the other species was negligible.  However, considering that folate-drug conjugates fail to accumulate in the lungs of patients, the consequence of this finding was not considered to be of clin. concern.  Overall, this new methodol. is reliable for detg. functional FR expression levels in tissues, and it could possibly be a useful clin. test to det. patient candidacy for FR-targeted therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwtgdifJwHuLVg90H21EOLACvtfcHk0lgQAai1Mty8nA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVaqur0%253D&md5=cec9651fddccd602d715a27ab93f288c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DN.%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DLewis%26aufirst%3DJ.%2BD.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DFolate%2520receptor%2520expression%2520in%2520carcinomas%2520and%2520normal%2520tissues%2520determined%2520by%2520a%2520quantitative%2520radioligand%2520binding%2520assay%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D338%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ross, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span> </span><span class="NLM_article-title">Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">â</span> <span class="NLM_lpage">2443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F1097-0142%2819940501%2973%3A9%3C2432%3A%3AAID-CNCR2820730929%3E3.0.CO%3B2-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=7513252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXksl2rsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1994&pages=2432-2443&author=J.+F.+Rossauthor=P.+K.+Chaudhuriauthor=M.+Ratnam&title=Differential+regulation+of+folate+receptor+isoforms+in+normal+and+malignant+tissues+in+vivo+and+in+established+cell+lines.+Physiologic+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications</span></div><div class="casAuthors">Ross, John F.; Chaudhuri, Prabir K.; Ratnam, Manohar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2432-43</span>CODEN:
                <span class="NLM_cas:coden">CANCAR</span>;
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    </div><div class="casAbstract">Despite significant differences in ligand binding between the two known isoforms of the human membrane folate receptor (FR), designated herein as FR-Î² (placenta) and FR-Î± (placenta, KB cells), little is known about their tissue specificities, and there is no report on the relative expression of FR-Î² in any tissue other than in placenta.  The mRNA for each FR isoform in a wide variety of normal fetal and adult tissue explants, primary normal cell cultures, malignant tumor explants, and established tumor cell lines was estd. by a polymerase chain reaction assay.  Total receptor levels were estd. by a [3H]folic acid binding assay.  Both FR isoforms were expressed in fetal as well as adult tissues.  Normal tissues generally expressed low to moderate amts. of FR-Î².  FR-Î± alone was expressed in normal epithelial cells and was frequently strikingly elevated in a variety of carcinomas, with the exception of squamous cell carcinomas of the head and neck.  In contrast, a variety of malignant tissues of nonepithelial origin generally expressed elevated levels of FR-Î² alone.  Established tumor cell lines expressed FR-Î± virtually alone and did not reflect FR expression patterns in vivo.  KB cells and JEG-3 cells grown at low folate concns. further up-regulated FR-Î± but not FR-Î².  Although FR-Î² is the more common isoform, FR-Î± and FR-Î² are differentially regulated in normal tissues, carcinomas, nonepithelial malignancies, and immortalized cells or in response to changes in extracellular folate concns.  The tissue specificity of FR isoforms and their elevation in malignant tissues may be a significant factor in FR-mediated folate uptake, in tissue responsiveness to promising novel antifolates, and in FR-related immunodiagnosis/immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xK8VoFPp_bVg90H21EOLACvtfcHk0lgQAai1Mty8nA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksl2rsrw%253D&md5=8086228b96186da1001161a048172a8e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%2819940501%2973%3A9%3C2432%3A%3AAID-CNCR2820730929%3E3.0.CO%3B2-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%252819940501%252973%253A9%253C2432%253A%253AAID-CNCR2820730929%253E3.0.CO%253B2-S%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%2BF.%26aulast%3DChaudhuri%26aufirst%3DP.%2BK.%26aulast%3DRatnam%26aufirst%3DM.%26atitle%3DDifferential%2520regulation%2520of%2520folate%2520receptor%2520isoforms%2520in%2520normal%2520and%2520malignant%2520tissues%2520in%2520vivo%2520and%2520in%2520established%2520cell%2520lines.%2520Physiologic%2520and%2520clinical%2520implications%26jtitle%3DCancer%26date%3D1994%26volume%3D73%26spage%3D2432%26epage%3D2443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kalli, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberg, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeney, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, L. C.</span><span> </span><span class="NLM_article-title">Folate receptor alpha as a tumor target in epithelial ovarian cancer</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">â</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ygyno.2007.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18222534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlCjtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=619-626&author=K.+R.+Kalliauthor=A.+L.+Obergauthor=G.+L.+Keeneyauthor=T.+J.+Christiansonauthor=P.+S.+Lowauthor=K.+L.+Knutsonauthor=L.+C.+Hartmann&title=Folate+receptor+alpha+as+a+tumor+target+in+epithelial+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor alpha as a tumor target in epithelial ovarian cancer</span></div><div class="casAuthors">Kalli, Kimberly R.; Oberg, Ann L.; Keeney, Gary L.; Christianson, Teresa J. H.; Low, Philip S.; Knutson, Keith L.; Hartmann, Lynn C.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-626</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Folate receptor Î± (FRÎ±) is a folate-binding protein overexpressed on ovarian and several other epithelial malignancies that can be used as a target for imaging and therapeutic strategies.  The goal of this study is to improve historical data that lack specific information about FRÎ± expression in rare histol. subtypes, primary disease vs. metastatic foci, and recurrent disease.  FRÎ± expression was analyzed by immunohistochem. on 186 primary and 27 recurrent ovarian tumors, including 24 pairs of samples obtained from the same individuals at diagnosis and at secondary debulking surgery.  For 20 of the 186 primaries, simultaneous metastatic foci were also analyzed.  FRÎ± staining was analyzed in light of disease morphol., stage, grade, debulking status, and time from diagnosis to recurrence and death.  FRÎ± expression was apparent in 134 of 186 (72%) primary and 22 of 27 (81.5%) recurrent ovarian tumors.  In 21 of 24 (87.5%) matched specimens, recurrent tumors reflected the FRÎ± status detected at diagnosis.  Metastatic foci were similar to primary tumors in FRÎ± staining.  FRÎ± status was not assocd. with time to recurrence or overall survival in either univariate or multivariable analyses.  FRÎ± expression occurs frequently, esp. in the common high-grade, high-stage serous tumors that are most likely to recur.  New findings from this study show that FRÎ± expression is maintained on metastatic foci and recurrent tumors, suggesting that novel folate-targeted therapies may hold promise for the majority of women with either newly diagnosed or recurrent ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1KsDibBMVfLVg90H21EOLACvtfcHk0ljTCwWdXSGYYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlCjtrc%253D&md5=565d54ee9ebd0461d1d1b6ff5e71923c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2007.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2007.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DKalli%26aufirst%3DK.%2BR.%26aulast%3DOberg%26aufirst%3DA.%2BL.%26aulast%3DKeeney%26aufirst%3DG.%2BL.%26aulast%3DChristianson%26aufirst%3DT.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DKnutson%26aufirst%3DK.%2BL.%26aulast%3DHartmann%26aufirst%3DL.%2BC.%26atitle%3DFolate%2520receptor%2520alpha%2520as%2520a%2520tumor%2520target%2520in%2520epithelial%2520ovarian%2520cancer%26jtitle%3DGynecol.%2520Oncol.%26date%3D2008%26volume%3D108%26spage%3D619%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nakashima-Matsushita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, T.</span><span> </span><span class="NLM_article-title">Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">â</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F1529-0131%28199908%2942%3A8%3C1609%3A%3AAID-ANR7%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=10446858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1MXlsFynsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1609-1616&author=N.+Nakashima-Matsushitaauthor=T.+Hommaauthor=S.+Yuauthor=T.+Matsudaauthor=N.+Sunaharaauthor=T.+Nakamuraauthor=M.+Tsukanoauthor=M.+Ratnamauthor=T.+Matsuyama&title=Selective+expression+of+folate+receptor+beta+and+its+possible+role+in+methotrexate+transport+in+synovial+macrophages+from+patients+with+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective expression of folate receptor Î² and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis</span></div><div class="casAuthors">Nakashima-Matsushita, Noriko; Homma, Toshio; Yu, Su; Matsuda, Takemasa; Sunahara, Nobuhiko; Nakamura, Tadashi; Tsukano, Michishi; Ratnam, Manohar; Matsuyama, Takami</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1609-1616</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To investigate the expression of folate receptors (FR) and reduced folate carrier (RFC) and det. their relevance to methotrexate (MTX) transport in synovial mononuclear cells (SMC) from patients with rheumatoid arthritis (RA).  Levels of FR and RFC mRNA (mRNA) were examd. by reverse transcriptase-polymerase chain reaction (RT-PCR) in SMC from RA patients and peripheral blood mononuclear cells from healthy donors.  Expression of FR-Î² mRNA and protein was detd. by Northern blot and Western blot analyses in RA SMC and monocyte/macrophage-lineage cells.  FR-Î² expression and folic acid binding capacity on the cell surface were examd. by flow cytometric anal. and 3H-folic acid binding anal.  Studies of the inhibition of 3H-MTX uptake in the presence of unlabeled folic acid were performed to investigate the uptake of MTX through FR in RA SMC.  RT-PCR, Northern blot, and Western blot analyses showed that FR-Î² mRNA and protein were expressed selectively in activated monocytes and CD14+ RA SMC.  These cells exhibited folic acid binding capacity.  Furthermore, the FR-Î² protein was shown to have folic acid binding capacity.  Uptake of 3H-MTX through RA SMC was significantly inhibited in the presence of unlabeled folic acid.  These results demonstrate that FR-Î² expression is selectively elevated in RA synovial macrophages and suggest that MTX is transported through FR-Î² in RA synovial macrophages.  The findings suggest that folate antagonists with higher affinity for FR-Î² would be useful in the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMaG5oH6VW7LVg90H21EOLACvtfcHk0ljTCwWdXSGYYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsFynsbc%253D&md5=b40475d6ea3199db2cfd4973b0e75a88</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28199908%2942%3A8%3C1609%3A%3AAID-ANR7%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528199908%252942%253A8%253C1609%253A%253AAID-ANR7%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima-Matsushita%26aufirst%3DN.%26aulast%3DHomma%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DSunahara%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DTsukano%26aufirst%3DM.%26aulast%3DRatnam%26aufirst%3DM.%26aulast%3DMatsuyama%26aufirst%3DT.%26atitle%3DSelective%2520expression%2520of%2520folate%2520receptor%2520beta%2520and%2520its%2520possible%2520role%2520in%2520methotrexate%2520transport%2520in%2520synovial%2520macrophages%2520from%2520patients%2520with%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1999%26volume%3D42%26spage%3D1609%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">van der Heijden, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oerlemans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkmans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Laken, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lems, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, G.</span><span> </span><span class="NLM_article-title">Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fart.24219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19116913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFequrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=12-21&author=J.+W.+van+der+Heijdenauthor=R.+Oerlemansauthor=B.+A.+Dijkmansauthor=H.+Qiauthor=C.+J.+van+der+Lakenauthor=W.+F.+Lemsauthor=A.+L.+Jackmanauthor=M.+C.+Kraanauthor=P.+P.+Takauthor=M.+Ratnamauthor=G.+Jansen&title=Folate+receptor+beta+as+a+potential+delivery+route+for+novel+folate+antagonists+to+macrophages+in+the+synovial+tissue+of+rheumatoid+arthritis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor Î² as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients</span></div><div class="casAuthors">van der Heijden, Joost W.; Oerlemans, Ruud; Dijkmans, Ben A. C.; Qi, Huiling; van der Laken, Conny J.; Lems, Willem F.; Jackman, Ann L.; Kraan, Maarten C.; Tak, Paul P.; Ratnam, Manohar; Jansen, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. the expression of folate receptor Î² (FRÎ²) in synovial biopsy tissues and peripheral blood lymphocytes from rheumatoid arthritis (RA) patients and to identify novel folate antagonists that are more selective in the targeting and internalization of FRÎ² than methotrexate (MTX).  Immunohistochem. and computer-assisted digital imaging analyses were used for the detection of FRÎ² protein expression on immunocompetent cells in synovial biopsy samples from RA patients with active disease and in noninflammatory control synovial tissues.  FRÎ² mRNA levels were detd. by reverse transcription-polymerase chain reaction anal.  Binding affinities of FRÎ² for folate antagonists were assessed by competition expts. for 3H-folic acid binding on FRÎ²-transfected cells.  Efficacy of FRÎ²-mediated internalization of folate antagonists was evaluated by assessment of antiproliferative effects against FRÎ²-transfected cells.  Immunohistochem. staining of RA synovial tissue showed high expression of FRÎ² on macrophages in the intimal lining layer and synovial sublining, whereas no staining was obsd. in T cell areas or in control synovial tissue.  Consistently, FRÎ² mRNA levels were highest in synovial tissue exts. and RA monocyte-derived macrophages, but low in peripheral blood T cells and monocytes.  Screening of 10 new-generation folate antagonists revealed 4 compds. for which FRÎ² had a high binding affinity (20-77-fold higher than for MTX).  One of these, the thymidylate synthase inhibitor BCG 945, displayed selective targeting against FRÎ²-transfected cells.  Abundant FRÎ² expression on activated macrophages in synovial tissue from RA patients deserves further exploration for selective therapeutic interventions with high-affinity-binding folate antagonists, of which BCG 945 may be a prototypical representative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozErFRUx-s5rVg90H21EOLACvtfcHk0ljTCwWdXSGYYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFequrs%253D&md5=58da14e3b0e9b4e2ad65bbb74676fed5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fart.24219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24219%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DJ.%2BW.%26aulast%3DOerlemans%26aufirst%3DR.%26aulast%3DDijkmans%26aufirst%3DB.%2BA.%26aulast%3DQi%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BLaken%26aufirst%3DC.%2BJ.%26aulast%3DLems%26aufirst%3DW.%2BF.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26aulast%3DKraan%26aufirst%3DM.%2BC.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DRatnam%26aufirst%3DM.%26aulast%3DJansen%26aufirst%3DG.%26atitle%3DFolate%2520receptor%2520beta%2520as%2520a%2520potential%2520delivery%2520route%2520for%2520novel%2520folate%2520antagonists%2520to%2520macrophages%2520in%2520the%2520synovial%2520tissue%2520of%2520rheumatoid%2520arthritis%2520patients%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D12%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenbrink, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteson, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockwood, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">â</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=438-446&author=W.+Xiaauthor=A.+R.+Hilgenbrinkauthor=E.+L.+Mattesonauthor=M.+B.+Lockwoodauthor=J.+X.+Chengauthor=P.+S.+Low&title=A+functional+folate+receptor+is+induced+during+macrophage+activation+and+can+be+used+to+target+drugs+to+activated+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DHilgenbrink%26aufirst%3DA.%2BR.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DLockwood%26aufirst%3DM.%2BB.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DA%2520functional%2520folate%2520receptor%2520is%2520induced%2520during%2520macrophage%2520activation%2520and%2520can%2520be%2520used%2520to%2520target%2520drugs%2520to%2520activated%2520macrophages%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D438%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breur, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmer, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulos, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grote, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1947</span><span class="NLM_x">â</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fart.10405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12124880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A280%3ADC%252BD38znsl2jtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=1947-1955&author=M.+J.+Turkauthor=G.+J.+Breurauthor=W.+R.+Widmerauthor=C.+M.+Paulosauthor=L.+C.+Xuauthor=L.+A.+Groteauthor=P.+S.+Low&title=Folate-targeted+imaging+of+activated+macrophages+in+rats+with+adjuvant-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis</span></div><div class="casAuthors">Turk Mary Jo; Breur Gert J; Widmer William R; Paulos Chrystal M; Xu Le-Cun; Grote Lee Ann; Low Philip S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1947-55</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine whether overexpression of the high-affinity folate receptor (FR) on activated macrophages can be exploited to selectively target imaging agents to sites of inflammation in rats with adjuvant-induced arthritis (AIA).  METHODS:  Folic acid was conjugated to a (99m)Tc chelator (the complex termed EC20), and its distribution was visualized using gamma scintigraphy in healthy rats, rats with AIA, and arthritic rats that had been depleted of macrophages.  To confirm that uptake was mediated by the FR, excess folic acid competition studies were conducted, and tissue FR levels were quantitated using a radioligand binding assay.  Flow cytometry was also used to investigate uptake of folate conjugates into macrophages of both arthritic and healthy rats.  RESULTS:  EC20 concentrated in the arthritic extremities of diseased rats but not in the extremities of healthy rats.  The intensity of images of affected tissues was greatly reduced in the presence of excess competing folic acid.  The livers and spleens of arthritic animals also showed enhanced uptake of EC20 and increased levels of FR.  Depletion of macrophages from arthritic animals reduced tissue FR content and concomitantly abolished uptake of EC20.  In addition, macrophages isolated from livers of rats with AIA exhibited a significantly higher binding capacity for folate conjugates than did macrophages obtained from healthy rats.  CONCLUSION:  Although EC20 is currently undergoing clinical evaluation for use in the imaging of ovarian carcinomas, the present results suggest that it may also be useful for assaying the participation of activated macrophages in inflammatory processes such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXPznsnxkDyEg6wdEZmT2rfW6udTcc2ebe9LKf7hH6wrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38znsl2jtg%253D%253D&md5=31a6b8eba0be0cf97924b90a0e4679ed</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fart.10405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.10405%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DBreur%26aufirst%3DG.%2BJ.%26aulast%3DWidmer%26aufirst%3DW.%2BR.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DGrote%26aufirst%3DL.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate-targeted%2520imaging%2520of%2520activated%2520macrophages%2520in%2520rats%2520with%2520adjuvant-induced%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2002%26volume%3D46%26spage%3D1947%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Elnakat, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span> </span><span class="NLM_article-title">Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">â</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2004.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15094207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtF2rt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1067-1084&author=H.+Elnakatauthor=M.+Ratnam&title=Distribution%2C+functionality+and+gene+regulation+of+folate+receptor+isoforms%3A+implications+in+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy</span></div><div class="casAuthors">Elnakat, Hala; Ratnam, Manohar</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1067-1084</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  This article reviews the role of the folate receptor in physiol., the folate receptor gene family, mechanisms governing gene expression and how this relates to its potential in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXsdpIKdWDbLVg90H21EOLACvtfcHk0lhUcqFiS9KHaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtF2rt7Y%253D&md5=526afa4ac9adc948b6f03980cf02ec81</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DElnakat%26aufirst%3DH.%26aulast%3DRatnam%26aufirst%3DM.%26atitle%3DDistribution%252C%2520functionality%2520and%2520gene%2520regulation%2520of%2520folate%2520receptor%2520isoforms%253A%2520implications%2520in%2520targeted%2520therapy%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1067%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kamen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. K.</span><span> </span><span class="NLM_article-title">A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">â</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1085-1097&author=B.+A.+Kamenauthor=A.+K.+Smith&title=A+review+of+folate+receptor+alpha+cycling+and+5-methyltetrahydrofolate+accumulation+with+an+emphasis+on+cell+models+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamen%26aufirst%3DB.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BK.%26atitle%3DA%2520review%2520of%2520folate%2520receptor%2520alpha%2520cycling%2520and%25205-methyltetrahydrofolate%2520accumulation%2520with%2520an%2520emphasis%2520on%2520cell%2520models%2520in%2520vitro%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1085%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">13872</span><span class="NLM_x">â</span> <span class="NLM_lpage">13877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.0601455103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16950881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFSkt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=13872-13877&author=J.+Yangauthor=H.+Chenauthor=I.+R.+Vlahovauthor=J.+X.+Chengauthor=P.+S.+Low&title=Evaluation+of+disulfide+reduction+during+receptor-mediated+endocytosis+by+using+FRET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging</span></div><div class="casAuthors">Yang, Jun; Chen, Hongtao; Vlahov, Iontcho R.; Cheng, Ji-Xin; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13872-13877</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Despite functional evidence for disulfide bond-reducing activity in endosomal compartments, the mechanistic details pertaining to such process (e.g., kinetics and sites of disulfide redn.) remain largely controversial.  To address these questions directly, the authors have synthesized a previously uncharacterized fluorescent folate conjugate, folate-(BODIPY FL)-SS-rhodamine (folate-FRET), that changes fluorescence from red to green upon disulfide bond redn.  Using this construct, the authors have obsd. that disulfide redn.: (i) occurs with a half-time of 6 h after folate-FRET endocytosis, (ii) begins in endosomes and does not depend significantly on redox machinery located on the cell surface or within the lysosome or the Golgi app., (iii) occurs independently of endocytic vesicle trafficking along microtubules, and (iv) yields products that are subsequently sorted into distinct endosomes and trafficked in different directions.  Finally, colocalization of folate and transferrin receptors suggest that conclusions derived from this study may apply to other endocytic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHr5o9L2HCBbVg90H21EOLACvtfcHk0lhzzHyk3LU8oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFSkt78%253D&md5=a1502f1a4a07ce60e7f6e5b654308f9a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601455103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601455103%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DEvaluation%2520of%2520disulfide%2520reduction%2520during%2520receptor-mediated%2520endocytosis%2520by%2520using%2520FRET%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D13872%26epage%3D13877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Paulos, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breur, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">â</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2004.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15094216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1205-1217&author=C.+M.+Paulosauthor=M.+J.+Turkauthor=G.+J.+Breurauthor=P.+S.+Low&title=Folate+receptor-mediated+targeting+of+therapeutic+and+imaging+agents+to+activated+macrophages+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis</span></div><div class="casAuthors">Paulos, Chrystal M.; Turk, Mary Jo; Breur, Gert J.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1217</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by inflammation of the joints and destruction of cartilage and bone, often compromising both the quality and duration of life.  The disease pathol. is complex, involving the infiltration and activation of various populations of immune cells along with the release of destructive inflammatory mediators into the synovium of affected joints.  Although it is still debatable whether activated macrophages are the primary promoters of RA, emerging data clearly show that the biol. activity of this subset of inflammatory cells greatly contributes to both the acute and chronic stages of the disease.  The further discovery of folate receptor expression on these activated (but not quiescent) macrophages in both animal models and human patients with naturally occurring RA has opened the possibility of exploiting folic acid to target attached drugs to this population of pathol. cells.  Indeed, recent studies have shown that folate-linked imaging and therapeutic agents can be selectively delivered to arthritic joints, allowing both the visualization and treatment of RA, with little or no collateral toxicity to normal tissues.  This review will first summarize data documenting specific expression of the folate receptor on activated macrophages and then focus on the development of folate-targeted diagnostic and therapeutic agents for guided intervention into rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj3K5ie2Jb_rVg90H21EOLACvtfcHk0lhzzHyk3LU8oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLk%253D&md5=da0707a0ea25b5501a38a25c4e2edf8a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DBreur%26aufirst%3DG.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate%2520receptor-mediated%2520targeting%2520of%2520therapeutic%2520and%2520imaging%2520agents%2520to%2520activated%2520macrophages%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1205%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span> </span><span class="NLM_article-title">Exploitation of the folate receptor in the management of cancer and inflammatory disease</span> <span class="citation_source-journal">Vitam. Horm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">â</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0083-6729%2808%2900407-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18804696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2008&pages=203-233&author=C.+P.+Leamonauthor=A.+L.+Jackman&title=Exploitation+of+the+folate+receptor+in+the+management+of+cancer+and+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Exploitation of the folate receptor in the management of cancer and inflammatory disease</span></div><div class="casAuthors">Leamon, Christopher P.; Jackman, Ann L.</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">Folic Acid and Folates</span>),
    <span class="NLM_cas:pages">203-233</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Over the last 25+ years, the folate receptor (FR) has emerged as an attractive tumor biomarker with the potential to be exploited for therapeutic purposes.  Increasing evidence suggests that this endocytosing protein can functionally mediate the cellular uptake and retention of natural folates, certain antifolates, and folate-drug conjugates; the consequences of the latter two events could result in biol. modulation, including (but not limited to) tumor-targeted cytotoxicity.  Because its tissue expression profile appears to be somewhat limited to either tissues responsible for whole body retention of folates (e.g., kidney and placenta), or certain pathol. tissues (e.g., tumors or activated macrophages), the FR is believed to be a useful biol. target for disease management.  Indeed, recent years have been peppered with reports of novel FR-targeted therapies, and many have demonstrated impressive in vivo potency, particularly against tumor xenografts, without the undesirable toxicity that often accompanies nontargeted drug regimens.  This chapter will provide essential details on the properties of the FR, including where it is expressed and how it has been successfully manipulated for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-fHwtetp0bLVg90H21EOLACvtfcHk0lhzzHyk3LU8oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7fP&md5=b332543e489e2b2cf3def5cc33dfbe98</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2808%2900407-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252808%252900407-X%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26atitle%3DExploitation%2520of%2520the%2520folate%2520receptor%2520in%2520the%2520management%2520of%2520cancer%2520and%2520inflammatory%2520disease%26jtitle%3DVitam.%2520Horm.%26date%3D2008%26volume%3D79%26spage%3D203%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sandoval, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitoris, B. A.</span><span> </span><span class="NLM_article-title">Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy</span> <span class="citation_source-journal">Am. J. Physiol.: Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">C517</span><span class="NLM_x">â</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2004&pages=C517-526&author=R.+M.+Sandovalauthor=M.+D.+Kennedyauthor=P.+S.+Lowauthor=B.+A.+Molitoris&title=Uptake+and+trafficking+of+fluorescent+conjugates+of+folic+acid+in+intact+kidney+determined+using+intravital+two-photon+microscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandoval%26aufirst%3DR.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BD.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DMolitoris%26aufirst%3DB.%2BA.%26atitle%3DUptake%2520and%2520trafficking%2520of%2520fluorescent%2520conjugates%2520of%2520folic%2520acid%2520in%2520intact%2520kidney%2520determined%2520using%2520intravital%2520two-photon%2520microscopy%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2004%26volume%3D287%26spage%3DC517%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics and exposureâtoxicity relationship of a folate-<i>Vinca</i> alkaloid conjugate EC145 in cancer patients</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">â</span> <span class="NLM_lpage">1476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1177%2F0091270009339740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19837906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1467-1476&author=J.+Liauthor=E.+A.+Sausvilleauthor=P.+J.+Kleinauthor=D.+Morgensternauthor=C.+P.+Leamonauthor=R.+A.+Messmannauthor=P.+LoRusso&title=Clinical+pharmacokinetics+and+exposure%E2%88%92toxicity+relationship+of+a+folate-Vinca+alkaloid+conjugate+EC145+in+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients</span></div><div class="casAuthors">Li, Jing; Sausville, Edward A.; Klein, Patrick J.; Morgenstern, David; Leamon, Christopher P.; Messmann, Richard A.; Lo Russo, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1467-1476</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The clin. pharmacokinetics and exposure-toxicity relationship were detd. for EC145, a conjugate of folic acid and the Vinca alkaloid desacetylvinblastine hydrazide (DAVLBH), in cancer patients.  EC145 plasma concn. and toxicity data were obtained from a first-in-man phase I study and analyzed by nonlinear mixed effect modeling with NONMEM.  EC145 concn.-time profile after i.v. administration was well described by a 2-compartment model with a first-order elimination process from the central compartment.  BSA was identified as a significant covariate on EC145 clearance, accounting for 14.6% of interindividual variation on EC145 clearance.  Population ests. for the clearance, steady-state vol. of distribution, distribution, and elimination half-lives were 56.1 L/h, 26.1 L, 6 min, and 26 min, resp.  Constipation and peripheral neuropathy were the most common and clin. relevant toxicities.  The clearance and area under the concn.-time curve (AUC) were significant predictors for the incidence of EC145-induced constipation but not peripheral neuropathy.  In conclusion, EC145 is rapidly distributed and eliminated in cancer patients.  BSA is a statistically significant covariate on EC145 clearance, but its clin. relevance remains to be defined.  EC145-induced constipation occurs at a higher frequency in the patients with lower EC145 clearance, where the drug exposure tends to be higher.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeWbU5dBosq7Vg90H21EOLACvtfcHk0ljrp1Bu-B_d-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLjI&md5=f7ed9c76db25964aebf94855a28850bf</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1177%2F0091270009339740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009339740%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DKlein%26aufirst%3DP.%2BJ.%26aulast%3DMorgenstern%26aufirst%3DD.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DMessmann%26aufirst%3DR.%2BA.%26aulast%3DLoRusso%26aufirst%3DP.%26atitle%3DClinical%2520pharmacokinetics%2520and%2520exposure%25E2%2588%2592toxicity%2520relationship%2520of%2520a%2520folate-Vinca%2520alkaloid%2520conjugate%2520EC145%2520in%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D1467%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Sausville, E. A.; LoRusso, P.; Quinn, M.; Forman, K.; Leamon, C. P.; Morgenstern, D.; Bever, S.; Messmann, R. A.</span><span> </span><span class="NLM_article-title">A Phase I Study of EC145 Administered Weeks 1 and 3 of a 4-Week Cycle in Patients with Refractory Solid Tumors</span>.  <span class="citation_source-book">ASCO Annual Meeting Proceedings, 2007</span>; <span class="NLM_publisher-name">American Society of Clinical Oncology</span>: <span class="NLM_publisher-loc">Alexandria, VA</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">2577</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2577&author=E.+A.+Sausville&author=P.+LoRusso&author=M.+Quinn&author=K.+Forman&author=C.+P.+Leamon&author=D.+Morgenstern&author=S.+Bever&author=R.+A.+Messmann&title=ASCO+Annual+Meeting+Proceedings%2C+2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DA%2520Phase%2520I%2520Study%2520of%2520EC145%2520Administered%2520Weeks%25201%2520and%25203%2520of%2520a%25204-Week%2520Cycle%2520in%2520Patients%2520with%2520Refractory%2520Solid%2520Tumors%26btitle%3DASCO%2520Annual%2520Meeting%2520Proceedings%252C%25202007%26pub%3DAmerican%2520Society%2520of%2520Clinical%2520Oncology%26date%3D2007%26spage%3D2577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Chancy, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kekuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhnel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirotnak, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganapathy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. B.</span><span> </span><span class="NLM_article-title">Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">20676</span><span class="NLM_x">â</span> <span class="NLM_lpage">20684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=20676-20684&author=C.+D.+Chancyauthor=R.+Kekudaauthor=W.+Huangauthor=P.+D.+Prasadauthor=J.+M.+Kuhnelauthor=F.+M.+Sirotnakauthor=P.+Roonauthor=V.+Ganapathyauthor=S.+B.+Smith&title=Expression+and+differential+polarization+of+the+reduced-folate+transporter-1+and+the+folate+receptor+alpha+in+mammalian+retinal+pigment+epithelium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChancy%26aufirst%3DC.%2BD.%26aulast%3DKekuda%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DPrasad%26aufirst%3DP.%2BD.%26aulast%3DKuhnel%26aufirst%3DJ.%2BM.%26aulast%3DSirotnak%26aufirst%3DF.%2BM.%26aulast%3DRoon%26aufirst%3DP.%26aulast%3DGanapathy%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DS.%2BB.%26atitle%3DExpression%2520and%2520differential%2520polarization%2520of%2520the%2520reduced-folate%2520transporter-1%2520and%2520the%2520folate%2520receptor%2520alpha%2520in%2520mammalian%2520retinal%2520pigment%2520epithelium%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D20676%26epage%3D20684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Mantovani, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspagliesi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span> </span><span class="NLM_article-title">Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19</span> <span class="citation_source-journal">Eur. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">30A</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30A&publication_year=1994&pages=363-369&author=L.+T.+Mantovaniauthor=S.+Miottiauthor=S.+Menardauthor=S.+Canevariauthor=F.+Raspagliesiauthor=C.+Bottiniauthor=F.+Botteroauthor=M.+I.+Colnaghi&title=Folate+binding+protein+distribution+in+normal+tissues+and+biological+fluids+from+ovarian+carcinoma+patients+as+detected+by+the+monoclonal+antibodies+MOv18+and+MOv19"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMantovani%26aufirst%3DL.%2BT.%26aulast%3DMiotti%26aufirst%3DS.%26aulast%3DMenard%26aufirst%3DS.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DRaspagliesi%26aufirst%3DF.%26aulast%3DBottini%26aufirst%3DC.%26aulast%3DBottero%26aufirst%3DF.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26atitle%3DFolate%2520binding%2520protein%2520distribution%2520in%2520normal%2520tissues%2520and%2520biological%2520fluids%2520from%2520ovarian%2520carcinoma%2520patients%2520as%2520detected%2520by%2520the%2520monoclonal%2520antibodies%2520MOv18%2520and%2520MOv19%26jtitle%3DEur.%2520J.%2520Cancer.%26date%3D1994%26volume%3D30A%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span> </span><span class="NLM_article-title">Comparative preclinical activity of the folate-targeted <i>Vinca</i> alkaloid conjugates EC140 and EC145</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">â</span> <span class="NLM_lpage">1592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fijc.22853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17551919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSns7zI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1585-1592&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=E.+Westrickauthor=N.+Parkerauthor=J.+S.+Nicosonauthor=M.+Vetzel&title=Comparative+preclinical+activity+of+the+folate-targeted+Vinca+alkaloid+conjugates+EC140+and+EC145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Westrick, Elaine; Parker, Nikki; Nicoson, Jeffrey S.; Vetzel, Marilynn</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1585-1592</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">EC140 is a water sol. folate conjugate of desacetylvinblastine monohydrazide (DAVLBH), which is constructed with an endosome-cleavable acyl hydrazone bond.  This agent has proven to be active and specific against well established, s.c. folate receptor (FR)-pos. tumors in multiple animal models.  Recent structure-activity and optimization studies have yielded a disulfide bond-contg. counterpart to EC140, herein referred to as EC145.  This new conjugate was found to retain high affinity for FR-pos. cells, and it produced specific, dose-responsive activity in vitro.  Comparative in vivo efficacy tests confirmed that, like EC140, EC145 displays activity against both syngeneic and xenograft tumor models.  However, EC145 was found to be more active and better tolerated than EC140; hence, more durable complete responses were consistently obsd. in EC145-treated tumor-bearing animals.  Furthermore, EC145 was not found to be active against a FR-neg. tumor model.  Addnl. preclin. studies are therefore warranted to better understand EC145's breadth of activity against FR-pos. tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGtkvrrhOcvrVg90H21EOLACvtfcHk0lh8nLkI1GjAyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSns7zI&md5=3a7b06fc117fca9d88730624d2ce9298</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fijc.22853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22853%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DParker%26aufirst%3DN.%26aulast%3DNicoson%26aufirst%3DJ.%2BS.%26aulast%3DVetzel%26aufirst%3DM.%26atitle%3DComparative%2520preclinical%2520activity%2520of%2520the%2520folate-targeted%2520Vinca%2520alkaloid%2520conjugates%2520EC140%2520and%2520EC145%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1585%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhapuram, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">Preclinical antitumor activity of a novel folate-targeted dual drug conjugate</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">â</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp070049c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtL3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=659-667&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=E.+Westrickauthor=A.+Dawsonauthor=R.+Dortonauthor=M.+Vetzelauthor=H.+K.+Santhapuramauthor=Y.+Wang&title=Preclinical+antitumor+activity+of+a+novel+folate-targeted+dual+drug+conjugate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Antitumor Activity of a Novel Folate-Targeted Dual Drug Conjugate</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Westrick, Elaine; Dawson, Alicia; Dorton, Ryan; Vetzel, Marilynn; Santhapuram, Hari Krishna; Wang, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">659-667</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed a new type of tumor-targeted agent by tethering two different drug mols., with distinct biol. mechanisms of action, to the same ligand.  This compd., named EC0225, represents the "first in class" multidrug, folate receptor (FR)-targeted agent to be disclosed.  It was constructed with a single folate mol., extended by a hydrophilic peptide-based spacer, which was in turn attached to mitomycin and Vinca alkaloid units via two sep. disulfide-contg. linkers.  EC0225 produced potent, dose-responsive activity in vitro, and curative activity was obsd. against FR-pos. syngeneic and xenograft tumors following the administration of well-tolerated dosing regimens.  Multiple complete responses and cures were also noted when EC0225 was used to treat mice initially bearing tumors as large as 750 mm3 in vol.  Overall, EC0225's impressive preclin. activity allowed for its selection as a development candidate and for the start of Phase 1 clin. trials, which began in March of 2007, for the treatment of advanced malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqEYQK1vIbQ7Vg90H21EOLACvtfcHk0lh8nLkI1GjAyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtL3I&md5=be9787edffad2aba1cbfdd990f85df4a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fmp070049c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp070049c%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DDawson%26aufirst%3DA.%26aulast%3DDorton%26aufirst%3DR.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DSanthapuram%26aufirst%3DH.%2BK.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPreclinical%2520antitumor%2520activity%2520of%2520a%2520novel%2520folate-targeted%2520dual%2520drug%2520conjugate%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D659%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors</span> <span class="citation_source-journal">Cancer Immunol. Immunother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs00262-002-0266-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=11941454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVGjsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=153-162&author=Y.+Luauthor=P.+S.+Low&title=Folate+targeting+of+haptens+to+cancer+cell+surfaces+mediates+immunotherapy+of+syngeneic+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors</span></div><div class="casAuthors">Lu, Yingjuan; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-162</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A variety of human cancers overexpress a cell surface receptor with high affinity for the vitamin, folic acid (Kd â¼ 10-10 M).  Covalent attachment of therapeutic agents to folic acid has been shown to allow efficient targeting of the folate-drug conjugates to folate receptor-expressing cancer cells, with little or no uptake by normal tissues except the kidneys.  We report here the use of folate's ability to deliver attached mols. specifically to cancer cells to convert poorly immunogenic tumors into highly immunogenic tissue targets.  By linking folic acid to a model hapten, we have been able to decorate folate receptor-expressing cancer cell surfaces with > 106 haptens/cell in vivo.  Following marking of such cells with haptens, the cells are obsd. to become opsonized with autologous anti-hapten antibodies, which is presumed to mediate cell removal via antibody-dependent cellular cytotoxicity (ADCC).  Supplemental administration of low levels of ADCC-activating cytokines [e.g. interleukin-2 (IL-2) and interferon-alpha (IFN-Î±)] has been shown to synergize with the folate-targeted immunotherapy.  Thus, using M109 syngeneic lung cancer cells injected i.p. into Balb/c mice that were previously immunized against fluorescein, a significant extension of life span is obsd. following treatment with folate-fluorescein conjugates, and complete cures are obsd. upon supplementation with moderate levels of IL-2 and IFN-Î±.  Because control tumor-bearing mice treated with the same cytokines but with non-targeted fluorescein show no extension of life span, we conclude that tumor-specific opsonization is an essential step in this immunotherapy.  Finally, because the anti-fluorescein antibodies are unable to access the folate receptors on the apical membranes of the kidney proximal tubules, no kidney or other normal tissue cytotoxicity is obsd.  These data suggest that retargeting of haptens to folate receptor-expressing cancers might constitute a method for mobilizing the immune system specifically against poorly immunogenic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOmKs6AgCtjbVg90H21EOLACvtfcHk0lh8nLkI1GjAyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVGjsr8%253D&md5=9b5edc238468ed97dfdcd718ad708212</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00262-002-0266-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-002-0266-6%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate%2520targeting%2520of%2520haptens%2520to%2520cancer%2520cell%2520surfaces%2520mediates%2520immunotherapy%2520of%2520syngeneic%2520murine%2520tumors%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2002%26volume%3D51%26spage%3D153%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantrip, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of [<sup>111</sup>In]DTPA-folate for use as a tumor-targeted radiopharmaceutical</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">â</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9701297" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2sXlslGmsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=673-679&author=S.+Wangauthor=J.+Luoauthor=D.+A.+Lantripauthor=D.+J.+Watersauthor=C.+J.+Mathiasauthor=M.+A.+Greenauthor=P.+L.+Fuchsauthor=P.+S.+Low&title=Design+and+synthesis+of+%5B111In%5DDTPA-folate+for+use+as+a+tumor-targeted+radiopharmaceutical"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of [111In]DTPA-Folate for Use as a Tumor-Targeted Radiopharmaceutical</span></div><div class="casAuthors">Wang, Susan; Luo, Jin; Lantrip, Douglas A.; Waters, David J.; Mathias, Carla J.; Green, Mark A.; Fuchs, Philip L.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">673-679</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Folate-conjugated metal chelates have been proposed as potential imaging agents for cancers that overexpress folate receptors.  In a previous study, folic acid was linked through its Î³-carboxyl group to deferoxamine (DF), and the 67Ga-labeled complex ([67Ga]DF-folate) was examd. for in vivo tumor targeting efficiency in athymic mice with a human tumor cell implant.  Although superb tumor-to-background contrast was obtained, slow hepatobiliary clearance would compromise imaging of abdominal tumors such as ovarian cancer.  In the present study, folic acid was conjugated to an alternative chelator, diethylenetriaminepentaacetic acid (DTPA), via an ethylenediamine spacer.  The desired DTPA-folate(Î³) regioisomer was synthesized by two different approaches, purified by reversed phase column chromatog., and characterized mainly by anal. HPLC, mass spectroscopy, and NMR.  In cultured tumor cells, uptake of [111In]DTPA-folate(Î³) was found to be specific for folate receptor-bearing cells, and the kinetics of uptake were similar to those of free folate and other folate-conjugated mols.  In the normal rat, i.v. administered [111In]DTPA-folate(Î³) was found to be rapidly excreted into the urine, giving intestinal levels of radiotracer 10-fold lower than those obsd. with [67Ga]DF-folate(Î³) at 4 h.  In a preliminary mouse imaging study, a folate receptor-pos. KB cell tumor was readily visualized by Î³ scintigraphy 1 h following i.v. administration of [111In]DTPA-folate(Î³).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgg4nZCBf__rVg90H21EOLACvtfcHk0liybDKbpAmcUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlslGmsbc%253D&md5=dec09d0d52f8d32ce6d7b6e1016f5f5a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbc9701297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9701297%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLantrip%26aufirst%3DD.%2BA.%26aulast%3DWaters%26aufirst%3DD.%2BJ.%26aulast%3DMathias%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DM.%2BA.%26aulast%3DFuchs%26aufirst%3DP.%2BL.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%255B111In%255DDTPA-folate%2520for%2520use%2520as%2520a%2520tumor-targeted%2520radiopharmaceutical%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D673%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Cytotoxicity of folate-<i>Pseudomonas</i> exotoxin conjugates toward tumor cells. Contribution of translocation domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">24847</span><span class="NLM_x">â</span> <span class="NLM_lpage">24854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=24847-24854&author=C.+P.+Leamonauthor=I.+Pastanauthor=P.+S.+Low&title=Cytotoxicity+of+folate-Pseudomonas+exotoxin+conjugates+toward+tumor+cells.+Contribution+of+translocation+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCytotoxicity%2520of%2520folate-Pseudomonas%2520exotoxin%2520conjugates%2520toward%2520tumor%2520cells.%2520Contribution%2520of%2520translocation%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D24847%26epage%3D24854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Cytotoxicity of momordin-folate conjugates in cultured human cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">24966</span><span class="NLM_x">â</span> <span class="NLM_lpage">24971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=24966-24971&author=C.+P.+Leamonauthor=P.+S.+Low&title=Cytotoxicity+of+momordin-folate+conjugates+in+cultured+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCytotoxicity%2520of%2520momordin-folate%2520conjugates%2520in%2520cultured%2520human%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D24966%26epage%3D24971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mayor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabharanjak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxfield, F. R.</span><span> </span><span class="NLM_article-title">Cholesterol-dependent retention of GPI-anchored proteins in endosomes</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4626</span><span class="NLM_x">â</span> <span class="NLM_lpage">4638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1093%2Femboj%2F17.16.4626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=9707422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1cXlslOhsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4626-4638&author=S.+Mayorauthor=S.+Sabharanjakauthor=F.+R.+Maxfield&title=Cholesterol-dependent+retention+of+GPI-anchored+proteins+in+endosomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol-dependent retention of GPI-anchored proteins in endosomes</span></div><div class="casAuthors">Mayor, Satyajit; Sabharanjak, Shefali; Maxfield, Frederick R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4626-4638</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Several cell surface eukaryotic proteins have a glycosylphosphatidylinositol (GPI) modification at the C-terminal end that serves as their sole means of membrane anchoring.  Using fluorescently labeled ligands and digital fluorescence microscopy, we show that contrary to the potocytosis model, GPI-anchored proteins are internalized into endosomes that contain markers for both receptor-mediated uptake (e.g. transferrin) and fluid phase endocytosis (e.g. dextrans).  This was confirmed by immunogold electron microscopy and the observation that a fluorescent folate deriv. bound to the GPI-anchored folate receptor is internalized into the same compartment as co-internalized horseradish peroxidase-transferrin; the folate fluorescence was quenched when cells subsequently were incubated with diaminobenzidine and H2O2.  Most of the GPI-anchored proteins are recycled back to the plasma membrane but at a rate that is at least 3-fold slower than C6-NBD-sphingomyelin or recycling receptors.  This endocytic retention is regulated by the level of cholesterol in cell membranes; GPI-anchored proteins are recycled back to the cell surface at the same rate as recycling transferrin receptors and C6-NBD-sphingomyelin in cholesterol-depleted cells.  Cholesterol-dependent endocytic sorting of GPI-anchored proteins is consistent with the involvement of specialized lipid domains or 'rafts' in endocytic sorting.  These results provide an alternative explanation for GPI-requiring functions of some GPI-anchored proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlM2pzgdrULVg90H21EOLACvtfcHk0liybDKbpAmcUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslOhsL0%253D&md5=f665f485114eddd34f174e2039031043</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.16.4626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.16.4626%26sid%3Dliteratum%253Aachs%26aulast%3DMayor%26aufirst%3DS.%26aulast%3DSabharanjak%26aufirst%3DS.%26aulast%3DMaxfield%26aufirst%3DF.%2BR.%26atitle%3DCholesterol-dependent%2520retention%2520of%2520GPI-anchored%2520proteins%2520in%2520endosomes%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4626%26epage%3D4638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kamen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdevila, A.</span><span> </span><span class="NLM_article-title">Receptor-mediated folate accumulation is regulated by the cellular folate content</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">5983</span><span class="NLM_x">â</span> <span class="NLM_lpage">5987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=5983-5987&author=B.+A.+Kamenauthor=A.+Capdevila&title=Receptor-mediated+folate+accumulation+is+regulated+by+the+cellular+folate+content"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamen%26aufirst%3DB.%2BA.%26aulast%3DCapdevila%26aufirst%3DA.%26atitle%3DReceptor-mediated%2520folate%2520accumulation%2520is%2520regulated%2520by%2520the%2520cellular%2520folate%2520content%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1986%26volume%3D83%26spage%3D5983%26epage%3D5987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ladino, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourret, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedersha, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmacher, V. S.</span><span> </span><span class="NLM_article-title">Folate-maytansinoids: target-selective drugs of low molecular weight</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">â</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C859%3A%3AAID-IJC16%3E3.0.CO%3B2-%23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=9399666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2sXnslOqsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1997&pages=859-864&author=C.+A.+Ladinoauthor=R.+V.+Chariauthor=L.+A.+Bourretauthor=N.+L.+Kedershaauthor=V.+S.+Goldmacher&title=Folate-maytansinoids%3A+target-selective+drugs+of+low+molecular+weight"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-maytansinoids: target-selective drugs of low molecular weight</span></div><div class="casAuthors">Ladino, Cynthia A.; Chari, Ravi V. J.; Bourret, Lizabeth A.; Kedersha, Nancy L.; Goldmacher, Victor S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">859-864</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Folate receptor is over-expressed in a variety of carcinomas.  To design a cytotoxic drug that would selectively target these carcinomas, we synthesized folate-maytansinoids.  These drugs showed high affinity toward folate receptor, appeared to enter cells exclusively via the folate receptor-mediated caveolar pathway and displayed high cytotoxic potency (in the range of 10-11 to 10-10M) and remarkable selectivity for folate receptor-expressing carcinoma cell lines.  Folate-maytansinoids represent a new class of tumor-specific agents in which the targeting and the cytotoxic function can be altered independently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxUw3TqJLHJbVg90H21EOLACvtfcHk0liwe9f2CW_9uA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnslOqsrg%253D&md5=67e0e0a918dae7616220a73876628a23</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C859%3A%3AAID-IJC16%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819971210%252973%253A6%253C859%253A%253AAID-IJC16%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DLadino%26aufirst%3DC.%2BA.%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DBourret%26aufirst%3DL.%2BA.%26aulast%3DKedersha%26aufirst%3DN.%2BL.%26aulast%3DGoldmacher%26aufirst%3DV.%2BS.%26atitle%3DFolate-maytansinoids%253A%2520target-selective%2520drugs%2520of%2520low%2520molecular%2520weight%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1997%26volume%3D73%26spage%3D859%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Measurement of endosome pH following folate receptor-mediated endocytosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1312</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">â</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1312&publication_year=1996&pages=237-242&author=R.+J.+Leeauthor=S.+Wangauthor=P.+S.+Low&title=Measurement+of+endosome+pH+following+folate+receptor-mediated+endocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DMeasurement%2520of%2520endosome%2520pH%2520following%2520folate%2520receptor-mediated%2520endocytosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1996%26volume%3D1312%26spage%3D237%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, P. L.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of Taxol-folic acid conjugates as targeted antineoplastics</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">â</span> <span class="NLM_lpage">2414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2397-2414&author=J.+W.+Leeauthor=J.+Y.+Luauthor=P.+S.+Lowauthor=P.+L.+Fuchs&title=Synthesis+and+evaluation+of+Taxol-folic+acid+conjugates+as+targeted+antineoplastics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DJ.%2BY.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DFuchs%26aufirst%3DP.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520Taxol-folic%2520acid%2520conjugates%2520as%2520targeted%2520antineoplastics%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2397%26epage%3D2414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">â</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1124%2Fjpet.106.117648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17289839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=462-468&author=J.+Yangauthor=H.+Chenauthor=I.+R.+Vlahovauthor=J.+X.+Chengauthor=P.+S.+Low&title=Characterization+of+the+pH+of+folate+receptor-containing+endosomes+and+the+rate+of+hydrolysis+of+internalized+acid-labile+folate-drug+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates</span></div><div class="casAuthors">Yang, Jun; Chen, Hongtao; Vlahov, Iontcho R.; Cheng, Ji-Xin; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">462-468</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the widely accepted assumption that most endosomal compartments are acidic, evaluation of the efficiency of pH-dependent drug release from a ligand-targeted drug conjugate during receptor-mediated endocytosis is lacking.  Therefore, the authors have characterized the kinetics of pH-dependent drug release from a model folate-drug conjugate during folate receptor (FR)-mediated endosomal trafficking.  For this purpose, the authors synthesized an acid-labile folate-fluorescence resonance energy transfer reporter (ALFR) that emits green fluorescence (BODIPY FL, 6-((4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diazas-indacene-3-propionyl)amino) hexanoic acid) only after acid-catalyzed hydrolysis of the acyl hydrazone linker.  In a cell-free system, cleavage of ALFR was found to be efficient only at acidic pH values (t1/2 = 1.95, 4.63, and 75 h at pH 4, 5, and 6, resp.) and essentially resistant to hydrolysis at pH 7.  Curiously, when applied to folate receptor-expressing cancer cells, the acid-labile folate-linked probe exhibited little or no recovery of BODIPY FL fluorescence (green), even after 55 h of incubation, arguing very inefficient cleavage within the FR endocytic pathway.  To understand this unanticipated observation, the authors measured the pH of FR-contg. endosomes using ratiometric fluorescence microscopy and obsd. that most FR+ endosomes are only mildly acidic (av. â¼pH 6.5).  Taken together, these data argue that the FR-trafficking pathway does not involve acidic compartments and that acyl hydrazone linkers may constitute a poor option for FR-mediated drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_WR8Ij4-63bVg90H21EOLACvtfcHk0liwe9f2CW_9uA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtLw%253D&md5=35f083bc26b11a1077bacb1f19d2476e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.117648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.117648%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCharacterization%2520of%2520the%2520pH%2520of%2520folate%2520receptor-containing%2520endosomes%2520and%2520the%2520rate%2520of%2520hydrolysis%2520of%2520internalized%2520acid-labile%2520folate-drug%2520conjugates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D462%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindl, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">â</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060145g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Kgt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1226-1232&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=P.+J.+Kleindlauthor=M.+Vetzelauthor=E.+Westrick&title=Synthesis+and+biological+evaluation+of+EC140%3A+a+novel+folate-targeted+vinca+alkaloid+conjugate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of EC140: A Novel Folate-Targeted Vinca Alkaloid Conjugate</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Kleindl, Paul J.; Vetzel, Marilynn; Westrick, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1226-1232</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel folate conjugate of desacetylvinblastine monohydrazide (DAVLBH), herein referred to as EC140, was designed and evaluated for biol. activity against folate receptor (FR)-pos. cells and tumors.  EC140 was produced by coupling a peptidic analog of the vitamin folic acid to DAVLBH via an acylhydrazone bond.  This water-sol. conjugate was found to retain high affinity for FR-pos. cells, and it produced specific, dose-responsive activity in vitro.  Initial in vivo tests confirmed EC140's activity in both syngeneic and xenograft models.  Hence, enduring complete responses were obsd. in animals bearing established, s.c. tumors prior to therapy using regimens that produced minor toxicity.  In contrast, treatment with the unconjugated DAVLBH drug produced nominal efficacy when dosed at its MTD.  Overall, EC140's performance in vitro and in vivo warrants further preclin. study before this novel targeted chemotherapeutic is considered for clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ7-32DTohULVg90H21EOLACvtfcHk0liwe9f2CW_9uA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Kgt7g%253D&md5=d5e26d02977f76ef9343b55a719dbdf3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbc060145g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060145g%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DKleindl%26aufirst%3DP.%2BJ.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DWestrick%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520EC140%253A%2520a%2520novel%2520folate-targeted%2520vinca%2520alkaloid%2520conjugate%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D1226%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4434</span><span class="NLM_x">â</span> <span class="NLM_lpage">4442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4434-4442&author=J.+A.+Reddyauthor=R.+Dortonauthor=E.+Westrickauthor=A.+Dawsonauthor=T.+Smithauthor=L.+C.+Xuauthor=M.+Vetzelauthor=P.+Kleindlauthor=I.+R.+Vlahovauthor=C.+P.+Leamon&title=Preclinical+evaluation+of+EC145%2C+a+folate-vinca+alkaloid+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DDorton%26aufirst%3DR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DDawson%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DKleindl%26aufirst%3DP.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DPreclinical%2520evaluation%2520of%2520EC145%252C%2520a%2520folate-vinca%2520alkaloid%2520conjugate%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4434%26epage%3D4442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Vlashi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1868</span><span class="NLM_x">â</span> <span class="NLM_lpage">1875</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp900158d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KntrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1868-1875&author=E.+Vlashiauthor=J.+E.+Sturgisauthor=M.+Thomasauthor=P.+S.+Low&title=Real+time%2C+noninvasive+imaging+and+quantitation+of+the+accumulation+of+ligand-targeted+drugs+into+receptor-expressing+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Real Time, Noninvasive Imaging and Quantitation of the Accumulation of Ligand-Targeted Drugs into Receptor-Expressing Solid Tumors</span></div><div class="casAuthors">Vlashi, Erina; Sturgis, Jennifer E.; Thomas, Mini; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1868-1875</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted therapies are emerging as a preferred strategy for treatment of cancer and other diseases.  To evaluate the effect of high affinity receptors on the rate and extent of tumor penetration of receptor-targeted drugs, the authors have characterized the kinetics of folate-rhodamine uptake by folate receptor (FR)-expressing tumors in live mice.  Folate-rhodamine was selected to model receptor-targeted drugs, because (i) it has high affinity (Kd = 10-9 M) for FR-rich tumors, (ii) its uptake can be monitored in vivo by multiphoton microscopy, and (iii) five folate-targeted drugs of similar size are currently undergoing clin. trials.  The authors demonstrate that folate-rhodamine sats. tumor FR in <5 min, <30 min, and <100 min following i.v., paraorbital, and i.p. injection, resp.; complete clearance of folate-rhodamine from receptor-neg. tissues requires â¥50 min, and a "binding site barrier" may retard, but does not prevent, penetration of the ligand-targeted drug.  The authors conclude that low mol. wt. ligand-targeted drugs have appropriate pharmacokinetic properties for tumor-selective delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0ttlLS39mbVg90H21EOLACvtfcHk0li1k4UFMWUrHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KntrbJ&md5=feb728a1117b44790d3de6d7f8a769d2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fmp900158d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp900158d%26sid%3Dliteratum%253Aachs%26aulast%3DVlashi%26aufirst%3DE.%26aulast%3DSturgis%26aufirst%3DJ.%2BE.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DReal%2520time%252C%2520noninvasive%2520imaging%2520and%2520quantitation%2520of%2520the%2520accumulation%2520of%2520ligand-targeted%2520drugs%2520into%2520receptor-expressing%2520solid%2520tumors%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D1868%26epage%3D1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamineâfolate, a potential radiopharmaceutical for tumor imaging</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">â</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9500709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK28XivVarsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=56-62&author=S.+Wangauthor=R.+J.+Leeauthor=C.+J.+Mathiasauthor=M.+A.+Greenauthor=P.+S.+Low&title=Synthesis%2C+purification%2C+and+tumor+cell+uptake+of+67Ga-deferoxamine%E2%88%92folate%2C+a+potential+radiopharmaceutical+for+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Purification, and Tumor Cell Uptake of 67Ga-Deferoxamine-Folate, a Potential Radiopharmaceutical for Tumor Imaging</span></div><div class="casAuthors">Wang, Susan; Lee, Robert J.; Mathias, Carla J.; Green, Mark A.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-62</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The vitamin folic acid was covalently linked to the chelating agent deferoxamine (DF) via an amide bond using a simple carbodiimide coupling reaction.  A mixt. of two isomers, DF-folate(Î±) and DF-folate(Î³), was produced involving the Î±- and Î³-carboxyl group of folic acid, resp.  These two isomers were sepd. by anion-exchange chromatog. using a NH4HCO3 gradient.  Competitive binding studies revealed that only the DF-folate(Î³) is recognized by the folate receptor on KB cells, interacting with an affinity comparable to unconjugated folic acid.  The DF-folate conjugates were radiolabeled with the Î³-emitting radionuclide 67Ga3+ and tested for uptake by cultured KB cells overexpressing the folate receptor.  The cellular accumulation of 67Ga-DF-folate(Î³) complex was found to be time-, temp.-, and concn.-dependent.  The 67Ga-DF-folate(Î³) tracer exhibited rapid uptake kinetics in cell culture with a t1/2 of â¼3 min.  The KB cell assocn. of 67Ga-DF-folate(Î³) was competitively blocked by free folic acid, indicating that uptake of the 67Ga-DF-folate(Î³) was specifically mediated by the folate receptor.  Since the folate receptor is overexpressed on the surfaces of many neoplastic cells, these results suggest that 67Ga-DF-folate(Î³) complex might be useful as a diagnostic agent for noninvasive imaging of folate receptor-positing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-l2E_I0vsmLVg90H21EOLACvtfcHk0li1k4UFMWUrHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVarsA%253D%253D&md5=20ebe8d7e80ab68c0bf5f53f71c3c3d9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fbc9500709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9500709%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DMathias%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DM.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%252C%2520purification%252C%2520and%2520tumor%2520cell%2520uptake%2520of%252067Ga-deferoxamine%25E2%2588%2592folate%252C%2520a%2520potential%2520radiopharmaceutical%2520for%2520tumor%2520imaging%26jtitle%3DBioconjugate%2520Chem.%26date%3D1996%26volume%3D7%26spage%3D56%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhapuram, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmacher, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6376</span><span class="NLM_x">â</span> <span class="NLM_lpage">6382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6376-6382&author=J.+A.+Reddyauthor=E.+Westrickauthor=H.+K.+Santhapuramauthor=S.+J.+Howardauthor=M.+L.+Millerauthor=M.+Vetzelauthor=I.+Vlahovauthor=R.+V.+Chariauthor=V.+S.+Goldmacherauthor=C.+P.+Leamon&title=Folate+receptor-specific+antitumor+activity+of+EC131%2C+a+folate-maytansinoid+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DSanthapuram%26aufirst%3DH.%2BK.%26aulast%3DHoward%26aufirst%3DS.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BL.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DVlahov%26aufirst%3DI.%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DGoldmacher%26aufirst%3DV.%2BS.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DFolate%2520receptor-specific%2520antitumor%2520activity%2520of%2520EC131%252C%2520a%2520folate-maytansinoid%2520conjugate%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6376%26epage%3D6382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I.</span><span> </span><span class="NLM_article-title">Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9839</span><span class="NLM_x">â</span> <span class="NLM_lpage">9844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1158%2F0008-5472.CAN-08-2341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19047164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtbnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9839-9844&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=M.+Vetzelauthor=R.+Dortonauthor=E.+Westrickauthor=N.+Parkerauthor=Y.+Wangauthor=I.+Vlahov&title=Folate+targeting+enables+durable+and+specific+antitumor+responses+from+a+therapeutically+null+tubulysin+B+analogue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vetzel, Marilynn; Dorton, Ryan; Westrick, Elaine; Parker, Nikki; Wang, Yu; Vlahov, Iontcho</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9839-9844</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The membrane-bound high-affinity folate receptor (FR) is highly expressed on a wide range of primary and metastatic human cancers, such as those originating in ovary, lung, breast, endometrium, kidney, and brain.  Because folate-linked conjugates bind to and become internalized within FR-expressing cells (similar to that of free folic acid), we explored the possibility of using the folate ligand to target a potent, semisynthetic analog of the microtubule inhibitor tubulysin B to FR-enriched tumors.  When tested in vitro, a novel folate conjugate, herein referred to as EC0305, was found to specifically inhibit the growth of a panel of FR-pos. cell lines (IC50 range, 1-10 nmol/L) in a dose-dependent manner, whereas cells lacking FR expression were unaffected.  The potency of EC0305 was also confirmed against a human KB xenograft-nu/nu mouse cancer model.  Here, a brief three times per wk, 2-wk regimen yielded remarkable antitumor activity (100% tumor-free animals) without causing significant wt. loss or major organ tissue degeneration.  In contrast, antitumor activity was completely abolished in EC0305-treated animals that were co-dosed with an excess of a nontoxic folate-contg. analog, thereby confirming that the antitumor effect of this agent was mediated by FRs.  The advantage provided by folate conjugation was further proved by the untargeted free drug, which was found to be completely inactive at both tolerable and highly toxic dose levels.  Collectively, these results show that this potent antiproliferative tubulysin compd. can be specifically delivered to FR-pos. tumors to provide substantial therapeutic benefit using well-tolerable dosing regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERb5UAdy0OLVg90H21EOLACvtfcHk0lj5fIKfJGo1vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtbnM&md5=bd1df729a17da7cd97983e3c65edc6ff</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2341%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DDorton%26aufirst%3DR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DParker%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVlahov%26aufirst%3DI.%26atitle%3DFolate%2520targeting%2520enables%2520durable%2520and%2520specific%2520antitumor%2520responses%2520from%2520a%2520therapeutically%2520null%2520tubulysin%2520B%2520analogue%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9839%26epage%3D9844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">â</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc049709b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFOmu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=803-811&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=M.+Vetzelauthor=N.+Parkerauthor=J.+S.+Nicosonauthor=L.+C.+Xuauthor=E.+Westrick&title=Synthesis+and+biological+evaluation+of+EC72%3A+a+new+folate-targeted+chemotherapeutic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of EC72: A New Folate-Targeted Chemotherapeutic</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Vetzel, Marilynn; Parker, Nikki; Nicoson, Jeffrey S.; Xu, Le-Cun; Westrick, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">803-811</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel folate conjugate of mitomycin C, herein referred to as EC72, was designed and evaluated for biol. activity against FR-pos. cells and tumors.  EC72 was produced by coupling folic acid-Î³-cysteine to 7-N-modified MMC via a disulfide bond.  This water sol. conjugate was found to retain high affinity for FR-pos. cells, and it produced dose responsive activity in vitro against a panel of folate receptor (FR)-pos. cell lines.  EC72's activity was considered to be targeted and specific for the FR since (i) excess folic acid blocked biol. activity, and (ii) FR-neg. cell lines were unresponsive to this drug.  Initial in vivo tests confirmed EC72's activity in both syngeneic and xenograft models, and this activity occurred in the apparent absence of gross or pathol. toxicity.  These results are significant, since daily dosing of EC72 for more than 30 consecutive days yielded no evidence of myelosuppression or toxicity to major organs, including the FR-pos. kidneys.  The latter observation supports published data, indicating that the apically oriented kidney proximal tubule FRs function to salvage folates prior to their excretion and to return these mols. back into systemic circulation.  Overall, EC72's performance in vitro and in vivo warrants further preclin. study before this novel targeted chemotherapeutic is considered for clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjrIFT4HT-2rVg90H21EOLACvtfcHk0lj5fIKfJGo1vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFOmu7g%253D&md5=53335ae1329fe478972c189eac23a337</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbc049709b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc049709b%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DN.%26aulast%3DNicoson%26aufirst%3DJ.%2BS.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DWestrick%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520EC72%253A%2520a%2520new%2520folate-targeted%2520chemotherapeutic%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D803%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Henne, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doorneweerd, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenbrink, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Synthesis and activity of a folate peptide camptothecin prodrug</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5350</span><span class="NLM_x">â</span> <span class="NLM_lpage">5355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5350-5355&author=W.+A.+Henneauthor=D.+D.+Doorneweerdauthor=A.+R.+Hilgenbrinkauthor=S.+A.+Kularatneauthor=P.+S.+Low&title=Synthesis+and+activity+of+a+folate+peptide+camptothecin+prodrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenne%26aufirst%3DW.%2BA.%26aulast%3DDoorneweerd%26aufirst%3DD.%2BD.%26aulast%3DHilgenbrink%26aufirst%3DA.%2BR.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520a%2520folate%2520peptide%2520camptothecin%2520prodrug%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5350%26epage%3D5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Crippa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seregni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavoni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarfone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buraggi, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombardieri, E.</span><span> </span><span class="NLM_article-title">Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">31A</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">â</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31A&publication_year=1995&pages=686-690&author=F.+Crippaauthor=G.+Bolisauthor=E.+Seregniauthor=N.+Gavoniauthor=G.+Scarfoneauthor=C.+Ferrarisauthor=G.+L.+Buraggiauthor=E.+Bombardieri&title=Single-dose+intraperitoneal+radioimmunotherapy+with+the+murine+monoclonal+antibody+I-131+MOv18%3A+clinical+results+in+patients+with+minimal+residual+disease+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrippa%26aufirst%3DF.%26aulast%3DBolis%26aufirst%3DG.%26aulast%3DSeregni%26aufirst%3DE.%26aulast%3DGavoni%26aufirst%3DN.%26aulast%3DScarfone%26aufirst%3DG.%26aulast%3DFerraris%26aufirst%3DC.%26aulast%3DBuraggi%26aufirst%3DG.%2BL.%26aulast%3DBombardieri%26aufirst%3DE.%26atitle%3DSingle-dose%2520intraperitoneal%2520radioimmunotherapy%2520with%2520the%2520murine%2520monoclonal%2520antibody%2520I-131%2520MOv18%253A%2520clinical%2520results%2520in%2520patients%2520with%2520minimal%2520residual%2520disease%2520of%2520ovarian%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1995%26volume%3D31A%26spage%3D686%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arienti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolls, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Re, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggermont, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goey, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratama, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nooy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspagliesi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravagnani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarfone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trimbos, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnaar, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolhuis, R. L.</span><span> </span><span class="NLM_article-title">Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody</span> <span class="citation_source-journal">J. Natl. Cancer. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">â</span> <span class="NLM_lpage">1469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1093%2Fjnci%2F87.19.1463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=7674333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A280%3ADyaK2MvgsVKntQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1995&pages=1463-1469&author=S.+Canevariauthor=G.+Stoterauthor=F.+Arientiauthor=G.+Bollsauthor=M.+I.+Colnaghiauthor=E.+M.+Di+Reauthor=A.+M.+Eggermontauthor=S.+H.+Goeyauthor=J.+W.+Gratamaauthor=C.+H.+Lamersauthor=M.+A.+Nooyauthor=G.+Parmianiauthor=F.+Raspagliesiauthor=F.+Ravagnaniauthor=G.+Scarfoneauthor=J.+B.+Trimbosauthor=S.+O.+Warnaarauthor=R.+L.+Bolhuis&title=Regression+of+advanced+ovarian+carcinoma+by+intraperitoneal+treatment+with+autologous+T+lymphocytes+retargeted+by+a+bispecific+monoclonal+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody</span></div><div class="casAuthors">Canevari S; Stoter G; Arienti F; Bolis G; Colnaghi M I; Di Re E M; Eggermont A M; Goey S H; Gratama J W; Lamers C H; et al</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1463-9</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">BACKGROUND:  The high frequency of relapse after induction chemotherapy of advanced ovarian carcinoma calls for new therapeutic approaches.  Lysis of ovarian carcinoma cells can be achieved by retargeting of T lymphocytes using F(ab')2 fragments of the bispecific monoclonal antibody (MAb) OC/TR, which is directed to the CD3 molecule on T lymphocytes and to the folate receptor on ovarian carcinoma cells.  PURPOSE:  Our purpose was to assess in ovarian carcinoma patients the antitumor activity of in vitro-activated autologous peripheral blood T lymphocytes retargeted with OC/TR.  METHODS:  Patients with epithelial ovarian cancer (International Federation of Gynecology and Obstetrics stages III and IV) meeting specific criteria were eligible to enter a phase II immunotherapy trial.  Before immunotherapy, the 28 patients who entered the trial underwent laparotomy to reduce their tumor load and to allow measurement of all indicator lesions.  They then received two cycles of five daily intraperitoneal infusions of autologous in vitro activated peripheral blood T lymphocytes retargeted with OC/TR plus recombinant interleukin 2 (IL-2) with (n = 11) or without (n = 17) a second daily infusion of OC/TR F(ab')2 and IL-2.  Response to treatment could be assessed in 26 patients following explorative laparotomy; time to progression could be assessed in 27 patients.  RESULTS:  Seven patients had clinical evidence of progressive disease after treatment and therefore did not undergo laparotomy.  Of the 19 patients evaluated by surgery and histology, three showed complete response, one showed complete intraperitoneal response with progressive disease in retroperitoneal lymph nodes, three showed partial response, seven had stable disease, and five had progressive disease.  The overall intraperitoneal response rate was 27% (95% confidence interval [CI] = 10%-44%).  The complete responses seen in three patients lasted 26 months in one patient, 23 months in the second, and 18 months in the third.  Two patients were not assessable for response.  One of these patients had bowel perforation during catheter removal, which precluded further evaluation.  The second patient was positive only by cytologic examination before immunotherapy, was tumor free at laparotomy after immunotherapy, and remained so for the entire 21 months of follow-up, as determined by cytologic examination of random biopsy specimens.  The median time to disease progression in the 15 assessable patients plus those who had stable disease was 11 months (95% CI = 6-18 months).  Immunotherapy-related toxic effects included mild to moderate fever, nausea, emesis, and fatigue.  Anti-mouse antibodies were detectable by the end of the treatment in 21 of 25 patients tested.  CONCLUSIONS:  Locoregional immunotherapy of ovarian cancer with bispecific MAb-retargeted T lymphocytes can result in tumor regression.  Toxicity was mild to moderate and only transient.  IMPLICATIONS:  Improvement in systemic antitumor responses is needed before this approach can prove useful as adjunctive treatment following induction chemotherapy in patients with minimal residual disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRM_FUFogOCGZyxfu64m4ffW6udTcc2eYeVT8qtmq6arntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MvgsVKntQ%253D%253D&md5=48952650de6b77951092eaade2d7acc2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F87.19.1463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F87.19.1463%26sid%3Dliteratum%253Aachs%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DStoter%26aufirst%3DG.%26aulast%3DArienti%26aufirst%3DF.%26aulast%3DBolls%26aufirst%3DG.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26aulast%3DDi%2BRe%26aufirst%3DE.%2BM.%26aulast%3DEggermont%26aufirst%3DA.%2BM.%26aulast%3DGoey%26aufirst%3DS.%2BH.%26aulast%3DGratama%26aufirst%3DJ.%2BW.%26aulast%3DLamers%26aufirst%3DC.%2BH.%26aulast%3DNooy%26aufirst%3DM.%2BA.%26aulast%3DParmiani%26aufirst%3DG.%26aulast%3DRaspagliesi%26aufirst%3DF.%26aulast%3DRavagnani%26aufirst%3DF.%26aulast%3DScarfone%26aufirst%3DG.%26aulast%3DTrimbos%26aufirst%3DJ.%2BB.%26aulast%3DWarnaar%26aufirst%3DS.%2BO.%26aulast%3DBolhuis%26aufirst%3DR.%2BL.%26atitle%3DRegression%2520of%2520advanced%2520ovarian%2520carcinoma%2520by%2520intraperitoneal%2520treatment%2520with%2520autologous%2520T%2520lymphocytes%2520retargeted%2520by%2520a%2520bispecific%2520monoclonal%2520antibody%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D1995%26volume%3D87%26spage%3D1463%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Melani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicosia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luison, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casorati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshhar, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M. P.</span><span> </span><span class="NLM_article-title">Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4146</span><span class="NLM_x">â</span> <span class="NLM_lpage">4154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4146-4154&author=C.+Melaniauthor=M.+Figiniauthor=D.+Nicosiaauthor=E.+Luisonauthor=V.+Ramakrishnaauthor=G.+Casoratiauthor=G.+Parmianiauthor=Z.+Eshharauthor=S.+Canevariauthor=M.+P.+Colombo&title=Targeting+of+interleukin+2+to+human+ovarian+carcinoma+by+fusion+with+a+single-chain+Fv+of+antifolate+receptor+antibody"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelani%26aufirst%3DC.%26aulast%3DFigini%26aufirst%3DM.%26aulast%3DNicosia%26aufirst%3DD.%26aulast%3DLuison%26aufirst%3DE.%26aulast%3DRamakrishna%26aufirst%3DV.%26aulast%3DCasorati%26aufirst%3DG.%26aulast%3DParmiani%26aufirst%3DG.%26aulast%3DEshhar%26aufirst%3DZ.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520of%2520interleukin%25202%2520to%2520human%2520ovarian%2520carcinoma%2520by%2520fusion%2520with%2520a%2520single-chain%2520Fv%2520of%2520antifolate%2520receptor%2520antibody%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4146%26epage%3D4154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Spannuth, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. L.</span><span> </span><span class="NLM_article-title">Farletuzumab in epithelial ovarian carcinoma</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1517%2F14712591003592069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=20092424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=431-437&author=W.+A.+Spannuthauthor=A.+K.+Soodauthor=R.+L.+Coleman&title=Farletuzumab+in+epithelial+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Farletuzumab in epithelial ovarian carcinoma</span></div><div class="casAuthors">Spannuth, Whitney A.; Sood, Anil K.; Coleman, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">431-437</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Ovarian cancer is the leading cause of death from a gynecol. malignancy.  Recurrence is both common and lethal, necessitating the development of novel targeted therapies.  Farletuzumab (MORAb-003) is a humanized mAb with high affinity for folate receptor Î± (FRÎ±), a 38 kDa GPI-anchored protein that is overexpressed in 90% of epithelial ovarian cancers.Areas covered in this review: Preclin. and clin. trials, published or presented at national meetings from 2006 to the present, are presented in this review.What the reader will gain: Preclin. studies have demonstrated robust antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro, inhibition of tumor growth in ovarian tumor xenografts and a safe toxicol. profile in non-human primates.  Phase I and II studies have demonstrated single agent and combination therapy efficacy with minimal drug-specific toxicity.  The Phase III development plan in ovarian cancer patients includes combination chemotherapy studies in both platinum-sensitive (recently launched) and platinum-resistant (planned) recurrent disease.Take home message: FRÎ± is overexpressed in ovarian cancers but largely absent from normal tissue, making it an attractive therapeutic target.  Farletuzumab is a novel inhibitor of FRÎ± and has shown clin. efficacy in early phase trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0MP0Tnh8nJrVg90H21EOLACvtfcHk0lix1rtyckvJAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsb8%253D&md5=71c0426b2f81493887249bc61923f157</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1517%2F14712591003592069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712591003592069%26sid%3Dliteratum%253Aachs%26aulast%3DSpannuth%26aufirst%3DW.%2BA.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DColeman%26aufirst%3DR.%2BL.%26atitle%3DFarletuzumab%2520in%2520epithelial%2520ovarian%2520carcinoma%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D431%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Kranz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinella, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, E. J.</span><span> </span><span class="NLM_article-title">Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">9057</span><span class="NLM_x">â</span> <span class="NLM_lpage">9061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=9057-9061&author=D.+M.+Kranzauthor=T.+A.+Patrickauthor=K.+E.+Brigleauthor=M.+J.+Spinellaauthor=E.+J.+Roy&title=Conjugates+of+folate+and+anti-T-cell-receptor+antibodies+specifically+target+folate-receptor-positive+tumor+cells+for+lysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKranz%26aufirst%3DD.%2BM.%26aulast%3DPatrick%26aufirst%3DT.%2BA.%26aulast%3DBrigle%26aufirst%3DK.%2BE.%26aulast%3DSpinella%26aufirst%3DM.%2BJ.%26aulast%3DRoy%26aufirst%3DE.%2BJ.%26atitle%3DConjugates%2520of%2520folate%2520and%2520anti-T-cell-receptor%2520antibodies%2520specifically%2520target%2520folate-receptor-positive%2520tumor%2520cells%2520for%2520lysis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D9057%26epage%3D9061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Cho, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranz, D. M.</span><span> </span><span class="NLM_article-title">Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">â</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9700244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2sXivF2htLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=338-346&author=B.+K.+Choauthor=E.+J.+Royauthor=T.+A.+Patrickauthor=D.+M.+Kranz&title=Single-chain+Fv%2Ffolate+conjugates+mediate+efficient+lysis+of+folate-receptor-positive+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Single-Chain Fv/Folate Conjugates Mediate Efficient Lysis of Folate-Receptor-Positive Tumor Cells</span></div><div class="casAuthors">Cho, Bryan K.; Roy, Edward J.; Patrick, Todd A.; Kranz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bispecific antibodies that bind to a tumor antigen and the T cell receptor (TCR) redirect cytotoxic T lymphocytes (CTL) to lyse tumor cells which have escaped normal immune recognition mechanisms.  One well-characterized tumor antigen, the folate receptor (FR), is expressed on most ovarian carcinomas and some types of brain cancer.  Recently, it was shown that conjugates of folate and anti-TCR antibodies are extremely potent bispecific agents that target tumor cells expressing the high-affinity folate receptor, but not normal cells expressing only the reduced folate carrier protein.  In this paper, it is shown that the size of these conjugates can be reduced to the smallest bispecific agent yet described (30 kDa) by attaching folate to a single-chain antibody, scFv, of the anti-TCR antibody KJ16.  The scFv/folate conjugates are as effective as IgG/folate conjugates in mediating lysis of FR+ tumor cells by CTL.  The optimal folate d. was in the range of 5-15 folate mols. per scFv or IgG mol., which yielded half-maximal lysis values (EC50) of approx. 40 pM (1.2 ng/mL for scFv).  Finally, the scFv/folate conjugates could efficiently target tumor cells even in the presence of free folic acid at concns. that are normally found in serum.  Compared to conventional bispecific antibodies, the small size of scFv/folate conjugates may prove advantageous in the ability to penetrate tumors and in reduced immunogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpSkfzcKlocLVg90H21EOLACvtfcHk0lhHBi5MxwIlxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivF2htLc%253D&md5=c7e1c6b96b9097f1e7933dc2c3534f43</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbc9700244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9700244%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DB.%2BK.%26aulast%3DRoy%26aufirst%3DE.%2BJ.%26aulast%3DPatrick%26aufirst%3DT.%2BA.%26aulast%3DKranz%26aufirst%3DD.%2BM.%26atitle%3DSingle-chain%2520Fv%252Ffolate%2520conjugates%2520mediate%2520efficient%2520lysis%2520of%2520folate-receptor-positive%2520tumor%2520cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D338%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Rund, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holler, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranz, D. M.</span><span> </span><span class="NLM_article-title">Bispecific agents target endogenous murine T cells against human tumor xenografts</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F%28SICI%291097-0215%2819990924%2983%3A1%3C141%3A%3AAID-IJC24%3E3.0.CO%3B2-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=10449621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1MXlvF2nt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=141-149&author=L.+A.+Rundauthor=B.+K.+Choauthor=T.+C.+Manningauthor=P.+D.+Hollerauthor=E.+J.+Royauthor=D.+M.+Kranz&title=Bispecific+agents+target+endogenous+murine+T+cells+against+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Bispecific agents target endogenous murine T cells against human tumor xenografts</span></div><div class="casAuthors">Rund, Laurie A.; Cho, Bryan K.; Manning, Thomas C.; Holler, Phillip D.; Roy, Edward J.; Kranz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-149</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A variety of immunol. approaches to cancer treatment are currently being explored.  These include strategies designed to enhance or redirect the activity of T cells against tumors.  Bispecific antibodies comprise a class of agents capable of redirecting T cells by binding to a tumor antigen and the T-cell receptor (TCR).  In vivo pre-clin. testing of bispecific antibodies against human tumors has to date been limited to the use of immunodeficient mice that receive the bispecific agent, activated human effector T cells, and human tumor cells.  In this report, we show that TCR transgenic/RAG-I knockout mice (TCR/RAG) serve as a unique model allowing endogenous T cells to be redirected against transplanted human tumors.  The findings show that TCR/RAG mice (i) accepted transplants of human tumors, including the folate-receptor-pos. tumor line KB; (ii) contained endogenous cytotoxic T lymphocytes that could be activated in vivo with an antigenic peptide recognized by the transgenic TCR; (iii) rejected human tumors after treatment with the activating peptide and bispecific agents that contained folic acid covalently linked to an anti-TCR antibody.  Successful rejection was achieved with folate conjugates of Fab or scFv fragments.  Treatment with activating agents and bispecific conjugates resulted in the complete eradication of freshly transplanted tumors as well as significantly prolonging the survival of mice bearing established solid tumors.  Our results highlight the importance of including T-cell-activating modalities in combination with bispecific antibodies.  Addnl., we introduce a system that allows endogenous T cells to be redirected against human tumor xenografts and in which the T cells may be followed in vivo by use of a clonotypic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEvRidTOBqVrVg90H21EOLACvtfcHk0lhHBi5MxwIlxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvF2nt7k%253D&md5=e145c77f666f5b9cd4b8da003cbb09c5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819990924%2983%3A1%3C141%3A%3AAID-IJC24%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819990924%252983%253A1%253C141%253A%253AAID-IJC24%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DRund%26aufirst%3DL.%2BA.%26aulast%3DCho%26aufirst%3DB.%2BK.%26aulast%3DManning%26aufirst%3DT.%2BC.%26aulast%3DHoller%26aufirst%3DP.%2BD.%26aulast%3DRoy%26aufirst%3DE.%2BJ.%26aulast%3DKranz%26aufirst%3DD.%2BM.%26atitle%3DBispecific%2520agents%2520target%2520endogenous%2520murine%2520T%2520cells%2520against%2520human%2520tumor%2520xenografts%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1999%26volume%3D83%26spage%3D141%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Knutson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krco, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelemen, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalli, K. R.</span><span> </span><span class="NLM_article-title">T-Cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4254</span><span class="NLM_x">â</span> <span class="NLM_lpage">4261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1200%2FJCO.2006.05.9311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16908932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGju7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=4254-4261&author=K.+L.+Knutsonauthor=C.+J.+Krcoauthor=C.+L.+Erskineauthor=K.+Goodmanauthor=L.+E.+Kelemenauthor=P.+J.+Wettsteinauthor=P.+S.+Lowauthor=L.+C.+Hartmannauthor=K.+R.+Kalli&title=T-Cell+immunity+to+the+folate+receptor+alpha+is+prevalent+in+women+with+breast+or+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">T-Cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer</span></div><div class="casAuthors">Knutson, Keith L.; Krco, Christopher J.; Erskine, Courtney L.; Goodman, Karin; Kelemen, Linda E.; Wettstein, Peter J.; Low, Philip S.; Hartmann, Lynn C.; Kalli, Kimberly R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4254-4261</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Studies have demonstrated that the generation of immunity to tumor antigens is assocd. with improved prognosis for many cancers.  A candidate antigen is the folate receptor alpha (FRÎ±), which is overexpressed in breast and ovarian cancers.  Our goal in this study was to attain a better understanding of the extent of endogenous FRÎ± immunity.  Methods: Using a CD4+ T cell epitope prediction algorithm, we predicted promiscuous epitopes of FRÎ±, and tested for immunity in 30 breast (n = 17) or ovarian (n = 13) cancer patients and 18 healthy donors using enzyme-linked immunospot anal.  Results: Fourteen peptides were predicted, seven each from the carboxy- and amino-terminus halves of the protein.  More than 70% of patients demonstrated immunity to at least one FRÎ± peptide.  Patients responded to an av. of 3 Â± 0.5 peptides, whereas healthy donors responded to 1 Â± 0.4 peptides (P = .004).  Five peptides were recognized by more than 25% of patients.  Responses to three peptides were higher (P < .05) in patients than in healthy donors, suggesting augmented immunity.  Compared with healthy individuals, patients developed higher immunity to the amino-terminus half of the receptor (P = .03).  There was no difference between each group in the responses to nonspecific (P = .2) and viral stimuli (P = .5).  Lastly, patients demonstrated elevated levels of FRÎ± antibodies consistent with a coordinated immune response.  Conclusion: These findings demonstrate that the FRÎ± is a target of the immune system in breast and ovarian cancer patients.  Understanding which antigens are targeted by the immune system may be important for prognosis or immune-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNdnWKnElStrVg90H21EOLACvtfcHk0lhHBi5MxwIlxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGju7vF&md5=d7976f4a778bca6963073d98cca45b82</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.05.9311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.05.9311%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DK.%2BL.%26aulast%3DKrco%26aufirst%3DC.%2BJ.%26aulast%3DErskine%26aufirst%3DC.%2BL.%26aulast%3DGoodman%26aufirst%3DK.%26aulast%3DKelemen%26aufirst%3DL.%2BE.%26aulast%3DWettstein%26aufirst%3DP.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHartmann%26aufirst%3DL.%2BC.%26aulast%3DKalli%26aufirst%3DK.%2BR.%26atitle%3DT-Cell%2520immunity%2520to%2520the%2520folate%2520receptor%2520alpha%2520is%2520prevalent%2520in%2520women%2520with%2520breast%2520or%2520ovarian%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D4254%26epage%3D4261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0168-3659%2803%2900215-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12932634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVSktLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&pages=17-29&author=Y.+Luauthor=P.+S.+Low&title=Immunotherapy+of+folate+receptor-expressing+tumors%3A+review+of+recent+advances+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects</span></div><div class="casAuthors">Lu, Yingjuan; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The cell surface receptor for the vitamin folic acid (termed the folate receptor), is often elevated in cancers of the ovary, kidney, lung, mammary gland, brain, endometrium, and myeloid cells of hematopoietic origin.  Because the folate receptor (FR) is either absent from normal tissues or localized to the apical surfaces of polarized epithelia, where it is inaccessible to circulating drugs, folate-linked drugs do not normally accumulate in healthy tissues.  However, since the same receptor is fully accessible on cancer cells, it has frequently been exploited as a target for receptor-directed cancer therapies, including chemotherapies and immunotherapies.  In fact, most strategies for the immunotherapy of cancer have at some time been adapted to treat FR-expressing tumors.  In this article, recent progress in the retargeting of the immune system to folate receptor-expressing cancers is summarized and future strategies for redirecting natural killer cells, antibodies and cytotoxic T lymphocytes to this large class of malignancies are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShPjiB9PSs7Vg90H21EOLACvtfcHk0lhHBi5MxwIlxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVSktLw%253D&md5=a049999c82f8f567607bdeeec408790f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2803%2900215-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252803%252900215-3%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DImmunotherapy%2520of%2520folate%2520receptor-expressing%2520tumors%253A%2520review%2520of%2520recent%2520advances%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2003%26volume%3D91%26spage%3D17%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Yi, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Lopez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">â</span> <span class="NLM_lpage">1236</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp900070b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWjtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1228-1236&author=Y.+S.+Yiauthor=W.+Ayala-Lopezauthor=S.+A.+Kularatneauthor=P.+S.+Low&title=Folate-targeted+hapten+immunotherapy+of+adjuvant-induced+arthritis%3A+comparison+of+hapten+potencies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Targeted Hapten Immunotherapy of Adjuvant-Induced Arthritis: Comparison of Hapten Potencies</span></div><div class="casAuthors">Yi, Young-Su; Ayala-Lopez, Wilfredo; Kularatne, Sumith A.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1228-1236</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously reported that disease symptoms can be greatly ameliorated in rodents with adjuvant-induced arthritis (AIA) by first immunizing the rodents against fluorescein and then treating the animals with folate-fluorescein.  In this targeted hapten therapy, folate-fluorescein was shown to decorate folate receptor (FR)-expressing activated macrophages with fluorescein (an immunogenic hapten), leading to binding of antifluorescein antibodies and the consequent elimination of the activated macrophages by Fc receptor-expressing immune cells.  In the current study, we compare the therapeutic potencies of a variety of FR-targeted haptens in treating the symptoms of AIA in rats.  Rats were immunized with either dinitrophenyl (DNP) or trinitrophenyl (TNP) conjugated to keyhole limpet hemocyanin followed by induction of AIA with heat-inactivated Mycobacterium butyricum.  Following development of arthritis, rats were treated with one of five folate-hapten conjugates (folate-DNP1, folate-DNP2, folate-DNP3, folate-FITC, or folate-TNP) at two different doses (30 nmol/kg or 200 nmol/kg) 5Ã/wk for 25 days.  Symptoms of AIA in treated rats, including paw swelling, arthritis score, splenomegaly, bone erosion, and FR+ activated macrophage d. in inflamed tissues, were quantitated over the course of therapy.  Although all folate-hapten conjugates promoted a redn. in disease symptoms, folate-TNP and folate-FITC proved to be more potent than any of the 3 folate-DNP conjugates.  We conclude that both folate-TNP and folate-FITC constitute promising haptens for use in FR-targeted immunotherapy of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRXVgay8kFe7Vg90H21EOLACvtfcHk0likHDAqKko41A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWjtb8%253D&md5=a573c9e924c1a006a98f1b9a0b1df858</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fmp900070b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp900070b%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DY.%2BS.%26aulast%3DAyala-Lopez%26aufirst%3DW.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate-targeted%2520hapten%2520immunotherapy%2520of%2520adjuvant-induced%2520arthritis%253A%2520comparison%2520of%2520hapten%2520potencies%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D1228%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Miotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupa, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regazzoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliabue, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span> </span><span class="NLM_article-title">Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fijc.2910390306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=2434438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaL2sXhslCgtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1987&pages=297-303&author=S.+Miottiauthor=S.+Canevariauthor=S.+Menardauthor=D.+Mezzanzanicaauthor=G.+Porroauthor=S.+M.+Pupaauthor=M.+Regazzoniauthor=E.+Tagliabueauthor=M.+I.+Colnaghi&title=Characterization+of+human+ovarian+carcinoma-associated+antigens+defined+by+novel+monoclonal+antibodies+with+tumor-restricted+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity</span></div><div class="casAuthors">Miotti, S.; Canevari, S.; Menard, S.; Mezzanzanica, D.; Porro, G.; Pupa, S. M.; Regazzoni, M.; Tagliabue, E.; Colnachi, M. I.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-303</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Three new monoclonal antibodies (MAbs) (MOv16, MOv18 and MOv19) were raised against human ovarian carcinoma.  To obtain more specific reagents, the following exptl. approach was adopted: (1) the selection of a poorly differentiated ovarian carcinoma which was unreactive with all the MAb previously selected in the authors' lab.; and (2) the application of a particular immunization protocol.  The reactivity of the selected MAbs was studied by solid-phase RIA on live and fixed cells from tumor cell lines and by immunofluorescence on frozen sections from surgical specimens.  The MAb MOv16 reacted with 60% of ovarian carcinomas as well as with a high percentage of other carcinomas and with some normal tissues.  In contrast, MOv18 and MOv19 appeared to have restricted specificities for ovarian carcinomas and cystadenomas.  Reactivity to other carcinomas was obsd. in a few cases and no reactivity was found to non-epithelial tumors or normal tissues.  Immunopptn. expts. indicated that MOv16 recognizes a 48-50 kilodalton (kDA) protein, whereas MOv18 and MOv19 both identify a 38-40 kDA glycoprotein band.  Cross-competition expts., together with a double-determinant immunoradiometric assay which uses MOv18 as catcher and MOv19 as tracer, suggested that they recognize different epitopes carried by the same mol.  Thus, MOv18 and MOv19 could be efficient tools for in vivo diagnosis and therapy of ovarian carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Lylmslvx9LVg90H21EOLACvtfcHk0likHDAqKko41A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhslCgtrs%253D&md5=8891a5cfda16ff233b9b870daa5cf9d1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910390306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910390306%26sid%3Dliteratum%253Aachs%26aulast%3DMiotti%26aufirst%3DS.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DMenard%26aufirst%3DS.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DPorro%26aufirst%3DG.%26aulast%3DPupa%26aufirst%3DS.%2BM.%26aulast%3DRegazzoni%26aufirst%3DM.%26aulast%3DTagliabue%26aufirst%3DE.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26atitle%3DCharacterization%2520of%2520human%2520ovarian%2520carcinoma-associated%2520antigens%2520defined%2520by%2520novel%2520monoclonal%2520antibodies%2520with%2520tumor-restricted%2520specificity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1987%26volume%3D39%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Coney, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carayannopoulos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurawski, V. R.,  Jr.</span><span> </span><span class="NLM_article-title">Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6125</span><span class="NLM_x">â</span> <span class="NLM_lpage">6132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=6125-6132&author=L.+R.+Coneyauthor=A.+Tomassettiauthor=L.+Carayannopoulosauthor=V.+Frascaauthor=B.+A.+Kamenauthor=M.+I.+Colnaghiauthor=V.+R.+Zurawski&title=Cloning+of+a+tumor-associated+antigen%3A+MOv18+and+MOv19+antibodies+recognize+a+folate-binding+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConey%26aufirst%3DL.%2BR.%26aulast%3DTomassetti%26aufirst%3DA.%26aulast%3DCarayannopoulos%26aufirst%3DL.%26aulast%3DFrasca%26aufirst%3DV.%26aulast%3DKamen%26aufirst%3DB.%2BA.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26aulast%3DZurawski%26aufirst%3DV.%2BR.%26atitle%3DCloning%2520of%2520a%2520tumor-associated%2520antigen%253A%2520MOv18%2520and%2520MOv19%2520antibodies%2520recognize%2520a%2520folate-binding%2520protein%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D6125%26epage%3D6132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit-Taskar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâDonoghue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasquillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konner, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span> </span><span class="NLM_article-title">Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">â</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.nucmedbio.2007.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18355690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1KitLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=343-351&author=P.+M.+Smith-Jonesauthor=N.+Pandit-Taskarauthor=W.+Caoauthor=J.+O%E2%80%99Donoghueauthor=M.+D.+Philipsauthor=J.+Carrasquilloauthor=J.+A.+Konnerauthor=L.+J.+Oldauthor=S.+M.+Larson&title=Preclinical+radioimmunotargeting+of+folate+receptor+alpha+using+the+monoclonal+antibody+conjugate+DOTA-MORAb-003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003</span></div><div class="casAuthors">Smith-Jones, Peter M.; Pandit-Taskar, Neeta; Cao, Wei; O'Donoghue, Joseph; Philips, Martin D.; Carrasquillo, Jorge; Konner, Jason A.; Old, Lloyd J.; Larson, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-351</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: The in vitro and in vivo behavior of the radiolabeled monoclonal antibody MORAb-003 was investigated as a prelude to a clin. trial.  Methods: The cellular retention of 111In- and 131I-labeled MORAb-003 was investigated using IGROV1 and SW620 cells.  Biodistribution studies in tumor-bearing mice were performed with the more favorable agent.  Results: Five 1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid (DOTA) mols. were conjugated to MORAb-003 with no apparent loss of immunoreactivity.  Radiolabeled MORAb-003 had a high affinity for the folate receptor alpha (FRA) expressed by both IGROV1 and SW620 cells and was found to bind to around 8Ã105 and 7 Ã 105 sites/cell, resp.  Both cancer cell lines were found to internalize both 131I- and 111In-labeled MORAb-003, but 111In was retained and 131I was released as iodide.  In athymic mice, 111In-DOTA-MORAb-003 was cleared from the blood with a single exponential biol. clearance rate of 110 h.  The uptake in SW620 tumors was 32 Â± 5%ID/g after 4 days.  The clearance rate of activity from normal organs such as liver, kidney and spleen was similar to the blood clearance and was 5.36%ID/g, 4.03%ID/g and 4.36%ID/g at 1 day postinjection and 2.14%ID/g, 1.65%ID/g and 3.74%ID/g after 8 days, resp.  In a pilot clin. study, the biodistribution and tumor targeting of 111In-MORAb-003 was assessed in three patients undergoing treatment with cold MORAb-003.  Conclusion: MORAb-003 is an attractive antibody for radioimmunoscintigraphy and possibly radioimmunotherapy of FRA-expressing cancers in addn. to its potential direct therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFEvNdHveZ17Vg90H21EOLACvtfcHk0liAR2pCEkkd7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1KitLo%253D&md5=c2c06179a574b98083f5d429c0a6e4fc</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DPandit-Taskar%26aufirst%3DN.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DJ.%26aulast%3DPhilips%26aufirst%3DM.%2BD.%26aulast%3DCarrasquillo%26aufirst%3DJ.%26aulast%3DKonner%26aufirst%3DJ.%2BA.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26atitle%3DPreclinical%2520radioimmunotargeting%2520of%2520folate%2520receptor%2520alpha%2520using%2520the%2520monoclonal%2520antibody%2520conjugate%2520DOTA-MORAb-003%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D343%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Coney, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurawski, V. R.,  Jr.</span><span> </span><span class="NLM_article-title">Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2448</span><span class="NLM_x">â</span> <span class="NLM_lpage">2455</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=2448-2455&author=L.+R.+Coneyauthor=D.+Mezzanzanicaauthor=D.+Sanbornauthor=P.+Casaliniauthor=M.+I.+Colnaghiauthor=V.+R.+Zurawski&title=Chimeric+murine-human+antibodies+directed+against+folate+binding+receptor+are+efficient+mediators+of+ovarian+carcinoma+cell+killing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConey%26aufirst%3DL.%2BR.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DSanborn%26aufirst%3DD.%26aulast%3DCasalini%26aufirst%3DP.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26aulast%3DZurawski%26aufirst%3DV.%2BR.%26atitle%3DChimeric%2520murine-human%2520antibodies%2520directed%2520against%2520folate%2520binding%2520receptor%2520are%2520efficient%2520mediators%2520of%2520ovarian%2520carcinoma%2520cell%2520killing%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D2448%26epage%3D2455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Figini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, A. D.</span><span> </span><span class="NLM_article-title">In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">239</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">â</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=1994&pages=68-78&author=M.+Figiniauthor=J.+D.+Marksauthor=G.+Winterauthor=A.+D.+Griffiths&title=In+vitro+assembly+of+repertoires+of+antibody+chains+on+the+surface+of+phage+by+renaturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFigini%26aufirst%3DM.%26aulast%3DMarks%26aufirst%3DJ.%2BD.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DGriffiths%26aufirst%3DA.%2BD.%26atitle%3DIn%2520vitro%2520assembly%2520of%2520repertoires%2520of%2520antibody%2520chains%2520on%2520the%2520surface%2520of%2520phage%2520by%2520renaturation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1994%26volume%3D239%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Figini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luison, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripamonti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortarino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cioccio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurizi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span> </span><span class="NLM_article-title">Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor</span> <span class="citation_source-journal">Cancer Immunol. Immunother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">â</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs00262-008-0575-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18704410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Olsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=531-546&author=M.+Figiniauthor=F.+Martinauthor=R.+Ferriauthor=E.+Luisonauthor=E.+Ripamontiauthor=A.+Zacchettiauthor=M.+Mortarinoauthor=V.+Di+Cioccioauthor=G.+Mauriziauthor=M.+Allegrettiauthor=S.+Canevari&title=Conversion+of+murine+antibodies+to+human+antibodies+and+their+optimization+for+ovarian+cancer+therapy+targeted+to+the+folate+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor</span></div><div class="casAuthors">Figini, Mariangela; Martin, Franck; Ferri, Renata; Luison, Elena; Ripamonti, Elena; Zacchetti, Alberto; Mortarino, Mimosa; Cioccio, Vito; Maurizi, Giovanni; Allegretti, Marcello; Canevari, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-546</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We previously developed murine and chimeric antibodies against a specific epithelial ovarian carcinoma (EOC) marker, named folate receptor (FR), and promising results were obtained in phase II trials.  More recently, we successfully generated a completely human Fab fragment, C4, by conversion of one of the murine anti-FR antibodies to human antibody using phage display and guided selection.  However, subsequent efforts to obtain C4 in a dimer format, which seems esp. desirable for EOC locoregional treatment, resulted in a highly heterogeneous product upon natural dimerization and in a very poor prodn. yield upon chem. dimerization by a non-hydrolyzable linker to a di-Fab-maleimide (DFM).  We therefore designed, constructed and characterized a large Fab dual combinatorial human antibody phage display library obtained from EOC patients and potentially biased toward an anti-tumor response in an effort to obtain new anti-FR human antibodies suitable for therapy.  Using this library and guiding the selection on FR-expressing cells with murine/human antibody chains, we generated four new human anti-FR antibody (AFRA) Fab fragments, one of which was genetically and chem. manipulated to obtain a chem. dimer, designated AFRA-DFM5.3, with high yield prodn. and the capability for purifn. scaled-up to clin. grade.  Overall affinity of AFRA-DFM5.3 was in the 2-digit nanomolar range, and immunohistochem. indicated that the reagent recognized the FR expressed on EOC samples. 131I-AFRA-DFM5.3 showed high immunoreactivity, in vitro stability and integrity, and specifically accumulated only in FR-expressing tumors in s.c. preclin. in vivo models.  Overall, our studies demonstrate the successful conversion of murine to completely human anti-FR antibodies through the combined use of antibody phage display libraries biased toward an anti-tumor response, guided selection and chain shuffling, and point to the suitability of AFRA5.3 for future clin. application in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp77BCOtMmA7Vg90H21EOLACvtfcHk0liAR2pCEkkd7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Olsbc%253D&md5=21ad69dc44ff17f09748c583153d3776</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1007%2Fs00262-008-0575-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-008-0575-5%26sid%3Dliteratum%253Aachs%26aulast%3DFigini%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DF.%26aulast%3DFerri%26aufirst%3DR.%26aulast%3DLuison%26aufirst%3DE.%26aulast%3DRipamonti%26aufirst%3DE.%26aulast%3DZacchetti%26aufirst%3DA.%26aulast%3DMortarino%26aufirst%3DM.%26aulast%3DDi%2BCioccio%26aufirst%3DV.%26aulast%3DMaurizi%26aufirst%3DG.%26aulast%3DAllegretti%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DS.%26atitle%3DConversion%2520of%2520murine%2520antibodies%2520to%2520human%2520antibodies%2520and%2520their%2520optimization%2520for%2520ovarian%2520cancer%2520therapy%2520targeted%2520to%2520the%2520folate%2520receptor%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2009%26volume%3D58%26spage%3D531%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">â</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fijc.21126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15828051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXosVaqtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2005&pages=710-719&author=Y.+Luauthor=E.+Segaauthor=P.+S.+Low&title=Folate+receptor-targeted+immunotherapy%3A+induction+of+humoral+and+cellular+immunity+against+hapten-decorated+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-targeted immunotherapy: Induction of humoral and cellular immunity against hapten-decorated cancer cells</span></div><div class="casAuthors">Lu, Yingjuan; Sega, Emanuela; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">710-719</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We previously exploited the frequent overexpression of folate receptors on cancer cells to decorate malignant cell surfaces selectively with folate-hapten conjugates.  In antihapten-immunized hosts, this targeted localization of foreign haptens to tumor cells led to rapid accumulation of autologous antihapten IgG, which in turn yielded potent antitumor activity upon stimulation with cytokines (IL-2, IFN-Î±).  In an effort to understand the effector mechanisms responsible for tumor regression, we have now investigated the involvement of both humoral and cellular immune components in the tumor destruction process.  We report that the dependence of therapeutic efficacy on folate-hapten concn. is bimodal, suggesting that the conjugate must bridge between a cell surface FR and an antihapten IgG in order to mediate killing.  Studies with cancer cells in vitro further demonstrate that folate-fluorescein-marked tumor cells are killed primarily by antibody-dependent cellular cytotoxicity and phagocytosis, with no contribution from complement-dependent mechanisms.  Investigations of specific immune cell involvement also reveal that asialo-GMI+-natural killer cells, macrophages, CD4+ T cells and CD8+ T cells contribute significantly to recognition/removal of the cancer mass, and that elimination of these cell types markedly compromises the therapy.  Because the initial antibody-dependent stage of tumor cell killing is shown to lead to a long-term antibody-independent cellular immunity that involves both CD4+ and CD8+ T cells, we propose that Fc receptor-expressing immune cells not only initiate destruction of the IgG-marked tumor cells, but also participate in presentation of endogenous tumor antigens in a manner that leads to long-term cellular immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwssI7ou1kc7Vg90H21EOLACvtfcHk0ljwMlFybOY6dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXosVaqtLs%253D&md5=df153353c29643bc3adccd35e766e8ef</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fijc.21126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21126%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSega%26aufirst%3DE.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate%2520receptor-targeted%2520immunotherapy%253A%2520induction%2520of%2520humoral%2520and%2520cellular%2520immunity%2520against%2520hapten-decorated%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D116%26spage%3D710%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Douglas, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curiel, D. T.</span><span> </span><span class="NLM_article-title">Targeted gene delivery by tropism-modified adenoviral vectors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1574</span><span class="NLM_x">â</span> <span class="NLM_lpage">1578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=1574-1578&author=J.+T.+Douglasauthor=B.+E.+Rogersauthor=M.+E.+Rosenfeldauthor=S.+I.+Michaelauthor=M.+Fengauthor=D.+T.+Curiel&title=Targeted+gene+delivery+by+tropism-modified+adenoviral+vectors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DJ.%2BT.%26aulast%3DRogers%26aufirst%3DB.%2BE.%26aulast%3DRosenfeld%26aufirst%3DM.%2BE.%26aulast%3DMichael%26aufirst%3DS.%2BI.%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DCuriel%26aufirst%3DD.%2BT.%26atitle%3DTargeted%2520gene%2520delivery%2520by%2520tropism-modified%2520adenoviral%2520vectors%26jtitle%3DNat.%2520Biotechnol.%26date%3D1996%26volume%3D14%26spage%3D1574%26epage%3D1578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">El-Aneed, A.</span><span> </span><span class="NLM_article-title">An overview of current delivery systems in cancer gene therapy</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.jconrel.2003.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14684267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslCmu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=1-14&author=A.+El-Aneed&title=An+overview+of+current+delivery+systems+in+cancer+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of current delivery systems in cancer gene therapy</span></div><div class="casAuthors">El-Aneed, Anas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The main objective in gene therapy is the development of efficient, non-toxic gene carriers that can encapsulate and deliver foreign genetic materials into specific cell types such as cancerous cells.  During the past two decades, enormous research in the area of gene delivery has been conducted worldwide, in particular for cancer gene therapy application.  Viral vectors are biol. systems derived from naturally evolved viruses capable of transferring their genetic materials into the host cells.  Many viruses including retrovirus, adenovirus, herpes simplex virus (HSV), adeno-assocd. virus (AAV) and pox virus have been modified to eliminate their toxicity and maintain their high gene transfer capability.  The limitations assocd. with viral vectors, however, in terms of their safety, particularly immunogenicity, and in terms of their limited capacity of transgenic materials, have encouraged researchers to increasingly focus on non-viral vectors as an alternative to viral vectors.  Non-viral vectors are generally cationic in nature.  They include cationic polymers such as poly(ethylenimine) (PEI) and poly(l-lysine) (PLL), cationic peptides and cationic liposomes.  The newly described liposomal prepn. LPD (liposomes/protamine/DNA), for example, has shown superiority over conventional liposomes/DNA complexes (lipoplexes).  Although non-viral vectors are less efficient than viral ones, they have the advantages of safety, simplicity of prepn. and high gene encapsulation capability.  This article reviews the most recent studies highlighting the advantages and the limitations of various types of gene delivery systems used in cancer gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvZ_7RS8hEdLVg90H21EOLACvtfcHk0ljwMlFybOY6dg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslCmu70%253D&md5=2ac74d680875518c68d2dc89d7a92d85</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2003.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2003.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Aneed%26aufirst%3DA.%26atitle%3DAn%2520overview%2520of%2520current%2520delivery%2520systems%2520in%2520cancer%2520gene%2520therapy%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2004%26volume%3D94%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Gottschalk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiano, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S. L.</span><span> </span><span class="NLM_article-title">Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression</span> <span class="citation_source-journal">Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">â</span> <span class="NLM_lpage">191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=7584080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGitrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1994&pages=185-191&author=S.+Gottschalkauthor=R.+J.+Cristianoauthor=L.+C.+Smithauthor=S.+L.+Woo&title=Folate+receptor+mediated+DNA+delivery+into+tumor+cells%3A+potosomal+disruption+results+in+enhanced+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-mediated DNA delivery into tumor cells: Potosomal disruption results in enhanced gene expression</span></div><div class="casAuthors">Gottschalk, Stephen; Cristiano, Richard J.; Smith, Louis C.; Woo, Savio L. C.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Therapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">185-91</span>CODEN:
                <span class="NLM_cas:coden">GETHEC</span>;
        ISSN:<span class="NLM_cas:issn">0969-7128</span>.
    </div><div class="casAbstract">We have used a particular folate receptor, which is overexpressed in tumor cells, for targeted DNA delivery into these cell types.  This folate receptor internalizes folate through caveolae by a process named potocytosis, which is distinct from endocytosis, through clathrin-coated pits.  When folate conjugated to poly-L-lysine was used to deliver the E. coli Î²-galactosidase gene into tumor cells overexpressing the folate receptor, only low levels of Î²-galactosidase activity were detectable.  When a replication-defective adenovirus was coincubated with the DNA/folate complexes, 20 to 30% of the cells stained blue with X-gal and a 1000-fold increase of Î²-galactosidase activity was obsd.  Thus, for high efficient DNA delivery and gene expression via the caveolae system, a potosomal disruption agent is needed.  Furthermore, folate-mediated DNA delivery is restricted to tumor cells that highly overexpress the folate receptor, which will permit future development of tumor cell-specific delivery of toxic genes for cancer gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaYwwCPWEdArVg90H21EOLACvtfcHk0lglMltTbnJOhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGitrc%253D&md5=8be49f53dac6bdc1a02344767900f120</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGottschalk%26aufirst%3DS.%26aulast%3DCristiano%26aufirst%3DR.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BC.%26aulast%3DWoo%26aufirst%3DS.%2BL.%26atitle%3DFolate%2520receptor%2520mediated%2520DNA%2520delivery%2520into%2520tumor%2520cells%253A%2520potosomal%2520disruption%2520results%2520in%2520enhanced%2520gene%2520expression%26jtitle%3DGene%2520Ther.%26date%3D1994%26volume%3D1%26spage%3D185%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1112</span><span class="NLM_x">â</span> <span class="NLM_lpage">1118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=1112-1118&author=J.+A.+Reddyauthor=D.+Deanauthor=M.+D.+Kennedyauthor=P.+S.+Low&title=Optimization+of+folate-conjugated+liposomal+vectors+for+folate+receptor-mediated+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DDean%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DM.%2BD.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DOptimization%2520of%2520folate-conjugated%2520liposomal%2520vectors%2520for%2520folate%2520receptor-mediated%2520gene%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D1112%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">â</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2000&pages=27-37&author=J.+A.+Reddyauthor=P.+S.+Low&title=Enhanced+folate+receptor+mediated+gene+therapy+using+a+novel+pH-sensitive+lipid+formulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DEnhanced%2520folate%2520receptor%2520mediated%2520gene%2520therapy%2520using%2520a%2520novel%2520pH-sensitive%2520lipid%2520formulation%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2000%26volume%3D64%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Lungwitz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breunig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blunk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopferich, A.</span><span> </span><span class="NLM_article-title">Polyethylenimine-based non-viral gene delivery systems</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ejpb.2004.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15939236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCrsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2005&pages=247-266&author=U.+Lungwitzauthor=M.+Breunigauthor=T.+Blunkauthor=A.+Gopferich&title=Polyethylenimine-based+non-viral+gene+delivery+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Polyethylenimine-based non-viral gene delivery systems</span></div><div class="casAuthors">Lungwitz, U.; Breunig, M.; Blunk, T.; Goepferich, A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-266</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Gene therapy has become a promising strategy for the treatment of many inheritable or acquired diseases that are currently considered incurable.  Non-viral vectors have attracted great interest, as they are simple to prep., rather stable, easy to modify and relatively safe, compared to viral vectors.  Unfortunately, they also suffer from a lower transfection efficiency, requiring addnl. effort for their optimization.  The cationic polymer polyethylenimine (PEI) has been widely used for non-viral transfection in vitro and in vivo and has an advantage over other polycations in that it combines strong DNA compaction capacity with an intrinsic endosomolytic activity.  Here, we give some insight into strategies developed for PEI-based non-viral vectors to overcome intracellular obstacles, including the improvement of methods for polyplex prepn. and the incorporation of endosomolytic agents or nuclear localization signals.  In recent years, PEI-based non-viral vectors have been locally or systemically delivered, mostly to target gene delivery to tumor tissue, the lung or liver.  This requires strategies to efficiently shield transfection polyplexes against non-specific interaction with blood components, extracellular matrix and untargeted cells and the attachment of targeting moieties, which allow for the directed gene delivery to the desired cell or tissue.  In this context, materials, facilitating the design of novel PEI-based non-viral vectors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJB9zklqR36rVg90H21EOLACvtfcHk0lglMltTbnJOhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCrsrs%253D&md5=a736d2567d19d48826900c287c38c9fa</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2004.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2004.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLungwitz%26aufirst%3DU.%26aulast%3DBreunig%26aufirst%3DM.%26aulast%3DBlunk%26aufirst%3DT.%26aulast%3DGopferich%26aufirst%3DA.%26atitle%3DPolyethylenimine-based%2520non-viral%2520gene%2520delivery%2520systems%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2005%26volume%3D60%26spage%3D247%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Benns, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maheshwari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furgeson, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahato, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span> </span><span class="NLM_article-title">Folate-PEG-folate-graft-polyethylenimine-based gene delivery</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">â</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.3109%2F10611860108997923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=11697107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslKksr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=123-139&author=J.+M.+Bennsauthor=A.+Maheshwariauthor=D.+Y.+Furgesonauthor=R.+I.+Mahatoauthor=S.+W.+Kim&title=Folate-PEG-folate-graft-polyethylenimine-based+gene+delivery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-PEG-folate-graft-polyethylenimine-based gene delivery</span></div><div class="casAuthors">Benns, Jonathan M.; Maheshwari, Anurag; Furgeson, Darin Y.; Mahato, Ram I.; Kim, Sung Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-139, 176-178, Plate III, IV and V</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">Folate-polyethylene glycol-folate-grafted-polyethylenimine (FPF-g-PEI) was synthesized by linking folic acid to both ends of a mono-functional PEG and then grafting to PEI.  The graft ratio was detd. using Beer's law by measuring the UV absorbance at 363 nm.  The pH profile, diam. and shape of the carriers were detd.  Transfection efficiencies were optimized in normal smooth muscle cells (SMC) and CT-26 colon adenocarcinoma cells using plasmid DNA encoding luciferase reporter gene.  Free folic acid was shown to inhibit transfection with FPF-2.3g-PEI at neutral charge ratio.  Relative toxicity between PEI and the modified carrier was measured using MTT colorimetric assay.  Therapeutic potential of pmIFN-Î³ complexed with these polymeric carriers in terms of gene expression was detd. at protein and mRNA levels using ELISA and RT-PCR.  FPF-g-PEI was detd. to have 2.3 folate-PEG-folate (FPF) linear polymers grafted to each PEI mol.  The av. mol. wt. was measured to be â¼33,500 Mw and the pH profile was characteristic of endosomal disruption capacity.  At. Force Microscopy (AFM) and Dynamic Laser Light Scattering (DLLS) indicated FPF-2.3g-PEI and PEI (at 2 wt./wt. ratio) efficiently condensed plasmid DNA resulting in oblique spheroid polyplexes with a mean diam. of â¼150 nm.  FPF-2.3g-PEI was superior to PEI in terms of cytotoxicity and transfection efficiency in cancer cells.  Smooth muscle cells showed no specificity for folate tethered complexes, where PEI/pLuc complexes yielded higher efficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0pF6EjaU3xrVg90H21EOLACvtfcHk0lglMltTbnJOhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslKksr8%253D&md5=fd7a45a718a135d147371692a2fd4f5a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3109%2F10611860108997923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611860108997923%26sid%3Dliteratum%253Aachs%26aulast%3DBenns%26aufirst%3DJ.%2BM.%26aulast%3DMaheshwari%26aufirst%3DA.%26aulast%3DFurgeson%26aufirst%3DD.%2BY.%26aulast%3DMahato%26aufirst%3DR.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BW.%26atitle%3DFolate-PEG-folate-graft-polyethylenimine-based%2520gene%2520delivery%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2001%26volume%3D9%26spage%3D123%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Hofland, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iginla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osetinsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessodes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wils, P.</span><span> </span><span class="NLM_article-title">Folate-targeted gene transfer in vivo</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">â</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1006%2Fmthe.2002.0604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12027558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFGjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=739-744&author=H.+E.+Hoflandauthor=C.+Massonauthor=S.+Iginlaauthor=I.+Osetinskyauthor=J.+A.+Reddyauthor=C.+P.+Leamonauthor=D.+Schermanauthor=M.+Bessodesauthor=P.+Wils&title=Folate-targeted+gene+transfer+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted gene transfer in vivo</span></div><div class="casAuthors">Hofland, Hans E. J.; Masson, Christophe; Iginla, Shaff; Osetinsky, Irina; Reddy, Joseph A.; Leamon, Christopher P.; Scherman, Daniel; Bessodes, Michel; Wils, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Nonviral systemic delivery is one of the most attractive approaches for cancer gene therapy.  To achieve this goal, various labs. have developed cationic liposomes.  However, when injected i.v., cationic lipid-DNA complexes accumulate mostly into and transfect lung tissue.  Here, we describe a method by which these complexes can be targeted to tumors using folic acid.  Adding polyethylene glycol (PEG)-lipids to the complexes dramatically reduced both lung accumulation and gene transfer to lungs and tumors after i.v. administration.  The presence of folic acid at the distal end of the PEG-lipid did not modify tumor accumulation of the complexes.  However, with folate-targeted complexes, gene transfer activity was restored in tumors while the activity in lungs was reduced by 50- to 100-fold compared with nontargeted lipid-DNA complexes.  This approach provides a first in vivo proof of concept to achieve targeted tumor gene delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTem_XQj6E67Vg90H21EOLACvtfcHk0lgNdaATT_oU4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFGjtbY%253D&md5=edcf05ef071c79c4f1ec5b3c536fc0d4</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1006%2Fmthe.2002.0604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmthe.2002.0604%26sid%3Dliteratum%253Aachs%26aulast%3DHofland%26aufirst%3DH.%2BE.%26aulast%3DMasson%26aufirst%3DC.%26aulast%3DIginla%26aufirst%3DS.%26aulast%3DOsetinsky%26aufirst%3DI.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DBessodes%26aufirst%3DM.%26aulast%3DWils%26aufirst%3DP.%26atitle%3DFolate-targeted%2520gene%2520transfer%2520in%2520vivo%26jtitle%3DMol.%2520Ther.%26date%3D2002%26volume%3D5%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abburi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wils, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors</span> <span class="citation_source-journal">Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1542</span><span class="NLM_x">â</span> <span class="NLM_lpage">1550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fsj.gt.3301833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12407426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1Knsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=1542-1550&author=J.+A.+Reddyauthor=C.+Abburiauthor=H.+Hoflandauthor=S.+J.+Howardauthor=I.+Vlahovauthor=P.+Wilsauthor=C.+P.+Leamon&title=Folate-targeted%2C+cationic+liposome-mediated+gene+transfer+into+disseminated+peritoneal+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors</span></div><div class="casAuthors">Reddy, J. A.; Abburi, C.; Hofland, H.; Howard, S. J.; Vlahov, I.; Wils, P.; Leamon, C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1542-1550</span>CODEN:
                <span class="NLM_cas:coden">GETHEC</span>;
        ISSN:<span class="NLM_cas:issn">0969-7128</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A folate-targeted, cationic lipid based transfection complex was developed and found to specifically transfect folate receptor-expressing cells and tumors.  These liposomal vectors were comprised of protamine-condensed plasmid DNA, a mixt. of cationic and neutral lipids, and a folic acid-cysteine-polyethyleneglycol-phosphatidylethanolamine (FA-Cys-PEG-PE) conjugate.  Pre-optimization studies revealed that inclusion of low amts. (0.01 to 0.03%) of FA-Cys-PEG-PE yielded the highest binding activity of dioleoylphosphatidylcholine/cholesterol liposomes to folate receptor-bearing cells.  In contrast, higher amts. (>0.5%) of FA-Cys-PEG-PE progressively decreased cellular binding of the liposomes.  In vitro studies with cationic lipid/dioleoylphosphatidylethanolamine formulations indicated that as little as 0.01 to 0.3% of FA-Cys-PEG-PE was needed to produce optimal targeted expression of plasmid DNA.  Similarly, using a disseminated i.p. L1210A tumor model, max. in vivo transfection activity occurred with i.p. administered formulations that contained low amts. (0.01 mol%) of the FA-Cys-PEG-PE targeting lipid.  Overall, folate-labeled formulations produced an eight- to 10-fold increase in tumor-assocd. luciferase expression, as compared with the corresponding non-targeted cationic lipid/DNA formulations.  These results collectively indicate that transfection of widespread i.p. cancers can be significantly enhanced using folate-targeted techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6nXisO8BVy7Vg90H21EOLACvtfcHk0lgNdaATT_oU4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1Knsbo%253D&md5=8ed1a849bbaf44cf9b89f75419257d79</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.gt.3301833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gt.3301833%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DAbburi%26aufirst%3DC.%26aulast%3DHofland%26aufirst%3DH.%26aulast%3DHoward%26aufirst%3DS.%2BJ.%26aulast%3DVlahov%26aufirst%3DI.%26aulast%3DWils%26aufirst%3DP.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DFolate-targeted%252C%2520cationic%2520liposome-mediated%2520gene%2520transfer%2520into%2520disseminated%2520peritoneal%2520tumors%26jtitle%3DGene%2520Ther.%26date%3D2002%26volume%3D9%26spage%3D1542%26epage%3D1550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Bruckheimer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orthel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutzar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furstoss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anklesaria, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span> </span><span class="NLM_article-title">In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">â</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fsj.cgt.7700662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14671672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1yksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=128-134&author=E.+Bruckheimerauthor=P.+Harvieauthor=J.+Orthelauthor=B.+Dutzarauthor=K.+Furstossauthor=E.+Mebelauthor=P.+Anklesariaauthor=R.+Paul&title=In+vivo+efficacy+of+folate-targeted+lipid-protamine-DNA+%28LPD-PEG-folate%29+complexes+in+an+immunocompetent+syngeneic+model+for+breast+adenocarcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma</span></div><div class="casAuthors">Bruckheimer, Elizabeth; Harvie, Pierrot; Orthel, Jason; Dutzar, Benjamin; Furstoss, Kevin; Mebel, Elise; Anklesaria, Pervin; Paul, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene therapy utilizing lipid-based delivery systems holds tremendous promise for the treatment of cancer.  However, due to the potential adverse inflammatory and/or immune effects upon systemic administration, treatments thus far have been predominantly limited to intratumoral or regional treatment.  Previous studies from our group have demonstrated the antitumor efficacy of systemically administered, folate-targeted, lipid-protamine-DNA complexes (LPD-PEG-Folate) against breast cancer using an immunodeficient xenogenic murine model.  In the current study, the antitumor efficacy of LPD-PEG-Folate in a syngeneic, immune competent, murine model of breast cancer was examd.  In this model, the potential inflammatory or immune responses and their effects on systemic delivery can be addressed.  The 410.4 murine breast adenocarcinoma cell line was initially evaluated in vitro for its interactions with LPD-PEG-Folate and control LPD-PEG formulations.  Utilizing fluorescently labeled formulations and fluorscence-activated cell sorting (FACS) anal., a 1.6-fold enhancement of binding and internalization of LPD-PEG-Folate over LPD-PEG formulations was obsd., suggestive of specific receptor interaction.  Increased binding was manifested as 5-26-fold increases in luciferase gene expression in 410.4 cell transfection when comparing LPD-PEG-Folate to LPD-PEG.  Moreover, in vivo treatment of 410.4 breast tumors in BALB/c mice with i.v. injected LPD-PEG-Folate delivering the HSV-1 thymidine kinase (TK) gene, in combination with gancyclovir treatment, resulted in a significant redn. in mean tumor vol. (260.1 mm3) compared to the LPD-PEG-TK (914.1 mm3), as well as the vehicle (749.7 mm3) and untreated (825.3 mm3) control groups (day 25, P<.019).  In addn. to a reduced tumor vol., LPD-PEG-Folate-TK treatment also increased median survival from 25 days in the nontargeted LPD-PEG-TK groups to 31 days (P=.0011), which correlated with the termination of treatment.  Together, these results demonstrate that in the context of a fully functional immune system, LPD-PEG-Folate-TK treatment possesses significant specific antitumor efficacy and the potential for further preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEmYpbMVTQCLVg90H21EOLACvtfcHk0lgNdaATT_oU4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1yksw%253D%253D&md5=a4743514f32111a293a6c128dd80eacf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700662%26sid%3Dliteratum%253Aachs%26aulast%3DBruckheimer%26aufirst%3DE.%26aulast%3DHarvie%26aufirst%3DP.%26aulast%3DOrthel%26aufirst%3DJ.%26aulast%3DDutzar%26aufirst%3DB.%26aulast%3DFurstoss%26aufirst%3DK.%26aulast%3DMebel%26aufirst%3DE.%26aulast%3DAnklesaria%26aufirst%3DP.%26aulast%3DPaul%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520folate-targeted%2520lipid-protamine-DNA%2520%2528LPD-PEG-folate%2529%2520complexes%2520in%2520an%2520immunocompetent%2520syngeneic%2520model%2520for%2520breast%2520adenocarcinoma%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2004%26volume%3D11%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Robbins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLachlan, I.</span><span> </span><span class="NLM_article-title">siRNA and innate immunity</span> <span class="citation_source-journal">Oligonucleotides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1089%2Foli.2009.0180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19441890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFersLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=89-102&author=M.+Robbinsauthor=A.+Judgeauthor=I.+MacLachlan&title=siRNA+and+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">siRNA and Innate Immunity</span></div><div class="casAuthors">Robbins, Marjorie; Judge, Adam; MacLachlan, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Oligonucleotides</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-102</span>CODEN:
                <span class="NLM_cas:coden">OLIGAJ</span>;
        ISSN:<span class="NLM_cas:issn">1545-4576</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Canonical small interfering RNA (siRNA) duplexes are potent activators of the mammalian innate immune system.  The induction of innate immunity by siRNA is dependent on siRNA structure and sequence, method of delivery, and cell type.  Synthetic siRNA in delivery vehicles that facilitate cellular uptake can induce high levels of inflammatory cytokines and interferons after systemic administration in mammals and in primary human blood cell cultures.  This activation is predominantly mediated by immune cells, normally via a Toll-like receptor (TLR) pathway.  The siRNA sequence dependency of these pathways varies with the type and location of the TLR involved.  Alternatively nonimmune cell activation may also occur, typically resulting from siRNA interaction with cytoplasmic RNA sensors such as RIG1.  As immune activation by siRNA-based drugs represents an undesirable side effect due to the considerable toxicities assocd. with excessive cytokine release in humans, understanding and abrogating this activity will be a crit. component in the development of safe and effective therapeutics.  This review describes the intracellular mechanisms of innate immune activation by siRNA, the design of appropriate sequences and chem. modification approaches, and suitable exptl. methods for studying their effects, with a view toward reducing siRNA-mediated off-target effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZg2Zc8zr8_bVg90H21EOLACvtfcHk0lhWxG0kPwUtJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFersLc%253D&md5=7031cc4cd08d03f522b21184d3e2fc4b</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1089%2Foli.2009.0180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Foli.2009.0180%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DM.%26aulast%3DJudge%26aufirst%3DA.%26aulast%3DMacLachlan%26aufirst%3DI.%26atitle%3DsiRNA%2520and%2520innate%2520immunity%26jtitle%3DOligonucleotides%26date%3D2009%26volume%3D19%26spage%3D89%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Behlke, M. A.</span><span> </span><span class="NLM_article-title">Progress towards in vivo use of siRNAs</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">â</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ymthe.2006.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16481219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFOktL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=644-670&author=M.+A.+Behlke&title=Progress+towards+in+vivo+use+of+siRNAs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Progress towards in Vivo Use of siRNAs</span></div><div class="casAuthors">Behlke, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">644-670</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  RNA interference (RNAi) has become the method of choice to suppress gene expression in vitro.  It is also emerging as a powerful tool for in vivo research with over 90 studies published using synthetic small interfering RNAs in mammals.  These reports demonstrate the potential for use of synthetic small interfering RNAs (siRNAs) as therapeutic agents, esp. in the areas of cancer and viral infection.  The no. of reports using siRNAs for functional genomics applications, for validation of targets for small-mol. drug development programs, and to address questions of basic biol. will rapidly grow as methods and protocols for use in animals become more established.  This review will first discuss aspects of RNAi biochem. and biol. that impact in vivo use, esp. as it relates to exptl. design, and will then provide an overview of published work with a focus on methodol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLVP7e1w-4I7Vg90H21EOLACvtfcHk0lhWxG0kPwUtJg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFOktL8%253D&md5=c09bf54f5591b1d828a9ddb8331f2f6a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ymthe.2006.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymthe.2006.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBehlke%26aufirst%3DM.%2BA.%26atitle%3DProgress%2520towards%2520in%2520vivo%2520use%2520of%2520siRNAs%26jtitle%3DMol.%2520Ther.%26date%3D2006%26volume%3D13%26spage%3D644%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Targeted delivery systems for oligonucleotide therapeutics</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">â</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=195-203&author=B.+Yuauthor=X.+Zhaoauthor=L.+J.+Leeauthor=R.+J.+Lee&title=Targeted+delivery+systems+for+oligonucleotide+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DL.%2BJ.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DTargeted%2520delivery%2520systems%2520for%2520oligonucleotide%2520therapeutics%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Pirollo, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E. H.</span><span> </span><span class="NLM_article-title">Targeted delivery of small interfering RNA: approaching effective cancer therapies</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">â</span> <span class="NLM_lpage">1250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1247-1250&author=K.+F.+Pirolloauthor=E.+H.+Chang&title=Targeted+delivery+of+small+interfering+RNA%3A+approaching+effective+cancer+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPirollo%26aufirst%3DK.%2BF.%26aulast%3DChang%26aufirst%3DE.%2BH.%26atitle%3DTargeted%2520delivery%2520of%2520small%2520interfering%2520RNA%253A%2520approaching%2520effective%2520cancer%2520therapies%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1247%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Dominska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dykxhoorn, D. M.</span><span> </span><span class="NLM_article-title">Breaking down the barriers: siRNA delivery and endosome escape</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">â</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1242%2Fjcs.066399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=20356929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFeksL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=1183-1189&author=M.+Dominskaauthor=D.+M.+Dykxhoorn&title=Breaking+down+the+barriers%3A+siRNA+delivery+and+endosome+escape"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking down the barriers: siRNA delivery and endosome escape</span></div><div class="casAuthors">Dominska, Monika; Dykxhoorn, Derek M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1183-1189</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  RNA interference (RNAi)-based technologies offer an attractive strategy for the sequence-specific silencing of disease-causing genes.  The application of small interfering (si)RNAs as potential therapeutic agents requires safe and effective methods for their delivery to the cytoplasm of the target cells and tissues.  Recent studies have shown significant progress in the development of targeting reagents that facilitate the recognition of and siRNA delivery to specific cell types.  However, most of these delivery approaches are not optimized to enable the intracellular trafficking of the siRNAs into the cytoplasm where they must assoc. with the RNA-induced silencing complex (RISC) to direct the cleavage of mRNAs bearing complementary binding sites.  In particular, the trafficking of siRNAs from endosomes into the cytoplasm represents a major rate-limiting step for many delivery approaches.  This Commentary focuses on novel strategies designed to enhance endosomal escape and thereby increase the efficacy of siRNA-mediated gene silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkjWg97d22hbVg90H21EOLACvtfcHk0ljkGP8ZnK1dXg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFeksL0%253D&md5=90bbc1e0b5d62a4a6f00656d4128e2c1</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1242%2Fjcs.066399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.066399%26sid%3Dliteratum%253Aachs%26aulast%3DDominska%26aufirst%3DM.%26aulast%3DDykxhoorn%26aufirst%3DD.%2BM.%26atitle%3DBreaking%2520down%2520the%2520barriers%253A%2520siRNA%2520delivery%2520and%2520endosome%2520escape%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26spage%3D1183%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions</span> <span class="citation_source-journal">RNA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">â</span> <span class="NLM_lpage">583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=577-583&author=K.+Zhangauthor=Q.+Wangauthor=Y.+Xieauthor=G.+Morauthor=E.+Segaauthor=P.+S.+Lowauthor=Y.+Huang&title=Receptor-mediated+delivery+of+siRNAs+by+tethered+nucleic+acid+base-paired+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DMor%26aufirst%3DG.%26aulast%3DSega%26aufirst%3DE.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DReceptor-mediated%2520delivery%2520of%2520siRNAs%2520by%2520tethered%2520nucleic%2520acid%2520base-paired%2520interactions%26jtitle%3DRNA%26date%3D2008%26volume%3D14%26spage%3D577%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Citro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczylik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginobbi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zupi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabretta, B.</span><span> </span><span class="NLM_article-title">Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells</span> <span class="citation_source-journal">Br. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fbjc.1994.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=8123474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGju7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1994&pages=463-467&author=G.+Citroauthor=C.+Szczylikauthor=P.+Ginobbiauthor=G.+Zupiauthor=B.+Calabretta&title=Inhibition+of+leukaemia+cell+proliferation+by+folic+acid-polylysine-mediated+introduction+of+c-myb+antisense+oligodeoxynucleotides+into+HL-60+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells</span></div><div class="casAuthors">Citro, G.; Szczylik, C.; Ginobbi, P.; Zupi, G.; Calabretta, B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-7</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The inhibitory effect of c-myb antisense oligodeoxynucleotides (ODNs) conjugated to folic acid (FA) on HL-60 cell proliferation was examd.  Folic acid was covalently linked to a polylysine chain and purified by gel chromatog.  Sterile FA-polylysine was complexed with c-myb sense and antisense.  Exposure of HL-60 cells to the FA-polylysine-c-myb antisense ODN complex resulted in a down-regulation of c-myb expression and a greater inhibition of proliferation than that obtained using free ODNs.  Moreover, Fa-polylysine conjugate alone or complexes to c-myb sense ODN was not toxic to cells.  The antigenic properties and uptake of the vitamin were not affected by the polylysine chain.  These data suggest that this strategy is potentially useful for the selective delivery of anti-oncogene-targeted ODNs into cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTx8fhfT_SgbVg90H21EOLACvtfcHk0lhx_Wv-aqteJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGju7c%253D&md5=616a49aedb273a2d240df92b0a76b39d</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1994.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1994.84%26sid%3Dliteratum%253Aachs%26aulast%3DCitro%26aufirst%3DG.%26aulast%3DSzczylik%26aufirst%3DC.%26aulast%3DGinobbi%26aufirst%3DP.%26aulast%3DZupi%26aufirst%3DG.%26aulast%3DCalabretta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520leukaemia%2520cell%2520proliferation%2520by%2520folic%2520acid-polylysine-mediated%2520introduction%2520of%2520c-myb%2520antisense%2520oligodeoxynucleotides%2520into%2520HL-60%2520cells%26jtitle%3DBr.%2520J.%2520Cancer.%26date%3D1994%26volume%3D69%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Jeong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. G.</span><span> </span><span class="NLM_article-title">Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine)</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2005&pages=223-232&author=S.+H.+Kimauthor=J.+H.++Jeongauthor=K.+C.+Choauthor=S.+W.+Kimauthor=T.+G.+Park&title=Target-specific+gene+silencing+by+siRNA+plasmid+DNA+complexed+with+folate-modified+poly%28ethylenimine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DJeong%26aufirst%3DJ.%2BH.%26aulast%3DCho%26aufirst%3DK.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DPark%26aufirst%3DT.%2BG.%26atitle%3DTarget-specific%2520gene%2520silencing%2520by%2520siRNA%2520plasmid%2520DNA%2520complexed%2520with%2520folate-modified%2520poly%2528ethylenimine%2529%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2005%26volume%3D104%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">York, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holley, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, C. L.</span><span> </span><span class="NLM_article-title">Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression</span> <span class="citation_source-journal">Biomacromolecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">â</span> <span class="NLM_lpage">943</span></span><div class="citationLinks">[<a href="/doi/10.1021/bm8014768" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=936-943&author=A.+W.+Yorkauthor=Y.+Zhangauthor=A.+C.+Holleyauthor=Y.+Guoauthor=F.+Huangauthor=C.+L.+McCormick&title=Facile+synthesis+of+multivalent+folate-block+copolymer+conjugates+via+aqueous+RAFT+polymerization%3A+targeted+delivery+of+siRNA+and+subsequent+gene+suppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fbm8014768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm8014768%26sid%3Dliteratum%253Aachs%26aulast%3DYork%26aufirst%3DA.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHolley%26aufirst%3DA.%2BC.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DMcCormick%26aufirst%3DC.%2BL.%26atitle%3DFacile%2520synthesis%2520of%2520multivalent%2520folate-block%2520copolymer%2520conjugates%2520via%2520aqueous%2520RAFT%2520polymerization%253A%2520targeted%2520delivery%2520of%2520siRNA%2520and%2520subsequent%2520gene%2520suppression%26jtitle%3DBiomacromolecules%26date%3D2009%26volume%3D10%26spage%3D936%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauchon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorenstein, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">3318</span><span class="NLM_x">â</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=3318-3322&author=S.+Wangauthor=R.+J.+Leeauthor=G.+Cauchonauthor=D.+G.+Gorensteinauthor=P.+S.+Low&title=Delivery+of+antisense+oligodeoxyribonucleotides+against+the+human+epidermal+growth+factor+receptor+into+cultured+KB+cells+with+liposomes+conjugated+to+folate+via+polyethylene+glycol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DCauchon%26aufirst%3DG.%26aulast%3DGorenstein%26aufirst%3DD.%2BG.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DDelivery%2520of%2520antisense%2520oligodeoxyribonucleotides%2520against%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor%2520into%2520cultured%2520KB%2520cells%2520with%2520liposomes%2520conjugated%2520to%2520folate%2520via%2520polyethylene%2520glycol%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D3318%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Rait, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirollo, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E. H.</span><span> </span><span class="NLM_article-title">Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">â</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12435858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVWhsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=475-486&author=A.+S.+Raitauthor=K.+F.+Pirolloauthor=L.+Xiangauthor=D.+Ulickauthor=E.+H.+Chang&title=Tumor-targeting%2C+systemically+delivered+antisense+HER-2+chemosensitizes+human+breast+cancer+xenografts+irrespective+of+HER-2+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels</span></div><div class="casAuthors">Rait, Antonina S.; Pirollo, Kathleen F.; Xiang, Laiman; Ulick, David; Chang, Esther H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Baltimore, MD, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Johns Hopkins University Press</span>)
        </div><div class="casAbstract">Background: The failure to respond to chemotherapy is a major obstacle in the successful treatment of breast cancer.  The authors have previously shown that anti-HER-2 antisense oligonucleotide (AS HER-2 ODN) treatment was able to sensitize breast cancer cells to various chemotherapeutic agents in vitro irresp. of their HER-2 status, indicating that the use of AS HER-2 ODN therapy for breast cancer is not limited to tumors overexpressing the protein.  One of the main drawbacks to the use of antisense therapy in the clin. setting is the lack of an efficient, tumor-targeting, systemic delivery method.  The authors have developed a tumor-specific, ligand-targeting, cationic liposome delivery system designed for systemic gene therapy of cancer.  In this study the authors employ this ligand-liposome strategy to enhance the delivery of the AS Her-2 ODN to breast cancer cells, including those that do not overexpress HER-2, in vitro and in vivo.  Materials and Methods: A cationic liposome complex that includes folate as the targeting ligand was designed and optimized for more efficient delivery of AS HER-2 ODN to breast tumors cells in vitro, and more significantly, for systemic delivery with tumor-specific targeting in vivo.  Human breast cancer cell line MDA-MB-435, which does not overexpress HER-2, was used to compare the degree of chemosensitization to the taxanes of AS HER-2 ODN delivered via the optimized folate-liposome vs. com. Lipofectin.  MDA-MB-435 xenograft tumors were also used to evaluate the anti-tumor effect of the combination of systemically delivered folate-liposome-AS HER-2 ODN and docetaxel (Taxotere).  Results: The optimized folate-liposome-AS HER-2 ODN complex significantly increases the response of breast tumor cell lines to conventional chemotherapeutic agents in vitro as compared to AS HER-2 delivered via an unliganded com. available reagent, Lipofectin.  In vivo, the folate-liposome-AS HER-2 ODN complex has prolonged stability in blood and increased uptake in tumors.  More significantly, the combination of i.v. administered ligand-liposome-AS HER-2 ODN and docetaxel resulted in a marked inhibition of xenograft growth in an aggressive breast cancer model that does not overexpress HER-2, even after treatment ended.  Conclusions: Although there are other reports of liposomal delivery of AS ODNs, this is the first report of in vivo efficacy against human cancer cells using a tumor-targeting liposome delivery system for systemic AS therapy.  Moreover, the increased stability in circulation and anti-tumor efficacy obsd. were obtained without the need for continuous i.v. infusion.  HER-2 is an integral component within a network of cell growth pathways that can affect many different types of tumors where HER-2 may be a contributing factor, such as ovarian, esophageal, and GI malignancies including colon and pancreatic cancers.  Therefore, the effectiveness of this therapy with xenograft tumors that do not overexpress HER-2 has the potential to expand the clin. usefulness of this efficacious form of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryP5i681arc7Vg90H21EOLACvtfcHk0lhkCylNHzK6Ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVWhsr0%253D&md5=0f7327fc271777e437555341d44cefd2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRait%26aufirst%3DA.%2BS.%26aulast%3DPirollo%26aufirst%3DK.%2BF.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DUlick%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DE.%2BH.%26atitle%3DTumor-targeting%252C%2520systemically%2520delivered%2520antisense%2520HER-2%2520chemosensitizes%2520human%2520breast%2520cancer%2520xenografts%2520irrespective%2520of%2520HER-2%2520levels%26jtitle%3DMol.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D475%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardee, G. E.</span><span> </span><span class="NLM_article-title">Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">â</span> <span class="NLM_lpage">747</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc020089t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2ksbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=738-747&author=C.+P.+Leamonauthor=S.+R.+Cooperauthor=G.+E.+Hardee&title=Folate-liposome-mediated+antisense+oligodeoxynucleotide+targeting+to+cancer+cells%3A+evaluation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Liposome-Mediated Antisense Oligodeoxynucleotide Targeting to Cancer Cells: Evaluation in Vitro and in Vivo</span></div><div class="casAuthors">Leamon, Christopher P.; Cooper, Scott R.; Hardee, Gregory E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">738-747</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The objective of this study was to investigate the use of folate-targeted liposomes for the delivery of encapsulated oligonucleotides to folate receptor (FR)-pos. tumor cells in vitro and in vivo.  This project involved the synthesis and biol. evaluation of many folate-PEG-lipid conjugates, where the chem. form of the folate moiety (pteroate) and the length of the PEG linker chain were varied widely. Folate-targeted oligonucleotide-contg. liposomes were prepd. using conventional methods, and the extent of cell uptake was evaluated using, among others, the FR pos. KB cell line. Oligonucleotide-loaded folate-targeted liposomes were found to rapidly assoc. with the KB cells, and satn. was typically reached within the first hour of incubation at 37 Â°C.  Nearly 100 000 liposomes per cell were bound or internalized at satn. Importantly, cell assocn. was blocked by a large excess folic acid, thus reflecting the FR-specific nature of the cell interaction.  Full targeting potential was achieved with PEG linkers as low as 1000 in mol. wt., and pteroates bearing glycine or Î³-aminobutyryl residues juxtaposed to the pteroic acid moiety were also effective for targeting, provided that a terminal cysteine moiety was present at the distal end of the PEG chain for added hydrophilicity.  When tested in vivo, folate-targeted liposomes were found to deliver â¼1.8-fold more oligonucleotide to the livers of nude mice (relative to the nontargeted PEG-contg. formulations); however, no improvement in KB tumor uptake was obsd.  We conclude from these results that folate liposomes can effectively deliver oligonucleotides into folate receptor-bearing cells in vitro, but addnl. barriers exist in vivo that prevent or decrease effective tumor uptake and retention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOOpDFh4gFMLVg90H21EOLACvtfcHk0lhkCylNHzK6Ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2ksbc%253D&md5=0e0475958da2a1a0d0a976c9c61cb301</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fbc020089t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc020089t%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DCooper%26aufirst%3DS.%2BR.%26aulast%3DHardee%26aufirst%3DG.%2BE.%26atitle%3DFolate-liposome-mediated%2520antisense%2520oligodeoxynucleotide%2520targeting%2520to%2520cancer%2520cells%253A%2520evaluation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBioconjugate%2520Chem.%26date%3D2003%26volume%3D14%26spage%3D738%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Yoshizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitani, Y.</span><span> </span><span class="NLM_article-title">Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">â</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ejpb.2008.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18647651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlags7fI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=718-725&author=T.+Yoshizawaauthor=Y.+Hattoriauthor=M.+Hakoshimaauthor=K.+Kogaauthor=Y.+Maitani&title=Folate-linked+lipid-based+nanoparticles+for+synthetic+siRNA+delivery+in+KB+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts</span></div><div class="casAuthors">Yoshizawa, Takashi; Hattori, Yoshiyuki; Hakoshima, Motoki; Koga, Kimiko; Maitani, Yoshie</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">718-725</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RNA interference (RNAi) is a sequence-specific gene-silencing mechanism triggered by synthetic small interfering RNA (siRNA), and is utilized in a wide range of fields including cancer gene therapy by down-regulating a specific target protein.  In this study, for tumor-targeted siRNA delivery, the authors developed a folate-linked nanoparticle (NP-F), and evaluated the potential of NP-F-mediated tumor gene therapy in human nasopharyngeal KB cells, which overexpressed folate receptor (FR).  NP-F was composed of cholesteryl-3Î²-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol), Tween 80 and folate-poly(ethylene glycol)-distearoylphosphatidylethanolamine conjugate (f-PEG2000-DSPE), and NP-P was substituted f-PEG2000-DSPE in NP-F PEG2000-DSPE for a non-targeting nanoparticle.  The NP-F and siRNA complex (nanoplex) formed at a charge ratio (+/-) of 2/1 in the presence of 5 mM NaCl was injectable size and increased transfection efficiency in the cells.  NP-F showed a significantly higher intracellular amt. of siRNA and stronger localization of siRNA in the cytoplasm than NP-P.  When Her-2 siRNA was transfected into cells by NP-F and NP-P, NP-F significantly inhibited tumor growth, and selectively suppressed Her-2 protein expression more than NP-P.  In in vivo gene therapy, a NP-F nanoplex of Her-2 siRNA by intratumoral injection significantly inhibited tumor growth of KB xenografts compared with control siRNA, but a NP-P nanoplex did not.  These results of the expts. have provided optimal conditions to form folate-linked nanoparticle complexes with siRNA for folate-targeted gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJ3fiylKA-7Vg90H21EOLACvtfcHk0lifBK0N0owp6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlags7fI&md5=12de93cece4d7e8c1929ae0952527c8c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2008.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2008.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizawa%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DHakoshima%26aufirst%3DM.%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DMaitani%26aufirst%3DY.%26atitle%3DFolate-linked%2520lipid-based%2520nanoparticles%2520for%2520synthetic%2520siRNA%2520delivery%2520in%2520KB%2520tumor%2520xenografts%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2008%26volume%3D70%26spage%3D718%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Jeong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. G.</span><span> </span><span class="NLM_article-title">In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles</span> <span class="citation_source-journal">J. Biomater. Sci., Polym. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span><span class="NLM_x">â</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1163%2F156856205774472335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16370241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWlsLbF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1409-1419&author=J.+H.+Jeongauthor=S.+H.+Kimauthor=S.+W.+Kimauthor=T.+G.+Park&title=In+vivo+tumor+targeting+of+ODN-PEG-folic+acid%2FPEI+polyelectrolyte+complex+micelles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles</span></div><div class="casAuthors">Jeong, Ji Hoon; Kim, Sun Hwa; Kim, Sung Wan; Park, Tae Gwan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomaterials Science, Polymer Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1409-1419</span>CODEN:
                <span class="NLM_cas:coden">JBSEEA</span>;
        ISSN:<span class="NLM_cas:issn">0920-5063</span>.
    
            (<span class="NLM_cas:orgname">VSP</span>)
        </div><div class="casAbstract">A tumor-targeting antisense oligodeoxynucleotide (ODN) delivery system based on polyelectrolyte complex (PEC) micelles is demonstrated.  ODN-PEG-folic acid (ODN-PEG-FA) was synthesized using a heterofunctional PEG linker.  The PEC micelles for the targeted ODN delivery to tumor cells were produced by ionic interactions between the ODN-PEG-FA and polyethylenimine (PEI).  The in vivo targeting properties of the PEC micelles were assessed using a mouse tumor model.  The size of ODN-PEG-FA/PEI PEC micelles was 92.3 nm with a relatively narrow distribution.  Cellular uptake of the ODN-PEG-FA/PEI PEC micelles by folic acid receptor over-expressing cells (KB) was greatly enhanced compared to that of ODN-PEG/PEI PEC micelles.  When the ODN-PEG-FA/PEI PEC micelles were systemically administered to the mice bearing KB cell xenograft tumor, ODN was accumulated to the solid tumor in a target specific manner.  This study suggests that the PEC micelles with a receptor-recognizable targeting ligand on the surface have potential for passive and active targeted delivery of ODN drugs to cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jOvir3CyKLVg90H21EOLACvtfcHk0lj_0FcY0VqP6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWlsLbF&md5=e4689f95e6b27f5e1c3a50b45c31b9ee</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1163%2F156856205774472335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1163%252F156856205774472335%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DPark%26aufirst%3DT.%2BG.%26atitle%3DIn%2520vivo%2520tumor%2520targeting%2520of%2520ODN-PEG-folic%2520acid%252FPEI%2520polyelectrolyte%2520complex%2520micelles%26jtitle%3DJ.%2520Biomater.%2520Sci.%252C%2520Polym.%2520Ed.%26date%3D2005%26volume%3D16%26spage%3D1409%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">van Vlerken, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amiji, M. M.</span><span> </span><span class="NLM_article-title">Multi-functional polymeric nanoparticles for tumour-targeted drug delivery</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">â</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=205-216&author=L.+E.+van+Vlerkenauthor=M.+M.+Amiji&title=Multi-functional+polymeric+nanoparticles+for+tumour-targeted+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BVlerken%26aufirst%3DL.%2BE.%26aulast%3DAmiji%26aufirst%3DM.%2BM.%26atitle%3DMulti-functional%2520polymeric%2520nanoparticles%2520for%2520tumour-targeted%2520drug%2520delivery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2006%26volume%3D3%26spage%3D205%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Hobbs, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsky, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torchilin, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">â</span> <span class="NLM_lpage">4612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.95.8.4607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=9539785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1cXis1OgsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=4607-4612&author=S.+K.+Hobbsauthor=W.+L.+Monskyauthor=F.+Yuanauthor=W.+G.+Robertsauthor=L.+Griffithauthor=V.+P.+Torchilinauthor=R.+K.+Jain&title=Regulation+of+transport+pathways+in+tumor+vessels%3A+role+of+tumor+type+and+microenvironment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment</span></div><div class="casAuthors">Hobbs, Susan K.; Monsky, Wayne L.; Yuan, Fan; Roberts, W. Gregory; Griffith, Linda; Torchilin, Vladimir P.; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4607-4612</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Novel anti-neoplastic agents such as gene targeting vectors and encapsulated carriers are quite large (approx. 100-300 nm in diam.).  An understanding of the functional size and physiol. regulation of transvascular pathways is necessary to optimize delivery of these agents.  Here we analyze the functional limits of transvascular transport and its modulation by the microenvironment.  One human and five murine tumors including mammary and colorectal carcinomas, hepatoma, glioma, and sarcoma were implanted in the dorsal skin-fold chamber or cranial window, and the pore cutoff size, a functional measure of transvascular gap size, was detd.  The microenvironment was modulated: (i) spatially, by growing tumors in s.c. or cranial locations and (ii) temporally, by inducing vascular regression in hormone-dependent tumors.  Tumors grown s.c. exhibited a characteristic pore cutoff size ranging from 200 nm to 1.2 Î¼m.  This pore cutoff size was reduced in tumors grown in the cranium or in regressing tumors after hormone withdrawal.  Vessels induced in basic fibroblast growth factor-contg. gels had a pore cutoff size of 200 nm.  Albumin permeability was independent of pore cutoff size.  These results have three major implications for the delivery of therapeutic agents: (i) delivery may be less efficient in cranial tumors than in s.c. tumors, (ii) delivery may be reduced during tumor regression induced by hormonal ablation, and (iii) permeability to a mol. is independent of pore cutoff size as long as the diam. of the mol. is much less than the pore diam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88VvYDuUcTLVg90H21EOLACvtfcHk0lj_0FcY0VqP6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1OgsLc%253D&md5=ac230a357069787fb819e23a043bd3f0</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.8.4607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.8.4607%26sid%3Dliteratum%253Aachs%26aulast%3DHobbs%26aufirst%3DS.%2BK.%26aulast%3DMonsky%26aufirst%3DW.%2BL.%26aulast%3DYuan%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DGriffith%26aufirst%3DL.%26aulast%3DTorchilin%26aufirst%3DV.%2BP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DRegulation%2520of%2520transport%2520pathways%2520in%2520tumor%2520vessels%253A%2520role%2520of%2520tumor%2520type%2520and%2520microenvironment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D4607%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Immordino, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattel, L.</span><span> </span><span class="NLM_article-title">Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.2217%2F17435889.1.3.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17717971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlantb7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=297-315&author=M.+L.+Immordinoauthor=F.+Dosioauthor=L.+Cattel&title=Stealth+liposomes%3A+review+of+the+basic+science%2C+rationale%2C+and+clinical+applications%2C+existing+and+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential</span></div><div class="casAuthors">Immordino, Maria Laura; Dosio, Franco; Cattel, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1176-9114</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Among several promising new drug-delivery systems, liposomes represent an advanced technol. to deliver active mols. to the site of action, and at present several formulations are in clin. use.  Research on liposome technol. has progressed from conventional vesicles ("first-generation liposomes") to "second-generation liposomes", in which long-circulating liposomes are obtained by modulating the lipid compn., size, and charge of the vesicle.  Liposomes with modified surfaces have also been developed using several mols., such as glycolipids or sialic acid.  A significant step in the development of long-circulating liposomes came with inclusion of the synthetic polymer poly-(ethylene glycol) (PEG) in liposome compn.  The presence of PEG on the surface of the liposomal carrier has been shown to extend blood-circulation time while reducing mononuclear phagocyte system uptake (stealth liposomes).  This technol. has resulted in a large no. of liposome formulations encapsulating active mols., with high target efficiency and activity.  Further, by synthetic modification of the terminal PEG mol., stealth liposomes can be actively targeted with monoclonal antibodies or ligands.  This review focuses on stealth technol. and summarizes pre-clin. and clin. data relating to the principal liposome formulations; it also discusses emerging trends of this promising technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL8BsakziX-bVg90H21EOLACvtfcHk0lj_0FcY0VqP6A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlantb7E&md5=0ecb6e03b94783f06b71f41dc2d1fe78</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.2217%2F17435889.1.3.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17435889.1.3.297%26sid%3Dliteratum%253Aachs%26aulast%3DImmordino%26aufirst%3DM.%2BL.%26aulast%3DDosio%26aufirst%3DF.%26aulast%3DCattel%26aufirst%3DL.%26atitle%3DStealth%2520liposomes%253A%2520review%2520of%2520the%2520basic%2520science%252C%2520rationale%252C%2520and%2520clinical%2520applications%252C%2520existing%2520and%2520potential%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2006%26volume%3D1%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1233</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">â</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1233&publication_year=1995&pages=134-144&author=R.+J.+Leeauthor=P.+S.+Low&title=Folate-mediated+tumor+cell+targeting+of+liposome-entrapped+doxorubicin+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate-mediated%2520tumor%2520cell%2520targeting%2520of%2520liposome-entrapped%2520doxorubicin%2520in%2520vitro%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1995%26volume%3D1233%26spage%3D134%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliot, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. A.</span><span> </span><span class="NLM_article-title">Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">â</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=316-322&author=K.+E.+Andersonauthor=L.+A.+Eliotauthor=B.+R.+Stevensonauthor=J.+A.+Rogers&title=Formulation+and+evaluation+of+a+folic+acid+receptor-targeted+oral+vancomycin+liposomal+dosage+form"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DEliot%26aufirst%3DL.%2BA.%26aulast%3DStevenson%26aufirst%3DB.%2BR.%26aulast%3DRogers%26aufirst%3DJ.%2BA.%26atitle%3DFormulation%2520and%2520evaluation%2520of%2520a%2520folic%2520acid%2520receptor-targeted%2520oral%2520vancomycin%2520liposomal%2520dosage%2520form%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26spage%3D316%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Pan, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">594</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=594-602&author=X.+Q.+Panauthor=X.+Zhengauthor=G.+Shiauthor=H.+Wangauthor=M.+Ratnamauthor=R.+J.+Lee&title=Strategy+for+the+treatment+of+acute+myelogenous+leukemia+based+on+folate+receptor+beta-targeted+liposomal+doxorubicin+combined+with+receptor+induction+using+all-trans+retinoic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%2BQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRatnam%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DStrategy%2520for%2520the%2520treatment%2520of%2520acute%2520myelogenous%2520leukemia%2520based%2520on%2520folate%2520receptor%2520beta-targeted%2520liposomal%2520doxorubicin%2520combined%2520with%2520receptor%2520induction%2520using%2520all-trans%2520retinoic%2520acid%26jtitle%3DBlood%26date%3D2002%26volume%3D100%26spage%3D594%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Gabizon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmeeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalipsky, S.</span><span> </span><span class="NLM_article-title">Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1177</span><span class="NLM_x">â</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2004.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15094214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1177-1192&author=A.+Gabizonauthor=H.+Shmeedaauthor=A.+T.+Horowitzauthor=S.+Zalipsky&title=Tumor+cell+targeting+of+liposome-entrapped+drugs+with+phospholipid-anchored+folic+acid-PEG+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates</span></div><div class="casAuthors">Gabizon, Alberto; Shmeeda, Hilary; Horowitz, Aviva T.; Zalipsky, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1177-1192</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Targeting of liposomes with phospholipid-anchored folate conjugates is an attractive approach to deliver chemotherapeutic agents to folate receptor (FR) expressing tumors.  The use of polyethylene glycol (PEG)-coated liposomes with folate attached to the outer end of a small fraction of phospholipid-anchored PEG mols. appears to be the most appropriate way to combine long-circulating properties crit. for liposome deposition in tumors and binding of liposomes to FR on tumor cells.  Although a no. of important formulation parameters remain to be optimized, there are indications, at least in one ascitic tumor model, that folate targeting shifts intra-tumor distribution of liposomes to the cellular compartment.  In vitro, folate targeting enhances the cytotoxicity of liposomal drugs against FR-expressing tumor cells.  In vivo, the therapeutic data are still fragmentary and appear to be formulation- and tumor model-dependent.  Further studies are required to det. whether folate targeting can confer a clear advantage in efficacy and/or toxicity to liposomal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXmcjmN9RMbVg90H21EOLACvtfcHk0ljMA_0o4VmCag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLs%253D&md5=b6948331c4bc8ab98a988af1434b5016</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DGabizon%26aufirst%3DA.%26aulast%3DShmeeda%26aufirst%3DH.%26aulast%3DHorowitz%26aufirst%3DA.%2BT.%26aulast%3DZalipsky%26aufirst%3DS.%26atitle%3DTumor%2520cell%2520targeting%2520of%2520liposome-entrapped%2520drugs%2520with%2520phospholipid-anchored%2520folic%2520acid-PEG%2520conjugates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1177%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Gabizon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzemach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmeeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalipsky, S.</span><span> </span><span class="NLM_article-title">In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">6551</span><span class="NLM_x">â</span> <span class="NLM_lpage">6559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14695160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSqurnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=6551-6559&author=A.+Gabizonauthor=A.+T.+Horowitzauthor=D.+Gorenauthor=D.+Tzemachauthor=H.+Shmeedaauthor=S.+Zalipsky&title=In+vivo+fate+of+folate-targeted+polyethylene-glycol+liposomes+in+tumor-bearing+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice</span></div><div class="casAuthors">Gabizon, Alberto; Horowitz, Aviva T.; Goren, Dorit; Tzemach, Dina; Shmeeda, Hilary; Zalipsky, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6551-6559</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To compare the in vivo tissue distribution of folate-targeted liposomes (FTLs) injected i.v. in mice bearing folate receptor (FR)-over-expressing tumors (mouse M109 and human KB carcinomas, and mouse J6456 lymphoma) to that of nontargeted liposomes (NTLs) of similar compn.  A small fraction of a folate-polyethylene-glycol (PEG)-distearoyl-phosphatidylethanolamine conjugate was incorporated in FTLs.  Both FTLs and NTLs were PEGylated with a PEG-distearoyl-phosphatidylethanolamine conjugate to prolong circulation time.  Liposomes were labeled with [3H]cholesterol hexadecyl ether with or without doxorubicin loading.  Liposome levels in plasma, tissues, or ascites were assessed by the no. of [3H] counts.  For doxorubicin-loaded formulations, the authors also detd. the tissue doxorubicin levels by fluorometry.  To est. the amt. of liposomes directly assocd. with tumor cells in vivo, we detd. the [3H]radiolabel counts in washed pellets of ascitic tumor cells using the ascitic J6456 lymphoma. RESULTS: FTLs retained the folate ligand in vivo, as demonstrated by their ability to bind ex vivo to FR-expressing cells after prolonged circulation and extravasation into malignant ascitic fluid.  In comparison with NTLs, FTLs were cleared faster from circulation as a result of greater liver uptake.  Despite the lower plasma levels, tumor levels of FTL-injected mice were not significantly different from those of NTL-injected mice.  When NTLs and FTLs were loaded with doxorubicin, liver uptake decreased because of liver blockade, and uptake by spleen and tumor increased.  When tumor-to-tissue liposome uptake ratios were analyzed, the targeting profile of FTLs was characterized by higher tumor:skin, and tumor:kidney ratios but lower tumor:liver ratio than NTLs.  After a concomitant dose of free folic acid, FTLs (but not NTLs) plasma clearance and liver uptake were inhibited, indicating that accelerated clearance was mediated by the folate ligand.  Surprisingly tumor uptake was not significantly affected by a codose of folic acid.  In the J6456 ascitic tumor model, tumor cell-assocd. liposome levels were significantly greater for FTL-injected mice than for NTL-injected mice, despite slightly higher levels of the latter in whole ascites.  Whereas folate targeting does not enhance overall liposome deposition in tumors, the targeting profile of tumor vs. other tissues is substantially different and intratumor liposome distribution in ascitic tumors is affected favorably with a selective shift toward liposome assocn. with FR-expressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquYwuKaHHaXrVg90H21EOLACvtfcHk0ljMA_0o4VmCag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSqurnF&md5=54bbb0802d87648c071098b28e8196d1</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabizon%26aufirst%3DA.%26aulast%3DHorowitz%26aufirst%3DA.%2BT.%26aulast%3DGoren%26aufirst%3DD.%26aulast%3DTzemach%26aufirst%3DD.%26aulast%3DShmeeda%26aufirst%3DH.%26aulast%3DZalipsky%26aufirst%3DS.%26atitle%3DIn%2520vivo%2520fate%2520of%2520folate-targeted%2520polyethylene-glycol%2520liposomes%2520in%2520tumor-bearing%2520mice%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D6551%26epage%3D6559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Ni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Folate receptor targeted delivery of liposomal daunorubicin into tumor cells</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2131</span><span class="NLM_x">â</span> <span class="NLM_lpage">2135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12174894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2ltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2131-2135&author=S.+Niauthor=S.+M.+Stephensonauthor=R.+J.+Lee&title=Folate+receptor+targeted+delivery+of+liposomal+daunorubicin+into+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor targeted delivery of liposomal daunorubicin into tumor cells</span></div><div class="casAuthors">Ni, Sandy; Stephenson, Stacy M.; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2131-2135</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">The folate receptor (FR) is amplified in a wide variety of human tumors.  Thus, targeting cytotoxic therapies to FR is a promising strategy for chemotherapy.  FR-targeted liposomal daunorubicin (f-L-DNR) was compared to non-targeted liposomal DNR (L-DNR) for cellular uptake and cytotoxicity in FR-expressing cells.  Liposomal DNR retention was evaluated for liposomes loaded with either sodium citrate or ammonium sulfate as the trapping agent.  The cellular uptake of liposomal DNR was detd. by flow cytometry and fluorometry measurements while cytotoxicity was detd. by the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.  Liposomal DNR retention was superior for liposomes prepd. using ammonium sulfate.  Cellular uptake of f-L-DNR in KB oral carcinoma cells, Chinese hamster ovary (CHO-FR-Î²), and KG-1 human acute myelogenous leukemia cells were 9.4, 40, and 4.6-fold higher than non-targeted L-DNR, resp.  The cytotoxicity of f-L-DNR in KB and CHO-FR-Î² cells was 18 times and 49 times higher than L-DNR, resp.  Both cellular uptake and cytotoxicity of f-L-DNR could be inhibited by 1 mM folic acid.  FR-mediated delivery of liposomal DNR to FR-expressing cells increases DNR cellular uptake and cytotoxicity.  Therefore, therapeutic evaluation in relevant animal models is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUMCSJ43Nb6bVg90H21EOLACvtfcHk0lgFvyFOoBSoew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2ltrY%253D&md5=d48ef6f27006bfb6e13978bbc4303ae6</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DStephenson%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DFolate%2520receptor%2520targeted%2520delivery%2520of%2520liposomal%2520daunorubicin%2520into%2520tumor%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2002%26volume%3D22%26spage%3D2131%26epage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Saul, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annapragada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamkonda, R. V.</span><span> </span><span class="NLM_article-title">Controlled targeting of liposomal doxorubicin via the folate receptor in vitro</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0168-3659%2803%2900295-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14499185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1SntLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=49-67&author=J.+M.+Saulauthor=A.+Annapragadaauthor=J.+V.+Natarajanauthor=R.+V.+Bellamkonda&title=Controlled+targeting+of+liposomal+doxorubicin+via+the+folate+receptor+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled targeting of liposomal doxorubicin via the folate receptor in vitro</span></div><div class="casAuthors">Saul, Justin M.; Annapragada, Ananth; Natarajan, Jayaganesh V.; Bellamkonda, Ravi V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">49-67</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Differential expression of folate receptor has been exploited to target liposomes to tumors.  Astrogliomas express low folate receptor levels and are typically surrounded by normal cells expressing little or no folate receptors.  While targeting cells with high over-expression of folate receptor (KB and HeLa) has been demonstrated, it is unclear whether targeting tumors expressing low levels of folate receptor is possible.  In this study, it was demonstrated that optimizing the no. of targeting ligands (folic acid) enables differential liposomal doxorubicin uptake in C6 glioma while sparing healthy cortical cells.  By micellization of folate conjugates and their controlled insertion into pre-formed liposomes, tight control over the no. of targeting ligands per liposome was demonstrated.  Doxorubicin uptake in KB and C6 cells was dependent on the no. of targeting ligands, while cortical cells showed increasing non-specific uptake with ligand no.  Co-culture of C6 glioma with cortical cells confirmed preferential uptake in C6 glioma relative to cortical cells.  A cell kill expt. showed that folate-targeted liposomal doxorubicin is cytotoxic and slows proliferation of KB and C6 cells with minimal effect on cortical cells.  Therefore modulation of targeting ligand no. enables significant differential uptake of doxorubicin in cells with low levels of folate receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD5V0hn8bmprVg90H21EOLACvtfcHk0lgFvyFOoBSoew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1SntLg%253D&md5=e678e4a0b840f749773eea501e6d6d28</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2803%2900295-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252803%252900295-5%26sid%3Dliteratum%253Aachs%26aulast%3DSaul%26aufirst%3DJ.%2BM.%26aulast%3DAnnapragada%26aufirst%3DA.%26aulast%3DNatarajan%26aufirst%3DJ.%2BV.%26aulast%3DBellamkonda%26aufirst%3DR.%2BV.%26atitle%3DControlled%2520targeting%2520of%2520liposomal%2520doxorubicin%2520via%2520the%2520folate%2520receptor%2520in%2520vitro%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2003%26volume%3D92%26spage%3D49%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Shi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">â</span> <span class="NLM_lpage">319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=309-319&author=G.+Shiauthor=W.+Guoauthor=S.+M.+Stephensonauthor=R.+J.+Lee&title=Efficient+intracellular+drug+and+gene+delivery+using+folate+receptor-targeted+pH-sensitive+liposomes+composed+of+cationic%2Fanionic+lipid+combinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DStephenson%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DEfficient%2520intracellular%2520drug%2520and%2520gene%2520delivery%2520using%2520folate%2520receptor-targeted%2520pH-sensitive%2520liposomes%2520composed%2520of%2520cationic%252Fanionic%2520lipid%2520combinations%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2002%26volume%3D80%26spage%3D309%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Pan, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1629</span><span class="NLM_x">â</span> <span class="NLM_lpage">1633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12168846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFWksLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=1629-1633&author=X.+Q.+Panauthor=H.+Wangauthor=R.+J.+Lee&title=Boron+delivery+to+a+murine+lung+carcinoma+using+folate+receptor-targeted+liposomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes</span></div><div class="casAuthors">Pan, Xing Q.; Wang, Huaqing; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1629-1633</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Folate receptor (FR) is amplified in a variety of human tumors.  Folate-derived liposomes have been shown to selectively deliver entrapped agents into tumor cells via receptor-mediated endocytosis.  In this preliminary study, the biodistribution of FR-targeted liposomes were evaluated as a potential delivery agent for Na3 (B20H17NH3) for boron neutron capture therapy (BNCT) of FR(+) tumors.  Na3 (B20H17NH3) was incorporated into liposomes by passive entrapment, following which they were administered i.v. into BALB/c mice bearing s.c. implants of FR(+) M109 murine lung carcinoma.  Tumor and normal tissue boron content was measured by d.c. plasma at. emission spectroscopy.  Mice that received FR-targeted and non-targeted control liposomes showed indistinguishable levels of tumor boron uptake (up to 85 Î¼g/g tumor), which reached a max. at the 24 h time point, while the tumor-to-blood (T/B) ratio continued to rise until the 72 h time point.  High-level boron delivery is possible using liposomes as a delivery agent.  FR targeting does not significantly enhance overall tumor localization but may improve boron delivery at the cellular and subcellular levels, which warrant further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2YT3Wi3pE7Vg90H21EOLACvtfcHk0lhs_cujtb8IJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFWksLw%253D&md5=ea6c020204b2b3f57995b2000458ef3b</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%2BQ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DBoron%2520delivery%2520to%2520a%2520murine%2520lung%2520carcinoma%2520using%2520folate%2520receptor-targeted%2520liposomes%26jtitle%3DAnticancer%2520Res.%26date%3D2002%26volume%3D22%26spage%3D1629%26epage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Stephenson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjarks, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">â</span> <span class="NLM_lpage">3345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12926073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVCgsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3341-3345&author=S.+M.+Stephensonauthor=W.+Yangauthor=P.+J.+Stevensauthor=W.+Tjarksauthor=R.+F.+Barthauthor=R.+J.+Lee&title=Folate+receptor-targeted+liposomes+as+possible+delivery+vehicles+for+boron+neutron+capture+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy</span></div><div class="casAuthors">Stephenson, Stacy M.; Yang, Weilian; Stevens, Phillip J.; Tjarks, Werner; Barth, Rolf F.; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">3341-3345</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: The folate receptor is amplified in a variety of human tumors including over 90% of ovarian carcinoma.  FR-targeted liposomes have previously been used by us to selectively deliver entrapped boron-contg. compds. to tumor cells for neutron capture therapy (NCT).  In the present study we have evaluated the delivery of Na3(B20H17NH3), which has been loaded into FR-targeted liposomes, in mice bearing xenograft implants of FR (+) KB s.c. tumor.  Materials and Methods: Na3(B20H17NH3) was passively entrapped into FR-targeted liposomes, which were administered i.v. into nude mice bearing s.c. implants of the FR(+) human oral carcinoma KB cell line.  Normal and tumor boron content was measured by d.c. plasma-at. emission spectroscopy.  Results: Mice that received FR-targeted liposomes contg. boron showed the highest tumor boron levels at 24 h (6.1 Î¼g/g) and tumor/blood boron ratios continued to rise for up to 120 h.  Conclusion: Boron delivery via FR-targeted liposomes is feasible and potentially can improve tumor uptake compared to non-targeted liposomes, and may improve cellular and subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonC_eqV7gfzbVg90H21EOLACvtfcHk0lhs_cujtb8IJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVCgsL4%253D&md5=2f9779aa3e670687bd27f8dabaaa3b4c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStephenson%26aufirst%3DS.%2BM.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DStevens%26aufirst%3DP.%2BJ.%26aulast%3DTjarks%26aufirst%3DW.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DFolate%2520receptor-targeted%2520liposomes%2520as%2520possible%2520delivery%2520vehicles%2520for%2520boron%2520neutron%2520capture%2520therapy%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3341%26epage%3D3345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Thirumamagal, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandyopadhyaya, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naranyanasamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnsamuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golightly, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jehning, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjarks, W.</span><span> </span><span class="NLM_article-title">Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT)</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">â</span> <span class="NLM_lpage">1150</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060075d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1141-1150&author=B.+T.+Thirumamagalauthor=X.+B.+Zhaoauthor=A.+K.+Bandyopadhyayaauthor=S.+Naranyanasamyauthor=J.+Johnsamuelauthor=R.+Tiwariauthor=D.+W.+Golightlyauthor=V.+Patelauthor=B.+T.+Jehningauthor=M.+V.+Backerauthor=R.+F.+Barthauthor=R.+J.+Leeauthor=J.+M.+Backerauthor=W.+Tjarks&title=Receptor-targeted+liposomal+delivery+of+boron-containing+cholesterol+mimics+for+boron+neutron+capture+therapy+%28BNCT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)</span></div><div class="casAuthors">Thirumamagal, B. T. S.; Zhao, Xiaobin B.; Bandyopadhyaya, Achintya K.; Narayanasamy, Sureshbabu; Johnsamuel, Jayaseharan; Tiwari, Rohit; Golightly, Danold W.; Patel, Vimalkumar; Jehning, Brian T.; Backer, Marina V.; Barth, Rolf F.; Lee, Robert J.; Backer, Joseph M.; Tjarks, Werner</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1141-1150</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liposomes have been a main focus of tumor-selective boron delivery strategies in boron neutron capture therapy (BNCT), a binary method for the treatment of cancer that is based on the nuclear reaction between boron atoms and low-energy thermal neutrons.  Three novel carboranyl cholesterol derivs. were prepd. as lipid bilayer components for the construction of nontargeted and receptor-targeted boronated liposomes for BNCT.  A major structural feature of these novel boronated cholesterol mimics is the replacement of the B and the C ring of cholesterol with a carborane cluster.  Computational analyses indicated that all three boronated compds. have structural features and physicochem. properties that are very similar to those of cholesterol.  One of the synthesized boronated cholesterol mimics was stably incorporated into non-, folate receptor (FR)-, and vascular endothelial growth factor receptor-2 (VEGFR-2)-targeted liposomes.  No major differences were found in appearance, size distribution, and lamellarity between conventional dipalmitoylphosphatidylcholine (DPPC)/cholesterol liposomes, nontargeted, and FR-targeted liposomal formulations of this carboranyl cholesterol deriv.  FR-targeted boronated liposomes were taken up extensively in FR overexpressing KB cells in vitro, and the uptake was effectively blocked in the presence of free folate.  In contrast, a boronated cholesterol mimic incorporated into nontargeted liposomes showed significantly lower cellular uptake.  There was no apparent in vitro cytotoxicity in FR overexpressing KB cells and VEGFR-2 overexpressing 293/KDR cells when these were incubated with boronated FR- and (VEGFR-2)-targeted liposomes, resp., although the former accumulated extensively in KB cells and the latter effectively interacted with VEGFR-2 by causing autophosphorylation and protecting 293/KDR cells from SLT (Shiga-like toxin)-VEGF cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeLUOoPO0-LVg90H21EOLACvtfcHk0lhs_cujtb8IJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D&md5=4a6a65107118389c48d5ee8233e563f8</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fbc060075d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060075d%26sid%3Dliteratum%253Aachs%26aulast%3DThirumamagal%26aufirst%3DB.%2BT.%26aulast%3DZhao%26aufirst%3DX.%2BB.%26aulast%3DBandyopadhyaya%26aufirst%3DA.%2BK.%26aulast%3DNaranyanasamy%26aufirst%3DS.%26aulast%3DJohnsamuel%26aufirst%3DJ.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DGolightly%26aufirst%3DD.%2BW.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DJehning%26aufirst%3DB.%2BT.%26aulast%3DBacker%26aufirst%3DM.%2BV.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DBacker%26aufirst%3DJ.%2BM.%26aulast%3DTjarks%26aufirst%3DW.%26atitle%3DReceptor-targeted%2520liposomal%2520delivery%2520of%2520boron-containing%2520cholesterol%2520mimics%2520for%2520boron%2520neutron%2520capture%2520therapy%2520%2528BNCT%2529%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D1141%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Henriksen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoultz, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruland, O. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, R. H.</span><span> </span><span class="NLM_article-title">Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">â</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.nucmedbio.2003.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15093814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Sit7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=441-449&author=G.+Henriksenauthor=B.+W.+Schoultzauthor=T.+E.+Michaelsenauthor=O.+S.+Brulandauthor=R.+H.+Larsen&title=Sterically+stabilized+liposomes+as+a+carrier+for+alpha-emitting+radium+and+actinium+radionuclides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Sterically stabilized liposomes as a carrier for Î±-emitting radium and actinium radionuclides</span></div><div class="casAuthors">Henriksen, Gjermund; Schoultz, B. W.; Michaelsen, T. E.; Bruland, O. S.; Larsen, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The Î±-particle emitting radionuclides 223Ra (t12 = 11.4 d), 224Ra (t1/2 = 3.6 d), and 225Ac(t1/2 = 10.0 d) may have a broad application in targeted radiotherapy provided that they could be linked to vehicles with tumor affinity.  The potential usefulness of liposomes as carriers was studied in the present work.  Radium and actinium radionuclides could be loaded in good yields into sterically stabilized lipsomes.  Subsequent coating of the lipsomes with a folate-F(ab')2 construct yielded a product with affinity towards tumor cells expressing folate receptors.  Radionuclide loaded liposomes showed excellent stability in serum in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUjtCDuUGfLVg90H21EOLACvtfcHk0lhJYEcxr2F4-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Sit7k%253D&md5=58c47b8a4d9df93b15d8f6fe91025e52</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2003.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2003.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DG.%26aulast%3DSchoultz%26aufirst%3DB.%2BW.%26aulast%3DMichaelsen%26aufirst%3DT.%2BE.%26aulast%3DBruland%26aufirst%3DO.%2BS.%26aulast%3DLarsen%26aufirst%3DR.%2BH.%26atitle%3DSterically%2520stabilized%2520liposomes%2520as%2520a%2520carrier%2520for%2520alpha-emitting%2520radium%2520and%2520actinium%2520radionuclides%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2004%26volume%3D31%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">3198</span><span class="NLM_x">â</span> <span class="NLM_lpage">3204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=8106354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXhsVeqsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=3198-3204&author=R.+J.+Leeauthor=P.+S.+Low&title=Delivery+of+liposomes+into+cultured+KB+cells+via+folate+receptor-mediated+endocytosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis</span></div><div class="casAuthors">Lee, Robert J.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3198-204</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Folic acid was covalently conjugated to 66-nm liposomes via spacers of various lengths in an attempt to target the liposomes to KB cells expressing folate receptors.  Spacers of short and intermediate lengths were unable to mediate assocn. of folate-conjugated liposomes with receptor-bearing cells, however, use of a 250 Ã polyethylene glycol spacer (PEG, Mr â¼3350) permitted avid uptake of the liposomes at â¼2.5 Ã 105 sites/cell.  The binding of folate-PEG liposomes to KB cells could be competitively inhibited by excess free folate or by anti-serum against the folate receptor, demonstrating the interaction is mediated by the cell surface folate-binding protein.  Following binding, cell-assocd. folate-PEG liposomes were internalized by folate-receptor-mediated endocytosis at 37Â° but not at 4Â°.  These folate-PEG liposomes show potential for delivering large quantities of low mol. wt. compds. non-destructively into folate receptor-bearing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3o2kccFYlLVg90H21EOLACvtfcHk0lhJYEcxr2F4-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsVeqsbk%253D&md5=1b269b76044c296a71134dc583404b37</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DDelivery%2520of%2520liposomes%2520into%2520cultured%2520KB%2520cells%2520via%2520folate%2520receptor-mediated%2520endocytosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D3198%26epage%3D3204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Gabizon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzemach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelbaum-Shavit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qazen, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalipsky, S.</span><span> </span><span class="NLM_article-title">Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">â</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9801124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1MXnsF2ntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=289-298&author=A.+Gabizonauthor=A.+T.+Horowitzauthor=D.+Gorenauthor=D.+Tzemachauthor=F.+Mandelbaum-Shavitauthor=M.+M.+Qazenauthor=S.+Zalipsky&title=Targeting+folate+receptor+with+folate+linked+to+extremities+of+poly%28ethylene+glycol%29-grafted+liposomes%3A+in+vitro+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Folate Receptor with Folate Linked to Extremities of Poly(ethylene glycol)-Grafted Liposomes: In Vitro Studies</span></div><div class="casAuthors">Gabizon, Alberto; Horowitz, Aviva T.; Goren, Dorit; Tzemach, Dinah; Mandelbaum-Shavit, Frederika; Qazen, Masoud M.; Zalipsky, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugates of 3 components, folic acid-polyethylene glycol-distearoylphosphatidylethanolamine (FA-PEG-DSPE), derived from PEG with mol. wts. of 2000 and 3350 Da were synthesized by a carbodiimide-mediated coupling of FA to H2N-PEG-DSPE.  The conjugates were characterized by 1H NMR, MALDI-TOF, and HPLC anal. of enzymic cleavage with carboxypeptidase G.  As a prototype of a folate receptor (FR)-targeted system, the conjugates were formulated at 0.5 mol% phospholipid in hydrogenated phosphatidylcholine/cholesterol liposomes with or without addnl. methoxyPEG2000-DSPE.  In vitro binding studies were performed with sublines of M109 (murine lung carcinoma) and KB (human epidermal carcinoma) cells each contg. high and low densities of FR. FA-PEG-DSPE significantly enhanced liposome binding to tumor cells.  The best binding was obsd. when FA-PEG liposomes contained no addnl. mPEG-lipid.  The presence of mPEG on liposomal surfaces significantly inhibited FA-PEG-liposome binding to FR.  Increasing the mol. wt. of the PEG tether from 2000 to 3350 Da improved the FR binding, particularly in the case of mPEG-coated liposomes.  The FA-PEG liposomes bound to M109-HiFR cells very avidly as demonstrated by the inability of free FA (used in a 700-fold excess either at the beginning or at the end of the incubation) to prevent the cell binding.  This is in contrast to the 5-10-fold lower cell binding activity of mPEG-FA compared to that of free FA, and likely to be related to the multivalent nature of the liposome-bound FA.  Only 22% of FA-PEG3350 and 32% of FA-PEG3350/mPEG cell-assocd. liposomes could be removed by exposure to pH 3, conditions that dissoc. FA-FR, suggesting that more than two-thirds of the bound liposomes were internalized during incubation for 24 h at 37Â°.  FA-targeted liposomes also show enhanced nonspecific binding to extracellular tissue culture components, a phenomenon esp. relevant in short incubation time expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCEu1Kbj71LVg90H21EOLACvtfcHk0lhJYEcxr2F4-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsF2ntw%253D%253D&md5=90ecb245128b81bb59c834bcc3ba37de</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fbc9801124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9801124%26sid%3Dliteratum%253Aachs%26aulast%3DGabizon%26aufirst%3DA.%26aulast%3DHorowitz%26aufirst%3DA.%2BT.%26aulast%3DGoren%26aufirst%3DD.%26aulast%3DTzemach%26aufirst%3DD.%26aulast%3DMandelbaum-Shavit%26aufirst%3DF.%26aulast%3DQazen%26aufirst%3DM.%2BM.%26aulast%3DZalipsky%26aufirst%3DS.%26atitle%3DTargeting%2520folate%2520receptor%2520with%2520folate%2520linked%2520to%2520extremities%2520of%2520poly%2528ethylene%2520glycol%2529-grafted%2520liposomes%253A%2520in%2520vitro%2520studies%26jtitle%3DBioconjugate%2520Chem.%26date%3D1999%26volume%3D10%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Yamada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitani, Y.</span><span> </span><span class="NLM_article-title">Design of folate-linked liposomal doxorubicin to its antitumor effect in mice</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8161</span><span class="NLM_x">â</span> <span class="NLM_lpage">8168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1158%2F1078-0432.CCR-08-0159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19088031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=8161-8168&author=A.+Yamadaauthor=Y.+Taniguchiauthor=K.+Kawanoauthor=T.+Hondaauthor=Y.+Hattoriauthor=Y.+Maitani&title=Design+of+folate-linked+liposomal+doxorubicin+to+its+antitumor+effect+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice</span></div><div class="casAuthors">Yamada, Atsushi; Taniguchi, Yukimi; Kawano, Kumi; Honda, Takashi; Hattori, Yoshiyuki; Maitani, Yoshie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8161-8168</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Tumor cell targeting is a promising strategy for enhancing the therapeutic potential of chemotherapy agents.  Polyethylene glycol (PEG)-coated (sterically stabilized) liposomes show enhanced accumulation on the surface of tumors, but steric hindrance by PEGylation reduces the assocn. of the liposome-bound ligand with its receptor.  To increase folate receptor (FR) targeting, we optimized the concn. and PEG spacer length of folate-PEG-lipid in liposomes.  Exptl. Design: Three types of folate-linked liposomal doxorubicin were designed and prepd. by optimizing the concn. and PEG spacer length of folate-PEG-lipid in PEGylated or non-PEGylated liposomes and by masking folate-linked liposomes where the folate ligand is "masked" by adjacent PEG spacers.  The liposome targeting efficacy was evaluated in vitro and in vivo.  RESULTS: In human oral carcinoma KB cells, which overexpress FR, modification with sufficiently long PEG spacer and a high concn. of folate ligand to non-PEGylated liposomes increased the FR-mediated assocn. and cytotoxicity more than with PEGylated and masked folate-linked liposomes.  On the contrary, in mice bearing murine lung carcinoma M109, modification with the folate ligand in PEGylated and masked folate-linked liposomes showed significantly higher antitumor effect than with non-PEGylated liposomes irresp. of the length of time in the circulation after i.v. injection.  CONCLUSIONS: The results of this study will be beneficial for the design and prepn. of ligand-targeting carriers for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4ecs3n74xLVg90H21EOLACvtfcHk0lg2DsZjRqyb3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7vJ&md5=6fa8be912557ebcb5d029db920dd1f72</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0159%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DA.%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DMaitani%26aufirst%3DY.%26atitle%3DDesign%2520of%2520folate-linked%2520liposomal%2520doxorubicin%2520to%2520its%2520antitumor%2520effect%2520in%2520mice%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2008%26volume%3D14%26spage%3D8161%26epage%3D8168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Zhao, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthusamy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2424</span><span class="NLM_x">â</span> <span class="NLM_lpage">2435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2424-2435&author=X.+B.+Zhaoauthor=N.+Muthusamyauthor=J.+C.+Byrdauthor=R.+J.+Lee&title=Cholesterol+as+a+bilayer+anchor+for+PEGylation+and+targeting+ligand+in+folate-receptor-targeted+liposomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BB.%26aulast%3DMuthusamy%26aufirst%3DN.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DCholesterol%2520as%2520a%2520bilayer%2520anchor%2520for%2520PEGylation%2520and%2520targeting%2520ligand%2520in%2520folate-receptor-targeted%2520liposomes%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2424%26epage%3D2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Xiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ijpharm.2007.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18258394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFCks74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2008&pages=29-36&author=G.+Xiangauthor=J.+Wuauthor=Y.+Luauthor=Z.+Liuauthor=R.+J.+Lee&title=Synthesis+and+evaluation+of+a+novel+ligand+for+folate-mediated+targeting+liposomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes</span></div><div class="casAuthors">Xiang, Guangya; Wu, Jun; Lu, Yanhui; Liu, Zhilan; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Folate receptors (FRs) have been identified as cellular surface markers for cancer and leukemia.  Liposomes contg. lipophilic derivs. of folate have been shown to effectively target FR-expressing cells.  Here, the authors report the synthesis of a novel lipophilic folate deriv., folate-polyethylene glycol-cholesterol hemisuccinate (F-PEG-CHEMS), and its evaluation as a targeting ligand for liposomal doxorubicin (L-DOX) in FR-expressing cells.  Liposomes contg. F-PEG-CHEMS, with a mean diam. of 120Â±20 nm, were synthesized by polycarbonate membrane extrusion and were shown to have excellent colloidal stability.  The liposomes were taken up selectively by KB cells, which overexpress FR-Î±.  Compared to folate-PEG-cholesterol (F-PEG-Chol), which contains a carbamate linkage, F-PEG-CHEMS better retained its FR-targeting activity during prolonged storage.  In addn., F-PEG-CHEMS contg. liposomes loaded with DOX (F-L-DOX) showed greater cytotoxicity (IC50 = 10.0 Î¼M) than nontargeted control L-DOX (IC50 = 57.5 Î¼M) in KB cells.  In ICR mice, both targeted and nontargeted liposomes exhibited long circulation properties, although F-L-DOX (t 1/2 = 12.34 h) showed more rapid plasma clearance than L-DOX (t 1/2 = 17.10 h).  These results suggest that F-PEG-CHEMS is effective as a novel ligand for the synthesis of FR-targeted liposomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWYXc8r5W7z7Vg90H21EOLACvtfcHk0lg2DsZjRqyb3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFCks74%253D&md5=839eb82aa5c367f4b8cbbd868fef857c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2007.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2007.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520ligand%2520for%2520folate-mediated%2520targeting%2520liposomes%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2008%26volume%3D356%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Vogel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Peptide-mediated release of folate-targeted liposome contents from endosomal compartments</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">â</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja952725m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=1581-1586&author=K.+Vogelauthor=S.+Wangauthor=R.+J.+Leeauthor=J.+Chmielewskiauthor=P.+S.+Low&title=Peptide-mediated+release+of+folate-targeted+liposome+contents+from+endosomal+compartments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fja952725m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja952725m%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DChmielewski%26aufirst%3DJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DPeptide-mediated%2520release%2520of%2520folate-targeted%2520liposome%2520contents%2520from%2520endosomal%2520compartments%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D1581%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielewski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1559</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1559&publication_year=2002&pages=56-68&author=M.+J.+Turkauthor=J.+A.+Reddyauthor=J.+A.+Chmielewskiauthor=P.+S.+Low&title=Characterization+of+a+novel+pH-sensitive+peptide+that+enhances+drug+release+from+folate-targeted+liposomes+at+endosomal+pHs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DChmielewski%26aufirst%3DJ.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520pH-sensitive%2520peptide%2520that%2520enhances%2520drug%2520release%2520from%2520folate-targeted%2520liposomes%2520at%2520endosomal%2520pHs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1559%26spage%3D56%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Rui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. H.</span><span> </span><span class="NLM_article-title">Diplasmenylcholine-folate liposomes: an efficient vehicle for intracellular drug delivery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">11213</span><span class="NLM_x">â</span> <span class="NLM_lpage">11218</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9742949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=11213-11218&author=Y.+Ruiauthor=S.+Wangauthor=P.+S.+Lowauthor=D.+H.+Thompson&title=Diplasmenylcholine-folate+liposomes%3A+an+efficient+vehicle+for+intracellular+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fja9742949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9742949%26sid%3Dliteratum%253Aachs%26aulast%3DRui%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DD.%2BH.%26atitle%3DDiplasmenylcholine-folate%2520liposomes%253A%2520an%2520efficient%2520vehicle%2520for%2520intracellular%2520drug%2520delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D11213%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Sudimack, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjarks, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">A novel pH-sensitive liposome formulation containing oleyl alcohol</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1564</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">â</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1564&publication_year=2002&pages=31-37&author=J.+J.+Sudimackauthor=W.+Guoauthor=W.+Tjarksauthor=R.+J.+Lee&title=A+novel+pH-sensitive+liposome+formulation+containing+oleyl+alcohol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudimack%26aufirst%3DJ.%2BJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DTjarks%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DA%2520novel%2520pH-sensitive%2520liposome%2520formulation%2520containing%2520oleyl%2520alcohol%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1564%26spage%3D31%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Liggins, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, H. M.</span><span> </span><span class="NLM_article-title">Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations</span> <span class="citation_source-journal">Adv. Drug. Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0169-409X%2802%2900016-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=11897145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVWnsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=191-202&author=R.+T.+Ligginsauthor=H.+M.+Burt&title=Polyether-polyester+diblock+copolymers+for+the+preparation+of+paclitaxel+loaded+polymeric+micelle+formulations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations</span></div><div class="casAuthors">Liggins, R. T.; Burt, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  A no. of hypersensitivity reactions have been attributed to the presence of Cremophor EL in the current formulation for paclitaxel.  This has led to the development of formulations for paclitaxel employing polyether-polyester diblock copolymers as micelle forming carriers.  Diblock copolymers of methoxypolyethylene glycol-block-poly(d,l-lactide) (MePEG:PDLLA) were synthesized from monomers of d,l-lactide and MePEG by a ring opening bulk polymn. in the presence of stannous octoate.  Up to 25% paclitaxel could be loaded into matrixes of MePEG:PDLLA (60:40, MePEG mol. wt. of 2000) using the soln. casting method.  Dissoln. of paclitaxel/copolymer matrixes in aq. media resulted in complete solubilization of paclitaxel within the hydrophobic PDLLA core of the micelles.  This review article describes the synthetic reaction conditions influencing the degree of conversion of monomer to copolymer, thermal properties, crit. micelle concns. of copolymers, methods of incorporation of paclitaxel into copolymer matrixes and subsequent constitution in aq. media and biol. evaluations of micellar paclitaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBDTjhuysbILVg90H21EOLACvtfcHk0lhixNBITeEUDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVWnsr4%253D&md5=f0288c0317a8793e4a4e4d59bcca3e5b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900016-9%26sid%3Dliteratum%253Aachs%26aulast%3DLiggins%26aufirst%3DR.%2BT.%26aulast%3DBurt%26aufirst%3DH.%2BM.%26atitle%3DPolyether-polyester%2520diblock%2520copolymers%2520for%2520the%2520preparation%2520of%2520paclitaxel%2520loaded%2520polymeric%2520micelle%2520formulations%26jtitle%3DAdv.%2520Drug.%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span> </span><span class="NLM_article-title">Preparation of micelle-forming polymerâdrug conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">â</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc00016a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK38XksFGktbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1992&pages=295-301&author=M.+Yokoyamaauthor=G.+S.+Kwonauthor=T.+Okanoauthor=Y.+Sakuraiauthor=T.+Setoauthor=K.+Kataoka&title=Preparation+of+micelle-forming+polymer%E2%88%92drug+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of micelle-forming polymer-drug conjugates</span></div><div class="casAuthors">Yokoyama, Masayuki; Kwon, Glenn S.; Okano, Teruo; Sakurai, Yasuhisa; Seto, Takashi; Kataoka, Kazunori</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-301</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    </div><div class="casAbstract">Adriamycin, a hydrophobic anticancer drug, was conjugated with poly(ethylene oxide)-poly(aspartic acid) block copolymers composed of various lengths of each block copolymer segment ranging from 1000 to 12 000 in mol. wt. and from 10 to 80 units, resp.  Conjugation was achieved without pptn. by adjusting the ratio of adriamycin to aspartic acid residues of the block copolymer and the quantity of DMF used for the reaction.  The conjugates showed high water soly. irresp. of a large amt. of the conjugated adriamycin.  Furthermore, these conjugates form micellar structures with a hydrophobic inner core and a hydrophilic outer shell.  This micellar architecture may be utilized for effective drug targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVj5MFFU862LVg90H21EOLACvtfcHk0lhixNBITeEUDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XksFGktbc%253D&md5=cf145162a9079cf81c4446f99ef916be</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fbc00016a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc00016a007%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DKwon%26aufirst%3DG.%2BS.%26aulast%3DOkano%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DSeto%26aufirst%3DT.%26aulast%3DKataoka%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520micelle-forming%2520polymer%25E2%2588%2592drug%2520conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D1992%26volume%3D3%26spage%3D295%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Yoo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. G.</span><span> </span><span class="NLM_article-title">Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">â</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=17-27&author=H.+S.+Yooauthor=E.+A.+Leeauthor=T.+G.+Park&title=Doxorubicin-conjugated+biodegradable+polymeric+micelles+having+acid-cleavable+linkages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DE.%2BA.%26aulast%3DPark%26aufirst%3DT.%2BG.%26atitle%3DDoxorubicin-conjugated%2520biodegradable%2520polymeric%2520micelles%2520having%2520acid-cleavable%2520linkages%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2002%26volume%3D82%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Kwon, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, T.</span><span> </span><span class="NLM_article-title">Soluble self-assembled block copolymers for drug delivery</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">â</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=597-600&author=G.+S.+Kwonauthor=T.+Okano&title=Soluble+self-assembled+block+copolymers+for+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DG.%2BS.%26aulast%3DOkano%26aufirst%3DT.%26atitle%3DSoluble%2520self-assembled%2520block%2520copolymers%2520for%2520drug%2520delivery%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D597%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. H.</span><span> </span><span class="NLM_article-title">Polymeric micelle for tumor pH and folate-mediated targeting</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">â</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0168-3659%2803%2900239-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12932642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVSkur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&pages=103-113&author=E.+S.+Leeauthor=K.+Naauthor=Y.+H.+Bae&title=Polymeric+micelle+for+tumor+pH+and+folate-mediated+targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Polymeric micelle for tumor pH and folate-mediated targeting</span></div><div class="casAuthors">Lee, Eun Seong; Na, Kun; Bae, You Han</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Novel pH-sensitive polymeric mixed micelles composed of poly(l-histidine) (polyHis; Mw 5000)/PEG (Mn 2000) and poly(l-lactic acid) (PLLA) (Mn 3000)/PEG (Mn 2000) block copolymers with or without folate conjugation were prepd. by diafiltration.  The micelles were investigated for pH-dependent drug release, folate receptor-mediated internalization and cytotoxicity using MCF-7 cells in vitro.  The polyHis/PEG micelles showed accelerated adriamycin release as the pH decreased from 8.0.  When the cumulative release for 24 h was plotted as a function of pH, the gradual transition in release rate appeared in a pH range from 8.0 to 6.8.  In order to tailor the triggering pH of the polymeric micelles to the more acidic extracellular pH of tumors, while improving the micelle stability at pH 7.4, the PLLA/PEG block copolymer was blended with polyHis/PEG to form mixed micelles.  Blending shifted the triggering pH to a lower value.  Depending on the amt. of PLLA/PEG, the mixed micelles were destabilized in the pH range of 7.2-6.6 (triggering pH for adriamycin release).  When the mixed micelles were conjugated with folic acid, the in vitro results demonstrated that the micelles were more effective in tumor cell kill due to accelerated drug release and folate receptor-mediated tumor uptake.  In addn., after internalization polyHis was found to be effective for cytosolic ADR delivery by virtue of fusogenic activity.  This approach is expected to be useful for treatment of solid tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEjbof8z6xm7Vg90H21EOLACvtfcHk0li8iwwTBO2bqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVSkur4%253D&md5=9ac80e60647cfb9cccfc8e859afddb27</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2803%2900239-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252803%252900239-6%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DNa%26aufirst%3DK.%26aulast%3DBae%26aufirst%3DY.%2BH.%26atitle%3DPolymeric%2520micelle%2520for%2520tumor%2520pH%2520and%2520folate-mediated%2520targeting%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2003%26volume%3D91%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. H.</span><span> </span><span class="NLM_article-title">Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">â</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.jconrel.2004.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15763623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitV2hsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2005&pages=405-418&author=E.+S.+Leeauthor=K.+Naauthor=Y.+H.+Bae&title=Doxorubicin+loaded+pH-sensitive+polymeric+micelles+for+reversal+of+resistant+MCF-7+tumor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor</span></div><div class="casAuthors">Lee, Eun Seong; Na, Kun; Bae, You Han</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-418</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to overcome multidrug resistance in solid tumors, doxorubicin (DOX) loaded pH-sensitive micelles of which surface was decorated with folate (PHSM/f) were evaluated both in vitro and in vivo expts.  PHSM/f were fabricated from a mixt. of two block copolymers of poly(-histidine) (Mn: 5K)-b-PEG (Mn: 2K)-folate (polyHis/PEG-folate) (75%) and poly(-lactic acid) (Mn: 3K)-b-PEG (Mn: 2K)-folate (PLLA/PEG-folate) (25%).  The PHSM/f showed more than 90% cytotoxicity of DOX resistant MCF-7 (MCF-7/DOXR) when cultured with PHSM/f at a concn. of 10 Î¼g/mL DOX.  The result was interpreted by a sequential event of active internalization of PHSM/f via folate-receptor mediated endocytosis and ionization of His residues which result in micelle destabilization and probably disturbance of endosomal membranes.  This potential mechanism may endow the drug carriers to bypass Pgp efflux pump and sequestration of DOX in acidic intracellular compartments, yielding high cytotoxicity.  Exptl. evaluation of tumor regression was carried out in a small animal model bearing s.c.  MCF-7 or MCF-7/DOXR xenografts.  The tumor (MCF-7/DOXR) vols. of mice treated with PHSM/f were significantly less than control groups treated with free DOX or similar micelles but without folate (PHSM).  In the MCF-7/DOXR xenograft model, the accumulated DOX level of PHSM/f in solid tumors was 20 times higher than free DOX group, and 3 times higher than PHSM group.  The results demonstrate that PHSM/f is a viable means for treating drug resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowgQ6vR9ReyLVg90H21EOLACvtfcHk0li8iwwTBO2bqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitV2hsbY%253D&md5=0b50c93ce8f43324d6d8b4d36172c36c</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2004.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2004.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DNa%26aufirst%3DK.%26aulast%3DBae%26aufirst%3DY.%2BH.%26atitle%3DDoxorubicin%2520loaded%2520pH-sensitive%2520polymeric%2520micelles%2520for%2520reversal%2520of%2520resistant%2520MCF-7%2520tumor%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2005%26volume%3D103%26spage%3D405%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span> </span><span class="NLM_article-title">Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging</span> <span class="citation_source-journal">Langmuir</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5213</span><span class="NLM_x">â</span> <span class="NLM_lpage">5217</span></span><div class="citationLinks">[<a href="/doi/10.1021/la703570m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1emt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2008&pages=5213-5217&author=H.+Chenauthor=S.+Kimauthor=W.+Heauthor=H.+Wangauthor=P.+S.+Lowauthor=K.+Parkauthor=J.+X.+Cheng&title=Fast+release+of+lipophilic+agents+from+circulating+PEG-PDLLA+micelles+revealed+by+in+vivo+Forster+resonance+energy+transfer+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Release of Lipophilic Agents from Circulating PEG-PDLLA Micelles Revealed by in Vivo Foerster Resonance Energy Transfer Imaging</span></div><div class="casAuthors">Chen, Hongtao; Kim, Sungwon; He, Wei; Wang, Haifeng; Low, Philip S.; Park, Kinam; Cheng, Ji-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Langmuir</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5213-5217</span>CODEN:
                <span class="NLM_cas:coden">LANGD5</span>;
        ISSN:<span class="NLM_cas:issn">0743-7463</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the in vivo behavior of nanoparticles is crit. for the translation of nanomedicine from lab. research to clin. trials.  In this work, in vivo Forster resonance energy transfer (FRET) imaging was employed to monitor the release of hydrophobic mols. from circulating poly(ethylene glycol)-poly(D,L-lactic acid) (PEG-PDLLA) micelles.  A lipophilic FRET pair (DiIC18 and DiOC18) was phys. entrapped into micelle cores by mimicking the loading of hydrophobic drugs.  The FRET efficiency was found significantly reduced within 15 min after i.v. injection, implying that DiIC18 and DiOC18 quickly escaped from the circulating micelles.  FRET spectroscopy studies further demonstrated that Î±- and Î²-globulins were major factors for the obsd. fast release, while Î³-globulins, albumin, and red blood cells played minor roles.  These results provide useful information for developing blood-stable micelles to deliver hydrophobic drugs to the target site via prolonged circulation and extravasation from the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUPY59sUkK67Vg90H21EOLACvtfcHk0li8iwwTBO2bqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1emt7Y%253D&md5=009eaa2532346849e723c7bf4277064b</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fla703570m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fla703570m%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26atitle%3DFast%2520release%2520of%2520lipophilic%2520agents%2520from%2520circulating%2520PEG-PDLLA%2520micelles%2520revealed%2520by%2520in%2520vivo%2520Forster%2520resonance%2520energy%2520transfer%2520imaging%26jtitle%3DLangmuir%26date%3D2008%26volume%3D24%26spage%3D5213%26epage%3D5217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span> </span><span class="NLM_article-title">Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6596</span><span class="NLM_x">â</span> <span class="NLM_lpage">6601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.0707046105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18445654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVOgtr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=6596-6601&author=H.+Chenauthor=S.+Kimauthor=L.+Liauthor=S.+Wangauthor=K.+Parkauthor=J.+X.+Cheng&title=Release+of+hydrophobic+molecules+from+polymer+micelles+into+cell+membranes+revealed+by+Forster+resonance+energy+transfer+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging</span></div><div class="casAuthors">Chen, Hongtao; Kim, Sungwon; Li, Li; Wang, Shuyi; Park, Kinam; Cheng, Ji-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6596-6601,</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">It is generally assumed that polymeric micelles, upon administration into the blood stream, carry drug mols. until they are taken up into cells followed by intracellular release.  The current work revisits this conventional wisdom.  The study using dual-labeled micelles contg. fluorescently labeled copolymers and hydrophobic fluorescent probes entrapped in the polymeric micelle core showed that cellular uptake of hydrophobic probes was much faster than that of labeled copolymers.  This result implies that the hydrophobic probes in the core are released from micelles in the extracellular space.  Forster resonance energy transfer (FRET) imaging and spectroscopy were used to monitor this process in real time.  A FRET pair, DiIC18(3) and DiOC18(3), was loaded into monomethoxy poly(ethylene glycol)-block-poly(D,L-lactic acid) micelles.  By monitoring the FRET efficiency, release of the core-loaded probes to model membranes was demonstrated.  During administration of polymeric micelles to tumor cells, a decrease of FRET was obsd. both on the cell membrane and inside of cells, indicating the release of core-loaded probes to the cell membrane before internalization.  The decrease of FRET on the plasma membrane was also obsd. during administration of paclitaxel-loaded micelles.  Taken together, our results suggest a membrane-mediated pathway for cellular uptake of hydrophobic mols. preloaded in polymeric micelles.  The plasma membrane provides a temporal residence for micelle-released hydrophobic mols. before their delivery to target intracellular destinations.  A putative role of the PEG shell in the mol. transport from micelle to membrane is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSnLzySl0dybVg90H21EOLACvtfcHk0lgjZyyTpT2gBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVOgtr0%253D&md5=7b15b05760ca3954ca7991a4e02c4636</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0707046105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0707046105%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26atitle%3DRelease%2520of%2520hydrophobic%2520molecules%2520from%2520polymer%2520micelles%2520into%2520cell%2520membranes%2520revealed%2520by%2520Forster%2520resonance%2520energy%2520transfer%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D6596%26epage%3D6601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Konda, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiener, E. C.</span><span> </span><span class="NLM_article-title">Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts</span> <span class="citation_source-journal">Invest. Radiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=199-204&author=S.+D.+Kondaauthor=S.+Wangauthor=M.+Brechbielauthor=E.+C.+Wiener&title=Biodistribution+of+a+153+Gd-folate+dendrimer%2C+generation+%3D+4%2C+in+mice+with+folate-receptor+positive+and+negative+ovarian+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonda%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBrechbiel%26aufirst%3DM.%26aulast%3DWiener%26aufirst%3DE.%2BC.%26atitle%3DBiodistribution%2520of%2520a%2520153%2520Gd-folate%2520dendrimer%252C%2520generation%2520%253D%25204%252C%2520in%2520mice%2520with%2520folate-receptor%2520positive%2520and%2520negative%2520ovarian%2520tumor%2520xenografts%26jtitle%3DInvest.%2520Radiol.%26date%3D2002%26volume%3D37%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Quintana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raczka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piehler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myc, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majoros, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patri, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mule, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1310</span><span class="NLM_x">â</span> <span class="NLM_lpage">1316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2002&pages=1310-1316&author=A.+Quintanaauthor=E.+Raczkaauthor=L.+Piehlerauthor=I.+Leeauthor=A.+Mycauthor=I.+Majorosauthor=A.+K.+Patriauthor=T.+Thomasauthor=J.+Muleauthor=J.+R.+Baker&title=Design+and+function+of+a+dendrimer-based+therapeutic+nanodevice+targeted+to+tumor+cells+through+the+folate+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana%26aufirst%3DA.%26aulast%3DRaczka%26aufirst%3DE.%26aulast%3DPiehler%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DMyc%26aufirst%3DA.%26aulast%3DMajoros%26aufirst%3DI.%26aulast%3DPatri%26aufirst%3DA.%2BK.%26aulast%3DThomas%26aufirst%3DT.%26aulast%3DMule%26aufirst%3DJ.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DDesign%2520and%2520function%2520of%2520a%2520dendrimer-based%2520therapeutic%2520nanodevice%2520targeted%2520to%2520tumor%2520cells%2520through%2520the%2520folate%2520receptor%26jtitle%3DPharm.%2520Res.%26date%3D2002%26volume%3D19%26spage%3D1310%26epage%3D1316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Kukowska-Latallo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candido, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigavekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majoros, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balogh, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">5317</span><span class="NLM_x">â</span> <span class="NLM_lpage">5324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=5317-5324&author=J.+F.+Kukowska-Latalloauthor=K.+A.+Candidoauthor=Z.+Caoauthor=S.+S.+Nigavekarauthor=I.+J.+Majorosauthor=T.+P.+Thomasauthor=L.+P.+Baloghauthor=M.+K.+Khanauthor=J.+R.+Baker&title=Nanoparticle+targeting+of+anticancer+drug+improves+therapeutic+response+in+animal+model+of+human+epithelial+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukowska-Latallo%26aufirst%3DJ.%2BF.%26aulast%3DCandido%26aufirst%3DK.%2BA.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DNigavekar%26aufirst%3DS.%2BS.%26aulast%3DMajoros%26aufirst%3DI.%2BJ.%26aulast%3DThomas%26aufirst%3DT.%2BP.%26aulast%3DBalogh%26aufirst%3DL.%2BP.%26aulast%3DKhan%26aufirst%3DM.%2BK.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DNanoparticle%2520targeting%2520of%2520anticancer%2520drug%2520improves%2520therapeutic%2520response%2520in%2520animal%2520model%2520of%2520human%2520epithelial%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D5317%26epage%3D5324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Patri, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukowska-Latallo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">â</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2005.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16290254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12ksbrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=2203-2214&author=A.+K.+Patriauthor=J.+F.+Kukowska-Latalloauthor=J.+R.+Baker&title=Targeted+drug+delivery+with+dendrimers%3A+comparison+of+the+release+kinetics+of+covalently+conjugated+drug+and+non-covalent+drug+inclusion+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex</span></div><div class="casAuthors">Patri, Anil K.; Kukowska-Latallo, Jolanta F.; Baker, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2203-2214</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dendrimers have unique characteristics including monodispersity and modifiable surface functionality, along with highly defined size and structure.  This makes these polymers attractive candidates as carriers in drug delivery applications.  Drug delivery can be achieved by coupling a drug to polymer through one of two approaches.  Hydrophobic drugs can be complexed within the hydrophobic dendrimer interior to make them water-sol. or drugs can be covalently coupled onto the surface of the dendrimer.  Using both methods we compared the efficacy of generation 5 PAMAM dendrimers in the targeted drug delivery of methotrexate coupled to the polymer.  The amine-terminated dendrimers bind to neg. charged membranes of cells in a non-specific manner and can cause toxicity in vitro and in vivo.  To reduce toxicity and to increase aq. soly., modifications were made to the surface hydroxyl groups of the dendrimers.  For targeted drug delivery, the dendrimer was modified to have a neutral terminal functionality for use with surface-conjugated folic acid as the targeting agent.  The complexation of methotrexate within a dendrimer changes the water insol. drug into a stable and readily water-sol. compd.  When this dendrimer complexed drug, however, was placed in a soln. of phosphate buffered saline, the methotrexate was immediately released and displayed diffusion characteristics identical to free methotrexate.  Covalently coupled methotrexate dendrimer conjugates were stable under identical conditions in water and buffered saline.  Cytotoxicity tests showed that methotrexate as the dendrimer inclusion complex had an activity identical to the free drug in vitro.  In contrast, folic acid targeted dendrimer with covalently conjugated methotrexate specifically killed receptor-expressing cells by intracellular delivery of the drug through receptor-mediated endocytosis.  This study demonstrates that while drug as a dendrimer inclusion complex is readily released and active in vitro, covalently conjugated drug to dendrimer is better suited for specifically targeted drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGossybNL6K9gLVg90H21EOLACvtfcHk0lgjZyyTpT2gBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12ksbrM&md5=1f91bba62e990c8de2ccb054a74eafcd</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2005.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2005.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DPatri%26aufirst%3DA.%2BK.%26aulast%3DKukowska-Latallo%26aufirst%3DJ.%2BF.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DTargeted%2520drug%2520delivery%2520with%2520dendrimers%253A%2520comparison%2520of%2520the%2520release%2520kinetics%2520of%2520covalently%2520conjugated%2520drug%2520and%2520non-covalent%2520drug%2520inclusion%2520complex%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D2203%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Sonvico, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mornet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasseur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubernet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaillard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrouard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebeke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duguet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvreur, P.</span><span> </span><span class="NLM_article-title">Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1181</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc050050z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleqsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1181-1188&author=F.+Sonvicoauthor=S.+Mornetauthor=S.+Vasseurauthor=C.+Dubernetauthor=D.+Jaillardauthor=J.+Degrouardauthor=J.+Hoebekeauthor=E.+Duguetauthor=P.+Colomboauthor=P.+Couvreur&title=Folate-conjugated+iron+oxide+nanoparticles+for+solid+tumor+targeting+as+potential+specific+magnetic+hyperthermia+mediators%3A+synthesis%2C+physicochemical+characterization%2C+and+in+vitro+experiments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Conjugated Iron Oxide Nanoparticles for Solid Tumor Targeting as Potential Specific Magnetic Hyperthermia Mediators: Synthesis, Physicochemical Characterization, and in Vitro Experiments</span></div><div class="casAuthors">Sonvico, Fabio; Mornet, Stephane; Vasseur, Sebastien; Dubernet, Catherine; Jaillard, Danielle; Degrouard, Jeril; Hoebeke, Johan; Duguet, Etienne; Colombo, Paolo; Couvreur, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1181-1188</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New folate-conjugated superparamagnetic maghemite nanoparticles have been synthesized for the intracellular hyperthermia treatment of solid tumors.  These ultradispersed nanosystems have been characterized for their physicochem. properties and tumor cell targeting ability, facilitated by surface modification with folic acid.  Preliminary expts. of nanoparticles heating under the influence of an alternating magnetic field at 108 kHz have been also performed.  The nanoparticle size, surface charge, and colloidal stability have been assessed in various conditions of ionic strength and pH.  The ability of these folate "decorated" maghemite nanoparticles to recognize the folate receptor has been investigated both by surface plasmon resonance and in folate receptor expressing cell lines, using radiolabeled folic acid in competitive binding expts.  The specificity of nanoparticle cellular uptake has been further investigated by transmission electron microscopy after incubation of these nanoparticles in the presence of three cell lines with differing folate receptor expression levels.  Qual. and quant. detns. of both folate nanoparticles and nontargeted control nanoparticles demonstrated a specific cell internalization of the folate superparamagnetic nanoparticles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkulGEiwuaZ7Vg90H21EOLACvtfcHk0lic8x8TgTh_JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleqsrs%253D&md5=95288a7b68e44b62a3151cf73f89ef68</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fbc050050z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc050050z%26sid%3Dliteratum%253Aachs%26aulast%3DSonvico%26aufirst%3DF.%26aulast%3DMornet%26aufirst%3DS.%26aulast%3DVasseur%26aufirst%3DS.%26aulast%3DDubernet%26aufirst%3DC.%26aulast%3DJaillard%26aufirst%3DD.%26aulast%3DDegrouard%26aufirst%3DJ.%26aulast%3DHoebeke%26aufirst%3DJ.%26aulast%3DDuguet%26aufirst%3DE.%26aulast%3DColombo%26aufirst%3DP.%26aulast%3DCouvreur%26aufirst%3DP.%26atitle%3DFolate-conjugated%2520iron%2520oxide%2520nanoparticles%2520for%2520solid%2520tumor%2520targeting%2520as%2520potential%2520specific%2520magnetic%2520hyperthermia%2520mediators%253A%2520synthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520in%2520vitro%2520experiments%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D1181%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Kohler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells</span> <span class="citation_source-journal">Langmuir</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">8858</span><span class="NLM_x">â</span> <span class="NLM_lpage">8864</span></span><div class="citationLinks">[<a href="/doi/10.1021/la0503451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=8858-8864&author=N.+Kohlerauthor=C.+Sunauthor=J.+Wangauthor=M.+Zhang&title=Methotrexate-modified+superparamagnetic+nanoparticles+and+their+intracellular+uptake+into+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fla0503451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fla0503451%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DMethotrexate-modified%2520superparamagnetic%2520nanoparticles%2520and%2520their%2520intracellular%2520uptake%2520into%2520human%2520cancer%2520cells%26jtitle%3DLangmuir%26date%3D2005%26volume%3D21%26spage%3D8858%26epage%3D8864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span> </span><span class="NLM_article-title">Gold nanorods mediate tumor cell death by compromising membrane integrity</span> <span class="citation_source-journal">Adv. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3136</span><span class="NLM_x">â</span> <span class="NLM_lpage">3141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fadma.200701974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19020672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jt73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=3136-3141&author=L.+Tongauthor=Y.+Zhaoauthor=T.+B.+Huffauthor=M.+N.+Hansenauthor=A.+Weiauthor=J.+X.+Cheng&title=Gold+nanorods+mediate+tumor+cell+death+by+compromising+membrane+integrity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Gold nanorods mediate tumor cell death by compromising membrane integrity</span></div><div class="casAuthors">Tong, Ling; Zhao, Yan; Huff, Terry B.; Hansen, Matthew N.; Wei, Alexander; Cheng, Ji-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Materials (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3136-3141</span>CODEN:
                <span class="NLM_cas:coden">ADVMEW</span>;
        ISSN:<span class="NLM_cas:issn">0935-9648</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Folate-conjugated gold nanorods targeted to tumor cell surfaces produced severe membrane damage upon near-IR irradn.  Photoinduced injury to the plasma membrane resulted in a rapid increase in intracellular calcium with subsequent disruption of the actin network, featured prominently by the formation of membrane blebs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo425_eiGtB07Vg90H21EOLACvtfcHk0lic8x8TgTh_JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jt73J&md5=30d2a5b35633ea13c81eb6284b56f0b2</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fadma.200701974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.200701974%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHuff%26aufirst%3DT.%2BB.%26aulast%3DHansen%26aufirst%3DM.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26atitle%3DGold%2520nanorods%2520mediate%2520tumor%2520cell%2520death%2520by%2520compromising%2520membrane%2520integrity%26jtitle%3DAdv.%2520Mater.%26date%3D2007%26volume%3D19%26spage%3D3136%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Huff, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span> </span><span class="NLM_article-title">Hyperthermic effects of gold nanorods on tumor cells</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">â</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.2217%2F17435889.2.1.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17716198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvF2it74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=125-132&author=T.+B.+Huffauthor=L.+Tongauthor=Y.+Zhaoauthor=M.+N.+Hansenauthor=J.+X.+Chengauthor=A.+Wei&title=Hyperthermic+effects+of+gold+nanorods+on+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperthermic effects of gold nanorods on tumor cells</span></div><div class="casAuthors">Huff, Terry B.; Tong, Ling; Zhao, Yan; Hansen, Matthew N.; Cheng, Ji-Xin; Wei, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1743-5889</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Plasmon-resonant gold nanorods, which have large absorption cross sections at near-IR frequencies, are excellent candidates as multifunctional agents for image-guided therapies based on localized hyperthermia.  The controlled modification of the surface chem. of the nanorods is of crit. importance, as issues of cell-specific targeting and nonspecific uptake must be addressed prior to clin. evaluation.  Nanorods coated with cetyltrimethylammonium bromide (a cationic surfactant used in nanorod synthesis) are internalized within hours into KB cells by a nonspecific uptake pathway, whereas the careful removal of cetyltrimethylammonium bromide from nanorods functionalized with folate results in their accumulation on the cell surface over the same time interval.  In either case, the nanorods render the tumor cells highly susceptible to photothermal damage when irradiated at the nanorods' longitudinal plasmon resonance, generating extensive blebbing of the cell membrane at laser fluences as low as 30 J/cm2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhLB5c4NMMbVg90H21EOLACvtfcHk0lhq5Ds0N0y8lA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvF2it74%253D&md5=e33b3d6bfb71dd422e80e171f26efd3e</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.2217%2F17435889.2.1.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17435889.2.1.125%26sid%3Dliteratum%253Aachs%26aulast%3DHuff%26aufirst%3DT.%2BB.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHansen%26aufirst%3DM.%2BN.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DWei%26aufirst%3DA.%26atitle%3DHyperthermic%2520effects%2520of%2520gold%2520nanorods%2520on%2520tumor%2520cells%26jtitle%3DNanomedicine%26date%3D2007%26volume%3D2%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, R. D.</span><span> </span><span class="NLM_article-title">On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles</span> <span class="citation_source-journal">Acta Biomater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">â</span> <span class="NLM_lpage">48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=40-48&author=J.+Zhangauthor=S.+Ranaauthor=R.+S.+Srivastavaauthor=R.+D.+Misra&title=On+the+chemical+synthesis+and+drug+delivery+response+of+folate+receptor-activated%2C+polyethylene+glycol-functionalized+magnetite+nanoparticles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DR.%2BS.%26aulast%3DMisra%26aufirst%3DR.%2BD.%26atitle%3DOn%2520the%2520chemical%2520synthesis%2520and%2520drug%2520delivery%2520response%2520of%2520folate%2520receptor-activated%252C%2520polyethylene%2520glycol-functionalized%2520magnetite%2520nanoparticles%26jtitle%3DActa%2520Biomater.%26date%3D2008%26volume%3D4%26spage%3D40%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Kam, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisdom, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span> </span><span class="NLM_article-title">Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">11600</span><span class="NLM_x">â</span> <span class="NLM_lpage">11605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.0502680102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16087878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGgsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=11600-11605&author=N.+W.+Kamauthor=M.+O%E2%80%99Connellauthor=J.+A.+Wisdomauthor=H.+Dai&title=Carbon+nanotubes+as+multifunctional+biological+transporters+and+near-infrared+agents+for+selective+cancer+cell+destruction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction</span></div><div class="casAuthors">Kam, Nadine Wong Shi; O'Connell, Michael; Wisdom, Jeffrey A.; Dai, Hongjie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11600-11605</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Biol. systems are known to be highly transparent to 700 to 1,100 nm near-IR (NIR) light.  It is shown here that the strong optical absorbance of single-walled carbon nanotubes (SWNTs) in this special spectral window, an intrinsic property of SWNTs, can be used for optical stimulation of nanotubes inside living cells to afford multifunctional nanotube biol. transporters.  For oligonucleotides transported inside living cells by nanotubes, the oligos can translocate into cell nucleus upon endosomal rupture triggered by NIR laser pulses.  Continuous NIR radiation can cause cell death because of excessive local heating of SWNT in vitro.  Selective cancer cell destruction can be achieved by functionalization of SWNT with a folate moiety, selective internalization of SWNTs inside cells labeled with folate receptor tumor markers, and NIR-triggered cell death, without harming receptor-free normal cells.  Thus, the transporting capabilities of carbon nanotubes combined with suitable functionalization chem. and their intrinsic optical properties can lead to new classes of novel nanomaterials for drug delivery and cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrLCeiVQ0vLVg90H21EOLACvtfcHk0lhq5Ds0N0y8lA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGgsbs%253D&md5=e0bb2015153d9fb4698237130666d82a</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502680102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502680102%26sid%3Dliteratum%253Aachs%26aulast%3DKam%26aufirst%3DN.%2BW.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DM.%26aulast%3DWisdom%26aufirst%3DJ.%2BA.%26aulast%3DDai%26aufirst%3DH.%26atitle%3DCarbon%2520nanotubes%2520as%2520multifunctional%2520biological%2520transporters%2520and%2520near-infrared%2520agents%2520for%2520selective%2520cancer%2520cell%2520destruction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D11600%26epage%3D11605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resasco, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. R.</span><span> </span><span class="NLM_article-title">Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes</span> <span class="citation_source-journal">J. Biomed. Opt.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">021009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1117%2F1.3078803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19405722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKms7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=021009&author=F.+Zhouauthor=D.+Xingauthor=Z.+Ouauthor=B.+Wuauthor=D.+E.+Resascoauthor=W.+R.+Chen&title=Cancer+photothermal+therapy+in+the+near-infrared+region+by+using+single-walled+carbon+nanotubes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes</span></div><div class="casAuthors">Zhou, Feifan; Xing, Da; Ou, Zhongmin; Wu, Baoyan; Resasco, Daniel E.; Chen, Wei R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Optics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">021009/1-021009/7</span>CODEN:
                <span class="NLM_cas:coden">JBOPFO</span>;
        ISSN:<span class="NLM_cas:issn">1083-3668</span>.
    
            (<span class="NLM_cas:orgname">Society of Photo-Optical Instrumentation Engineers</span>)
        </div><div class="casAbstract">Single-walled carbon nanotubes (SWNTs) have a high optical absorbance in the near-IR (NIR) region.  In this special optical window, biol. systems are known to be highly transparent.  The optical properties of SWNTs provide an opportunity for selective photothermal therapy for cancer treatment.  Specifically, CoMoCAT nanotubes with a uniform size (about 0.81 nm) and a narrow absorption peak at 980 nm are ideal candidates for such a novel approach.  Here, CoMoCAT SWNTs are conjugated to folate, which can bind specifically to the surface of the folate receptor tumor markers.  Folate-SWNT (FA-SWNT) targeted tumor cells were irradiated by a 980-nm laser.  In our in vitro and in vivo expts., FA-SWNT effectively enhanced the photothermal destruction on tumor cells and noticeably spared the photothermal destruction for nontargeted normal cells.  Thus, SWNTs, combined with suitable tumor markers, can be used as novel nanomaterials for selective photothermal therapy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5lLuSAUnGsrVg90H21EOLACvtfcHk0lhq5Ds0N0y8lA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKms7o%253D&md5=df9e0964257b4f324dd022e6176cd74e</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1117%2F1.3078803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1117%252F1.3078803%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DOu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DResasco%26aufirst%3DD.%2BE.%26aulast%3DChen%26aufirst%3DW.%2BR.%26atitle%3DCancer%2520photothermal%2520therapy%2520in%2520the%2520near-infrared%2520region%2520by%2520using%2520single-walled%2520carbon%2520nanotubes%26jtitle%3DJ.%2520Biomed.%2520Opt.%26date%3D2009%26volume%3D14%26spage%3D021009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Zheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickson, J. D.</span><span> </span><span class="NLM_article-title">Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17757</span><span class="NLM_x">â</span> <span class="NLM_lpage">17762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17757-17762&author=G.+Zhengauthor=J.+Chenauthor=H.+Liauthor=J.+D.+Glickson&title=Rerouting+lipoprotein+nanoparticles+to+selected+alternate+receptors+for+the+targeted+delivery+of+cancer+diagnostic+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGlickson%26aufirst%3DJ.%2BD.%26atitle%3DRerouting%2520lipoprotein%2520nanoparticles%2520to%2520selected%2520alternate%2520receptors%2520for%2520the%2520targeted%2520delivery%2520of%2520cancer%2520diagnostic%2520and%2520therapeutic%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D17757%26epage%3D17762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Glickson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund-Katz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chance, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, G.</span><span> </span><span class="NLM_article-title">Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents</span> <span class="citation_source-journal">Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">â</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18706292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Wmu7%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=101-110&author=J.+D.+Glicksonauthor=S.+Lund-Katzauthor=R.+Zhouauthor=H.+Choiauthor=I.+W.+Chenauthor=H.+Liauthor=I.+Corbinauthor=A.+V.+Popovauthor=W.+Caoauthor=L.+Songauthor=C.+Qiauthor=D.+Marottaauthor=D.+S.+Nelsonauthor=J.+Chenauthor=B.+Chanceauthor=G.+Zheng&title=Lipoprotein+nanoplatform+for+targeted+delivery+of+diagnostic+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents</span></div><div class="casAuthors">Glickson, Jerry D.; Lund-Katz, Sissel; Zhou, Rong; Choi, Hoon; Chen, I.-Wei; Li, Hui; Corbin, Ian; Popov, Anatoliy V.; Cao, Weiguo; Song, Liping; Qi, Chenze; Marotta, Diane; Nelson, David S.; Chen, Juan; Chance, Britton; Zheng, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">MIOMBP</span>;
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    
            (<span class="NLM_cas:orgname">BC Decker Inc.</span>)
        </div><div class="casAbstract">A review.  Low-d. lipoprotein (LDL) provides a highly versatile natural nanoplatform for delivery of visible or near-IR fluorescent optical and magnetic resonance imaging (MRI) contrast agents and photodynamic therapy and chemotherapeutic agents to normal and neoplastic cells that overexpress low-d. lipoprotein receptors (LDLRs).  Extension to other lipoproteins ranging in diam. from about 10 nm (high-d. lipoprotein [HDL]) to over a micron (chylomicrons) is feasible.  Loading of contrast or therapeutic agents onto or into these particles has been achieved by protein loading (covalent attachment to protein side chains), surface loading (intercalation into the phospholipid monolayer), and core loading (extn. and reconstitution of the triglyceride/cholesterol ester core).  Core and surface loading of LDL have been used for delivery of optical imaging agents to tumor cells in vivo and in culture.  Surface loading was used for delivery of gadolinium-bis-stearylamide contrast agents for in vivo MRI detection in tumor-bearing mice.  Chlorin and phthalocyanine near-IR photodynamic therapy agents (â¤ 400/LDL) have been attached by core loading.  Protein loading was used to reroute the LDL from its natural receptor (LDLR) to folate receptors and could be used to target other receptors.  A semisynthetic nanoparticle has been constructed by coating magnetite iron oxide nanoparticles with carboxylated cholesterol and overlaying a monolayer of phospholipid to which apolipoprotein A1 or E was adsorbed for targeting HDL or adsorbing synthetic amphipathic helical peptides Itargeting LDL or folate receptors.  These particles can be used for in situ loading of magnetite into cells for MRI-monitored cell tracking or gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonTC2hmeUW7Vg90H21EOLACvtfcHk0lhjRdRv6RdamQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Wmu7%252FE&md5=34e75605118bb849bf46cb575b659716</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlickson%26aufirst%3DJ.%2BD.%26aulast%3DLund-Katz%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DCorbin%26aufirst%3DI.%26aulast%3DPopov%26aufirst%3DA.%2BV.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DC.%26aulast%3DMarotta%26aufirst%3DD.%26aulast%3DNelson%26aufirst%3DD.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChance%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DLipoprotein%2520nanoplatform%2520for%2520targeted%2520delivery%2520of%2520diagnostic%2520and%2520therapeutic%2520agents%26jtitle%3DMol.%2520Imaging%26date%3D2008%26volume%3D7%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Nayak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, L. A.</span><span> </span><span class="NLM_article-title">Folate-mediated cell targeting and cytotoxicity using thermoresponsive microgels</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">10258</span><span class="NLM_x">â</span> <span class="NLM_lpage">10259</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0474143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=10258-10259&author=S.+Nayakauthor=H.+Leeauthor=J.+Chmielewskiauthor=L.+A.+Lyon&title=Folate-mediated+cell+targeting+and+cytotoxicity+using+thermoresponsive+microgels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fja0474143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0474143%26sid%3Dliteratum%253Aachs%26aulast%3DNayak%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DChmielewski%26aufirst%3DJ.%26aulast%3DLyon%26aufirst%3DL.%2BA.%26atitle%3DFolate-mediated%2520cell%2520targeting%2520and%2520cytotoxicity%2520using%2520thermoresponsive%2520microgels%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D10258%26epage%3D10259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span> </span><span class="NLM_article-title">Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">â</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ijpharm.2004.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15541922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXps1Oqtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2004&pages=155-162&author=L.+Zhangauthor=S.+Houauthor=S.+Maoauthor=D.+Weiauthor=X.+Songauthor=Y.+Lu&title=Uptake+of+folate-conjugated+albumin+nanoparticles+to+the+SKOV3+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells</span></div><div class="casAuthors">Zhang, Liangke; Hou, Shixiang; Mao, Shengjun; Wei, Dapeng; Song, Xiangrong; Lu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">155-162</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bovine serum albumin nanoparticles (BSANPs) were prepd. by a coacervation method and chem. crosslinking with glutaraldehyde.  Furthermore, the BSANPs were reacted with the activated folic acid to conjugate folate via amino groups of the BSANPs, to improve their intracellular uptake to target cells.  The nanoparticles were apparently spherical with diams. less than 150 nm and their av. diam. was 70 nm by a transmission electron microscope (TEM) and a laser light scattering particle analyzer, resp.  An extent of folate conjugation with the BSANPs was 169 Î¼mol/g BSA by spectrophotometric anal.  Cell uptake studies were carried out in SKOV3 cells (human ovarian cancer cell line) using fluorescein isothiocyanate labeled nanoparticles.  The extent of BSANPs taken up by the cells was measured with a fluorescence spectrophotometer.  The nanoparticles were taken up to the cells and levels of binding and uptake were increased with the time of incubation until 4 h.  The levels of folate-conjugated BSANPs were higher than those of BSANPs and saturable.  The assocn. of folate-conjugated BSANPs to SKOV3 cells was inhibited by an excess amt. of folic acid, suggesting that the binding and/or uptake were mediated by the folate receptor.  These results implied that the folate-conjugated BSANPs might be useful as a drug carrier system to deliver drugs into the cells expressing folate receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-VnVL4-HDLLVg90H21EOLACvtfcHk0lhjRdRv6RdamQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXps1Oqtbw%253D&md5=cdd983a9386e2201a71fef72c6fc7b54</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DUptake%2520of%2520folate-conjugated%2520albumin%2520nanoparticles%2520to%2520the%2520SKOV3%2520cells%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2004%26volume%3D287%26spage%3D155%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, L. Y.</span><span> </span><span class="NLM_article-title">Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">836</span><span class="NLM_x">â</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060361p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjslWht70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=836-843&author=Y.+Renauthor=S.+M.+Wongauthor=L.+Y.+Lim&title=Folic+acid-conjugated+protein+cages+of+a+plant+virus%3A+a+novel+delivery+platform+for+doxorubicin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin</span></div><div class="casAuthors">Ren, Yupeng; Wong, Sek Man; Lim, Lee-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">836-843</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein cage of a plant virus may provide a template for monodispersed nanosized systems for drug delivery.  Using the Hibiscus chlorotic ringspot virus (HCRSV) as a model plant virus, we have prepd. nanosized protein cages (30 nm) capable of encapsulating the anticancer drug, doxorubicin.  The technique utilized the simultaneous encapsulation of a polyprotic acid of mw 200 kDa to produce an encapsulation efficiency for doxorubicin of about 7.5%.  Folic acid was conjugated onto the capsids to impart cancer-targeting capability.  The resultant nanosized systems improved the uptake and cytotoxicity of doxorubicin in the ovarian cancer cells, OVCAR-3, with statistical significance.  Plant virus capsids may therefore provide viable templates for targeted drug delivery in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbnAw0nh0R1rVg90H21EOLACvtfcHk0lgMmuTnbbaKnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjslWht70%253D&md5=08e224dd6f3502f22404a9dd99bdd5ac</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fbc060361p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060361p%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DS.%2BM.%26aulast%3DLim%26aufirst%3DL.%2BY.%26atitle%3DFolic%2520acid-conjugated%2520protein%2520cages%2520of%2520a%2520plant%2520virus%253A%2520a%2520novel%2520delivery%2520platform%2520for%2520doxorubicin%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D836%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Destito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, M.</span><span> </span><span class="NLM_article-title">Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">â</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.chembiol.2007.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17961827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amt77P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1152-1162&author=G.+Destitoauthor=R.+Yehauthor=C.+S.+Raeauthor=M.+G.+Finnauthor=M.+Manchester&title=Folic+acid-mediated+targeting+of+cowpea+mosaic+virus+particles+to+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Folic Acid-Mediated Targeting of Cowpea Mosaic Virus Particles to Tumor Cells</span></div><div class="casAuthors">Destito, Giuseppe; Yeh, Robert; Rae, Chris S.; Finn, M. G.; Manchester, Marianne</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1152-1162</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cowpea mosaic virus (CPMV) is a well-characterized nanoparticle that has been used for a variety of nanobiotechnol. applications.  CPMV interacts with several mammalian cell lines and tissues in vivo.  To overcome natural CPMV targeting and redirect CPMV particles to cells of interest, we attached a folic acid-PEG conjugate by using the copper-catalyzed azide-alkyne cycloaddn. reaction.  PEGylation of CPMV completely eliminated background binding of the virus to tumor cells.  The PEG-folate moiety allowed CPMV-specific recognition of tumor cells bearing the folate receptor.  In addn., by testing CPMV formulations with different amts. of the PEG-FA moiety displayed on the surface, we show that higher-d. loading of targeting ligands on CPMV may not be necessary for efficient targeting to tumor cells.  These studies help to define the requirements for efficiently targeting nanoparticles and protein cages to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv3X6Aa3BAqLVg90H21EOLACvtfcHk0lgMmuTnbbaKnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amt77P&md5=7643b83dc78dd293e03802ad1bf6cd37</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DDestito%26aufirst%3DG.%26aulast%3DYeh%26aufirst%3DR.%26aulast%3DRae%26aufirst%3DC.%2BS.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DManchester%26aufirst%3DM.%26atitle%3DFolic%2520acid-mediated%2520targeting%2520of%2520cowpea%2520mosaic%2520virus%2520particles%2520to%2520tumor%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D1152%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Liu, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiradharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. Y.</span><span> </span><span class="NLM_article-title">Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">â</span> <span class="NLM_lpage">1433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.biomaterials.2006.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17141308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlClsrbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1423-1433&author=S.+Q.+Liuauthor=N.+Wiradharmaauthor=S.+J.+Gaoauthor=Y.+W.+Tongauthor=Y.+Y.+Yang&title=Bio-functional+micelles+self-assembled+from+a+folate-conjugated+block+copolymer+for+targeted+intracellular+delivery+of+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs</span></div><div class="casAuthors">Liu, Shao-Qiong; Wiradharma, Nikken; Gao, Shu-Jun; Tong, Yen Wah; Yang, Yi-Yan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1423-1433</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study, a block copolymer, poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide-co-2-aminoethyl methacrylate)-b-poly(10-undecenoic acid) (P(NIPAAm-co-DMAAm-co-AMA)-b-PUA) was synthesized, and folic acid was conjugated to the hydrophilic block through the amine group in AMA.  This polymer was self-assembled into micelles, which exhibited pH-induced temp. sensitivity.  They were smaller in size, and possessed a better-defined core-shell structure as well as more stable hydrophobic core than the random copolymer P(NIPAAm-co-DMAAm-co-UA), and provided a shell with folate mols.  An anti-cancer drug, doxorubicin (DOX) was encapsulated into the micelles.  The mean diam. of the blank and DOX-loaded micelles was less than 100 nm.  DOX release was pH-dependent, being faster at low pH (endosomes/lysosomes).  Therefore, DOX was readily released from the micelles into the nucleus after being taken up.  More importantly, IC50 of DOX-loaded micelles with folate against folate receptor-expressing 4T1 and KB cells was much lower than that of the DOX-loaded micelles without folate (3.8 vs. 7.6 mg/L for 4T1 cells and 1.2 vs. 3.0 mg/L for KB cells).  In vivo expts. conducted in a 4T1 mouse breast cancer model demonstrated that DOX-loaded micelles had a longer blood circulation time than free DOX (t 1/2: 30 min and 140 min, resp.).  In addn., the micelles delivered an increased amt. of DOX to the tumor when compared to free DOX.  These bio-functional micelles may make a promising carrier to transport anticancer drugs specifically to tumor cells and release the drug mols. inside the cells to the cytosols for improved chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQG4zLELhdbVg90H21EOLACvtfcHk0lgMmuTnbbaKnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlClsrbL&md5=a1b83819956a86bbad3ef9c74f8a1d4b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2006.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2006.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%2BQ.%26aulast%3DWiradharma%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DS.%2BJ.%26aulast%3DTong%26aufirst%3DY.%2BW.%26aulast%3DYang%26aufirst%3DY.%2BY.%26atitle%3DBio-functional%2520micelles%2520self-assembled%2520from%2520a%2520folate-conjugated%2520block%2520copolymer%2520for%2520targeted%2520intracellular%2520delivery%2520of%2520anticancer%2520drugs%26jtitle%3DBiomaterials%26date%3D2007%26volume%3D28%26spage%3D1423%26epage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Perentes, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiew, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padera, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, Y.</span><span> </span><span class="NLM_article-title">In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">â</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fnmeth.1295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19151720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFGksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=143-145&author=J.+Y.+Perentesauthor=T.+D.+McKeeauthor=C.+D.+Leyauthor=H.+Mathiewauthor=M.+Dawsonauthor=T.+P.+Paderaauthor=L.+L.+Munnauthor=R.+K.+Jainauthor=Y.+Boucher&title=In+vivo+imaging+of+extracellular+matrix+remodeling+by+tumor-associated+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts</span></div><div class="casAuthors">Perentes, Jean Y.; McKee, Trevor D.; Ley, Carsten D.; Mathiew, Hannah; Dawson, Michelle; Padera, Timothy P.; Munn, Lance L.; Jain, Rakesh K.; Boucher, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-145</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we integrated multiphoton laser scanning microscopy and the registration of second harmonic generation images of collagen fibers to overcome difficulties in tracking stromal cell-matrix interactions for several days in live mice.  We show that the matrix-modifying hormone relaxin increased tumor-assocd. fibroblast (TAF) interaction with collagen fibers by stimulating Î²1-integrin activity, which is necessary for fiber remodeling by matrix metalloproteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr07EJpIjJbxbVg90H21EOLACvtfcHk0lgey2BfGJDu7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFGksg%253D%253D&md5=ca1737a6476120136556ec7cd15245a1</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.1295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.1295%26sid%3Dliteratum%253Aachs%26aulast%3DPerentes%26aufirst%3DJ.%2BY.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLey%26aufirst%3DC.%2BD.%26aulast%3DMathiew%26aufirst%3DH.%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DPadera%26aufirst%3DT.%2BP.%26aulast%3DMunn%26aufirst%3DL.%2BL.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DBoucher%26aufirst%3DY.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520extracellular%2520matrix%2520remodeling%2520by%2520tumor-associated%2520fibroblasts%26jtitle%3DNat.%2520Methods%26date%3D2009%26volume%3D6%26spage%3D143%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 331 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yanjun Zheng, Kutty Selva Nandakumar, <span class="NLM_string-name hlFld-ContribAuthor">Kui Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9577-9591. <a href="https://doi.org/10.1021/acs.jmedchem.0c02054" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02054%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BCAR-T%252BCell-Based%252BTherapies%252BUsing%252BSmall-Molecule-Based%252BSafety%252BSwitches%26aulast%3DZheng%26aufirst%3DYanjun%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30112020%26date%3D30062021%26volume%3D64%26issue%3D14%26spage%3D9577%26epage%3D9591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Syed Muhammad Usama, <span class="NLM_string-name hlFld-ContribAuthor">Kevin Burgess</span>. </span><span class="cited-content_cbyCitation_article-title">Hows and Whys of Tumor-Seeking Dyes. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (9)
                                     , 2121-2131. <a href="https://doi.org/10.1021/acs.accounts.0c00733" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00733%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DHows%252Band%252BWhys%252Bof%252BTumor-Seeking%252BDyes%26aulast%3DUsama%26aufirst%3DSyed%2BMuhammad%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05112020%26date%3D20042021%26volume%3D54%26issue%3D9%26spage%3D2121%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yujie Zhang, Shufeng Li, Hang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Haiwei Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Application of Receptor-Targeted Fluorescent Probes Based on Small Molecular Fluorescent Dyes. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (1)
                                     , 4-24. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00606" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00606%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDesign%252Band%252BApplication%252Bof%252BReceptor-Targeted%252BFluorescent%252BProbes%252BBased%252Bon%252BSmall%252BMolecular%252BFluorescent%252BDyes%26aulast%3DZhang%26aufirst%3DYujie%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D05112020%26date%3D09122020%26date%3D07012021%26volume%3D32%26issue%3D1%26spage%3D4%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Deepak Subedi, Amanda K. Ashley, Melissa V. Chavez, <span class="NLM_string-name hlFld-ContribAuthor">Sergei N. Smirnov</span>. </span><span class="cited-content_cbyCitation_article-title">Mixed Silane Monolayers Reveal the Disparity of Biotin and Folate in Targeting Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Nano Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (6)
                                     , 5372-5380. <a href="https://doi.org/10.1021/acsanm.0c00731" title="DOI URL">https://doi.org/10.1021/acsanm.0c00731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsanm.0c00731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsanm.0c00731%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Nano%2520Materials%26atitle%3DMixed%252BSilane%252BMonolayers%252BReveal%252Bthe%252BDisparity%252Bof%252BBiotin%252Band%252BFolate%252Bin%252BTargeting%252BCancer%252BCells%26aulast%3DSubedi%26aufirst%3DDeepak%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D13052020%26date%3D27052020%26date%3D13052020%26volume%3D3%26issue%3D6%26spage%3D5372%26epage%3D5380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radhika Raveendran, Fan Chen, Ben Kent, <span class="NLM_string-name hlFld-ContribAuthor">Martina H. Stenzel</span>. </span><span class="cited-content_cbyCitation_article-title">Estrone-Decorated Polyion Complex Micelles for Targeted Melittin Delivery to Hormone-Responsive Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Biomacromolecules</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3)
                                     , 1222-1233. <a href="https://doi.org/10.1021/acs.biomac.9b01681" title="DOI URL">https://doi.org/10.1021/acs.biomac.9b01681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biomac.9b01681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biomac.9b01681%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomacromolecules%26atitle%3DEstrone-Decorated%252BPolyion%252BComplex%252BMicelles%252Bfor%252BTargeted%252BMelittin%252BDelivery%252Bto%252BHormone-Responsive%252BBreast%252BCancer%252BCells%26aulast%3DRaveendran%26aufirst%3DRadhika%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D07122019%26date%3D03022020%26date%3D24022020%26date%3D05022020%26volume%3D21%26issue%3D3%26spage%3D1222%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Yan, Yangyang Dong, Shujing Yue, Xinyun Qiu, Huanli Sun, <span class="NLM_string-name hlFld-ContribAuthor">Zhiyuan Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumors. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2019,</strong> <em>11 </em>
                                    (50)
                                     , 46548-46557. <a href="https://doi.org/10.1021/acsami.9b17223" title="DOI URL">https://doi.org/10.1021/acsami.9b17223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.9b17223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.9b17223%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DDually%252BActive%252BTargeting%252BNanomedicines%252BBased%252Bon%252Ba%252BDirect%252BConjugate%252Bof%252BTwo%252BPurely%252BNatural%252BLigands%252Bfor%252BPotent%252BChemotherapy%252Bof%252BOvarian%252BTumors%26aulast%3DYan%26aufirst%3DYu%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23092019%26date%3D25112019%26date%3D09122019%26date%3D25112019%26volume%3D11%26issue%3D50%26spage%3D46548%26epage%3D46557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anas Ahmad, Farheen Khan, Rakesh Kumar Mishra, <span class="NLM_string-name hlFld-ContribAuthor">Rehan Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (23)
                                     , 10475-10496. <a href="https://doi.org/10.1021/acs.jmedchem.9b00511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPrecision%252BCancer%252BNanotherapy%25253A%252BEvolving%252BRole%252Bof%252BMultifunctional%252BNanoparticles%252Bfor%252BCancer%252BActive%252BTargeting%26aulast%3DAhmad%26aufirst%3DAnas%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23032019%26date%3D01082019%26date%3D24072019%26volume%3D62%26issue%3D23%26spage%3D10475%26epage%3D10496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yun Teng, , Jue Shi, , <span class="NLM_string-name hlFld-ContribAuthor">Philip W. T. Pong</span>. </span><span class="cited-content_cbyCitation_article-title">Sensitive and Specific Colorimetric Detection of Cancer Cells Based on Folate-Conjugated GoldâIron-Oxide Composite Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Nano Materials</span><span> <strong>2019,</strong> <em>2 </em>
                                    (11)
                                     , 7421-7431. <a href="https://doi.org/10.1021/acsanm.9b01947" title="DOI URL">https://doi.org/10.1021/acsanm.9b01947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsanm.9b01947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsanm.9b01947%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Nano%2520Materials%26atitle%3DSensitive%252Band%252BSpecific%252BColorimetric%252BDetection%252Bof%252BCancer%252BCells%252BBased%252Bon%252BFolate-Conjugated%252BGold%2525E2%252580%252593Iron-Oxide%252BComposite%252BNanoparticles%26aulast%3DTeng%26aufirst%3DYun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08102019%26date%3D04112019%26date%3D14112019%26date%3D04112019%26volume%3D2%26issue%3D11%26spage%3D7421%26epage%3D7431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinchang Yin, Yu Zhang, Dongyu Ma, Renlong Yang, Feihong Xu, Haonan Wu, Chunshan He, Lizhi Liu, Jianwen Dong, <span class="NLM_string-name hlFld-ContribAuthor">Yuanzhi Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Nanoassembly and Multiscale Computation of Multifunctional Optical-Magnetic Nanoprobes for Tumor-Targeted Theranostics. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2019,</strong> <em>11 </em>
                                    (44)
                                     , 41069-41081. <a href="https://doi.org/10.1021/acsami.9b14668" title="DOI URL">https://doi.org/10.1021/acsami.9b14668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.9b14668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.9b14668%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DNanoassembly%252Band%252BMultiscale%252BComputation%252Bof%252BMultifunctional%252BOptical-Magnetic%252BNanoprobes%252Bfor%252BTumor-Targeted%252BTheranostics%26aulast%3DYin%26aufirst%3DJinchang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15082019%26date%3D10102019%26date%3D24102019%26date%3D10102019%26volume%3D11%26issue%3D44%26spage%3D41069%26epage%3D41081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Meden F. Isaac-Lam, <span class="NLM_string-name hlFld-ContribAuthor">Alexandra D. Mee</span>. </span><span class="cited-content_cbyCitation_article-title">Photodynamic Activity of Vitamin-Chlorin Conjugates at Nanomolar Concentrations against Triple-Negative Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 2907-2920. <a href="https://doi.org/10.1021/acsomega.8b02323" title="DOI URL">https://doi.org/10.1021/acsomega.8b02323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02323%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPhotodynamic%252BActivity%252Bof%252BVitamin-Chlorin%252BConjugates%252Bat%252BNanomolar%252BConcentrations%252Bagainst%252BTriple-Negative%252BBreast%252BCancer%252BCells%26aulast%3DIsaac-Lam%26aufirst%3DMeden%2BF.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D27092018%26date%3D15102018%26volume%3D4%26issue%3D2%26spage%3D2907%26epage%3D2920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gagandeep Kaur, Savita Kumari, Piyali Saha, Rafat Ali, Sandip Patil, Subramaniam Ganesh, <span class="NLM_string-name hlFld-ContribAuthor">Sandeep Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Cell Adhesion on PeptideâPolymer Electrospun Fiber Mats. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 4376-4383. <a href="https://doi.org/10.1021/acsomega.8b03494" title="DOI URL">https://doi.org/10.1021/acsomega.8b03494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b03494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b03494%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSelective%252BCell%252BAdhesion%252Bon%252BPeptide%2525E2%252580%252593Polymer%252BElectrospun%252BFiber%252BMats%26aulast%3DKaur%26aufirst%3DGagandeep%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13122018%26date%3D14022019%26volume%3D4%26issue%3D2%26spage%3D4376%26epage%3D4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianxin Wang, Mini Thomas, Peng Lin, Ji-Xin Cheng, Daniela E. Matei, <span class="NLM_string-name hlFld-ContribAuthor">Alexander Wei</span>. </span><span class="cited-content_cbyCitation_article-title">siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (2)
                                     , 443-453. <a href="https://doi.org/10.1021/acs.bioconjchem.8b00723" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.8b00723</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.8b00723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.8b00723%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DsiRNA%252BDelivery%252BUsing%252BDithiocarbamate-Anchored%252BOligonucleotides%252Bon%252BGold%252BNanorods%26aulast%3DWang%26aufirst%3DJianxin%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09102018%26date%3D02112018%26date%3D15112018%26date%3D05112018%26volume%3D30%26issue%3D2%26spage%3D443%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kai Ding, Rong Li, Yao Ma, Nan Li, Ting Zhang, Xing Cheng-Mei, Hai-Tao Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Yong-Kuan Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Folate Ligand Orientation Optimized during Cell Membrane Mimetic Micelle Formation for Enhanced Tumor Cell Targeting. </span><span class="cited-content_cbyCitation_journal-name">Langmuir</span><span> <strong>2019,</strong> <em>35 </em>
                                    (5)
                                     , 1257-1265. <a href="https://doi.org/10.1021/acs.langmuir.8b00744" title="DOI URL">https://doi.org/10.1021/acs.langmuir.8b00744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.langmuir.8b00744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.langmuir.8b00744%26sid%3Dliteratum%253Aachs%26jtitle%3DLangmuir%26atitle%3DFolate%252BLigand%252BOrientation%252BOptimized%252Bduring%252BCell%252BMembrane%252BMimetic%252BMicelle%252BFormation%252Bfor%252BEnhanced%252BTumor%252BCell%252BTargeting%26aulast%3DDing%26aufirst%3DKai%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07032018%26date%3D13052018%26date%3D09072018%26date%3D24062018%26volume%3D35%26issue%3D5%26spage%3D1257%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Reece
G. Kenny, <span class="NLM_string-name hlFld-ContribAuthor">Celine J. Marmion</span>. </span><span class="cited-content_cbyCitation_article-title">Toward Multi-Targeted Platinum and Ruthenium DrugsâA New Paradigm in Cancer Drug Treatment Regimens?. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1058-1137. <a href="https://doi.org/10.1021/acs.chemrev.8b00271" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00271%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DToward%252BMulti-Targeted%252BPlatinum%252Band%252BRuthenium%252BDrugs%2525E2%252580%252594A%252BNew%252BParadigm%252Bin%252BCancer%252BDrug%252BTreatment%252BRegimens%25253F%26aulast%3DKenny%26aufirst%3DReece%2BG.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27042018%26date%3D14012019%26volume%3D119%26issue%3D2%26spage%3D1058%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shanshan Li, Bingchen Yu, Jiajia Wang, Yueqin Zheng, Huajie Zhang, Margaret J. Walker, Zhengnan Yuan, He Zhu, Jun Zhang, Peng George Wang, <span class="NLM_string-name hlFld-ContribAuthor">Binghe Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Biomarker-Based Metabolic Labeling for Redirected and Enhanced Immune Response. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (6)
                                     , 1686-1694. <a href="https://doi.org/10.1021/acschembio.8b00350" title="DOI URL">https://doi.org/10.1021/acschembio.8b00350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00350%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DBiomarker-Based%252BMetabolic%252BLabeling%252Bfor%252BRedirected%252Band%252BEnhanced%252BImmune%252BResponse%26aulast%3DLi%26aufirst%3DShanshan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16042018%26date%3D24052018%26date%3D01062018%26date%3D24052018%26volume%3D13%26issue%3D6%26spage%3D1686%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manasa Ravindra, Mike R. Wilson, Nian Tong, Carrie OâConnor, Mohammad Karim, Lisa Polin, Adrianne Wallace-Povirk, Kathryn White, Juiwanna Kushner, Zhanjun Hou, Larry H. Matherly, <span class="NLM_string-name hlFld-ContribAuthor">Aleem Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-Substituted Pyrrolo[2,3-d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor Î± and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 4228-4248. <a href="https://doi.org/10.1021/acs.jmedchem.8b00408" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00408%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine-Substituted%252BPyrrolo%25255B2%25252C3-d%25255DPyrimidine%252BAnalogues%252Bwith%252BTumor%252BTargeting%252Bvia%252BCellular%252BUptake%252Bby%252BFolate%252BReceptor%252B%2525CE%2525B1%252Band%252Bthe%252BProton-Coupled%252BFolate%252BTransporter%252Band%252BInhibition%252Bof%252Bde%252BNovo%252BPurine%252BNucleotide%252BBiosynthesis%26aulast%3DRavindra%26aufirst%3DManasa%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13032018%26date%3D27042018%26volume%3D61%26issue%3D9%26spage%3D4228%26epage%3D4248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Loganathan Rangasamy, Venkatesh Chelvam, Ananda Kumar Kanduluru, Madduri Srinivasarao, N. Achini Bandara, Fei You, Esteban A. Orellana, Andrea L. Kasinski, <span class="NLM_string-name hlFld-ContribAuthor">Philip S. Low</span>. </span><span class="cited-content_cbyCitation_article-title">New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2018,</strong> <em>29 </em>
                                    (4)
                                     , 1047-1059. <a href="https://doi.org/10.1021/acs.bioconjchem.7b00714" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.7b00714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.7b00714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.7b00714%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DNew%252BMechanism%252Bfor%252BRelease%252Bof%252BEndosomal%252BContents%25253A%252BOsmotic%252BLysis%252Bvia%252BNigericin-Mediated%252BK%25252B%25252FH%25252B%252BExchange%26aulast%3DRangasamy%26aufirst%3DLoganathan%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D20112017%26date%3D09022018%26date%3D02032018%26date%3D15022018%26volume%3D29%26issue%3D4%26spage%3D1047%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Iwao Ojima, Xin Wang, Yunrong Jing, <span class="NLM_string-name hlFld-ContribAuthor">Changwei Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2018,</strong> <em>81 </em>
                                    (3)
                                     , 703-721. <a href="https://doi.org/10.1021/acs.jnatprod.7b01012" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.7b01012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.7b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.7b01012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DQuest%252Bfor%252BEfficacious%252BNext-Generation%252BTaxoid%252BAnticancer%252BAgents%252Band%252BTheir%252BTumor-Targeted%252BDelivery%26aulast%3DOjima%26aufirst%3DIwao%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D01122017%26date%3D22022018%26volume%3D81%26issue%3D3%26spage%3D703%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manasa Ravindra, Adrianne Wallace-Povirk, Mohammad A. Karim, Mike R. Wilson, Carrie OâConnor, Kathryn White, Juiwanna Kushner, Lisa Polin, Christina George, Zhanjun Hou, Larry H. Matherly, <span class="NLM_string-name hlFld-ContribAuthor">Aleem Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3-d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor Î± and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 2027-2040. <a href="https://doi.org/10.1021/acs.jmedchem.7b01708" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01708%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTumor%252BTargeting%252Bwith%252BNovel%252BPyridyl%252B6-Substituted%252BPyrrolo%25255B2%25252C3-d%25255DPyrimidine%252BAntifolates%252Bvia%252BCellular%252BUptake%252Bby%252BFolate%252BReceptor%252B%2525CE%2525B1%252Band%252Bthe%252BProton-Coupled%252BFolate%252BTransporter%252Band%252BInhibition%252Bof%252BDe%252BNovo%252BPurine%252BNucleotide%252BBiosynthesis%26aulast%3DRavindra%26aufirst%3DManasa%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D27112017%26date%3D21022018%26date%3D09022018%26volume%3D61%26issue%3D5%26spage%3D2027%26epage%3D2040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">RÃ©mi RosiÃ¨re, Matthias Van Woensel, Michel Gelbcke, VÃ©ronique Mathieu, Julien Hecq, Thomas Mathivet, Marjorie Vermeersch, Pierre Van Antwerpen, Karim Amighi, <span class="NLM_string-name hlFld-ContribAuthor">Nathalie Wauthoz</span>. </span><span class="cited-content_cbyCitation_article-title">New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (3)
                                     , 899-910. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00846" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00846%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DNew%252BFolate-Grafted%252BChitosan%252BDerivative%252BTo%252BImprove%252BDelivery%252Bof%252BPaclitaxel-Loaded%252BSolid%252BLipid%252BNanoparticles%252Bfor%252BLung%252BTumor%252BTherapy%252Bby%252BInhalation%26aulast%3DRosi%25C3%25A8re%26aufirst%3DR%25C3%25A9mi%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D26092017%26date%3D17012018%26date%3D21122017%26date%3D30012018%26date%3D17012018%26volume%3D15%26issue%3D3%26spage%3D899%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">James
A. Vassie, John M. Whitelock, <span class="NLM_string-name hlFld-ContribAuthor">Megan S. Lord</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Delivery and Redox Activity of Folic Acid-Functionalized Nanoceria in Tumor Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (3)
                                     , 994-1004. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00920" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00920</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00920%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DTargeted%252BDelivery%252Band%252BRedox%252BActivity%252Bof%252BFolic%252BAcid-Functionalized%252BNanoceria%252Bin%252BTumor%252BCells%26aulast%3DVassie%26aufirst%3DJames%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D20102017%26date%3D04022018%26date%3D14012018%26date%3D09022018%26date%3D04022018%26volume%3D15%26issue%3D3%26spage%3D994%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele  Amata</span>, <span class="hlFld-ContribAuthor ">Maria  Dichiara</span>, <span class="hlFld-ContribAuthor ">Emanuela  Arena</span>, <span class="hlFld-ContribAuthor ">Valeria  PittalÃ </span>, <span class="hlFld-ContribAuthor ">Venerando  PistarÃ </span>, <span class="hlFld-ContribAuthor ">Venera  Cardile</span>, <span class="hlFld-ContribAuthor ">Adriana Carol Eleonora  Graziano</span>, <span class="hlFld-ContribAuthor ">Aurore  Fraix</span>, <span class="hlFld-ContribAuthor ">Agostino  Marrazzo</span>, <span class="hlFld-ContribAuthor ">Salvatore  Sortino</span>, and <span class="hlFld-ContribAuthor ">Orazio  Prezzavento</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Sigma Receptor LigandâNitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9531-9544. <a href="https://doi.org/10.1021/acs.jmedchem.7b00791" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00791%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSigma%252BReceptor%252BLigand%2525E2%252580%252593Nitric%252BOxide%252BPhotodonors%25253A%252BMolecular%252BHybrids%252Bfor%252BDouble-Targeted%252BAntiproliferative%252BEffect%26aulast%3DAmata%26aufirst%3DEmanuele%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01062017%26date%3D04122017%26date%3D14122017%26date%3D27112017%26volume%3D60%26issue%3D23%26spage%3D9531%26epage%3D9544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ananda Kumar  Kanduluru</span> and <span class="hlFld-ContribAuthor ">Philip S.  Low</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (11)
                                     , 3859-3865. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00583" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00583%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DDevelopment%252Bof%252Ba%252BLigand-Targeted%252BTherapeutic%252BAgent%252Bfor%252BNeurokinin-1%252BReceptor%252BExpressing%252BCancers%26aulast%3DKanduluru%26aufirst%3DAnanda%2BKumar%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08072017%26date%3D02102017%26date%3D30092017%26date%3D17102017%26date%3D06112017%26date%3D02102017%26volume%3D14%26issue%3D11%26spage%3D3859%26epage%3D3865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiao  Lu</span>, <span class="hlFld-ContribAuthor ">Yongjun  Hu</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Chen</span>, and <span class="hlFld-ContribAuthor ">Shan  Jin</span>  . </span><span class="cited-content_cbyCitation_article-title">Laser Desorption Postionization Mass Spectrometry Imaging of Folic Acid Molecules in Tumor Tissue. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2017,</strong> <em>89 </em>
                                    (16)
                                     , 8238-8243. <a href="https://doi.org/10.1021/acs.analchem.7b00140" title="DOI URL">https://doi.org/10.1021/acs.analchem.7b00140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.7b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.7b00140%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DLaser%252BDesorption%252BPostionization%252BMass%252BSpectrometry%252BImaging%252Bof%252BFolic%252BAcid%252BMolecules%252Bin%252BTumor%252BTissue%26aulast%3DLu%26aufirst%3DQiao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12012017%26date%3D12072017%26date%3D02082017%26date%3D15082017%26date%3D12072017%26volume%3D89%26issue%3D16%26spage%3D8238%26epage%3D8243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swagata  Roy</span>, <span class="hlFld-ContribAuthor ">Pradip  Thakur</span>, <span class="hlFld-ContribAuthor ">Nur Amin  Hoque</span>, <span class="hlFld-ContribAuthor ">Biswajoy  Bagchi</span>, <span class="hlFld-ContribAuthor ">Nayim  Sepay</span>, <span class="hlFld-ContribAuthor ">Farha  Khatun</span>, <span class="hlFld-ContribAuthor ">Arpan  Kool</span>, and <span class="hlFld-ContribAuthor ">Sukhen  Das</span>  . </span><span class="cited-content_cbyCitation_article-title">Electroactive and High Dielectric Folic Acid/PVDF Composite Film Rooted Simplistic Organic Photovoltaic Self-Charging Energy Storage Cell with Superior Energy Density and Storage Capability. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2017,</strong> <em>9 </em>
                                    (28)
                                     , 24198-24209. <a href="https://doi.org/10.1021/acsami.7b05540" title="DOI URL">https://doi.org/10.1021/acsami.7b05540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.7b05540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.7b05540%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DElectroactive%252Band%252BHigh%252BDielectric%252BFolic%252BAcid%25252FPVDF%252BComposite%252BFilm%252BRooted%252BSimplistic%252BOrganic%252BPhotovoltaic%252BSelf-Charging%252BEnergy%252BStorage%252BCell%252Bwith%252BSuperior%252BEnergy%252BDensity%252Band%252BStorage%252BCapability%26aulast%3DRoy%26aufirst%3DSwagata%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20042017%26date%3D27062017%26date%3D06072017%26date%3D19072017%26date%3D27062017%26volume%3D9%26issue%3D28%26spage%3D24198%26epage%3D24209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaowen  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Wolfgang  RÃ¶dl</span>, <span class="hlFld-ContribAuthor ">Kevin  Maier</span>, <span class="hlFld-ContribAuthor ">Ulrich  LÃ¤chelt</span>, and <span class="hlFld-ContribAuthor ">Ernst  Wagner</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward Artificial Immunotoxins: Traceless Reversible Conjugation of RNase A with Receptor Targeting and Endosomal Escape Domains. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (5)
                                     , 1439-1449. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00701" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00701%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DToward%252BArtificial%252BImmunotoxins%25253A%252BTraceless%252BReversible%252BConjugation%252Bof%252BRNase%252BA%252Bwith%252BReceptor%252BTargeting%252Band%252BEndosomal%252BEscape%252BDomains%26aulast%3DLiu%26aufirst%3DXiaowen%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28072016%26date%3D28112016%26date%3D28102016%26date%3D07122016%26date%3D01052017%26date%3D28112016%26volume%3D14%26issue%3D5%26spage%3D1439%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anyanee  Kamkaew</span>, <span class="hlFld-ContribAuthor ">Nanyan  Fu</span>, <span class="hlFld-ContribAuthor ">Weibo  Cai</span>, and <span class="hlFld-ContribAuthor ">Kevin  Burgess</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Small Molecule Probes for Metastatic Melanoma. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 179-184. <a href="https://doi.org/10.1021/acsmedchemlett.6b00368" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00368%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BSmall%252BMolecule%252BProbes%252Bfor%252BMetastatic%252BMelanoma%26aulast%3DKamkaew%26aufirst%3DAnyanee%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21092016%26date%3D29112016%26date%3D09122016%26date%3D09022017%26volume%3D8%26issue%3D2%26spage%3D179%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arindam  Saha</span>, <span class="hlFld-ContribAuthor ">Subas Chandra  Mohanta</span>, <span class="hlFld-ContribAuthor ">Kashmiri  Deka</span>, <span class="hlFld-ContribAuthor ">Pritam  Deb</span>, and <span class="hlFld-ContribAuthor ">Parukuttyamma Sujatha  Devi</span>  . </span><span class="cited-content_cbyCitation_article-title">Surface-Engineered Multifunctional Eu:Gd2O3 Nanoplates for Targeted and pH-Responsive Drug Delivery and Imaging Applications. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2017,</strong> <em>9 </em>
                                    (4)
                                     , 4126-4141. <a href="https://doi.org/10.1021/acsami.6b12804" title="DOI URL">https://doi.org/10.1021/acsami.6b12804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.6b12804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.6b12804%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DSurface-Engineered%252BMultifunctional%252BEu%25253AGd2O3%252BNanoplates%252Bfor%252BTargeted%252Band%252BpH-Responsive%252BDrug%252BDelivery%252Band%252BImaging%252BApplications%26aulast%3DSaha%26aufirst%3DArindam%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D08102016%26date%3D03012017%26date%3D18012017%26date%3D01022017%26volume%3D9%26issue%3D4%26spage%3D4126%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruhani  Singh</span>, <span class="hlFld-ContribAuthor ">Diwei  Ho</span>, <span class="hlFld-ContribAuthor ">Lee Yong  Lim</span>, <span class="hlFld-ContribAuthor ">K. Swaminathan  Iyer</span>, and <span class="hlFld-ContribAuthor ">Nicole M.  Smith</span>  . </span><span class="cited-content_cbyCitation_article-title">Colloidal Polymeric Platform for Facile Click-Assisted Ligand Functionalization and Receptor Targeting. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2016,</strong> <em>1 </em>
                                    (6)
                                     , 1114-1120. <a href="https://doi.org/10.1021/acsomega.6b00239" title="DOI URL">https://doi.org/10.1021/acsomega.6b00239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.6b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.6b00239%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DColloidal%252BPolymeric%252BPlatform%252Bfor%252BFacile%252BClick-Assisted%252BLigand%252BFunctionalization%252Band%252BReceptor%252BTargeting%26aulast%3DSingh%26aufirst%3DRuhani%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26092016%26date%3D17102016%26date%3D31122016%26volume%3D1%26issue%3D6%26spage%3D1114%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lalit K.  Golani</span>, <span class="hlFld-ContribAuthor ">Adrianne  Wallace-Povirk</span>, <span class="hlFld-ContribAuthor ">Siobhan M.  Deis</span>, <span class="hlFld-ContribAuthor ">Jennifer  Wong</span>, <span class="hlFld-ContribAuthor ">Jiyuan  Ke</span>, <span class="hlFld-ContribAuthor ">Xin  Gu</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Mike R.  Wilson</span>, <span class="hlFld-ContribAuthor ">Xinxin  Li</span>, <span class="hlFld-ContribAuthor ">Lisa  Polin</span>, <span class="hlFld-ContribAuthor ">Parker W.  de Waal</span>, <span class="hlFld-ContribAuthor ">Kathryn  White</span>, <span class="hlFld-ContribAuthor ">Juiwanna  Kushner</span>, <span class="hlFld-ContribAuthor ">Carrie  OâConnor</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Hou</span>, <span class="hlFld-ContribAuthor ">H. Eric  Xu</span>, <span class="hlFld-ContribAuthor ">Karsten  Melcher</span>, <span class="hlFld-ContribAuthor ">Charles E.  Dann, III</span>, <span class="hlFld-ContribAuthor ">Larry H.  Matherly</span>, and <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>  . </span><span class="cited-content_cbyCitation_article-title">Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor Î± and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 7856-7876. <a href="https://doi.org/10.1021/acs.jmedchem.6b00594" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00594%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTumor%252BTargeting%252Bwith%252BNovel%252B6-Substituted%252BPyrrolo%252B%25255B2%25252C3-d%25255D%252BPyrimidine%252BAntifolates%252Bwith%252BHeteroatom%252BBridge%252BSubstitutions%252Bvia%252BCellular%252BUptake%252Bby%252BFolate%252BReceptor%252B%2525CE%2525B1%252Band%252Bthe%252BProton-Coupled%252BFolate%252BTransporter%252Band%252BInhibition%252Bof%252Bde%252BNovo%252BPurine%252BNucleotide%252BBiosynthesis%26aulast%3DGolani%26aufirst%3DLalit%2BK.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18042016%26date%3D26082016%26date%3D08092016%26date%3D26072016%26volume%3D59%26issue%3D17%26spage%3D7856%26epage%3D7876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Ju</span>, <span class="hlFld-ContribAuthor ">Qiong  Dai</span>, <span class="hlFld-ContribAuthor ">Jiwei  Cui</span>, <span class="hlFld-ContribAuthor ">Yunlu  Dai</span>, <span class="hlFld-ContribAuthor ">Tomoya  Suma</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Richardson</span>, and <span class="hlFld-ContribAuthor ">Frank  Caruso</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Targeting of MetalâPhenolic Capsules by the Presence of Protein Coronas. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2016,</strong> <em>8 </em>
                                    (35)
                                     , 22914-22922. <a href="https://doi.org/10.1021/acsami.6b07613" title="DOI URL">https://doi.org/10.1021/acsami.6b07613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.6b07613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.6b07613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DImproving%252BTargeting%252Bof%252BMetal%2525E2%252580%252593Phenolic%252BCapsules%252Bby%252Bthe%252BPresence%252Bof%252BProtein%252BCoronas%26aulast%3DJu%26aufirst%3DYi%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22062016%26date%3D16082016%26date%3D25082016%26date%3D07092016%26volume%3D8%26issue%3D35%26spage%3D22914%26epage%3D22922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina  MÃ¼ller</span>, <span class="hlFld-ContribAuthor ">Eva  Kessel</span>, <span class="hlFld-ContribAuthor ">Philipp M.  Klein</span>, <span class="hlFld-ContribAuthor ">Miriam  HÃ¶hn</span>, and <span class="hlFld-ContribAuthor ">Ernst  Wagner</span>  . </span><span class="cited-content_cbyCitation_article-title">Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (7)
                                     , 2332-2345. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00102" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00102%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DPost-PEGylation%252Bof%252BsiRNA%252BLipo-oligoamino%252BAmide%252BPolyplexes%252BUsing%252BTetra-glutamylated%252BFolic%252BAcid%252Bas%252BLigand%252Bfor%252BReceptor-Targeted%252BDelivery%26aulast%3DM%25C3%25BCller%26aufirst%3DKatharina%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D04022016%26date%3D13052016%26date%3D06042016%26date%3D31052016%26date%3D05072016%26date%3D13052016%26volume%3D13%26issue%3D7%26spage%3D2332%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Ju</span>, <span class="hlFld-ContribAuthor ">Jiwei  Cui</span>, <span class="hlFld-ContribAuthor ">Huanli  Sun</span>, <span class="hlFld-ContribAuthor ">Markus  MÃ¼llner</span>, <span class="hlFld-ContribAuthor ">Yunlu  Dai</span>, <span class="hlFld-ContribAuthor ">Junling  Guo</span>, <span class="hlFld-ContribAuthor ">Nadja  Bertleff-Zieschang</span>, <span class="hlFld-ContribAuthor ">Tomoya  Suma</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Richardson</span>, and <span class="hlFld-ContribAuthor ">Frank  Caruso</span>  . </span><span class="cited-content_cbyCitation_article-title">Engineered Metal-Phenolic Capsules Show Tunable Targeted Delivery to Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Biomacromolecules</span><span> <strong>2016,</strong> <em>17 </em>
                                    (6)
                                     , 2268-2276. <a href="https://doi.org/10.1021/acs.biomac.6b00537" title="DOI URL">https://doi.org/10.1021/acs.biomac.6b00537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biomac.6b00537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biomac.6b00537%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomacromolecules%26atitle%3DEngineered%252BMetal-Phenolic%252BCapsules%252BShow%252BTunable%252BTargeted%252BDelivery%252Bto%252BCancer%252BCells%26aulast%3DJu%26aufirst%3DYi%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14042016%26date%3D16052016%26date%3D01062016%26date%3D13062016%26volume%3D17%26issue%3D6%26spage%3D2268%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jihye  Park</span>, <span class="hlFld-ContribAuthor ">Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Dawei  Feng</span>, <span class="hlFld-ContribAuthor ">Lanqun  Mao</span>, and <span class="hlFld-ContribAuthor ">Hong-Cai  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Size-Controlled Synthesis of Porphyrinic MetalâOrganic Framework and Functionalization for Targeted Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (10)
                                     , 3518-3525. <a href="https://doi.org/10.1021/jacs.6b00007" title="DOI URL">https://doi.org/10.1021/jacs.6b00007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b00007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSize-Controlled%252BSynthesis%252Bof%252BPorphyrinic%252BMetal%2525E2%252580%252593Organic%252BFramework%252Band%252BFunctionalization%252Bfor%252BTargeted%252BPhotodynamic%252BTherapy%26aulast%3DPark%26aufirst%3DJihye%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01012016%26date%3D04032016%26date%3D16032016%26date%3D19022016%26volume%3D138%26issue%3D10%26spage%3D3518%26epage%3D3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Mengyao  Zheng</span>, <span class="hlFld-ContribAuthor ">Damiano  Librizzi</span>, <span class="hlFld-ContribAuthor ">Thomas  Renette</span>, <span class="hlFld-ContribAuthor ">Olivia M.  Merkel</span>, and <span class="hlFld-ContribAuthor ">Thomas  Kissel</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEIâPCLâPEGâFol). </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (1)
                                     , 134-143. <a href="https://doi.org/10.1021/acs.molpharmaceut.5b00575" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.5b00575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.5b00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.5b00575%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DEfficient%252Band%252BTumor%252BTargeted%252BsiRNA%252BDelivery%252Bby%252BPolyethylenimine-graft-polycaprolactone-block-poly%252528ethylene%252Bglycol%252529-folate%252B%252528PEI%2525E2%252580%252593PCL%2525E2%252580%252593PEG%2525E2%252580%252593Fol%252529%26aulast%3DLiu%26aufirst%3DLi%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21072015%26date%3D07122015%26date%3D24112015%26date%3D16122015%26date%3D04012016%26date%3D07122015%26volume%3D13%26issue%3D1%26spage%3D134%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Meng  Yu</span>, <span class="hlFld-ContribAuthor ">Jinping  Wang</span>, <span class="hlFld-ContribAuthor ">Fengping  Tan</span>, and <span class="hlFld-ContribAuthor ">Nan  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2015,</strong> <em>7 </em>
                                    (37)
                                     , 20556-20567. <a href="https://doi.org/10.1021/acsami.5b06552" title="DOI URL">https://doi.org/10.1021/acsami.5b06552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.5b06552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.5b06552%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DSmart%252BIR780%252BTheranostic%252BNanocarrier%252Bfor%252BTumor-Specific%252BTherapy%25253A%252BHyperthermia-Mediated%252BBubble-Generating%252Band%252BFolate-Targeted%252BLiposomes%26aulast%3DGuo%26aufirst%3DFang%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D23042015%26date%3D31082015%26date%3D09092015%26date%3D23092015%26date%3D31082015%26volume%3D7%26issue%3D37%26spage%3D20556%26epage%3D20567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Adrianne  Wallace</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Siobhan M.  Deis</span>, <span class="hlFld-ContribAuthor ">Mike R.  Wilson</span>, <span class="hlFld-ContribAuthor ">Si  Yang</span>, <span class="hlFld-ContribAuthor ">Lisa  Polin</span>, <span class="hlFld-ContribAuthor ">Kathryn  White</span>, <span class="hlFld-ContribAuthor ">Juiwanna  Kushner</span>, <span class="hlFld-ContribAuthor ">Steven  Orr</span>, <span class="hlFld-ContribAuthor ">Christina  George</span>, <span class="hlFld-ContribAuthor ">Carrie  OâConnor</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Hou</span>, <span class="hlFld-ContribAuthor ">Shermaine  Mitchell-Ryan</span>, <span class="hlFld-ContribAuthor ">Charles E.  Dann, III</span>, <span class="hlFld-ContribAuthor ">Larry H.  Matherly</span>, and <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>  . </span><span class="cited-content_cbyCitation_article-title">6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor Î± and the Proton-Coupled Folate Transporter in Human Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6938-6959. <a href="https://doi.org/10.1021/acs.jmedchem.5b00801" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00801%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Substituted%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252BThienoyl%252BRegioisomers%252Bas%252BTargeted%252BAntifolates%252Bfor%252BFolate%252BReceptor%252B%2525CE%2525B1%252Band%252Bthe%252BProton-Coupled%252BFolate%252BTransporter%252Bin%252BHuman%252BTumors%26aulast%3DWang%26aufirst%3DLei%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26052015%26date%3D28082015%26date%3D10092015%26volume%3D58%26issue%3D17%26spage%3D6938%26epage%3D6959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shantanu V.  Lale</span>, <span class="hlFld-ContribAuthor ">Arun  Kumar</span>, <span class="hlFld-ContribAuthor ">Shyam  Prasad</span>, <span class="hlFld-ContribAuthor ">Alok C.  Bharti</span>, and <span class="hlFld-ContribAuthor ">Veena  Koul</span>  . </span><span class="cited-content_cbyCitation_article-title">Folic Acid and Trastuzumab Functionalized Redox Responsive Polymersomes for Intracellular Doxorubicin Delivery in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomacromolecules</span><span> <strong>2015,</strong> <em>16 </em>
                                    (6)
                                     , 1736-1752. <a href="https://doi.org/10.1021/acs.biomac.5b00244" title="DOI URL">https://doi.org/10.1021/acs.biomac.5b00244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biomac.5b00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biomac.5b00244%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomacromolecules%26atitle%3DFolic%252BAcid%252Band%252BTrastuzumab%252BFunctionalized%252BRedox%252BResponsive%252BPolymersomes%252Bfor%252BIntracellular%252BDoxorubicin%252BDelivery%252Bin%252BBreast%252BCancer%26aulast%3DLale%26aufirst%3DShantanu%2BV.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D20022015%26date%3D14042015%26date%3D15052015%26date%3D08062015%26date%3D28042015%26volume%3D16%26issue%3D6%26spage%3D1736%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiong  Dai</span>, <span class="hlFld-ContribAuthor ">Yan  Yan</span>, <span class="hlFld-ContribAuthor ">Ching-Seng  Ang</span>, <span class="hlFld-ContribAuthor ">Kristian  Kempe</span>, <span class="hlFld-ContribAuthor ">Marloes M. J.  Kamphuis</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Dodds</span>, and <span class="hlFld-ContribAuthor ">Frank  Caruso</span>  . </span><span class="cited-content_cbyCitation_article-title">Monoclonal Antibody-Functionalized Multilayered Particles: Targeting Cancer Cells in the Presence of Protein Coronas. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2015,</strong> <em>9 </em>
                                    (3)
                                     , 2876-2885. <a href="https://doi.org/10.1021/nn506929e" title="DOI URL">https://doi.org/10.1021/nn506929e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/nn506929e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnn506929e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DMonoclonal%252BAntibody-Functionalized%252BMultilayered%252BParticles%25253A%252BTargeting%252BCancer%252BCells%252Bin%252Bthe%252BPresence%252Bof%252BProtein%252BCoronas%26aulast%3DDai%26aufirst%3DQiong%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D15022015%26date%3D25022015%26date%3D24032015%26volume%3D9%26issue%3D3%26spage%3D2876%26epage%3D2885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Li</span>, <span class="hlFld-ContribAuthor ">Zheyu  Shen</span>, <span class="hlFld-ContribAuthor ">Xuehua  Ma</span>, <span class="hlFld-ContribAuthor ">Wenzhi  Ren</span>, <span class="hlFld-ContribAuthor ">Lingchao  Xiang</span>, <span class="hlFld-ContribAuthor ">An  Gong</span>, <span class="hlFld-ContribAuthor ">Tian  Xia</span>, <span class="hlFld-ContribAuthor ">Junming  Guo</span>, and <span class="hlFld-ContribAuthor ">Aiguo  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Neuropeptide Y Y1 Receptors Meditate Targeted Delivery of Anticancer Drug with Encapsulated Nanoparticles to Breast Cancer Cells with High Selectivity and Its Potential for Breast Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2015,</strong> <em>7 </em>
                                    (9)
                                     , 5574-5582. <a href="https://doi.org/10.1021/acsami.5b00270" title="DOI URL">https://doi.org/10.1021/acsami.5b00270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.5b00270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.5b00270%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DNeuropeptide%252BY%252BY1%252BReceptors%252BMeditate%252BTargeted%252BDelivery%252Bof%252BAnticancer%252BDrug%252Bwith%252BEncapsulated%252BNanoparticles%252Bto%252BBreast%252BCancer%252BCells%252Bwith%252BHigh%252BSelectivity%252Band%252BIts%252BPotential%252Bfor%252BBreast%252BCancer%252BTherapy%26aulast%3DLi%26aufirst%3DJuan%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10012015%26date%3D19022015%26date%3D26022015%26date%3D11032015%26date%3D19022015%26volume%3D7%26issue%3D9%26spage%3D5574%26epage%3D5582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paresh  Agarwal</span> and <span class="hlFld-ContribAuthor ">Carolyn R.  Bertozzi</span>  . </span><span class="cited-content_cbyCitation_article-title">Site-Specific AntibodyâDrug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2015,</strong> <em>26 </em>
                                    (2)
                                     , 176-192. <a href="https://doi.org/10.1021/bc5004982" title="DOI URL">https://doi.org/10.1021/bc5004982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bc5004982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbc5004982%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DSite-Specific%252BAntibody%2525E2%252580%252593Drug%252BConjugates%25253A%252BThe%252BNexus%252Bof%252BBioorthogonal%252BChemistry%25252C%252BProtein%252BEngineering%25252C%252Band%252BDrug%252BDevelopment%26aulast%3DAgarwal%26aufirst%3DParesh%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D31102014%26date%3D12122014%26date%3D30012015%26date%3D18022015%26date%3D12122014%26volume%3D26%26issue%3D2%26spage%3D176%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Shermaine  Mitchell-Ryan</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Christina  George</span>, <span class="hlFld-ContribAuthor ">Steven  Orr</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Hou</span>, <span class="hlFld-ContribAuthor ">Larry H.  Matherly</span>, and <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 5-Substituted Pyrrolo[2,3-d]pyrimidines as Dual Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase and as Potential Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1479-1493. <a href="https://doi.org/10.1021/jm501787c" title="DOI URL">https://doi.org/10.1021/jm501787c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501787c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501787c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B5-Substituted%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252BDual%252BInhibitors%252Bof%252BGlycinamide%252BRibonucleotide%252BFormyltransferase%252Band%252B5-Aminoimidazole-4-carboxamide%252BRibonucleotide%252BFormyltransferase%252Band%252Bas%252BPotential%252BAntitumor%252BAgents%26aulast%3DWang%26aufirst%3DYiqiang%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D19112014%26date%3D02022015%26date%3D12022015%26date%3D20012015%26volume%3D58%26issue%3D3%26spage%3D1479%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chin Siang  Kue</span>, <span class="hlFld-ContribAuthor ">Anyanee  Kamkaew</span>, <span class="hlFld-ContribAuthor ">Hong Boon  Lee</span>, <span class="hlFld-ContribAuthor ">Lip Yong  Chung</span>, <span class="hlFld-ContribAuthor ">Lik Voon  Kiew</span>, and <span class="hlFld-ContribAuthor ">Kevin  Burgess</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeted PDT Agent Eradicates TrkC Expressing Tumors via Photodynamic Therapy (PDT). </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2015,</strong> <em>12 </em>
                                    (1)
                                     , 212-222. <a href="https://doi.org/10.1021/mp5005564" title="DOI URL">https://doi.org/10.1021/mp5005564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp5005564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp5005564%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DTargeted%252BPDT%252BAgent%252BEradicates%252BTrkC%252BExpressing%252BTumors%252Bvia%252BPhotodynamic%252BTherapy%252B%252528PDT%252529%26aulast%3DKue%26aufirst%3DChin%2BSiang%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13082014%26date%3D18112014%26date%3D13112014%26date%3D09122014%26date%3D05012015%26volume%3D12%26issue%3D1%26spage%3D212%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory  Nkepang</span>, <span class="hlFld-ContribAuthor ">Moses  Bio</span>, <span class="hlFld-ContribAuthor ">Pallavi  Rajaputra</span>, <span class="hlFld-ContribAuthor ">Samuel G.  Awuah</span>, and <span class="hlFld-ContribAuthor ">Youngjae  You</span>  . </span><span class="cited-content_cbyCitation_article-title">Folate Receptor-Mediated Enhanced and Specific Delivery of Far-Red Light-Activatable Prodrugs of Combretastatin A-4 to FR-Positive Tumor. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2014,</strong> <em>25 </em>
                                    (12)
                                     , 2175-2188. <a href="https://doi.org/10.1021/bc500376j" title="DOI URL">https://doi.org/10.1021/bc500376j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bc500376j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbc500376j%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DFolate%252BReceptor-Mediated%252BEnhanced%252Band%252BSpecific%252BDelivery%252Bof%252BFar-Red%252BLight-Activatable%252BProdrugs%252Bof%252BCombretastatin%252BA-4%252Bto%252BFR-Positive%252BTumor%26aulast%3DNkepang%26aufirst%3DGregory%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D14082014%26date%3D12102014%26date%3D21112014%26date%3D17122014%26date%3D28102014%26volume%3D25%26issue%3D12%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rasa  Ghaffarian</span> and <span class="hlFld-ContribAuthor ">Silvia  Muro</span>  . </span><span class="cited-content_cbyCitation_article-title">Distinct Subcellular Trafficking Resulting from Monomeric vs Multimeric Targeting to Endothelial ICAM-1: Implications for Drug Delivery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2014,</strong> <em>11 </em>
                                    (12)
                                     , 4350-4362. <a href="https://doi.org/10.1021/mp500409y" title="DOI URL">https://doi.org/10.1021/mp500409y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp500409y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp500409y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DDistinct%252BSubcellular%252BTrafficking%252BResulting%252Bfrom%252BMonomeric%252Bvs%252BMultimeric%252BTargeting%252Bto%252BEndothelial%252BICAM-1%25253A%252BImplications%252Bfor%252BDrug%252BDelivery%26aulast%3DGhaffarian%26aufirst%3DRasa%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D09062014%26date%3D09102014%26date%3D16092014%26date%3D24102014%26date%3D01122014%26date%3D09102014%26volume%3D11%26issue%3D12%26spage%3D4350%26epage%3D4362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa  Howard</span>, <span class="hlFld-ContribAuthor ">Blaine J.  Zern</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Anselmo</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Shuvaev</span>, <span class="hlFld-ContribAuthor ">Samir  Mitragotri</span>, and <span class="hlFld-ContribAuthor ">Vladimir  Muzykantov</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2014,</strong> <em>8 </em>
                                    (5)
                                     , 4100-4132. <a href="https://doi.org/10.1021/nn500136z" title="DOI URL">https://doi.org/10.1021/nn500136z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/nn500136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnn500136z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DVascular%252BTargeting%252Bof%252BNanocarriers%25253A%252BPerplexing%252BAspects%252Bof%252Bthe%252BSeemingly%252BStraightforward%252BParadigm%26aulast%3DHoward%26aufirst%3DMelissa%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08012014%26date%3D30042014%26date%3D07052014%26date%3D27052014%26date%3D30042014%26volume%3D8%26issue%3D5%26spage%3D4100%26epage%3D4132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuchen  Cao</span> and <span class="hlFld-ContribAuthor ">Jerry  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Folate Receptor (FR)-Targeted Indenoisoquinoline Using a pH-Sensitive N-Ethoxybenzylimidazole (NEBI) Bifunctional Cross-Linker. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2014,</strong> <em>25 </em>
                                    (5)
                                     , 873-878. <a href="https://doi.org/10.1021/bc500146p" title="DOI URL">https://doi.org/10.1021/bc500146p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bc500146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbc500146p%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BFolate%252BReceptor%252B%252528FR%252529-Targeted%252BIndenoisoquinoline%252BUsing%252Ba%252BpH-Sensitive%252BN-Ethoxybenzylimidazole%252B%252528NEBI%252529%252BBifunctional%252BCross-Linker%26aulast%3DCao%26aufirst%3DYuchen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D02042014%26date%3D22042014%26date%3D29042014%26date%3D21052014%26date%3D23042014%26volume%3D25%26issue%3D5%26spage%3D873%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shermaine  Mitchell-Ryan</span>, <span class="hlFld-ContribAuthor ">Yiqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Manasa Punaha  Ravindra</span>, <span class="hlFld-ContribAuthor ">Eric  Hales</span>, <span class="hlFld-ContribAuthor ">Steven  Orr</span>, <span class="hlFld-ContribAuthor ">Christina  Cherian</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Hou</span>, <span class="hlFld-ContribAuthor ">Larry H.  Matherly</span>, and <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-Substituted Pyrrolo[2,3-d]pyrimidine Antifolates as Dual-Acting Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase in De Novo Purine Nucleotide Biosynthesis: Implications of Inhibiting 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase to AMPK Activation and Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (24)
                                     , 10016-10032. <a href="https://doi.org/10.1021/jm401328u" title="DOI URL">https://doi.org/10.1021/jm401328u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401328u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401328u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5-Substituted%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252BAntifolates%252Bas%252BDual-Acting%252BInhibitors%252Bof%252BGlycinamide%252BRibonucleotide%252BFormyltransferase%252Band%252B5-Aminoimidazole-4-carboxamide%252BRibonucleotide%252BFormyltransferase%252Bin%252BDe%252BNovo%252BPurine%252BNucleotide%252BBiosynthesis%25253A%252BImplications%252Bof%252BInhibiting%252B5-Aminoimidazole-4-carboxamide%252BRibonucleotide%252BFormyltransferase%252Bto%252BAMPK%252BActivation%252Band%252BAntitumor%252BActivity%26aulast%3DMitchell-Ryan%26aufirst%3DShermaine%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28082013%26date%3D11122013%26date%3D27122013%26date%3D20112013%26volume%3D56%26issue%3D24%26spage%3D10016%26epage%3D10032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Rong  Ke</span>, <span class="hlFld-ContribAuthor ">Sin-Lui  Yeung</span>, <span class="hlFld-ContribAuthor ">Dennis K. P.  Ng</span>, <span class="hlFld-ContribAuthor ">Wing-Ping  Fong</span>, and <span class="hlFld-ContribAuthor ">Pui-Chi  Lo</span>  . </span><span class="cited-content_cbyCitation_article-title">Preparation and in Vitro Photodynamic Activities of Folate-Conjugated Distyryl Boron Dipyrromethene Based Photosensitizers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (21)
                                     , 8475-8483. <a href="https://doi.org/10.1021/jm4009168" title="DOI URL">https://doi.org/10.1021/jm4009168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4009168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4009168%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPreparation%252Band%252Bin%252BVitro%252BPhotodynamic%252BActivities%252Bof%252BFolate-Conjugated%252BDistyryl%252BBoron%252BDipyrromethene%252BBased%252BPhotosensitizers%26aulast%3DKe%26aufirst%3DMei-Rong%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19062013%26date%3D22102013%26date%3D14112013%26date%3D02102013%26volume%3D56%26issue%3D21%26spage%3D8475%26epage%3D8483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Hsin  Chien</span>, <span class="hlFld-ContribAuthor ">Yu-Lin  Chou</span>, <span class="hlFld-ContribAuthor ">Shu-Wen  Wang</span>, <span class="hlFld-ContribAuthor ">Shu-Ting  Hung</span>, <span class="hlFld-ContribAuthor ">Min-Chiau  Liau</span>, <span class="hlFld-ContribAuthor ">Yu-Jo  Chao</span>, <span class="hlFld-ContribAuthor ">Chia-Hao  Su</span>, and <span class="hlFld-ContribAuthor ">Chen-Sheng  Yeh</span>  . </span><span class="cited-content_cbyCitation_article-title">Near-Infrared Light Photocontrolled Targeting, Bioimaging, and Chemotherapy with Caged Upconversion Nanoparticles in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2013,</strong> <em>7 </em>
                                    (10)
                                     , 8516-8528. <a href="https://doi.org/10.1021/nn402399m" title="DOI URL">https://doi.org/10.1021/nn402399m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/nn402399m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnn402399m%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DNear-Infrared%252BLight%252BPhotocontrolled%252BTargeting%25252C%252BBioimaging%25252C%252Band%252BChemotherapy%252Bwith%252BCaged%252BUpconversion%252BNanoparticles%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DChien%26aufirst%3DYi-Hsin%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D13052013%26date%3D26092013%26date%3D30092013%26date%3D22102013%26date%3D26092013%26volume%3D7%26issue%3D10%26spage%3D8516%26epage%3D8528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anyanee  Kamkaew</span> and <span class="hlFld-ContribAuthor ">Kevin  Burgess</span>  . </span><span class="cited-content_cbyCitation_article-title">Double-Targeting Using a TrkC Ligand Conjugated to Dipyrrometheneboron Difluoride (BODIPY) Based Photodynamic Therapy (PDT) Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (19)
                                     , 7608-7614. <a href="https://doi.org/10.1021/jm4012142" title="DOI URL">https://doi.org/10.1021/jm4012142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4012142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4012142%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDouble-Targeting%252BUsing%252Ba%252BTrkC%252BLigand%252BConjugated%252Bto%252BDipyrrometheneboron%252BDifluoride%252B%252528BODIPY%252529%252BBased%252BPhotodynamic%252BTherapy%252B%252528PDT%252529%252BAgent%26aulast%3DKamkaew%26aufirst%3DAnyanee%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28062013%26date%3D24092013%26date%3D10102013%26volume%3D56%26issue%3D19%26spage%3D7608%26epage%3D7614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iwao  Ojima</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploration of Fluorine Chemistry at the Multidisciplinary Interface of Chemistry and Biology. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (13)
                                     , 6358-6383. <a href="https://doi.org/10.1021/jo400301u" title="DOI URL">https://doi.org/10.1021/jo400301u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo400301u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo400301u%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DExploration%252Bof%252BFluorine%252BChemistry%252Bat%252Bthe%252BMultidisciplinary%252BInterface%252Bof%252BChemistry%252Band%252BBiology%26aulast%3DOjima%26aufirst%3DIwao%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08022013%26date%3D06052013%26date%3D05072013%26date%3D24042013%26volume%3D78%26issue%3D13%26spage%3D6358%26epage%3D6383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte  Gehin</span>, <span class="hlFld-ContribAuthor ">Javier  Montenegro</span>, <span class="hlFld-ContribAuthor ">Eun-Kyoung  Bang</span>, <span class="hlFld-ContribAuthor ">Ana  Cajaraville</span>, <span class="hlFld-ContribAuthor ">Shota  Takayama</span>, <span class="hlFld-ContribAuthor ">Hisaaki  Hirose</span>, <span class="hlFld-ContribAuthor ">Shiroh  Futaki</span>, <span class="hlFld-ContribAuthor ">Stefan  Matile</span>, and <span class="hlFld-ContribAuthor ">Howard  Riezman</span>  . </span><span class="cited-content_cbyCitation_article-title">Dynamic Amphiphile Libraries To Screen for the âFragrantâ Delivery of siRNA into HeLa Cells and Human Primary Fibroblasts. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (25)
                                     , 9295-9298. <a href="https://doi.org/10.1021/ja404153m" title="DOI URL">https://doi.org/10.1021/ja404153m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja404153m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja404153m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDynamic%252BAmphiphile%252BLibraries%252BTo%252BScreen%252Bfor%252Bthe%252B%2525E2%252580%25259CFragrant%2525E2%252580%25259D%252BDelivery%252Bof%252BsiRNA%252Binto%252BHeLa%252BCells%252Band%252BHuman%252BPrimary%252BFibroblasts%26aulast%3DGehin%26aufirst%3DCharlotte%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26042013%26date%3D14062013%26date%3D26062013%26volume%3D135%26issue%3D25%26spage%3D9295%26epage%3D9298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lindsay E.  Kelderhouse</span>, <span class="hlFld-ContribAuthor ">Venkatesh  Chelvam</span>, <span class="hlFld-ContribAuthor ">Charity  Wayua</span>, <span class="hlFld-ContribAuthor ">Sakkarapalayam  Mahalingam</span>, <span class="hlFld-ContribAuthor ">Scott  Poh</span>, <span class="hlFld-ContribAuthor ">Sumith A.  Kularatne</span>, and <span class="hlFld-ContribAuthor ">Philip S.  Low</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Tumor-Targeted Near Infrared Probes for Fluorescence Guided Surgery. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2013,</strong> <em>24 </em>
                                    (6)
                                     , 1075-1080. <a href="https://doi.org/10.1021/bc400131a" title="DOI URL">https://doi.org/10.1021/bc400131a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bc400131a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbc400131a%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDevelopment%252Bof%252BTumor-Targeted%252BNear%252BInfrared%252BProbes%252Bfor%252BFluorescence%252BGuided%252BSurgery%26aulast%3DKelderhouse%26aufirst%3DLindsay%2BE.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11032013%26date%3D02052013%26date%3D21052013%26date%3D19062013%26date%3D05052013%26volume%3D24%26issue%3D6%26spage%3D1075%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariadna  Grau-Campistany</span>, <span class="hlFld-ContribAuthor ">Anna  Massaguer</span>, <span class="hlFld-ContribAuthor ">Dolors  Carrion-Salip</span>, <span class="hlFld-ContribAuthor ">Flavia  BarragÃ¡n</span>, <span class="hlFld-ContribAuthor ">Gerard  Artigas</span>, <span class="hlFld-ContribAuthor ">Paula  LÃ³pez-SenÃ­n</span>, <span class="hlFld-ContribAuthor ">Virtudes  Moreno</span>, and <span class="hlFld-ContribAuthor ">Vicente  MarchÃ¡n</span>  . </span><span class="cited-content_cbyCitation_article-title">Conjugation of a Ru(II) Arene Complex to Neomycin or to Guanidinoneomycin Leads to Compounds with Differential Cytotoxicities and Accumulation between Cancer and Normal Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2013,</strong> <em>10 </em>
                                    (5)
                                     , 1964-1976. <a href="https://doi.org/10.1021/mp300723b" title="DOI URL">https://doi.org/10.1021/mp300723b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp300723b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp300723b%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DConjugation%252Bof%252Ba%252BRu%252528II%252529%252BArene%252BComplex%252Bto%252BNeomycin%252Bor%252Bto%252BGuanidinoneomycin%252BLeads%252Bto%252BCompounds%252Bwith%252BDifferential%252BCytotoxicities%252Band%252BAccumulation%252Bbetween%252BCancer%252Band%252BNormal%252BCells%26aulast%3DGrau-Campistany%26aufirst%3DAriadna%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D2013%26date%3D21122012%26date%3D19032013%26date%3D11032013%26date%3D05042013%26date%3D06052013%26date%3D19032013%26volume%3D10%26issue%3D5%26spage%3D1964%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jared F.  Stefanick</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Ashley</span>, <span class="hlFld-ContribAuthor ">Tanyel  Kiziltepe</span>, and <span class="hlFld-ContribAuthor ">Basar  Bilgicer</span>  . </span><span class="cited-content_cbyCitation_article-title">A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2013,</strong> <em>7 </em>
                                    (4)
                                     , 2935-2947. <a href="https://doi.org/10.1021/nn305663e" title="DOI URL">https://doi.org/10.1021/nn305663e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/nn305663e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnn305663e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DA%252BSystematic%252BAnalysis%252Bof%252BPeptide%252BLinker%252BLength%252Band%252BLiposomal%252BPolyethylene%252BGlycol%252BCoating%252Bon%252BCellular%252BUptake%252Bof%252BPeptide-Targeted%252BLiposomes%26aulast%3DStefanick%26aufirst%3DJared%2BF.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D07122012%26date%3D19022013%26date%3D05032013%26date%3D23042013%26date%3D19022013%26volume%3D7%26issue%3D4%26spage%3D2935%26epage%3D2947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keigo  Mizusawa</span>, <span class="hlFld-ContribAuthor ">Yousuke  Takaoka</span>, and <span class="hlFld-ContribAuthor ">Itaru  Hamachi</span>  . </span><span class="cited-content_cbyCitation_article-title">Specific Cell Surface Protein Imaging by Extended Self-Assembling Fluorescent Turn-on Nanoprobes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (32)
                                     , 13386-13395. <a href="https://doi.org/10.1021/ja304239g" title="DOI URL">https://doi.org/10.1021/ja304239g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja304239g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja304239g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSpecific%252BCell%252BSurface%252BProtein%252BImaging%252Bby%252BExtended%252BSelf-Assembling%252BFluorescent%252BTurn-on%252BNanoprobes%26aulast%3DMizusawa%26aufirst%3DKeigo%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02052012%26date%3D07082012%26date%3D15082012%26date%3D18072012%26volume%3D134%26issue%3D32%26spage%3D13386%26epage%3D13395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Kiat Hwa  Chan</span>, <span class="hlFld-ContribAuthor ">Robert K.  Prud'homme</span>, and <span class="hlFld-ContribAuthor ">A. James  Link</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Clickable Block Copolymers for Targeted Nanoparticle Drug Delivery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2012,</strong> <em>9 </em>
                                    (8)
                                     , 2228-2236. <a href="https://doi.org/10.1021/mp3000748" title="DOI URL">https://doi.org/10.1021/mp3000748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp3000748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp3000748%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BClickable%252BBlock%252BCopolymers%252Bfor%252BTargeted%252BNanoparticle%252BDrug%252BDelivery%26aulast%3DZhang%26aufirst%3DSiyan%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D08022012%26date%3D26062012%26date%3D10062012%26date%3D12072012%26date%3D06082012%26date%3D26062012%26volume%3D9%26issue%3D8%26spage%3D2228%26epage%3D2236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian  Willibald</span>, <span class="hlFld-ContribAuthor ">Johannes  Harder</span>, <span class="hlFld-ContribAuthor ">Konstantin  Sparrer</span>, <span class="hlFld-ContribAuthor ">Karl-Klaus  Conzelmann</span>, and <span class="hlFld-ContribAuthor ">Thomas  Carell</span>  . </span><span class="cited-content_cbyCitation_article-title">Click-Modified Anandamide siRNA Enables Delivery and Gene Silencing in Neuronal and Immune Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (30)
                                     , 12330-12333. <a href="https://doi.org/10.1021/ja303251f" title="DOI URL">https://doi.org/10.1021/ja303251f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja303251f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja303251f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DClick-Modified%252BAnandamide%252BsiRNA%252BEnables%252BDelivery%252Band%252BGene%252BSilencing%252Bin%252BNeuronal%252Band%252BImmune%252BCells%26aulast%3DWillibald%26aufirst%3DJulian%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D04042012%26date%3D23072012%26date%3D01082012%26date%3D19072012%26volume%3D134%26issue%3D30%26spage%3D12330%26epage%3D12333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilie  Roger</span>, <span class="hlFld-ContribAuthor ">Stephen  Kalscheuer</span>, <span class="hlFld-ContribAuthor ">Ameya  Kirtane</span>, <span class="hlFld-ContribAuthor ">Bharath Raja  Guru</span>, <span class="hlFld-ContribAuthor ">Alex E.  Grill</span>, <span class="hlFld-ContribAuthor ">Judith  Whittum-Hudson</span>, and <span class="hlFld-ContribAuthor ">Jayanth  Panyam</span>  . </span><span class="cited-content_cbyCitation_article-title">Folic Acid Functionalized Nanoparticles for Enhanced Oral Drug Delivery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2012,</strong> <em>9 </em>
                                    (7)
                                     , 2103-2110. <a href="https://doi.org/10.1021/mp2005388" title="DOI URL">https://doi.org/10.1021/mp2005388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp2005388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp2005388%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DFolic%252BAcid%252BFunctionalized%252BNanoparticles%252Bfor%252BEnhanced%252BOral%252BDrug%252BDelivery%26aulast%3DRoger%26aufirst%3DEmilie%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D2012%26date%3D20102011%26date%3D06062012%26date%3D18042012%26date%3D13062012%26date%3D02072012%26date%3D06062012%26volume%3D9%26issue%3D7%26spage%3D2103%26epage%3D2110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Dohmen</span>, <span class="hlFld-ContribAuthor ">Daniel  Edinger</span>, <span class="hlFld-ContribAuthor ">Thomas  FrÃ¶hlich</span>, <span class="hlFld-ContribAuthor ">Laura  Schreiner</span>, <span class="hlFld-ContribAuthor ">Ulrich  LÃ¤chelt</span>, <span class="hlFld-ContribAuthor ">Christina  Troiber</span>, <span class="hlFld-ContribAuthor ">Joachim  RÃ¤dler</span>, <span class="hlFld-ContribAuthor ">Philipp  Hadwiger</span>, <span class="hlFld-ContribAuthor ">Hans-Peter  Vornlocher</span>, and <span class="hlFld-ContribAuthor ">Ernst  Wagner</span>  . </span><span class="cited-content_cbyCitation_article-title">Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2012,</strong> <em>6 </em>
                                    (6)
                                     , 5198-5208. <a href="https://doi.org/10.1021/nn300960m" title="DOI URL">https://doi.org/10.1021/nn300960m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/nn300960m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnn300960m%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DNanosized%252BMultifunctional%252BPolyplexes%252Bfor%252BReceptor-Mediated%252BSiRNA%252BDelivery%26aulast%3DDohmen%26aufirst%3DChristian%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D03032012%26date%3D30052012%26date%3D07062012%26date%3D26062012%26date%3D30052012%26volume%3D6%26issue%3D6%26spage%3D5198%26epage%3D5208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Mengyao  Zheng</span>, <span class="hlFld-ContribAuthor ">Thomas  Renette</span>, and <span class="hlFld-ContribAuthor ">Thomas  Kissel</span>  . </span><span class="cited-content_cbyCitation_article-title">Modular Synthesis of Folate Conjugated Ternary Copolymers: Polyethylenimine-graft-Polycaprolactone-block-Poly(ethylene glycol)-Folate for Targeted Gene Delivery. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2012,</strong> <em>23 </em>
                                    (6)
                                     , 1211-1220. <a href="https://doi.org/10.1021/bc300025d" title="DOI URL">https://doi.org/10.1021/bc300025d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bc300025d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbc300025d%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DModular%252BSynthesis%252Bof%252BFolate%252BConjugated%252BTernary%252BCopolymers%25253A%252BPolyethylenimine-graft-Polycaprolactone-block-Poly%252528ethylene%252Bglycol%252529-Folate%252Bfor%252BTargeted%252BGene%252BDelivery%26aulast%3DLiu%26aufirst%3DLi%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D18012012%26date%3D27032012%26date%3D11052012%26date%3D20062012%26date%3D02052012%26volume%3D23%26issue%3D6%26spage%3D1211%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander A.  Kislukhin</span>, <span class="hlFld-ContribAuthor ">Cody J.  Higginson</span>, <span class="hlFld-ContribAuthor ">Vu P.  Hong</span>, and <span class="hlFld-ContribAuthor ">M. G.  Finn</span>  . </span><span class="cited-content_cbyCitation_article-title">Degradable Conjugates from Oxanorbornadiene Reagents. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (14)
                                     , 6491-6497. <a href="https://doi.org/10.1021/ja301491h" title="DOI URL">https://doi.org/10.1021/ja301491h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja301491h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja301491h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDegradable%252BConjugates%252Bfrom%252BOxanorbornadiene%252BReagents%26aulast%3DKislukhin%26aufirst%3DAlexander%2BA.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D14022012%26date%3D28032012%26date%3D11042012%26volume%3D134%26issue%3D14%26spage%3D6491%26epage%3D6497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Christina  Cherian</span>, <span class="hlFld-ContribAuthor ">Sita  Kugel Desmoulin</span>, <span class="hlFld-ContribAuthor ">Shermaine  Mitchell-Ryan</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Hou</span>, <span class="hlFld-ContribAuthor ">Larry H.  Matherly</span>, and <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activity of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (4)
                                     , 1758-1770. <a href="https://doi.org/10.1021/jm201688n" title="DOI URL">https://doi.org/10.1021/jm201688n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201688n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201688n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BActivity%252Bof%252B6-Substituted%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252BThienoyl%252BRegioisomers%252Bas%252BInhibitors%252Bof%252Bde%252BNovo%252BPurine%252BBiosynthesis%252Bwith%252BSelectivity%252Bfor%252BCellular%252BUptake%252Bby%252BHigh%252BAffinity%252BFolate%252BReceptors%252Band%252Bthe%252BProton-Coupled%252BFolate%252BTransporter%252Bover%252Bthe%252BReduced%252BFolate%252BCarrier%26aulast%3DWang%26aufirst%3DLei%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D14122011%26date%3D03022012%26date%3D23022012%26date%3D13012012%26volume%3D55%26issue%3D4%26spage%3D1758%26epage%3D1770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annalisa  Guaragna</span>, <span class="hlFld-ContribAuthor ">Angela  Chiaviello</span>, <span class="hlFld-ContribAuthor ">Concetta  Paolella</span>, <span class="hlFld-ContribAuthor ">Daniele  DâAlonzo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Palumbo</span>, and <span class="hlFld-ContribAuthor ">Giovanni  Palumbo</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Folate-Based Chlorambucil Delivery Systems for Tumor-Targeted Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2012,</strong> <em>23 </em>
                                    (1)
                                     , 84-96. <a href="https://doi.org/10.1021/bc200410d" title="DOI URL">https://doi.org/10.1021/bc200410d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bc200410d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbc200410d%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BFolate-Based%252BChlorambucil%252BDelivery%252BSystems%252Bfor%252BTumor-Targeted%252BChemotherapy%26aulast%3DGuaragna%26aufirst%3DAnnalisa%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D12082011%26date%3D31102011%26date%3D07122011%26date%3D18012012%26date%3D28112011%26volume%3D23%26issue%3D1%26spage%3D84%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Koon Gee  Neoh</span>, and <span class="hlFld-ContribAuthor ">En-Tang  Kang</span>  . </span><span class="cited-content_cbyCitation_article-title">Combined ATRP and âClickâ Chemistry for Designing Stable Tumor-Targeting Superparamagnetic Iron Oxide Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Langmuir</span><span> <strong>2012,</strong> <em>28 </em>
                                    (1)
                                     , 563-571. <a href="https://doi.org/10.1021/la202441j" title="DOI URL">https://doi.org/10.1021/la202441j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/la202441j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fla202441j%26sid%3Dliteratum%253Aachs%26jtitle%3DLangmuir%26atitle%3DCombined%252BATRP%252Band%252B%2525E2%252580%252598Click%2525E2%252580%252599%252BChemistry%252Bfor%252BDesigning%252BStable%252BTumor-Targeting%252BSuperparamagnetic%252BIron%252BOxide%252BNanoparticles%26aulast%3DHuang%26aufirst%3DChao%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D28062011%26date%3D11112011%26date%3D09122011%26date%3D10012012%26date%3D28112011%26volume%3D28%26issue%3D1%26spage%3D563%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina  Mamasheva</span>, <span class="hlFld-ContribAuthor ">Christi  OâDonnell</span>, <span class="hlFld-ContribAuthor ">Amey  Bandekar</span>, and <span class="hlFld-ContribAuthor ">Stavroula  Sofou</span>  . </span><span class="cited-content_cbyCitation_article-title">Heterogeneous Liposome Membranes with pH-Triggered Permeability Enhance the in Vitro Antitumor Activity of Folate-Receptor Targeted Liposomal Doxorubicin. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2011,</strong> <em>8 </em>
                                    (6)
                                     , 2224-2232. <a href="https://doi.org/10.1021/mp200079y" title="DOI URL">https://doi.org/10.1021/mp200079y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp200079y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp200079y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DHeterogeneous%252BLiposome%252BMembranes%252Bwith%252BpH-Triggered%252BPermeability%252BEnhance%252Bthe%252Bin%252BVitro%252BAntitumor%252BActivity%252Bof%252BFolate-Receptor%252BTargeted%252BLiposomal%252BDoxorubicin%26aulast%3DMamasheva%26aufirst%3DElina%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D17022011%26date%3D07092011%26date%3D03092011%26date%3D21092011%26date%3D05122011%26date%3D07092011%26volume%3D8%26issue%3D6%26spage%3D2224%26epage%3D2232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyo Won  Lee</span>, <span class="hlFld-ContribAuthor ">Dong Joon  Lee</span>, <span class="hlFld-ContribAuthor ">Chang Su  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Research Trends of TwoâPhoton Photosensitizer for Simultaneous Imaging and Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2021,</strong> <em>14 </em><a href="https://doi.org/10.1002/bkcs.12354" title="DOI URL">https://doi.org/10.1002/bkcs.12354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.12354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.12354%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DRecent%252BResearch%252BTrends%252Bof%252BTwo%2525E2%252580%252590Photon%252BPhotosensitizer%252Bfor%252BSimultaneous%252BImaging%252Band%252BPhotodynamic%252BTherapy%26aulast%3DLee%26aufirst%3DHyo%2BWon%26date%3D2021%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhilash  Rana</span>, <span class="hlFld-ContribAuthor ">Seema  Bhatnagar</span>. </span><span class="cited-content_cbyCitation_article-title">Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>112 </em>, 104946. <a href="https://doi.org/10.1016/j.bioorg.2021.104946" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104946%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAdvancements%252Bin%252Bfolate%252Breceptor%252Btargeting%252Bfor%252Banti-cancer%252Btherapy%25253A%252BA%252Bsmall%252Bmolecule-drug%252Bconjugate%252Bapproach%26aulast%3DRana%26aufirst%3DAbhilash%26date%3D2021%26volume%3D112%26spage%3D104946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhishek  Saini</span>, <span class="hlFld-ContribAuthor ">Jyoti  Singh</span>, <span class="hlFld-ContribAuthor ">Sonu  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Optically superior fluorescent probes for selective imaging of cells, tumors, and reactive chemical species. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (24)
                                     , 5208-5236. <a href="https://doi.org/10.1039/D1OB00509J" title="DOI URL">https://doi.org/10.1039/D1OB00509J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00509J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00509J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DOptically%252Bsuperior%252Bfluorescent%252Bprobes%252Bfor%252Bselective%252Bimaging%252Bof%252Bcells%25252C%252Btumors%25252C%252Band%252Breactive%252Bchemical%252Bspecies%26aulast%3DSaini%26aufirst%3DAbhishek%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D24%26spage%3D5208%26epage%3D5236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chelvam  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Derek D.  Doorneweerd</span>, <span class="hlFld-ContribAuthor ">Wei  Xia</span>, <span class="hlFld-ContribAuthor ">Karson S.  Putt</span>, <span class="hlFld-ContribAuthor ">Philip S.  Low</span>. </span><span class="cited-content_cbyCitation_article-title">Folate-targeted verrucarin A reduces the number of activated macrophages in a mouse model of acute peritonitis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 128091. <a href="https://doi.org/10.1016/j.bmcl.2021.128091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFolate-targeted%252Bverrucarin%252BA%252Breduces%252Bthe%252Bnumber%252Bof%252Bactivated%252Bmacrophages%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bacute%252Bperitonitis%26aulast%3DVenkatesh%26aufirst%3DChelvam%26date%3D2021%26volume%3D42%26spage%3D128091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.H.  Koelzer</span>, <span class="hlFld-ContribAuthor ">P.  Herzig</span>, <span class="hlFld-ContribAuthor ">I.  Zlobec</span>, <span class="hlFld-ContribAuthor ">V.  Heinzelmann</span>, <span class="hlFld-ContribAuthor ">D.  Lardinois</span>, <span class="hlFld-ContribAuthor ">E.  Walseng</span>, <span class="hlFld-ContribAuthor ">C.  Rader</span>, <span class="hlFld-ContribAuthor ">K.D.  Mertz</span>, <span class="hlFld-ContribAuthor ">A.  Zippelius</span>, <span class="hlFld-ContribAuthor ">D.S.  Thommen</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform. </span><span class="cited-content_cbyCitation_journal-name">Immuno-Oncology Technology</span><span> <strong>2021,</strong> <em>359 </em>, 100034. <a href="https://doi.org/10.1016/j.iotech.2021.100034" title="DOI URL">https://doi.org/10.1016/j.iotech.2021.100034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.iotech.2021.100034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.iotech.2021.100034%26sid%3Dliteratum%253Aachs%26jtitle%3DImmuno-Oncology%2520Technology%26atitle%3DIntegrated%252Bfunctional%252Band%252Bspatial%252Bprofiling%252Bof%252Btumour%252Bimmune%252Bresponses%252Binduced%252Bby%252Bimmunotherapy%25253A%252Bthe%252BiPROFILER%252Bplatform%26aulast%3DKoelzer%26aufirst%3DV.H.%26date%3D2021%26volume%3D359%26spage%3D100034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Blach</span>, <span class="hlFld-ContribAuthor ">Carlos E.  Alves De Souza</span>, <span class="hlFld-ContribAuthor ">Stelia C.  MÃ©ndez</span>, <span class="hlFld-ContribAuthor ">Fernando O.  MartÃ­nez</span>. </span><span class="cited-content_cbyCitation_article-title">Conjugated anisotropic gold nanoparticles through pterin derivatives for a selective plasmonic photothermal therapy: in vitro studies in HeLa and normal human endocervical cells. </span><span class="cited-content_cbyCitation_journal-name">Gold Bulletin</span><span> <strong>2021,</strong> <em>54 </em>
                                    (1)
                                     , 9-23. <a href="https://doi.org/10.1007/s13404-020-00288-9" title="DOI URL">https://doi.org/10.1007/s13404-020-00288-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13404-020-00288-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13404-020-00288-9%26sid%3Dliteratum%253Aachs%26jtitle%3DGold%2520Bulletin%26atitle%3DConjugated%252Banisotropic%252Bgold%252Bnanoparticles%252Bthrough%252Bpterin%252Bderivatives%252Bfor%252Ba%252Bselective%252Bplasmonic%252Bphotothermal%252Btherapy%25253A%252Bin%252Bvitro%252Bstudies%252Bin%252BHeLa%252Band%252Bnormal%252Bhuman%252Bendocervical%252Bcells%26aulast%3DBlach%26aufirst%3DDiana%26date%3D2021%26date%3D2021%26volume%3D54%26issue%3D1%26spage%3D9%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jordi  BorrÃ s</span>, <span class="hlFld-ContribAuthor ">Julie  Foster</span>, <span class="hlFld-ContribAuthor ">Roxana  Kashani</span>, <span class="hlFld-ContribAuthor ">Laura  MelÃ©ndez-Alafort</span>, <span class="hlFld-ContribAuthor ">Jane  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Joan  Suades</span>, <span class="hlFld-ContribAuthor ">Ramon  Barnadas-RodrÃ­guez</span>. </span><span class="cited-content_cbyCitation_article-title">New Bioconjugated Technetium and Rhenium Folates Synthesized by Transmetallation Reaction with Zinc Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (8)
                                     , 2373. <a href="https://doi.org/10.3390/molecules26082373" title="DOI URL">https://doi.org/10.3390/molecules26082373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26082373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26082373%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNew%252BBioconjugated%252BTechnetium%252Band%252BRhenium%252BFolates%252BSynthesized%252Bby%252BTransmetallation%252BReaction%252Bwith%252BZinc%252BDerivatives%26aulast%3DBorr%25C3%25A0s%26aufirst%3DJordi%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D8%26spage%3D2373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarun Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Swati  Biswas</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (12)
                                     , 5291-5321. <a href="https://doi.org/10.1039/D0NJ04134C" title="DOI URL">https://doi.org/10.1039/D0NJ04134C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ04134C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ04134C%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSmall%252Bmolecule%252Bdrug%252Bconjugates%252B%252528SMDCs%252529%25253A%252Ban%252Bemerging%252Bstrategy%252Bfor%252Banticancer%252Bdrug%252Bdesign%252Band%252Bdiscovery%26aulast%3DPatel%26aufirst%3DTarun%2BKumar%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D12%26spage%3D5291%26epage%3D5321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Young  Yoo</span>, <span class="hlFld-ContribAuthor ">Margaret  Yeh</span>, <span class="hlFld-ContribAuthor ">Balveen  Kaur</span>, <span class="hlFld-ContribAuthor ">Tae Jin  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted delivery of small noncoding RNA for glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2021,</strong> <em>500 </em>, 274-280. <a href="https://doi.org/10.1016/j.canlet.2020.11.004" title="DOI URL">https://doi.org/10.1016/j.canlet.2020.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2020.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2020.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DTargeted%252Bdelivery%252Bof%252Bsmall%252Bnoncoding%252BRNA%252Bfor%252Bglioblastoma%26aulast%3DYoo%26aufirst%3DJi%2BYoung%26date%3D2021%26volume%3D500%26spage%3D274%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanti  Marasini</span>, <span class="hlFld-ContribAuthor ">Huan  Yue</span>, <span class="hlFld-ContribAuthor ">Son-Long  Ho</span>, <span class="hlFld-ContribAuthor ">Ji-Ae  Park</span>, <span class="hlFld-ContribAuthor ">Soyeon  Kim</span>, <span class="hlFld-ContribAuthor ">Ji-Ung  Yang</span>, <span class="hlFld-ContribAuthor ">Hyunsil  Cha</span>, <span class="hlFld-ContribAuthor ">Shuwen  Liu</span>, <span class="hlFld-ContribAuthor ">Tirusew  Tegafaw</span>, <span class="hlFld-ContribAuthor ">Mohammad Yaseen  Ahmad</span>, <span class="hlFld-ContribAuthor ">Abdullah Khamis Ali Al  Saidi</span>, <span class="hlFld-ContribAuthor ">Dejun  Zhao</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Kwon-Seok  Chae</span>, <span class="hlFld-ContribAuthor ">Yongmin  Chang</span>, <span class="hlFld-ContribAuthor ">Gang-Ho  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Positive Magnetic Resonance Imaging of Brain Cancer (U87MG) Using Folic Acid-Conjugated Polyacrylic Acid-Coated Ultrasmall Manganese Oxide Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 2596. <a href="https://doi.org/10.3390/app11062596" title="DOI URL">https://doi.org/10.3390/app11062596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app11062596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp11062596%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DIn%252BVivo%252BPositive%252BMagnetic%252BResonance%252BImaging%252Bof%252BBrain%252BCancer%252B%252528U87MG%252529%252BUsing%252BFolic%252BAcid-Conjugated%252BPolyacrylic%252BAcid-Coated%252BUltrasmall%252BManganese%252BOxide%252BNanoparticles%26aulast%3DMarasini%26aufirst%3DShanti%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Gangopadhyay</span>, <span class="hlFld-ContribAuthor ">Rahul R.  Nikam</span>, <span class="hlFld-ContribAuthor ">Kiran R.  Gore</span>. </span><span class="cited-content_cbyCitation_article-title">Folate Receptor-Mediated Small Interfering RNA Delivery: Recent Developments and Future Directions for RNA Interference Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acid Therapeutics</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1089/nat.2020.0882" title="DOI URL">https://doi.org/10.1089/nat.2020.0882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/nat.2020.0882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fnat.2020.0882%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acid%2520Therapeutics%26atitle%3DFolate%252BReceptor-Mediated%252BSmall%252BInterfering%252BRNA%252BDelivery%25253A%252BRecent%252BDevelopments%252Band%252BFuture%252BDirections%252Bfor%252BRNA%252BInterference%252BTherapeutics%26aulast%3DGangopadhyay%26aufirst%3DSumit%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joydeb  Majumder</span>, <span class="hlFld-ContribAuthor ">Tamara  Minko</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 2000203. <a href="https://doi.org/10.1002/adtp.202000203" title="DOI URL">https://doi.org/10.1002/adtp.202000203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.202000203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.202000203%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DTargeted%252BNanotherapeutics%252Bfor%252BRespiratory%252BDiseases%25253A%252BCancer%25252C%252BFibrosis%25252C%252Band%252BCoronavirus%26aulast%3DMajumder%26aufirst%3DJoydeb%26date%3D2021%26date%3D2020%26volume%3D4%26issue%3D2%26spage%3D2000203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fanchen  Jing</span>, <span class="hlFld-ContribAuthor ">Guiliang  Li</span>, <span class="hlFld-ContribAuthor ">Yingsa  Wang</span>, <span class="hlFld-ContribAuthor ">Shangbin  Zhu</span>, <span class="hlFld-ContribAuthor ">Rundong  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  He</span>, <span class="hlFld-ContribAuthor ">Jiandu  Lei</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of folic acidâmodified carboxymethyl chitosanâursolic acid targeted nanoâdrug carrier for the delivery of ursolic acid and 10âhydroxycamptothecin. </span><span class="cited-content_cbyCitation_journal-name">Polymers for Advanced Technologies</span><span> <strong>2021,</strong> <em>32 </em>
                                    (1)
                                     , 343-354. <a href="https://doi.org/10.1002/pat.5090" title="DOI URL">https://doi.org/10.1002/pat.5090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pat.5090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpat.5090%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymers%2520for%2520Advanced%2520Technologies%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252Bfolic%252Bacid%2525E2%252580%252590modified%252Bcarboxymethyl%252Bchitosan%2525E2%252580%252590ursolic%252Bacid%252Btargeted%252Bnano%2525E2%252580%252590drug%252Bcarrier%252Bfor%252Bthe%252Bdelivery%252Bof%252Bursolic%252Bacid%252Band%252B10%2525E2%252580%252590hydroxycamptothecin%26aulast%3DJing%26aufirst%3DFanchen%26date%3D2021%26date%3D2020%26volume%3D32%26issue%3D1%26spage%3D343%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabyasachi  Chakrabortty</span>, <span class="hlFld-ContribAuthor ">Sunil Kumar  Vimal</span>, <span class="hlFld-ContribAuthor ">Sanjib  Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Some Bioactive Nanomaterials and Applications of Various Nanoconjugates for Targeted Therapeutic Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 347-376. <a href="https://doi.org/10.1007/978-3-030-44925-4_9" title="DOI URL">https://doi.org/10.1007/978-3-030-44925-4_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-44925-4_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-44925-4_9%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252BSome%252BBioactive%252BNanomaterials%252Band%252BApplications%252Bof%252BVarious%252BNanoconjugates%252Bfor%252BTargeted%252BTherapeutic%252BApplications%26aulast%3DChakrabortty%26aufirst%3DSabyasachi%26date%3D2021%26date%3D2020%26spage%3D347%26epage%3D376%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNanopharmaceuticals%25253A%252BPrinciples%252Band%252BApplications%252BVol.%252B1%26aulast%3DYata%26aufirst%3DVinod%2BKumar%26date%3D2021%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junpeng  Qi</span>, <span class="hlFld-ContribAuthor ">Christoph  Rader</span>. </span><span class="cited-content_cbyCitation_article-title">Redirecting cytotoxic T cells with chemically programmed antibodies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115834. <a href="https://doi.org/10.1016/j.bmc.2020.115834" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115834%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRedirecting%252Bcytotoxic%252BT%252Bcells%252Bwith%252Bchemically%252Bprogrammed%252Bantibodies%26aulast%3DQi%26aufirst%3DJunpeng%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Prasad</span>, <span class="hlFld-ContribAuthor ">N.K.  Jain</span>, <span class="hlFld-ContribAuthor ">J.  Conde</span>, <span class="hlFld-ContribAuthor ">R.  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Localized nanotheranostics: recent developments in cancer nanomedicine. </span><span class="cited-content_cbyCitation_journal-name">Materials Today Advances</span><span> <strong>2020,</strong> <em>8 </em>, 100087. <a href="https://doi.org/10.1016/j.mtadv.2020.100087" title="DOI URL">https://doi.org/10.1016/j.mtadv.2020.100087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mtadv.2020.100087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mtadv.2020.100087%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%2520Advances%26atitle%3DLocalized%252Bnanotheranostics%25253A%252Brecent%252Bdevelopments%252Bin%252Bcancer%252Bnanomedicine%26aulast%3DPrasad%26aufirst%3DR.%26date%3D2020%26volume%3D8%26spage%3D100087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Song</span>, <span class="hlFld-ContribAuthor ">Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Hua  Ma</span>, <span class="hlFld-ContribAuthor ">Zhixin  Tang</span>, <span class="hlFld-ContribAuthor ">Chaolong  Liu</span>, <span class="hlFld-ContribAuthor ">Jinhua  Zou</span>, <span class="hlFld-ContribAuthor ">Mingqian  Tan</span>, <span class="hlFld-ContribAuthor ">Jingli  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-targetable magnetoluminescent silica nanoparticles for bimodal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Talanta</span><span> <strong>2020,</strong> <em>220 </em>, 121378. <a href="https://doi.org/10.1016/j.talanta.2020.121378" title="DOI URL">https://doi.org/10.1016/j.talanta.2020.121378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.talanta.2020.121378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.talanta.2020.121378%26sid%3Dliteratum%253Aachs%26jtitle%3DTalanta%26atitle%3DTumor-targetable%252Bmagnetoluminescent%252Bsilica%252Bnanoparticles%252Bfor%252Bbimodal%252Btime-gated%252Bluminescence%25252Fmagnetic%252Bresonance%252Bimaging%252Bof%252Bcancer%252Bcells%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DSong%26aufirst%3DBo%26date%3D2020%26volume%3D220%26spage%3D121378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sascha  G. Keller</span>, <span class="hlFld-ContribAuthor ">Mako  Kamiya</span>, <span class="hlFld-ContribAuthor ">Yasuteru  Urano</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in Small Spirocyclic, Xanthene-Based Fluorescent Probes. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5964. <a href="https://doi.org/10.3390/molecules25245964" title="DOI URL">https://doi.org/10.3390/molecules25245964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245964%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BProgress%252Bin%252BSmall%252BSpirocyclic%25252C%252BXanthene-Based%252BFluorescent%252BProbes%26aulast%3DG.%2BKeller%26aufirst%3DSascha%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Hosein  AyoubiâJoshaghani</span>, <span class="hlFld-ContribAuthor ">Khaled  Seidi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Azizi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Jaymand</span>, <span class="hlFld-ContribAuthor ">Tahereh  Javaheri</span>, <span class="hlFld-ContribAuthor ">Rana  JahanbanâEsfahlan</span>, <span class="hlFld-ContribAuthor ">Michael R.  Hamblin</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Applications of Advanced Nano/Hydrogels in Biomedicine: Static, Dynamic, MultiâStage, and Bioinspired. </span><span class="cited-content_cbyCitation_journal-name">Advanced Functional Materials</span><span> <strong>2020,</strong> <em>30 </em>
                                    (45)
                                     , 2004098. <a href="https://doi.org/10.1002/adfm.202004098" title="DOI URL">https://doi.org/10.1002/adfm.202004098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adfm.202004098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadfm.202004098%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Functional%2520Materials%26atitle%3DPotential%252BApplications%252Bof%252BAdvanced%252BNano%25252FHydrogels%252Bin%252BBiomedicine%25253A%252BStatic%25252C%252BDynamic%25252C%252BMulti%2525E2%252580%252590Stage%25252C%252Band%252BBioinspired%26aulast%3DAyoubi%25E2%2580%2590Joshaghani%26aufirst%3DMohammad%2BHosein%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D45%26spage%3D2004098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Jiang</span>, <span class="hlFld-ContribAuthor ">Cuihong  Wang</span>, <span class="hlFld-ContribAuthor ">Meiling  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuening  Fei</span>, <span class="hlFld-ContribAuthor ">Yingchun  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Type and size effect of functional groups on the novel antifolate target recognition folate receptors Î± and Î²: Docking, molecular dynamics and MM/PBSA study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>100 </em>, 107663. <a href="https://doi.org/10.1016/j.jmgm.2020.107663" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107663%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DType%252Band%252Bsize%252Beffect%252Bof%252Bfunctional%252Bgroups%252Bon%252Bthe%252Bnovel%252Bantifolate%252Btarget%252Brecognition%252Bfolate%252Breceptors%252B%2525CE%2525B1%252Band%252B%2525CE%2525B2%25253A%252BDocking%25252C%252Bmolecular%252Bdynamics%252Band%252BMM%25252FPBSA%252Bstudy%26aulast%3DJiang%26aufirst%3DYue%26date%3D2020%26volume%3D100%26spage%3D107663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esra Maltas  Cagil</span>. </span><span class="cited-content_cbyCitation_article-title">Production and characterization of a new pH-responsive shellac system for controlled drug release. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1217 </em>, 128382. <a href="https://doi.org/10.1016/j.molstruc.2020.128382" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128382%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DProduction%252Band%252Bcharacterization%252Bof%252Ba%252Bnew%252BpH-responsive%252Bshellac%252Bsystem%252Bfor%252Bcontrolled%252Bdrug%252Brelease%26aulast%3DCagil%26aufirst%3DEsra%2BMaltas%26date%3D2020%26volume%3D1217%26spage%3D128382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert  Gandioso</span>, <span class="hlFld-ContribAuthor ">Anna  Rovira</span>, <span class="hlFld-ContribAuthor ">Huayun  Shi</span>, <span class="hlFld-ContribAuthor ">Peter J.  Sadler</span>, <span class="hlFld-ContribAuthor ">Vicente  MarchÃ¡n</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected photoactivation pathways in a folate-receptor-targeted
              trans
              -diazido Pt(
              iv
              ) anticancer pro-drug. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (34)
                                     , 11828-11834. <a href="https://doi.org/10.1039/D0DT02577A" title="DOI URL">https://doi.org/10.1039/D0DT02577A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT02577A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT02577A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DUnexpected%252Bphotoactivation%252Bpathways%252Bin%252Ba%252Bfolate-receptor-targeted%252Btrans%252B-diazido%252BPt%252528%252Biv%252B%252529%252Banticancer%252Bpro-drug%26aulast%3DGandioso%26aufirst%3DAlbert%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D34%26spage%3D11828%26epage%3D11834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sneha  Mahalunkar</span>, <span class="hlFld-ContribAuthor ">Gopal C.  Kundu</span>, <span class="hlFld-ContribAuthor ">Suresh W.  Gosavi</span>. </span><span class="cited-content_cbyCitation_article-title">Folated curcumin-gold nanoformulations: A nanotherapeutic strategy for breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Vacuum Science & Technology B</span><span> <strong>2020,</strong> <em>38 </em>
                                    (5)
                                     , 050802. <a href="https://doi.org/10.1116/6.0000148" title="DOI URL">https://doi.org/10.1116/6.0000148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1116/6.0000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1116%2F6.0000148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Vacuum%2520Science%2520%2526%2520Technology%2520B%26atitle%3DFolated%252Bcurcumin-gold%252Bnanoformulations%25253A%252BA%252Bnanotherapeutic%252Bstrategy%252Bfor%252Bbreast%252Bcancer%252Btherapy%26aulast%3DMahalunkar%26aufirst%3DSneha%26date%3D2020%26volume%3D38%26issue%3D5%26spage%3D050802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingqiang  Hao</span>, <span class="hlFld-ContribAuthor ">Beibei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Zhao</span>, <span class="hlFld-ContribAuthor ">Nana  Zhao</span>, <span class="hlFld-ContribAuthor ">Fu-Jian  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Organic/inorganic nanocomposites for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Materials Chemistry Frontiers</span><span> <strong>2020,</strong> <em>4 </em>
                                    (9)
                                     , 2571-2609. <a href="https://doi.org/10.1039/D0QM00323A" title="DOI URL">https://doi.org/10.1039/D0QM00323A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QM00323A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QM00323A%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Chemistry%2520Frontiers%26atitle%3DOrganic%25252Finorganic%252Bnanocomposites%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DHao%26aufirst%3DMingqiang%26date%3D2020%26date%3D2020%26volume%3D4%26issue%3D9%26spage%3D2571%26epage%3D2609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archu  Singh</span>, <span class="hlFld-ContribAuthor ">Sadat  Shafi</span>, <span class="hlFld-ContribAuthor ">Tanya  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Abul Kalam  Najmi</span>, <span class="hlFld-ContribAuthor ">Kanchan  Kohli</span>, <span class="hlFld-ContribAuthor ">Faheem Hyder  Pottoo</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (20)
                                     , 1839-1854. <a href="https://doi.org/10.2174/1568026620666200624161801" title="DOI URL">https://doi.org/10.2174/1568026620666200624161801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200624161801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200624161801%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252BNanotherapeutic%252BStrategies%252Bas%252Ban%252BImpending%252BApproach%252Bto%252BLiver%252BCancer%252BTreatment%26aulast%3DSingh%26aufirst%3DArchu%26date%3D2020%26volume%3D20%26issue%3D20%26spage%3D1839%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuechen  Qian</span>, <span class="hlFld-ContribAuthor ">Yinjie  Wang</span>, <span class="hlFld-ContribAuthor ">Youfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Ling  Ma</span>, <span class="hlFld-ContribAuthor ">Nianyu  Xue</span>, <span class="hlFld-ContribAuthor ">Zhenqi  Jiang</span>, <span class="hlFld-ContribAuthor ">Yi  Cao</span>, <span class="hlFld-ContribAuthor ">Ozioma Udochukwu  Akakuru</span>, <span class="hlFld-ContribAuthor ">Juan  Li</span>, <span class="hlFld-ContribAuthor ">Shengmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Aiguo  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Active targeting nano-scale bubbles enhanced ultrasound cavitation chemotherapy in Y
              1
              receptor-overexpressed breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2020,</strong> <em>8 </em>
                                    (31)
                                     , 6837-6844. <a href="https://doi.org/10.1039/D0TB00556H" title="DOI URL">https://doi.org/10.1039/D0TB00556H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0TB00556H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0TB00556H%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DActive%252Btargeting%252Bnano-scale%252Bbubbles%252Benhanced%252Bultrasound%252Bcavitation%252Bchemotherapy%252Bin%252BY%252B1%252Breceptor-overexpressed%252Bbreast%252Bcancer%26aulast%3DQian%26aufirst%3DXuechen%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D31%26spage%3D6837%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuldeep Kumar  Bansal</span>, <span class="hlFld-ContribAuthor ">Ezgi  Ãzliseli</span>, <span class="hlFld-ContribAuthor ">Gaurav Kumar  Saraogi</span>, <span class="hlFld-ContribAuthor ">Jessica M.  Rosenholm</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Intracellular Delivery Potential of Novel Sustainable Poly(Î´-decalactone)-Based Micelles. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 726. <a href="https://doi.org/10.3390/pharmaceutics12080726" title="DOI URL">https://doi.org/10.3390/pharmaceutics12080726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics12080726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics12080726%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DAssessment%252Bof%252BIntracellular%252BDelivery%252BPotential%252Bof%252BNovel%252BSustainable%252BPoly%252528%2525CE%2525B4-decalactone%252529-Based%252BMicelles%26aulast%3DBansal%26aufirst%3DKuldeep%2BKumar%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junpeng  Qi</span>, <span class="hlFld-ContribAuthor ">Kohei  Tsuji</span>, <span class="hlFld-ContribAuthor ">David  Hymel</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael  Hudecek</span>, <span class="hlFld-ContribAuthor ">Christoph  Rader</span>, <span class="hlFld-ContribAuthor ">Haiyong  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Chemically Programmable and Switchable CARâT Therapy. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (29)
                                     , 12276-12283. <a href="https://doi.org/10.1002/ange.202005432" title="DOI URL">https://doi.org/10.1002/ange.202005432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202005432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202005432%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DChemically%252BProgrammable%252Band%252BSwitchable%252BCAR%2525E2%252580%252590T%252BTherapy%26aulast%3DQi%26aufirst%3DJunpeng%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D29%26spage%3D12276%26epage%3D12283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junpeng  Qi</span>, <span class="hlFld-ContribAuthor ">Kohei  Tsuji</span>, <span class="hlFld-ContribAuthor ">David  Hymel</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael  Hudecek</span>, <span class="hlFld-ContribAuthor ">Christoph  Rader</span>, <span class="hlFld-ContribAuthor ">Haiyong  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Chemically Programmable and Switchable CARâT Therapy. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (29)
                                     , 12178-12185. <a href="https://doi.org/10.1002/anie.202005432" title="DOI URL">https://doi.org/10.1002/anie.202005432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202005432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202005432%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DChemically%252BProgrammable%252Band%252BSwitchable%252BCAR%2525E2%252580%252590T%252BTherapy%26aulast%3DQi%26aufirst%3DJunpeng%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D29%26spage%3D12178%26epage%3D12185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huaihong  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhou</span>, <span class="hlFld-ContribAuthor ">Qing  Yu</span>, <span class="hlFld-ContribAuthor ">Zhenqing  Yang</span>, <span class="hlFld-ContribAuthor ">Yu  Sun</span>, <span class="hlFld-ContribAuthor ">Zhaosheng  Cai</span>, <span class="hlFld-ContribAuthor ">Hui  Cang</span>. </span><span class="cited-content_cbyCitation_article-title">pH-Sensitive betulinic acid polymer prodrug nanoparticles for efficient and targeted cancer cells treatment. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Polymeric Materials and Polymeric Biomaterials</span><span> <strong>2020,</strong> <em>69 </em>
                                    (10)
                                     , 659-668. <a href="https://doi.org/10.1080/00914037.2019.1596916" title="DOI URL">https://doi.org/10.1080/00914037.2019.1596916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00914037.2019.1596916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00914037.2019.1596916%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Polymeric%2520Materials%2520and%2520Polymeric%2520Biomaterials%26atitle%3DpH-Sensitive%252Bbetulinic%252Bacid%252Bpolymer%252Bprodrug%252Bnanoparticles%252Bfor%252Befficient%252Band%252Btargeted%252Bcancer%252Bcells%252Btreatment%26aulast%3DZhang%26aufirst%3DHuaihong%26date%3D2020%26date%3D2019%26volume%3D69%26issue%3D10%26spage%3D659%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian Z.  Bentz</span>, <span class="hlFld-ContribAuthor ">Sakkarapalayam M.  Mahalingam</span>, <span class="hlFld-ContribAuthor ">Daniel  Ysselstein</span>, <span class="hlFld-ContribAuthor ">Paola C.  Montenegro Larrea</span>, <span class="hlFld-ContribAuthor ">Jason R.  Cannon</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Rochet</span>, <span class="hlFld-ContribAuthor ">Philip S.  Low</span>, <span class="hlFld-ContribAuthor ">Kevin  Webb</span>. </span><span class="cited-content_cbyCitation_article-title">Localization of Fluorescent Targets in Deep Tissue With Expanded Beam Illumination for Studies of Cancer and the Brain. </span><span class="cited-content_cbyCitation_journal-name">IEEE Transactions on Medical Imaging</span><span> <strong>2020,</strong> <em>39 </em>
                                    (7)
                                     , 2472-2481. <a href="https://doi.org/10.1109/TMI.2020.2972200" title="DOI URL">https://doi.org/10.1109/TMI.2020.2972200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1109/TMI.2020.2972200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1109%2FTMI.2020.2972200%26sid%3Dliteratum%253Aachs%26jtitle%3DIEEE%2520Transactions%2520on%2520Medical%2520Imaging%26atitle%3DLocalization%252Bof%252BFluorescent%252BTargets%252Bin%252BDeep%252BTissue%252BWith%252BExpanded%252BBeam%252BIllumination%252Bfor%252BStudies%252Bof%252BCancer%252Band%252Bthe%252BBrain%26aulast%3DBentz%26aufirst%3DBrian%2BZ.%26date%3D2020%26volume%3D39%26issue%3D7%26spage%3D2472%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fumiko  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Hidehisa  Kawashima</span>, <span class="hlFld-ContribAuthor ">Taiki  Morita</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (7)
                                     , 1615. <a href="https://doi.org/10.3390/cells9071615" title="DOI URL">https://doi.org/10.3390/cells9071615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9071615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9071615%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DWater-Soluble%252Bcloso-Docecaborate-Containing%252BPteroyl%252BDerivatives%252BTargeting%252BFolate%252BReceptor-Positive%252BTumors%252Bfor%252BBoron%252BNeutron%252BCapture%252BTherapy%26aulast%3DNakagawa%26aufirst%3DFumiko%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D7%26spage%3D1615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lalit K.  Golani</span>, <span class="hlFld-ContribAuthor ">Farhana  Islam</span>, <span class="hlFld-ContribAuthor ">Carrie  O'Connor</span>, <span class="hlFld-ContribAuthor ">Aamod S.  Dekhne</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Hou</span>, <span class="hlFld-ContribAuthor ">Larry H.  Matherly</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrier. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (12)
                                     , 115544. <a href="https://doi.org/10.1016/j.bmc.2020.115544" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115544%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bas%252Btumor-targeting%252Bagents%252Bwith%252Bselectivity%252Bfor%252Btumor%252Buptake%252Bby%252Bhigh%252Baffinity%252Bfolate%252Breceptors%252Bover%252Bthe%252Breduced%252Bfolate%252Bcarrier%26aulast%3DGolani%26aufirst%3DLalit%2BK.%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm100509v&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm100509v%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=331&amp;pagesCount=4&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="âtrueâ" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Comparison of [<sup>111</sup>In]DTPAâfolate uptake in a patient with stage III ovarian cancer (left) and a healthy volunteer (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. FR-mediated endocytosis of folateâdrug conjugates. Exogenously added folateâdrug conjugates bind specifically to FR with high affinity. The plasma membrane invaginates around the FR/folate conjugate complex to form an endosome. As the lumen of the maturing endosome acidifies, the receptor changes conformation and releases the conjugate, and the disulfide bond between folate and its drug cargo is reduced to release the parent drug cargo. Because the pH of FR-containing endosomes is only mildly acidic, acid-labile linkers do not release the attached drug as efficiently (see discussion in <a class="ref internalNav" href="#sec2_2" aria-label="section 2.2">section 2.2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. The folateâFRET reporter changes fluorescence from red to green upon disulfide reduction. In the nonreduced folateâFRET reporter (upper), excitation of BODIPY (488 nm) leads to rhodamine (red, 595 nm) emission due to FRET from BODIPY to rhodamine. Upon disulfide reduction (lower), rhodamine is released from the folateâBODIPY backbone, leading to loss of FRET signal and concurrent recovery of BODIPY (green, 520 nm) fluorescence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of endosomal compartment pH values encountered by monovalent and multivalent folate conjugates following their uptake by folate receptor-mediated endocytosis. Multivalent conjugates (left) bind simultaneously to multiple FR and traffic to acidic lysosomes following endocytosis.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In contrast, monovalent conjugates traffic to a mildly acidic recycling center where disulfide-linked drugs are rapidly released by disulfide reduction.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of two folateâdesacetylvinblastine monohydrazide conjugates.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structures of folateâÎ³-carboxyl derivatized disulfide-linked cytotoxic drugs.<a onclick="showRef(event, 'ref40 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref40 ref55 ref56 ref57">(40, 55-57)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Illustration of folateâhapten mediated immunotherapy. Mice previously immunized against a hapten (e.g., fluorescein) are treated with a folateâhapten conjugate (such as folateâfluorescein) that can bind to cell surface FR. After binding of antifluorescein antibodies induced during the immunization, the cancer cell is recognized by Fc receptor-expressing immune cells, leading to cancer cell destruction by antibody-dependent cell cytotoxicity (ADCC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Folate-mediated targeting of fluorescent oligonucleotides to solid tumors in vivo, as visualized using a Kodak imaging station.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The mouse on the left was injected with nontargeted Dylight 647-labeled siRNA, while the mouse on the right was injected with a folate-targeted version of the same siRNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/medium/jm-2010-00509v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structure of diplasmenylcholine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100509v/production/images/large/jm-2010-00509v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100509v&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 150 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Pytel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwinski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poplawski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferriola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majsterek, I.</span><span> </span><span class="NLM_article-title">Tyrosine kinase blockers: new hope for successful cancer therapy</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">â</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=66-76&author=D.+Pytelauthor=T.+Sliwinskiauthor=T.+Poplawskiauthor=D.+Ferriolaauthor=I.+Majsterek&title=Tyrosine+kinase+blockers%3A+new+hope+for+successful+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPytel%26aufirst%3DD.%26aulast%3DSliwinski%26aufirst%3DT.%26aulast%3DPoplawski%26aufirst%3DT.%26aulast%3DFerriola%26aufirst%3DD.%26aulast%3DMajsterek%26aufirst%3DI.%26atitle%3DTyrosine%2520kinase%2520blockers%253A%2520new%2520hope%2520for%2520successful%2520cancer%2520therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D66%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span> </span><span class="NLM_article-title">Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">â</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fnm0596-561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=8616716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=561-566&author=B.+J.+Drukerauthor=S.+Tamuraauthor=E.+Buchdungerauthor=S.+Ohnoauthor=G.+M.+Segalauthor=S.+Fanningauthor=J.+Zimmermannauthor=N.+B.+Lydon&title=Effects+of+a+selective+inhibitor+of+the+Abl+tyrosine+kinase+on+the+growth+of+Bcr-Abl+positive+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells</span></div><div class="casAuthors">Druker, Brian J.; Tamura, Shu; Buchdunger, Elisabeth; Ohno, Sayuri; Segal, Gerald M.; Fanning, Shane; Zimmermann, Jurg; Lydon, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">The Bcr-Abl oncogene, present in 95% of patients with chronic myelogenous leukemia (CML), has been implicated as the cause of this disease.  A compd., designed to inhibit the Abl protein tyrosine kinase (CGP 57148), was evaluated for its effects on cells contg. the Bcr-Abl fusion protein.  Cellular proliferation and tumor formation by Bcr-Abl-expressing cells were specifically inhibited by this compd.  In colony-forming assays of peripheral blood or bone marrow from patients with CML, there was a 92-98% decrease in the no. of Bcr-Abl colonies formed but no inhibition of normal colony formation.  This compd. may be useful in the treatment of Bcr-Abl-pos. leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjzXj-25AHOrVg90H21EOLACvtfcHk0lhdpNzuhIi6Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xislyhs70%253D&md5=1dc111cc883a1ed29964ae2c88c88cb9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnm0596-561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0596-561%26sid%3Dliteratum%253Aachs%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DSegal%26aufirst%3DG.%2BM.%26aulast%3DFanning%26aufirst%3DS.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26atitle%3DEffects%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Abl%2520tyrosine%2520kinase%2520on%2520the%2520growth%2520of%2520Bcr-Abl%2520positive%2520cells%26jtitle%3DNat.%2520Med.%26date%3D1996%26volume%3D2%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Heath, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicknell, R.</span><span> </span><span class="NLM_article-title">Anticancer strategies involving the vasculature</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">â</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fnrclinonc.2009.52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19424102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslKks78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=395-404&author=V.+L.+Heathauthor=R.+Bicknell&title=Anticancer+strategies+involving+the+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer strategies involving the vasculature</span></div><div class="casAuthors">Heath, Victoria L.; Bicknell, Roy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">395-404</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Understanding the process of tumor angiogenesis and ways to modify this is a key point in the fight against cancer.  This Review explores the current status of vascular-disrupting strategies, discusses how anti-VEGF-based anti-angiogenic therapies can be combined with conventional chemotherapy and radiotherapy, and highlights potential future targets for therapeutic intervention.  The growth and metastasis of solid tumors critically depends on their ability to develop their own blood supply, a process known as tumor angiogenesis.  Over the past decade much work has been performed to understand this process, and modifying this process provides a key point of therapeutic intervention in the fight against cancer.  This Review explores the development of anti-VEGF-based antiangiogenic therapies, of which there are currently three licensed for clin. use worldwide.  Although originally anticipated to inhibit the growth of tumor vessels, the induction of vascular normalization caused by these approved agents has provided a novel means of effective delivery of known chemotherapeutic agents.  The development of small mols. that target VEGF receptors has resulted in the generation of inhibitors with not only vascular activity but antitumor activity in certain cancers.  This Review will address the current status of vascular-disrupting strategies, such as therapies designed to induce tumor collapse by selectively destroying existing tumor vessels.  These therapies can be broadly divided into small-mol.-wt. vascular-disrupting agents and ligand-directed approaches.  We discuss the current status of development, drug mechanisms of actions, combination with conventional chemotherapy and radiotherapy, and potential future targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplD5MIHIdPorVg90H21EOLACvtfcHk0lj9d91gZ_aTBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslKks78%253D&md5=6fb8683aa2e4261029e30f79a854e063</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2009.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2009.52%26sid%3Dliteratum%253Aachs%26aulast%3DHeath%26aufirst%3DV.%2BL.%26aulast%3DBicknell%26aufirst%3DR.%26atitle%3DAnticancer%2520strategies%2520involving%2520the%2520vasculature%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2009%26volume%3D6%26spage%3D395%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Finn, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A. X.</span><span> </span><span class="NLM_article-title">Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">â</span> <span class="NLM_lpage">509</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1586%2Fera.09.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19374603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKlsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=503-509&author=R.+S.+Finnauthor=A.+X.+Zhu&title=Targeting+angiogenesis+in+hepatocellular+carcinoma%3A+focus+on+VEGF+and+bevacizumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab</span></div><div class="casAuthors">Finn, Richard S.; Zhu, Andrew X.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">503-509</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and one of the few malignancies with an increasing incidence in the USA.  While the relationship between HCC and its inciting risk factors (e.g., hepatitis B, hepatitis C and alc. liver disease) is well defined, driving genetic alterations are still yet to be identified.  Clin., HCC tends to be hypervascular and, for that reason, transarterial chemoembolization has proven to be effective in managing many patients with localized disease.  More recently, angiogenesis has been targeted effectively with pharmacol. strategies, including monoclonal antibodies against VEGF and the VEGF receptor, as well as small-mol. kinase inhibitors of the VEGF receptor.  Targeting angiogenesis with these approaches has been validated in several different solid tumors since the initial approval of bevacizumab for advanced colon cancer in 2004.  In HCC, only sorafenib has been shown to extend survival in patients with advanced HCC and has opened the door for other anti-angiogenic strategies.  Here, we will review the data supporting the targeting of the VEGF axis in HCC and the preclin. and early clin. development of bevacizumab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI-lj8p3lprbVg90H21EOLACvtfcHk0lj9d91gZ_aTBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKlsbc%253D&md5=e3fda6ba36821afd5104a1af84e8c051</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1586%2Fera.09.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.09.6%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DR.%2BS.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26atitle%3DTargeting%2520angiogenesis%2520in%2520hepatocellular%2520carcinoma%253A%2520focus%2520on%2520VEGF%2520and%2520bevacizumab%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D503%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lambert, J. M.</span><span> </span><span class="NLM_article-title">Drug-conjugated monoclonal antibodies for the treatment of cancer</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">â</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.coph.2005.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16087399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvV2ltLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=543-549&author=J.+M.+Lambert&title=Drug-conjugated+monoclonal+antibodies+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-conjugated monoclonal antibodies for the treatment of cancer</span></div><div class="casAuthors">Lambert, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">543-549</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Early clin. development in the field of targeted delivery of cytotoxic drugs to tumors was not successful because the limitations imposed by the pharmacokinetic and pharmacodynamic properties of monoclonal antibodies were not fully appreciated.  Recently, development of this concept has been reinvigorated by the approval of gemtuzumab ozogamicin for treatment of acute myeloid leukemia.  Other conjugates of calicheamicin and conjugates of potent tubulin poisons (maytansinoids, auristatins, and taxoids) are undergoing clin. evaluation or are in preclin. development.  What all of these drugs have in common is that their cytotoxic potencies are in the picomolar range.  Thirty years after the discovery of monoclonal antibodies, this new generation of highly potent compds. could yield targeted cytotoxic agents that are effective treatments for many cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqeCYpT56HHrVg90H21EOLACvtfcHk0liZWbkiNY0R6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvV2ltLg%253D&md5=8e6b043acd6934ef5804f69e112d0277</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26atitle%3DDrug-conjugated%2520monoclonal%2520antibodies%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D543%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rao, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmader, K.</span><span> </span><span class="NLM_article-title">Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults</span> <span class="citation_source-journal">Am. J. Geriatr. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.amjopharm.2007.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17996665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=247-262&author=A.+V.+Raoauthor=K.+Schmader&title=Monoclonal+antibodies+as+targeted+therapy+in+hematologic+malignancies+in+older+adults"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults</span></div><div class="casAuthors">Rao, Arati V.; Schmader, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-262</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1543-5946</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Biol. agents are proving to be increasingly useful and exciting addns. to the antineoplastic armamentarium, but many clinicians are unfamiliar with the properties of these types of agents.  Objectives: This review focuses on monoclonal antibodies (MAbs) that are used in the treatment of hematol. malignancies.  Our goal was to provide the reader with information on trials that led to US Food and Drug Administration (FDA) approval of commonly used MAbs in hematol. malignancies, including their mechanisms of action and pharmacokinetics, with specific emphasis on use in elderly patients; we also present data on toxicities and precautions to be aware of when administering these drugs.  Methods: Materials for this review were gathered based on a computerized literature search (English-language articles only) using the PubMed database covering the period Jan. 1998 to Dec. 2005.  Search terms used included the following: elderly, monoclonal antibodies, and neoplasms.  Results: Alemtuzumab is a recombinant DNA-derived, humanized MAb directed against the CD52 B-cell antigen.  It is indicated for the treatment of B-cell chronic lymphocytic leukemia (CLL) in patients who have been treated with alkylating agents and who have failed to respond to fludarabine therapy.  Gemtuzumab ozogamicin is an MAb conjugated with a cytotoxic antitumor antibiotic, calicheamicin.  It has been approved for use in patients with CD33-pos. acute myeloid leukemia (AML) in first relapse who are aged â¥60 years and who are not considered candidates for other cytotoxic chemotherapy.  Rituximab, one of the first MAbs approved by the FDA for use in human cancers, is an antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes.  It is extensively used in the treatment of B-cell malignancies, such as CLL, and non-Hodgkin's lymphomas (NHLs), such as follicular lymphoma and diffuse large B-cell lymphoma.  Conclusions: It is noteworthy that while there have been a no. of studies using these agents in the younger population, there continues to be a paucity of clin. trials targeting the elderly patient in particular; this continues to be an area of research interest.  More clin. studies of these agents-conducted specifically in elderly patients with CLL, NHL, AML, and other hematol. malignancies-are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_uDpFrh2o0rVg90H21EOLACvtfcHk0liZWbkiNY0R6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtr7J&md5=9673e5a985f0b89458488cdf612e3a5e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2007.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2007.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DA.%2BV.%26aulast%3DSchmader%26aufirst%3DK.%26atitle%3DMonoclonal%2520antibodies%2520as%2520targeted%2520therapy%2520in%2520hematologic%2520malignancies%2520in%2520older%2520adults%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Pharmacother.%26date%3D2007%26volume%3D5%26spage%3D247%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Modjtahedi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essapen, S.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">â</span> <span class="NLM_lpage">855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=851-855&author=H.+Modjtahediauthor=S.+Essapen&title=Epidermal+growth+factor+receptor+inhibitors+in+cancer+treatment%3A+advances%2C+challenges+and+opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DModjtahedi%26aufirst%3DH.%26aulast%3DEssapen%26aufirst%3DS.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%2520in%2520cancer%2520treatment%253A%2520advances%252C%2520challenges%2520and%2520opportunities%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2009%26volume%3D20%26spage%3D851%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Garanger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boturyn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumy, P.</span><span> </span><span class="NLM_article-title">Tumor targeting with RGD peptide ligandsâdesign of new molecular conjugates for imaging and therapy of cancers</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">â</span> <span class="NLM_lpage">558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=552-558&author=E.+Garangerauthor=D.+Boturynauthor=P.+Dumy&title=Tumor+targeting+with+RGD+peptide+ligands%E2%80%94design+of+new+molecular+conjugates+for+imaging+and+therapy+of+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaranger%26aufirst%3DE.%26aulast%3DBoturyn%26aufirst%3DD.%26aulast%3DDumy%26aufirst%3DP.%26atitle%3DTumor%2520targeting%2520with%2520RGD%2520peptide%2520ligands%25E2%2580%2594design%2520of%2520new%2520molecular%2520conjugates%2520for%2520imaging%2520and%2520therapy%2520of%2520cancers%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Irache, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamazo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espuelas, S.</span><span> </span><span class="NLM_article-title">Mannose-targeted systems for the delivery of therapeutics</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">â</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1517%2F17425247.5.6.703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18532925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslOrtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=703-724&author=J.+M.+Iracheauthor=H.+H.+Salmanauthor=C.+Gamazoauthor=S.+Espuelas&title=Mannose-targeted+systems+for+the+delivery+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mannose-targeted systems for the delivery of therapeutics</span></div><div class="casAuthors">Irache, Juan M.; Salman, Hesham H.; Gamazo, Carlos; Espuelas, Socorro</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">703-724</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The specific targeting of nanomedicines to mannose receptors, highly expressed in cells of the immune system, performs a useful strategy for improving the efficacy of vaccines and chemotherapy.  This review discusses the potential of mannose-targeted drug/antigen delivery systems for vaccination and treatment of diseases localized in macrophages and other antigen-presenting cells.  The first part of the review describes the characteristics, localization and functions of mannose receptors.  The following sections are devoted to the description of different methods used to deliver therapeutic agents, including mannose conjugates and mannosylated carriers or particulates (i.e., liposomes, nanoparticles and niosomes).  A general overview of published reports confirms the effectiveness of mannosylation strategies, although the optimization and full exploitation of mannose-targeted drug delivery systems would require a deeper understanding of the structure-activity relationship.  In the near future, these nanomedicines have the potential to treat a no. of diseases (including cancer) and improve the quality of life of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcTssJrIfvdLVg90H21EOLACvtfcHk0ljrLCDKCY1KdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslOrtbs%253D&md5=cca8209381ae3b11d7e5eccb0a2fddc2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1517%2F17425247.5.6.703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.5.6.703%26sid%3Dliteratum%253Aachs%26aulast%3DIrache%26aufirst%3DJ.%2BM.%26aulast%3DSalman%26aufirst%3DH.%2BH.%26aulast%3DGamazo%26aufirst%3DC.%26aulast%3DEspuelas%26aufirst%3DS.%26atitle%3DMannose-targeted%2520systems%2520for%2520the%2520delivery%2520of%2520therapeutics%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2008%26volume%3D5%26spage%3D703%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gupta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S. K.</span><span> </span><span class="NLM_article-title">Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents</span> <span class="citation_source-journal">Crit. Rev. Ther. Drug Carrier Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">â</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1615%2FCritRevTherDrugCarrierSyst.v25.i4.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18540842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFegt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=347-379&author=Y.+Guptaauthor=D.+V.+Kohliauthor=S.+K.+Jain&title=Vitamin+B12-mediated+transport%3A+a+potential+tool+for+tumor+targeting+of+antineoplastic+drugs+and+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents</span></div><div class="casAuthors">Gupta, Yashwant; Kohli, Dharm Veer; Jain, Sanjay K.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Therapeutic Drug Carrier Systems</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-379</span>CODEN:
                <span class="NLM_cas:coden">CRTSEO</span>;
        ISSN:<span class="NLM_cas:issn">0743-4863</span>.
    
            (<span class="NLM_cas:orgname">Begell House, Inc.</span>)
        </div><div class="casAbstract">A review.  The uptake of vitamin B12 (cyanocobalamin, Cbl/VB12) in mammalian cells is mediated by specific, high-affinity receptors for the vitamin B12-binding protein, transcobalamin II, which is expressed on the plasma membrane.  The receptor for vitamin B12 is overexpressed on a no. of human tumors, including cancers of the ovary, kidney, uterus, testis, brain, colon, lung, and myelocytic blood cells.  Furthermore, the affinity of cyanocobalamin conjugates for cell surface transcobalamin II receptors seems to be high enough so that vitamin B12 derivatization with the cytotoxic agent or carriers bearing cytotoxic drugs allows the selective delivery of diagnostic and therapeutic agents to cancer cells.  Thus, conjugates of vitamin B12 enter receptor-expressing cancer cells via receptor-mediated endocytosis, and targeting may be accomplished by multiple mechanisms, depending on the drug-delivery strategy.  This review summarizes the applications of vitamin B12 as a targeting ligand and highlights the various methods being developed for delivery of therapeutic and imaging agents to cancer cells in vitro and in vivo.  This review reflects the potentiality of vitamin B12 for tumor targeting of chemotherapeutic and diagnostic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD608wqR5cVrVg90H21EOLACvtfcHk0ljrLCDKCY1KdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFegt7g%253D&md5=2adb5e01cd3c0004229dd1dbf9bd7a2d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1615%2FCritRevTherDrugCarrierSyst.v25.i4.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevTherDrugCarrierSyst.v25.i4.20%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DY.%26aulast%3DKohli%26aufirst%3DD.%2BV.%26aulast%3DJain%26aufirst%3DS.%2BK.%26atitle%3DVitamin%2520B12-mediated%2520transport%253A%2520a%2520potential%2520tool%2520for%2520tumor%2520targeting%2520of%2520antineoplastic%2520drugs%2520and%2520imaging%2520agents%26jtitle%3DCrit.%2520Rev.%2520Ther.%2520Drug%2520Carrier%2520Syst.%26date%3D2008%26volume%3D25%26spage%3D347%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span> </span><span class="NLM_article-title">Folate-targeted therapeutic and imaging agents for cancer</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">â</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.cbpa.2009.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19419901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVWltbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=256-262&author=P.+S.+Lowauthor=S.+A.+Kularatne&title=Folate-targeted+therapeutic+and+imaging+agents+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted therapeutic and imaging agents for cancer</span></div><div class="casAuthors">Low, Philip Stewart; Kularatne, Sumith Anurasiri</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer therapies that exploit targeting ligands to deliver attached cytotoxic drugs selectively to malignant cells are currently receiving significant attention.  While antibody-targeted drugs have been the first to enter the clinic, recent studies demonstrate that the vitamin folic acid can also be used to deliver attached imaging and therapeutic agents selectively to malignant cells in both animal tumor models and human cancer patients.  Thus, folate conjugates bind to folate receptors that are overexpressed on â¼40% of human cancers and mediate internalization of their attached drugs by receptor-mediated endocytosis.  With the use of proper linkers, folate-targeted drugs can be released inside their target cells where they can perform their desired cytotoxic functions.  Based on this strategy, six folate-targeted drugs are currently in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp_l-sdKEElbVg90H21EOLACvtfcHk0ljrLCDKCY1KdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVWltbY%253D&md5=c6b6b07b0df9d1355e99da7c471a2a4b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2009.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2009.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26atitle%3DFolate-targeted%2520therapeutic%2520and%2520imaging%2520agents%2520for%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D13%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Carpenter, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aina, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightstone, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurth, M. J.</span><span> </span><span class="NLM_article-title">Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">â</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800313f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=14-19&author=R.+D.+Carpenterauthor=M.+Andreiauthor=O.+H.+Ainaauthor=E.+Y.+Lauauthor=F.+C.+Lightstoneauthor=R.+Liuauthor=K.+S.+Lamauthor=M.+J.+Kurth&title=Selectively+targeting+T-+and+B-cell+lymphomas%3A+a+benzothiazole+antagonist+of+alpha4beta1+integrin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800313f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800313f%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DR.%2BD.%26aulast%3DAndrei%26aufirst%3DM.%26aulast%3DAina%26aufirst%3DO.%2BH.%26aulast%3DLau%26aufirst%3DE.%2BY.%26aulast%3DLightstone%26aufirst%3DF.%2BC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DKurth%26aufirst%3DM.%2BJ.%26atitle%3DSelectively%2520targeting%2520T-%2520and%2520B-cell%2520lymphomas%253A%2520a%2520benzothiazole%2520antagonist%2520of%2520alpha4beta1%2520integrin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D14%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhapuram, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">â</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp900069d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsF2hsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=780-789&author=S.+A.+Kularatneauthor=K.+Wangauthor=H.+K.+Santhapuramauthor=P.+S.+Low&title=Prostate-specific+membrane+antigen+targeted+imaging+and+therapy+of+prostate+cancer+using+a+PSMA+inhibitor+as+a+homing+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand</span></div><div class="casAuthors">Kularatne, Sumith A.; Wang, Kevin; Santhapuram, Hari-Krishna R.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate cancer (PCa) is a major cause of mortality and morbidity in Western society today.  Current methods for detecting PCa are limited, leaving most early malignancies undiagnosed and sites of metastasis in advanced disease undetected.  Major deficiencies also exist in the treatment of PCa, esp. metastatic disease.  In an effort to improve both detection and therapy of PCa, we have developed a PSMA-targeted ligand that delivers attached imaging and therapeutic agents selectively to PCa cells without targeting normal cells.  The PSMA-targeted radioimaging agent (DUPA-99mTc) was found to bind PSMA-pos. human PCa cells (LNCaP cell line) with nanomolar affinity (KD = 14 nM).  Imaging and biodistribution studies revealed that DUPA-99mTc localizes primarily to LNCaP cell tumor xenografts in nu/nu mice (% injected dose/g = 11.3 at 4 h postinjection; tumor-to-muscle ratio = 75:1).  Two PSMA-targeted optical imaging agents (DUPA-FITC and DUPA-rhodamine B) were also shown to efficiently label PCa cells and to internalize and traffic to intracellular endosomes.  A PSMA-targeted chemotherapeutic agent (DUPA-TubH) was demonstrated to kill PSMA-pos. LNCaP cells in culture (IC50 = 3 nM) and to eliminate established tumor xenografts in nu/nu mice with no detectable wt. loss.  Blockade of tumor targeting upon administration of excess PSMA inhibitor (PMPA) and the absence of targeting to PSMA-neg. tumors confirmed the specificity of each of the above targeted reagents for PSMA.  Tandem use of the imaging and therapeutic agents targeted to the same receptor could allow detection, staging, monitoring, and treatment of PCa with improved accuracy and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF7vaoehkEsrVg90H21EOLACvtfcHk0lhIT6vGHFHXfg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsF2hsrw%253D&md5=2fba93274e7f4c4ff0910e2edef9e189</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fmp900069d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp900069d%26sid%3Dliteratum%253Aachs%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DSanthapuram%26aufirst%3DH.%2BK.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520targeted%2520imaging%2520and%2520therapy%2520of%2520prostate%2520cancer%2520using%2520a%2520PSMA%2520inhibitor%2520as%2520a%2520homing%2520ligand%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D780%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sega, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Tumor detection using folate receptor-targeted imaging agents</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs10555-008-9155-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18523731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCis7zF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=655-664&author=E.+I.+Segaauthor=P.+S.+Low&title=Tumor+detection+using+folate+receptor-targeted+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor detection using folate receptor-targeted imaging agents</span></div><div class="casAuthors">Sega, Emanuela I.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-664</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Folate receptors are up-regulated on a variety of human cancers, including cancers of the breast, ovaries, endometrium, lungs, kidneys, colon, brain, and myeloid cells of hematopoietic origin.  This over-expression of folate receptors (FR) on cancer tissues can be exploited to target folate-linked imaging and therapeutic agents specifically to FR-expressing tumors, thereby avoiding uptake by most healthy tissues that express few if any FR.  Four folate-targeted therapeutic drugs are currently undergoing clin. trials, and several folate-linked chemotherapeutic agents are in late stage preclin. development.  However, because not all cancers express FR, and because only FR-expressing cancers respond to FR-targeted therapies, FR-targeted imaging agents have been required to select patients with FR-expressing tumors likely to respond to folate-targeted therapies.  This review focuses on recent advances in the use of the vitamin folic acid to target PET agents, Î³-emitters, MRI contrast agents and fluorescent dyes to FR+ cancers for the purpose of diagnosing and imaging malignant masses with improved specificity and sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEDWzmWjsEhLVg90H21EOLACvtfcHk0lhIT6vGHFHXfg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCis7zF&md5=d02bc9ceff50817dd01f51fbe66c1c9b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9155-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9155-6%26sid%3Dliteratum%253Aachs%26aulast%3DSega%26aufirst%3DE.%2BI.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DTumor%2520detection%2520using%2520folate%2520receptor-targeted%2520imaging%2520agents%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D655%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, N.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">â</span> <span class="NLM_lpage">1210</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0200430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlSms74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=1200-1210&author=C.+P.+Leamonauthor=M.+A.+Parkerauthor=I.+R.+Vlahovauthor=L.+C.+Xuauthor=J.+A.+Reddyauthor=M.+Vetzelauthor=N.+Douglas&title=Synthesis+and+biological+evaluation+of+EC20%3A+a+new+folate-derived%2C+%2899m%29Tc-based+radiopharmaceutical"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical</span></div><div class="casAuthors">Leamon, Christopher P.; Parker, Matthew A.; Vlahov, Iontcho R.; Xu, Le-Cun; Reddy, Joseph A.; Vetzel, Marilynn; Douglas, Nikki</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1200-1210</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new peptide deriv. of folic acid was designed to efficiently coordinate 99mTc.  This new chelate, referred to as EC20, was found to bind cultured folate receptor (FR)-pos. tumor cells in both time- and concn.-dependent manner with very high affinity (KD â¼ 3 nM).  Using an in vitro relative affinity assay, EC20 was also found to effectively compete with 3H-folic acid for cell binding when presented either alone or as a formulated metal chelate.  Following i.v. injection into Balb/c mice, 99mTc-EC20 was rapidly removed from circulation (plasma t1/2 â¼ 4 min) and excreted into the urine in a nonmetabolized form.  Data from Î³ scintigraphic and quant. biodistribution studies performed in M109 tumor-bearing Balb/c mice confirmed that 99mTc-EC20 predominantly accumulates in FR-pos. tumor and kidney tissues.  These results suggest that 99mTc-EC20 may be clin. useful as a noninvasive radiodiagnostic imaging agent for the detection of FR-pos. human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx1u2XPLpJqbVg90H21EOLACvtfcHk0lgiriHuYSsm9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlSms74%253D&md5=9d1913e45db0e5aab3783301976d95fe</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbc0200430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0200430%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DParker%26aufirst%3DM.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DDouglas%26aufirst%3DN.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520EC20%253A%2520a%2520new%2520folate-derived%252C%2520%252899m%2529Tc-based%2520radiopharmaceutical%26jtitle%3DBioconjugate%2520Chem.%26date%3D2002%26volume%3D13%26spage%3D1200%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1175</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1175&publication_year=2009&pages=32-39&author=M.+Thomasauthor=S.+A.+Kularatneauthor=L.+Qiauthor=P.+Kleindlauthor=C.+P.+Leamonauthor=M.+J.+Hansenauthor=P.+S.+Low&title=Ligand-targeted+delivery+of+small+interfering+RNAs+to+malignant+cells+and+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DKleindl%26aufirst%3DP.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DHansen%26aufirst%3DM.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DLigand-targeted%2520delivery%2520of%2520small%2520interfering%2520RNAs%2520to%2520malignant%2520cells%2520and%2520tissues%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2009%26volume%3D1175%26spage%3D32%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doorneweerd, D. D.</span><span> </span><span class="NLM_article-title">Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">â</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar7000815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=120-129&author=P.+S.+Lowauthor=W.+A.+Henneauthor=D.+D.+Doorneweerd&title=Discovery+and+development+of+folic-acid-based+receptor+targeting+for+imaging+and+therapy+of+cancer+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases</span></div><div class="casAuthors">Low, Philip S.; Henne, Walter A.; Doorneweerd, Derek D.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-129</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of folic-acid-targeted drug delivery has grown rapidly over the past decade, with several applications currently in human clin. trials.  Owing to the small size of the vitamin, its high affinity for the folate receptor (Kd = 10-10 M), the limited distribution of its receptor in normal tissues (primarily in kidney proximal tubules), the overexpression of its receptor in pathol. cells (upregulated in cancer cells and activated macrophages/monocytes), and its ease of conjugation to imaging and therapeutic agents, the use of folate as a targeting ligand for selective delivery of attached mols. to tumor tissues and sites of inflammation has attracted considerable interest.  This account reviews the discovery of folic acid as a targeting ligand and its current use in the selective targeting of drugs to malignant masses and sites of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM5t9sRmCOBbVg90H21EOLACvtfcHk0lgiriHuYSsm9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Gltbk%253D&md5=20620eb124d19634b10c27a48ed46849</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Far7000815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far7000815%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHenne%26aufirst%3DW.%2BA.%26aulast%3DDoorneweerd%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520and%2520development%2520of%2520folic-acid-based%2520receptor%2520targeting%2520for%2520imaging%2520and%2520therapy%2520of%2520cancer%2520and%2520inflammatory%2520diseases%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D120%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tranoy-Opalinski, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papot, S.</span><span> </span><span class="NLM_article-title">Design of self-immolative linkers for tumour-activated prodrug therapy</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">â</span> <span class="NLM_lpage">637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=618-637&author=I.+Tranoy-Opalinskiauthor=A.+Fernandesauthor=M.+Thomasauthor=J.+P.+Gessonauthor=S.+Papot&title=Design+of+self-immolative+linkers+for+tumour-activated+prodrug+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTranoy-Opalinski%26aufirst%3DI.%26aulast%3DFernandes%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DPapot%26aufirst%3DS.%26atitle%3DDesign%2520of%2520self-immolative%2520linkers%2520for%2520tumour-activated%2520prodrug%2520therapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D618%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ojima, I.</span><span> </span><span class="NLM_article-title">Guided molecular missiles for tumor-targeting chemotherapyâcase studies using the second-generation taxoids as warheads</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">â</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700093f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=108-119&author=I.+Ojima&title=Guided+molecular+missiles+for+tumor-targeting+chemotherapy%E2%80%94case+studies+using+the+second-generation+taxoids+as+warheads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Far700093f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700093f%26sid%3Dliteratum%253Aachs%26aulast%3DOjima%26aufirst%3DI.%26atitle%3DGuided%2520molecular%2520missiles%2520for%2520tumor-targeting%2520chemotherapy%25E2%2580%2594case%2520studies%2520using%2520the%2520second-generation%2520taxoids%2520as%2520warheads%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D108%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Matherly, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span> </span><span class="NLM_article-title">Human reduced folate carrier: translation of basic biology to cancer etiology and therapy</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">â</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs10555-007-9046-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17334909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=111-128&author=L.+H.+Matherlyauthor=Z.+Houauthor=Y.+Deng&title=Human+reduced+folate+carrier%3A+translation+of+basic+biology+to+cancer+etiology+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human reduced folate carrier: Translation of basic biology to cancer etiology and therapy</span></div><div class="casAuthors">Matherly, Larry H.; Hou, Zhanjun; Deng, Yijun</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-128</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This review attempts to provide a comprehensive overview of the biol. of the physiol. and pharmacol. important transport system termed the "reduced folate carrier" (RFC).  The ubiquitously expressed RFC has unequivocally established itself as the major transport system in mammalian cells and tissues for a group of compds. including folate cofactors and classical antifolate therapeutics.  Loss of RFC expression or function may have potentially profound pathophysiol. consequences including cancer.  For chemotherapeutic antifolates used for cancer such as methotrexate or pemetrexed, synthesis of mutant RFCs or loss of RFC transcripts and proteins results in antifolate resistance due to incomplete inhibition of cellular enzyme targets and insufficient substrate for polyglutamate synthesis.  Since RFC was first cloned in 1994, tremendous advances have been made in understanding the complex transcriptional and posttranscriptional regulation of RFC, in identifying structurally and functionally important domains and amino acids in the RFC mol. as a prelude to establishing the mechanism of transport, and in characterizing the mol. defects in RFC assocd. with loss of transport in antifolate resistant cell line models. Many of the insights gained from lab. models of RFC portend opportunities for modulating carrier expression in drug resistant tumors, and for designing a new generation of agents with improved transport by RFC or substantially enhanced transport by other folate transporters over RFC.  Many of the advances in the basic biol. of RFC in cell line models are now being directly applied to human cancers in the clin. setting, most notably pediatric acute lymphoblastic leukemia and osteogenic sarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYdmMaSLKVPrVg90H21EOLACvtfcHk0liQGsW-jMbcUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Kqtb4%253D&md5=ea3e6431ea2321cc851f61a65120c49e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10555-007-9046-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-007-9046-2%26sid%3Dliteratum%253Aachs%26aulast%3DMatherly%26aufirst%3DL.%2BH.%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DHuman%2520reduced%2520folate%2520carrier%253A%2520translation%2520of%2520basic%2520biology%2520to%2520cancer%2520etiology%2520and%2520therapy%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2007%26volume%3D26%26spage%3D111%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, I. D.</span><span> </span><span class="NLM_article-title">A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">4267</span><span class="NLM_x">â</span> <span class="NLM_lpage">4274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=4267-4274&author=R.+Zhaoauthor=S.+H.+Minauthor=Y.+Wangauthor=E.+Campanellaauthor=P.+S.+Lowauthor=I.+D.+Goldman&title=A+role+for+the+proton-coupled+folate+transporter+%28PCFT-SLC46A1%29+in+folate+receptor-mediated+endocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DMin%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCampanella%26aufirst%3DE.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DGoldman%26aufirst%3DI.%2BD.%26atitle%3DA%2520role%2520for%2520the%2520proton-coupled%2520folate%2520transporter%2520%2528PCFT-SLC46A1%2529%2520in%2520folate%2520receptor-mediated%2520endocytosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D4267%26epage%3D4274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">â</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ab.2004.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15745749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVaqur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=284-293&author=N.+Parkerauthor=M.+J.+Turkauthor=E.+Westrickauthor=J.+D.+Lewisauthor=P.+S.+Lowauthor=C.+P.+Leamon&title=Folate+receptor+expression+in+carcinomas+and+normal+tissues+determined+by+a+quantitative+radioligand+binding+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay</span></div><div class="casAuthors">Parker, Nikki; Turk, Mary Jo; Westrick, Elaine; Lewis, Jeffrey D.; Low, Philip S.; Leamon, Christopher P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The folate receptor (FR) is a valuable therapeutic target that is highly expressed on a variety of cancers.  The current development of folate-targeted cancer therapies has created the need for quantitating functional FRs in clin. specimens.  In this article, we report on the creation of a highly sensitive radioactive binding method for quant. measuring FR expression in frozen tissue homogenates.  Expression was pos. in approx. 89% of human ovarian carcinomas but was negligible in both mucinous ovarian carcinomas and normal ovary.  Expression was also significant in carcinomas of the kidney, endometrium, lung, breast, bladder, and pancreas.  Normal tissues from humans and six different lab. species were also analyzed; surprisingly, some interspecies variability in FR expression (esp. in kidney, spleen, and lung tissue) was found.  Interestingly, normal human lung tissue displayed high expression levels, whereas expression in normal lung of the other species was negligible.  However, considering that folate-drug conjugates fail to accumulate in the lungs of patients, the consequence of this finding was not considered to be of clin. concern.  Overall, this new methodol. is reliable for detg. functional FR expression levels in tissues, and it could possibly be a useful clin. test to det. patient candidacy for FR-targeted therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwtgdifJwHuLVg90H21EOLACvtfcHk0liQGsW-jMbcUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVaqur0%253D&md5=cec9651fddccd602d715a27ab93f288c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DN.%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DLewis%26aufirst%3DJ.%2BD.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DFolate%2520receptor%2520expression%2520in%2520carcinomas%2520and%2520normal%2520tissues%2520determined%2520by%2520a%2520quantitative%2520radioligand%2520binding%2520assay%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D338%26spage%3D284%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ross, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span> </span><span class="NLM_article-title">Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">â</span> <span class="NLM_lpage">2443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F1097-0142%2819940501%2973%3A9%3C2432%3A%3AAID-CNCR2820730929%3E3.0.CO%3B2-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=7513252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXksl2rsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1994&pages=2432-2443&author=J.+F.+Rossauthor=P.+K.+Chaudhuriauthor=M.+Ratnam&title=Differential+regulation+of+folate+receptor+isoforms+in+normal+and+malignant+tissues+in+vivo+and+in+established+cell+lines.+Physiologic+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications</span></div><div class="casAuthors">Ross, John F.; Chaudhuri, Prabir K.; Ratnam, Manohar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2432-43</span>CODEN:
                <span class="NLM_cas:coden">CANCAR</span>;
        ISSN:<span class="NLM_cas:issn">0008-543X</span>.
    </div><div class="casAbstract">Despite significant differences in ligand binding between the two known isoforms of the human membrane folate receptor (FR), designated herein as FR-Î² (placenta) and FR-Î± (placenta, KB cells), little is known about their tissue specificities, and there is no report on the relative expression of FR-Î² in any tissue other than in placenta.  The mRNA for each FR isoform in a wide variety of normal fetal and adult tissue explants, primary normal cell cultures, malignant tumor explants, and established tumor cell lines was estd. by a polymerase chain reaction assay.  Total receptor levels were estd. by a [3H]folic acid binding assay.  Both FR isoforms were expressed in fetal as well as adult tissues.  Normal tissues generally expressed low to moderate amts. of FR-Î².  FR-Î± alone was expressed in normal epithelial cells and was frequently strikingly elevated in a variety of carcinomas, with the exception of squamous cell carcinomas of the head and neck.  In contrast, a variety of malignant tissues of nonepithelial origin generally expressed elevated levels of FR-Î² alone.  Established tumor cell lines expressed FR-Î± virtually alone and did not reflect FR expression patterns in vivo.  KB cells and JEG-3 cells grown at low folate concns. further up-regulated FR-Î± but not FR-Î².  Although FR-Î² is the more common isoform, FR-Î± and FR-Î² are differentially regulated in normal tissues, carcinomas, nonepithelial malignancies, and immortalized cells or in response to changes in extracellular folate concns.  The tissue specificity of FR isoforms and their elevation in malignant tissues may be a significant factor in FR-mediated folate uptake, in tissue responsiveness to promising novel antifolates, and in FR-related immunodiagnosis/immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xK8VoFPp_bVg90H21EOLACvtfcHk0liKrSZhVny3yQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksl2rsrw%253D&md5=8086228b96186da1001161a048172a8e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F1097-0142%2819940501%2973%3A9%3C2432%3A%3AAID-CNCR2820730929%3E3.0.CO%3B2-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0142%252819940501%252973%253A9%253C2432%253A%253AAID-CNCR2820730929%253E3.0.CO%253B2-S%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DJ.%2BF.%26aulast%3DChaudhuri%26aufirst%3DP.%2BK.%26aulast%3DRatnam%26aufirst%3DM.%26atitle%3DDifferential%2520regulation%2520of%2520folate%2520receptor%2520isoforms%2520in%2520normal%2520and%2520malignant%2520tissues%2520in%2520vivo%2520and%2520in%2520established%2520cell%2520lines.%2520Physiologic%2520and%2520clinical%2520implications%26jtitle%3DCancer%26date%3D1994%26volume%3D73%26spage%3D2432%26epage%3D2443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kalli, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberg, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeney, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christianson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, L. C.</span><span> </span><span class="NLM_article-title">Folate receptor alpha as a tumor target in epithelial ovarian cancer</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">â</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ygyno.2007.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18222534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlCjtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=619-626&author=K.+R.+Kalliauthor=A.+L.+Obergauthor=G.+L.+Keeneyauthor=T.+J.+Christiansonauthor=P.+S.+Lowauthor=K.+L.+Knutsonauthor=L.+C.+Hartmann&title=Folate+receptor+alpha+as+a+tumor+target+in+epithelial+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor alpha as a tumor target in epithelial ovarian cancer</span></div><div class="casAuthors">Kalli, Kimberly R.; Oberg, Ann L.; Keeney, Gary L.; Christianson, Teresa J. H.; Low, Philip S.; Knutson, Keith L.; Hartmann, Lynn C.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">619-626</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Folate receptor Î± (FRÎ±) is a folate-binding protein overexpressed on ovarian and several other epithelial malignancies that can be used as a target for imaging and therapeutic strategies.  The goal of this study is to improve historical data that lack specific information about FRÎ± expression in rare histol. subtypes, primary disease vs. metastatic foci, and recurrent disease.  FRÎ± expression was analyzed by immunohistochem. on 186 primary and 27 recurrent ovarian tumors, including 24 pairs of samples obtained from the same individuals at diagnosis and at secondary debulking surgery.  For 20 of the 186 primaries, simultaneous metastatic foci were also analyzed.  FRÎ± staining was analyzed in light of disease morphol., stage, grade, debulking status, and time from diagnosis to recurrence and death.  FRÎ± expression was apparent in 134 of 186 (72%) primary and 22 of 27 (81.5%) recurrent ovarian tumors.  In 21 of 24 (87.5%) matched specimens, recurrent tumors reflected the FRÎ± status detected at diagnosis.  Metastatic foci were similar to primary tumors in FRÎ± staining.  FRÎ± status was not assocd. with time to recurrence or overall survival in either univariate or multivariable analyses.  FRÎ± expression occurs frequently, esp. in the common high-grade, high-stage serous tumors that are most likely to recur.  New findings from this study show that FRÎ± expression is maintained on metastatic foci and recurrent tumors, suggesting that novel folate-targeted therapies may hold promise for the majority of women with either newly diagnosed or recurrent ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1KsDibBMVfLVg90H21EOLACvtfcHk0liKrSZhVny3yQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlCjtrc%253D&md5=565d54ee9ebd0461d1d1b6ff5e71923c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2007.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2007.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DKalli%26aufirst%3DK.%2BR.%26aulast%3DOberg%26aufirst%3DA.%2BL.%26aulast%3DKeeney%26aufirst%3DG.%2BL.%26aulast%3DChristianson%26aufirst%3DT.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DKnutson%26aufirst%3DK.%2BL.%26aulast%3DHartmann%26aufirst%3DL.%2BC.%26atitle%3DFolate%2520receptor%2520alpha%2520as%2520a%2520tumor%2520target%2520in%2520epithelial%2520ovarian%2520cancer%26jtitle%3DGynecol.%2520Oncol.%26date%3D2008%26volume%3D108%26spage%3D619%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nakashima-Matsushita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, T.</span><span> </span><span class="NLM_article-title">Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">â</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F1529-0131%28199908%2942%3A8%3C1609%3A%3AAID-ANR7%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=10446858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1MXlsFynsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1609-1616&author=N.+Nakashima-Matsushitaauthor=T.+Hommaauthor=S.+Yuauthor=T.+Matsudaauthor=N.+Sunaharaauthor=T.+Nakamuraauthor=M.+Tsukanoauthor=M.+Ratnamauthor=T.+Matsuyama&title=Selective+expression+of+folate+receptor+beta+and+its+possible+role+in+methotrexate+transport+in+synovial+macrophages+from+patients+with+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective expression of folate receptor Î² and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis</span></div><div class="casAuthors">Nakashima-Matsushita, Noriko; Homma, Toshio; Yu, Su; Matsuda, Takemasa; Sunahara, Nobuhiko; Nakamura, Tadashi; Tsukano, Michishi; Ratnam, Manohar; Matsuyama, Takami</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1609-1616</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To investigate the expression of folate receptors (FR) and reduced folate carrier (RFC) and det. their relevance to methotrexate (MTX) transport in synovial mononuclear cells (SMC) from patients with rheumatoid arthritis (RA).  Levels of FR and RFC mRNA (mRNA) were examd. by reverse transcriptase-polymerase chain reaction (RT-PCR) in SMC from RA patients and peripheral blood mononuclear cells from healthy donors.  Expression of FR-Î² mRNA and protein was detd. by Northern blot and Western blot analyses in RA SMC and monocyte/macrophage-lineage cells.  FR-Î² expression and folic acid binding capacity on the cell surface were examd. by flow cytometric anal. and 3H-folic acid binding anal.  Studies of the inhibition of 3H-MTX uptake in the presence of unlabeled folic acid were performed to investigate the uptake of MTX through FR in RA SMC.  RT-PCR, Northern blot, and Western blot analyses showed that FR-Î² mRNA and protein were expressed selectively in activated monocytes and CD14+ RA SMC.  These cells exhibited folic acid binding capacity.  Furthermore, the FR-Î² protein was shown to have folic acid binding capacity.  Uptake of 3H-MTX through RA SMC was significantly inhibited in the presence of unlabeled folic acid.  These results demonstrate that FR-Î² expression is selectively elevated in RA synovial macrophages and suggest that MTX is transported through FR-Î² in RA synovial macrophages.  The findings suggest that folate antagonists with higher affinity for FR-Î² would be useful in the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMaG5oH6VW7LVg90H21EOLACvtfcHk0liqantRb4aCeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsFynsbc%253D&md5=b40475d6ea3199db2cfd4973b0e75a88</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28199908%2942%3A8%3C1609%3A%3AAID-ANR7%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528199908%252942%253A8%253C1609%253A%253AAID-ANR7%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima-Matsushita%26aufirst%3DN.%26aulast%3DHomma%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DSunahara%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DTsukano%26aufirst%3DM.%26aulast%3DRatnam%26aufirst%3DM.%26aulast%3DMatsuyama%26aufirst%3DT.%26atitle%3DSelective%2520expression%2520of%2520folate%2520receptor%2520beta%2520and%2520its%2520possible%2520role%2520in%2520methotrexate%2520transport%2520in%2520synovial%2520macrophages%2520from%2520patients%2520with%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1999%26volume%3D42%26spage%3D1609%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">van der Heijden, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oerlemans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkmans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Laken, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lems, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, G.</span><span> </span><span class="NLM_article-title">Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fart.24219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19116913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFequrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=12-21&author=J.+W.+van+der+Heijdenauthor=R.+Oerlemansauthor=B.+A.+Dijkmansauthor=H.+Qiauthor=C.+J.+van+der+Lakenauthor=W.+F.+Lemsauthor=A.+L.+Jackmanauthor=M.+C.+Kraanauthor=P.+P.+Takauthor=M.+Ratnamauthor=G.+Jansen&title=Folate+receptor+beta+as+a+potential+delivery+route+for+novel+folate+antagonists+to+macrophages+in+the+synovial+tissue+of+rheumatoid+arthritis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor Î² as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients</span></div><div class="casAuthors">van der Heijden, Joost W.; Oerlemans, Ruud; Dijkmans, Ben A. C.; Qi, Huiling; van der Laken, Conny J.; Lems, Willem F.; Jackman, Ann L.; Kraan, Maarten C.; Tak, Paul P.; Ratnam, Manohar; Jansen, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. the expression of folate receptor Î² (FRÎ²) in synovial biopsy tissues and peripheral blood lymphocytes from rheumatoid arthritis (RA) patients and to identify novel folate antagonists that are more selective in the targeting and internalization of FRÎ² than methotrexate (MTX).  Immunohistochem. and computer-assisted digital imaging analyses were used for the detection of FRÎ² protein expression on immunocompetent cells in synovial biopsy samples from RA patients with active disease and in noninflammatory control synovial tissues.  FRÎ² mRNA levels were detd. by reverse transcription-polymerase chain reaction anal.  Binding affinities of FRÎ² for folate antagonists were assessed by competition expts. for 3H-folic acid binding on FRÎ²-transfected cells.  Efficacy of FRÎ²-mediated internalization of folate antagonists was evaluated by assessment of antiproliferative effects against FRÎ²-transfected cells.  Immunohistochem. staining of RA synovial tissue showed high expression of FRÎ² on macrophages in the intimal lining layer and synovial sublining, whereas no staining was obsd. in T cell areas or in control synovial tissue.  Consistently, FRÎ² mRNA levels were highest in synovial tissue exts. and RA monocyte-derived macrophages, but low in peripheral blood T cells and monocytes.  Screening of 10 new-generation folate antagonists revealed 4 compds. for which FRÎ² had a high binding affinity (20-77-fold higher than for MTX).  One of these, the thymidylate synthase inhibitor BCG 945, displayed selective targeting against FRÎ²-transfected cells.  Abundant FRÎ² expression on activated macrophages in synovial tissue from RA patients deserves further exploration for selective therapeutic interventions with high-affinity-binding folate antagonists, of which BCG 945 may be a prototypical representative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozErFRUx-s5rVg90H21EOLACvtfcHk0liqantRb4aCeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFequrs%253D&md5=58da14e3b0e9b4e2ad65bbb74676fed5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fart.24219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24219%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DJ.%2BW.%26aulast%3DOerlemans%26aufirst%3DR.%26aulast%3DDijkmans%26aufirst%3DB.%2BA.%26aulast%3DQi%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BLaken%26aufirst%3DC.%2BJ.%26aulast%3DLems%26aufirst%3DW.%2BF.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26aulast%3DKraan%26aufirst%3DM.%2BC.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DRatnam%26aufirst%3DM.%26aulast%3DJansen%26aufirst%3DG.%26atitle%3DFolate%2520receptor%2520beta%2520as%2520a%2520potential%2520delivery%2520route%2520for%2520novel%2520folate%2520antagonists%2520to%2520macrophages%2520in%2520the%2520synovial%2520tissue%2520of%2520rheumatoid%2520arthritis%2520patients%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D12%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenbrink, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteson, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockwood, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">â</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=438-446&author=W.+Xiaauthor=A.+R.+Hilgenbrinkauthor=E.+L.+Mattesonauthor=M.+B.+Lockwoodauthor=J.+X.+Chengauthor=P.+S.+Low&title=A+functional+folate+receptor+is+induced+during+macrophage+activation+and+can+be+used+to+target+drugs+to+activated+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DHilgenbrink%26aufirst%3DA.%2BR.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DLockwood%26aufirst%3DM.%2BB.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DA%2520functional%2520folate%2520receptor%2520is%2520induced%2520during%2520macrophage%2520activation%2520and%2520can%2520be%2520used%2520to%2520target%2520drugs%2520to%2520activated%2520macrophages%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D438%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breur, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmer, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulos, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grote, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1947</span><span class="NLM_x">â</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fart.10405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12124880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A280%3ADC%252BD38znsl2jtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=1947-1955&author=M.+J.+Turkauthor=G.+J.+Breurauthor=W.+R.+Widmerauthor=C.+M.+Paulosauthor=L.+C.+Xuauthor=L.+A.+Groteauthor=P.+S.+Low&title=Folate-targeted+imaging+of+activated+macrophages+in+rats+with+adjuvant-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis</span></div><div class="casAuthors">Turk Mary Jo; Breur Gert J; Widmer William R; Paulos Chrystal M; Xu Le-Cun; Grote Lee Ann; Low Philip S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1947-55</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine whether overexpression of the high-affinity folate receptor (FR) on activated macrophages can be exploited to selectively target imaging agents to sites of inflammation in rats with adjuvant-induced arthritis (AIA).  METHODS:  Folic acid was conjugated to a (99m)Tc chelator (the complex termed EC20), and its distribution was visualized using gamma scintigraphy in healthy rats, rats with AIA, and arthritic rats that had been depleted of macrophages.  To confirm that uptake was mediated by the FR, excess folic acid competition studies were conducted, and tissue FR levels were quantitated using a radioligand binding assay.  Flow cytometry was also used to investigate uptake of folate conjugates into macrophages of both arthritic and healthy rats.  RESULTS:  EC20 concentrated in the arthritic extremities of diseased rats but not in the extremities of healthy rats.  The intensity of images of affected tissues was greatly reduced in the presence of excess competing folic acid.  The livers and spleens of arthritic animals also showed enhanced uptake of EC20 and increased levels of FR.  Depletion of macrophages from arthritic animals reduced tissue FR content and concomitantly abolished uptake of EC20.  In addition, macrophages isolated from livers of rats with AIA exhibited a significantly higher binding capacity for folate conjugates than did macrophages obtained from healthy rats.  CONCLUSION:  Although EC20 is currently undergoing clinical evaluation for use in the imaging of ovarian carcinomas, the present results suggest that it may also be useful for assaying the participation of activated macrophages in inflammatory processes such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXPznsnxkDyEg6wdEZmT2rfW6udTcc2eYdHL-YjgwBTrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38znsl2jtg%253D%253D&md5=31a6b8eba0be0cf97924b90a0e4679ed</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fart.10405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.10405%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DBreur%26aufirst%3DG.%2BJ.%26aulast%3DWidmer%26aufirst%3DW.%2BR.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DGrote%26aufirst%3DL.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate-targeted%2520imaging%2520of%2520activated%2520macrophages%2520in%2520rats%2520with%2520adjuvant-induced%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2002%26volume%3D46%26spage%3D1947%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Elnakat, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span> </span><span class="NLM_article-title">Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">â</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2004.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15094207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtF2rt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1067-1084&author=H.+Elnakatauthor=M.+Ratnam&title=Distribution%2C+functionality+and+gene+regulation+of+folate+receptor+isoforms%3A+implications+in+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy</span></div><div class="casAuthors">Elnakat, Hala; Ratnam, Manohar</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1067-1084</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  This article reviews the role of the folate receptor in physiol., the folate receptor gene family, mechanisms governing gene expression and how this relates to its potential in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXsdpIKdWDbLVg90H21EOLACvtfcHk0lhaVpmh26YGIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtF2rt7Y%253D&md5=526afa4ac9adc948b6f03980cf02ec81</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DElnakat%26aufirst%3DH.%26aulast%3DRatnam%26aufirst%3DM.%26atitle%3DDistribution%252C%2520functionality%2520and%2520gene%2520regulation%2520of%2520folate%2520receptor%2520isoforms%253A%2520implications%2520in%2520targeted%2520therapy%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1067%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kamen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. K.</span><span> </span><span class="NLM_article-title">A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">â</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1085-1097&author=B.+A.+Kamenauthor=A.+K.+Smith&title=A+review+of+folate+receptor+alpha+cycling+and+5-methyltetrahydrofolate+accumulation+with+an+emphasis+on+cell+models+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamen%26aufirst%3DB.%2BA.%26aulast%3DSmith%26aufirst%3DA.%2BK.%26atitle%3DA%2520review%2520of%2520folate%2520receptor%2520alpha%2520cycling%2520and%25205-methyltetrahydrofolate%2520accumulation%2520with%2520an%2520emphasis%2520on%2520cell%2520models%2520in%2520vitro%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1085%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">13872</span><span class="NLM_x">â</span> <span class="NLM_lpage">13877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.0601455103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16950881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFSkt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=13872-13877&author=J.+Yangauthor=H.+Chenauthor=I.+R.+Vlahovauthor=J.+X.+Chengauthor=P.+S.+Low&title=Evaluation+of+disulfide+reduction+during+receptor-mediated+endocytosis+by+using+FRET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging</span></div><div class="casAuthors">Yang, Jun; Chen, Hongtao; Vlahov, Iontcho R.; Cheng, Ji-Xin; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13872-13877</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Despite functional evidence for disulfide bond-reducing activity in endosomal compartments, the mechanistic details pertaining to such process (e.g., kinetics and sites of disulfide redn.) remain largely controversial.  To address these questions directly, the authors have synthesized a previously uncharacterized fluorescent folate conjugate, folate-(BODIPY FL)-SS-rhodamine (folate-FRET), that changes fluorescence from red to green upon disulfide bond redn.  Using this construct, the authors have obsd. that disulfide redn.: (i) occurs with a half-time of 6 h after folate-FRET endocytosis, (ii) begins in endosomes and does not depend significantly on redox machinery located on the cell surface or within the lysosome or the Golgi app., (iii) occurs independently of endocytic vesicle trafficking along microtubules, and (iv) yields products that are subsequently sorted into distinct endosomes and trafficked in different directions.  Finally, colocalization of folate and transferrin receptors suggest that conclusions derived from this study may apply to other endocytic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHr5o9L2HCBbVg90H21EOLACvtfcHk0lhaVpmh26YGIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFSkt78%253D&md5=a1502f1a4a07ce60e7f6e5b654308f9a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601455103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601455103%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DEvaluation%2520of%2520disulfide%2520reduction%2520during%2520receptor-mediated%2520endocytosis%2520by%2520using%2520FRET%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D13872%26epage%3D13877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Paulos, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breur, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">â</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2004.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15094216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1205-1217&author=C.+M.+Paulosauthor=M.+J.+Turkauthor=G.+J.+Breurauthor=P.+S.+Low&title=Folate+receptor-mediated+targeting+of+therapeutic+and+imaging+agents+to+activated+macrophages+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis</span></div><div class="casAuthors">Paulos, Chrystal M.; Turk, Mary Jo; Breur, Gert J.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1217</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by inflammation of the joints and destruction of cartilage and bone, often compromising both the quality and duration of life.  The disease pathol. is complex, involving the infiltration and activation of various populations of immune cells along with the release of destructive inflammatory mediators into the synovium of affected joints.  Although it is still debatable whether activated macrophages are the primary promoters of RA, emerging data clearly show that the biol. activity of this subset of inflammatory cells greatly contributes to both the acute and chronic stages of the disease.  The further discovery of folate receptor expression on these activated (but not quiescent) macrophages in both animal models and human patients with naturally occurring RA has opened the possibility of exploiting folic acid to target attached drugs to this population of pathol. cells.  Indeed, recent studies have shown that folate-linked imaging and therapeutic agents can be selectively delivered to arthritic joints, allowing both the visualization and treatment of RA, with little or no collateral toxicity to normal tissues.  This review will first summarize data documenting specific expression of the folate receptor on activated macrophages and then focus on the development of folate-targeted diagnostic and therapeutic agents for guided intervention into rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj3K5ie2Jb_rVg90H21EOLACvtfcHk0liBe55VWr2b4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLk%253D&md5=da0707a0ea25b5501a38a25c4e2edf8a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DBreur%26aufirst%3DG.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate%2520receptor-mediated%2520targeting%2520of%2520therapeutic%2520and%2520imaging%2520agents%2520to%2520activated%2520macrophages%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1205%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, A. L.</span><span> </span><span class="NLM_article-title">Exploitation of the folate receptor in the management of cancer and inflammatory disease</span> <span class="citation_source-journal">Vitam. Horm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">â</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0083-6729%2808%2900407-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18804696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2008&pages=203-233&author=C.+P.+Leamonauthor=A.+L.+Jackman&title=Exploitation+of+the+folate+receptor+in+the+management+of+cancer+and+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Exploitation of the folate receptor in the management of cancer and inflammatory disease</span></div><div class="casAuthors">Leamon, Christopher P.; Jackman, Ann L.</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">Folic Acid and Folates</span>),
    <span class="NLM_cas:pages">203-233</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Over the last 25+ years, the folate receptor (FR) has emerged as an attractive tumor biomarker with the potential to be exploited for therapeutic purposes.  Increasing evidence suggests that this endocytosing protein can functionally mediate the cellular uptake and retention of natural folates, certain antifolates, and folate-drug conjugates; the consequences of the latter two events could result in biol. modulation, including (but not limited to) tumor-targeted cytotoxicity.  Because its tissue expression profile appears to be somewhat limited to either tissues responsible for whole body retention of folates (e.g., kidney and placenta), or certain pathol. tissues (e.g., tumors or activated macrophages), the FR is believed to be a useful biol. target for disease management.  Indeed, recent years have been peppered with reports of novel FR-targeted therapies, and many have demonstrated impressive in vivo potency, particularly against tumor xenografts, without the undesirable toxicity that often accompanies nontargeted drug regimens.  This chapter will provide essential details on the properties of the FR, including where it is expressed and how it has been successfully manipulated for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-fHwtetp0bLVg90H21EOLACvtfcHk0liBe55VWr2b4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOgu7fP&md5=b332543e489e2b2cf3def5cc33dfbe98</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2808%2900407-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252808%252900407-X%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DJackman%26aufirst%3DA.%2BL.%26atitle%3DExploitation%2520of%2520the%2520folate%2520receptor%2520in%2520the%2520management%2520of%2520cancer%2520and%2520inflammatory%2520disease%26jtitle%3DVitam.%2520Horm.%26date%3D2008%26volume%3D79%26spage%3D203%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sandoval, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitoris, B. A.</span><span> </span><span class="NLM_article-title">Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy</span> <span class="citation_source-journal">Am. J. Physiol.: Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">C517</span><span class="NLM_x">â</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2004&pages=C517-526&author=R.+M.+Sandovalauthor=M.+D.+Kennedyauthor=P.+S.+Lowauthor=B.+A.+Molitoris&title=Uptake+and+trafficking+of+fluorescent+conjugates+of+folic+acid+in+intact+kidney+determined+using+intravital+two-photon+microscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandoval%26aufirst%3DR.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BD.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DMolitoris%26aufirst%3DB.%2BA.%26atitle%3DUptake%2520and%2520trafficking%2520of%2520fluorescent%2520conjugates%2520of%2520folic%2520acid%2520in%2520intact%2520kidney%2520determined%2520using%2520intravital%2520two-photon%2520microscopy%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2004%26volume%3D287%26spage%3DC517%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetics and exposureâtoxicity relationship of a folate-<i>Vinca</i> alkaloid conjugate EC145 in cancer patients</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">â</span> <span class="NLM_lpage">1476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1177%2F0091270009339740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19837906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1467-1476&author=J.+Liauthor=E.+A.+Sausvilleauthor=P.+J.+Kleinauthor=D.+Morgensternauthor=C.+P.+Leamonauthor=R.+A.+Messmannauthor=P.+LoRusso&title=Clinical+pharmacokinetics+and+exposure%E2%88%92toxicity+relationship+of+a+folate-Vinca+alkaloid+conjugate+EC145+in+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients</span></div><div class="casAuthors">Li, Jing; Sausville, Edward A.; Klein, Patrick J.; Morgenstern, David; Leamon, Christopher P.; Messmann, Richard A.; Lo Russo, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1467-1476</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The clin. pharmacokinetics and exposure-toxicity relationship were detd. for EC145, a conjugate of folic acid and the Vinca alkaloid desacetylvinblastine hydrazide (DAVLBH), in cancer patients.  EC145 plasma concn. and toxicity data were obtained from a first-in-man phase I study and analyzed by nonlinear mixed effect modeling with NONMEM.  EC145 concn.-time profile after i.v. administration was well described by a 2-compartment model with a first-order elimination process from the central compartment.  BSA was identified as a significant covariate on EC145 clearance, accounting for 14.6% of interindividual variation on EC145 clearance.  Population ests. for the clearance, steady-state vol. of distribution, distribution, and elimination half-lives were 56.1 L/h, 26.1 L, 6 min, and 26 min, resp.  Constipation and peripheral neuropathy were the most common and clin. relevant toxicities.  The clearance and area under the concn.-time curve (AUC) were significant predictors for the incidence of EC145-induced constipation but not peripheral neuropathy.  In conclusion, EC145 is rapidly distributed and eliminated in cancer patients.  BSA is a statistically significant covariate on EC145 clearance, but its clin. relevance remains to be defined.  EC145-induced constipation occurs at a higher frequency in the patients with lower EC145 clearance, where the drug exposure tends to be higher.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeWbU5dBosq7Vg90H21EOLACvtfcHk0lgf6XCNXLNfKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SksLjI&md5=f7ed9c76db25964aebf94855a28850bf</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1177%2F0091270009339740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270009339740%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DKlein%26aufirst%3DP.%2BJ.%26aulast%3DMorgenstern%26aufirst%3DD.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DMessmann%26aufirst%3DR.%2BA.%26aulast%3DLoRusso%26aufirst%3DP.%26atitle%3DClinical%2520pharmacokinetics%2520and%2520exposure%25E2%2588%2592toxicity%2520relationship%2520of%2520a%2520folate-Vinca%2520alkaloid%2520conjugate%2520EC145%2520in%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D49%26spage%3D1467%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Sausville, E. A.; LoRusso, P.; Quinn, M.; Forman, K.; Leamon, C. P.; Morgenstern, D.; Bever, S.; Messmann, R. A.</span><span> </span><span class="NLM_article-title">A Phase I Study of EC145 Administered Weeks 1 and 3 of a 4-Week Cycle in Patients with Refractory Solid Tumors</span>.  <span class="citation_source-book">ASCO Annual Meeting Proceedings, 2007</span>; <span class="NLM_publisher-name">American Society of Clinical Oncology</span>: <span class="NLM_publisher-loc">Alexandria, VA</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">2577</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=2577&author=E.+A.+Sausville&author=P.+LoRusso&author=M.+Quinn&author=K.+Forman&author=C.+P.+Leamon&author=D.+Morgenstern&author=S.+Bever&author=R.+A.+Messmann&title=ASCO+Annual+Meeting+Proceedings%2C+2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DA%2520Phase%2520I%2520Study%2520of%2520EC145%2520Administered%2520Weeks%25201%2520and%25203%2520of%2520a%25204-Week%2520Cycle%2520in%2520Patients%2520with%2520Refractory%2520Solid%2520Tumors%26btitle%3DASCO%2520Annual%2520Meeting%2520Proceedings%252C%25202007%26pub%3DAmerican%2520Society%2520of%2520Clinical%2520Oncology%26date%3D2007%26spage%3D2577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Chancy, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kekuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhnel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirotnak, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganapathy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. B.</span><span> </span><span class="NLM_article-title">Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">20676</span><span class="NLM_x">â</span> <span class="NLM_lpage">20684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=20676-20684&author=C.+D.+Chancyauthor=R.+Kekudaauthor=W.+Huangauthor=P.+D.+Prasadauthor=J.+M.+Kuhnelauthor=F.+M.+Sirotnakauthor=P.+Roonauthor=V.+Ganapathyauthor=S.+B.+Smith&title=Expression+and+differential+polarization+of+the+reduced-folate+transporter-1+and+the+folate+receptor+alpha+in+mammalian+retinal+pigment+epithelium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChancy%26aufirst%3DC.%2BD.%26aulast%3DKekuda%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DPrasad%26aufirst%3DP.%2BD.%26aulast%3DKuhnel%26aufirst%3DJ.%2BM.%26aulast%3DSirotnak%26aufirst%3DF.%2BM.%26aulast%3DRoon%26aufirst%3DP.%26aulast%3DGanapathy%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DS.%2BB.%26atitle%3DExpression%2520and%2520differential%2520polarization%2520of%2520the%2520reduced-folate%2520transporter-1%2520and%2520the%2520folate%2520receptor%2520alpha%2520in%2520mammalian%2520retinal%2520pigment%2520epithelium%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D20676%26epage%3D20684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Mantovani, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspagliesi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span> </span><span class="NLM_article-title">Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19</span> <span class="citation_source-journal">Eur. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">30A</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">â</span> <span class="NLM_lpage">369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30A&publication_year=1994&pages=363-369&author=L.+T.+Mantovaniauthor=S.+Miottiauthor=S.+Menardauthor=S.+Canevariauthor=F.+Raspagliesiauthor=C.+Bottiniauthor=F.+Botteroauthor=M.+I.+Colnaghi&title=Folate+binding+protein+distribution+in+normal+tissues+and+biological+fluids+from+ovarian+carcinoma+patients+as+detected+by+the+monoclonal+antibodies+MOv18+and+MOv19"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMantovani%26aufirst%3DL.%2BT.%26aulast%3DMiotti%26aufirst%3DS.%26aulast%3DMenard%26aufirst%3DS.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DRaspagliesi%26aufirst%3DF.%26aulast%3DBottini%26aufirst%3DC.%26aulast%3DBottero%26aufirst%3DF.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26atitle%3DFolate%2520binding%2520protein%2520distribution%2520in%2520normal%2520tissues%2520and%2520biological%2520fluids%2520from%2520ovarian%2520carcinoma%2520patients%2520as%2520detected%2520by%2520the%2520monoclonal%2520antibodies%2520MOv18%2520and%2520MOv19%26jtitle%3DEur.%2520J.%2520Cancer.%26date%3D1994%26volume%3D30A%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span> </span><span class="NLM_article-title">Comparative preclinical activity of the folate-targeted <i>Vinca</i> alkaloid conjugates EC140 and EC145</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">â</span> <span class="NLM_lpage">1592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fijc.22853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17551919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSns7zI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1585-1592&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=E.+Westrickauthor=N.+Parkerauthor=J.+S.+Nicosonauthor=M.+Vetzel&title=Comparative+preclinical+activity+of+the+folate-targeted+Vinca+alkaloid+conjugates+EC140+and+EC145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Westrick, Elaine; Parker, Nikki; Nicoson, Jeffrey S.; Vetzel, Marilynn</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1585-1592</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">EC140 is a water sol. folate conjugate of desacetylvinblastine monohydrazide (DAVLBH), which is constructed with an endosome-cleavable acyl hydrazone bond.  This agent has proven to be active and specific against well established, s.c. folate receptor (FR)-pos. tumors in multiple animal models.  Recent structure-activity and optimization studies have yielded a disulfide bond-contg. counterpart to EC140, herein referred to as EC145.  This new conjugate was found to retain high affinity for FR-pos. cells, and it produced specific, dose-responsive activity in vitro.  Comparative in vivo efficacy tests confirmed that, like EC140, EC145 displays activity against both syngeneic and xenograft tumor models.  However, EC145 was found to be more active and better tolerated than EC140; hence, more durable complete responses were consistently obsd. in EC145-treated tumor-bearing animals.  Furthermore, EC145 was not found to be active against a FR-neg. tumor model.  Addnl. preclin. studies are therefore warranted to better understand EC145's breadth of activity against FR-pos. tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGtkvrrhOcvrVg90H21EOLACvtfcHk0lhqSOb4fA95GA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSns7zI&md5=3a7b06fc117fca9d88730624d2ce9298</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fijc.22853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22853%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DParker%26aufirst%3DN.%26aulast%3DNicoson%26aufirst%3DJ.%2BS.%26aulast%3DVetzel%26aufirst%3DM.%26atitle%3DComparative%2520preclinical%2520activity%2520of%2520the%2520folate-targeted%2520Vinca%2520alkaloid%2520conjugates%2520EC140%2520and%2520EC145%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1585%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhapuram, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">Preclinical antitumor activity of a novel folate-targeted dual drug conjugate</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">â</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp070049c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtL3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=659-667&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=E.+Westrickauthor=A.+Dawsonauthor=R.+Dortonauthor=M.+Vetzelauthor=H.+K.+Santhapuramauthor=Y.+Wang&title=Preclinical+antitumor+activity+of+a+novel+folate-targeted+dual+drug+conjugate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Antitumor Activity of a Novel Folate-Targeted Dual Drug Conjugate</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Westrick, Elaine; Dawson, Alicia; Dorton, Ryan; Vetzel, Marilynn; Santhapuram, Hari Krishna; Wang, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">659-667</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed a new type of tumor-targeted agent by tethering two different drug mols., with distinct biol. mechanisms of action, to the same ligand.  This compd., named EC0225, represents the "first in class" multidrug, folate receptor (FR)-targeted agent to be disclosed.  It was constructed with a single folate mol., extended by a hydrophilic peptide-based spacer, which was in turn attached to mitomycin and Vinca alkaloid units via two sep. disulfide-contg. linkers.  EC0225 produced potent, dose-responsive activity in vitro, and curative activity was obsd. against FR-pos. syngeneic and xenograft tumors following the administration of well-tolerated dosing regimens.  Multiple complete responses and cures were also noted when EC0225 was used to treat mice initially bearing tumors as large as 750 mm3 in vol.  Overall, EC0225's impressive preclin. activity allowed for its selection as a development candidate and for the start of Phase 1 clin. trials, which began in March of 2007, for the treatment of advanced malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqEYQK1vIbQ7Vg90H21EOLACvtfcHk0lhqSOb4fA95GA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtL3I&md5=be9787edffad2aba1cbfdd990f85df4a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fmp070049c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp070049c%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DDawson%26aufirst%3DA.%26aulast%3DDorton%26aufirst%3DR.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DSanthapuram%26aufirst%3DH.%2BK.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPreclinical%2520antitumor%2520activity%2520of%2520a%2520novel%2520folate-targeted%2520dual%2520drug%2520conjugate%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D659%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors</span> <span class="citation_source-journal">Cancer Immunol. Immunother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs00262-002-0266-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=11941454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVGjsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=153-162&author=Y.+Luauthor=P.+S.+Low&title=Folate+targeting+of+haptens+to+cancer+cell+surfaces+mediates+immunotherapy+of+syngeneic+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors</span></div><div class="casAuthors">Lu, Yingjuan; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-162</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A variety of human cancers overexpress a cell surface receptor with high affinity for the vitamin, folic acid (Kd â¼ 10-10 M).  Covalent attachment of therapeutic agents to folic acid has been shown to allow efficient targeting of the folate-drug conjugates to folate receptor-expressing cancer cells, with little or no uptake by normal tissues except the kidneys.  We report here the use of folate's ability to deliver attached mols. specifically to cancer cells to convert poorly immunogenic tumors into highly immunogenic tissue targets.  By linking folic acid to a model hapten, we have been able to decorate folate receptor-expressing cancer cell surfaces with > 106 haptens/cell in vivo.  Following marking of such cells with haptens, the cells are obsd. to become opsonized with autologous anti-hapten antibodies, which is presumed to mediate cell removal via antibody-dependent cellular cytotoxicity (ADCC).  Supplemental administration of low levels of ADCC-activating cytokines [e.g. interleukin-2 (IL-2) and interferon-alpha (IFN-Î±)] has been shown to synergize with the folate-targeted immunotherapy.  Thus, using M109 syngeneic lung cancer cells injected i.p. into Balb/c mice that were previously immunized against fluorescein, a significant extension of life span is obsd. following treatment with folate-fluorescein conjugates, and complete cures are obsd. upon supplementation with moderate levels of IL-2 and IFN-Î±.  Because control tumor-bearing mice treated with the same cytokines but with non-targeted fluorescein show no extension of life span, we conclude that tumor-specific opsonization is an essential step in this immunotherapy.  Finally, because the anti-fluorescein antibodies are unable to access the folate receptors on the apical membranes of the kidney proximal tubules, no kidney or other normal tissue cytotoxicity is obsd.  These data suggest that retargeting of haptens to folate receptor-expressing cancers might constitute a method for mobilizing the immune system specifically against poorly immunogenic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOmKs6AgCtjbVg90H21EOLACvtfcHk0lhqSOb4fA95GA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVGjsr8%253D&md5=9b5edc238468ed97dfdcd718ad708212</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00262-002-0266-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-002-0266-6%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate%2520targeting%2520of%2520haptens%2520to%2520cancer%2520cell%2520surfaces%2520mediates%2520immunotherapy%2520of%2520syngeneic%2520murine%2520tumors%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2002%26volume%3D51%26spage%3D153%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantrip, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of [<sup>111</sup>In]DTPA-folate for use as a tumor-targeted radiopharmaceutical</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">â</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9701297" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2sXlslGmsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=673-679&author=S.+Wangauthor=J.+Luoauthor=D.+A.+Lantripauthor=D.+J.+Watersauthor=C.+J.+Mathiasauthor=M.+A.+Greenauthor=P.+L.+Fuchsauthor=P.+S.+Low&title=Design+and+synthesis+of+%5B111In%5DDTPA-folate+for+use+as+a+tumor-targeted+radiopharmaceutical"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of [111In]DTPA-Folate for Use as a Tumor-Targeted Radiopharmaceutical</span></div><div class="casAuthors">Wang, Susan; Luo, Jin; Lantrip, Douglas A.; Waters, David J.; Mathias, Carla J.; Green, Mark A.; Fuchs, Philip L.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">673-679</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Folate-conjugated metal chelates have been proposed as potential imaging agents for cancers that overexpress folate receptors.  In a previous study, folic acid was linked through its Î³-carboxyl group to deferoxamine (DF), and the 67Ga-labeled complex ([67Ga]DF-folate) was examd. for in vivo tumor targeting efficiency in athymic mice with a human tumor cell implant.  Although superb tumor-to-background contrast was obtained, slow hepatobiliary clearance would compromise imaging of abdominal tumors such as ovarian cancer.  In the present study, folic acid was conjugated to an alternative chelator, diethylenetriaminepentaacetic acid (DTPA), via an ethylenediamine spacer.  The desired DTPA-folate(Î³) regioisomer was synthesized by two different approaches, purified by reversed phase column chromatog., and characterized mainly by anal. HPLC, mass spectroscopy, and NMR.  In cultured tumor cells, uptake of [111In]DTPA-folate(Î³) was found to be specific for folate receptor-bearing cells, and the kinetics of uptake were similar to those of free folate and other folate-conjugated mols.  In the normal rat, i.v. administered [111In]DTPA-folate(Î³) was found to be rapidly excreted into the urine, giving intestinal levels of radiotracer 10-fold lower than those obsd. with [67Ga]DF-folate(Î³) at 4 h.  In a preliminary mouse imaging study, a folate receptor-pos. KB cell tumor was readily visualized by Î³ scintigraphy 1 h following i.v. administration of [111In]DTPA-folate(Î³).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgg4nZCBf__rVg90H21EOLACvtfcHk0ljr3qFOzh0WQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlslGmsbc%253D&md5=dec09d0d52f8d32ce6d7b6e1016f5f5a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbc9701297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9701297%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLantrip%26aufirst%3DD.%2BA.%26aulast%3DWaters%26aufirst%3DD.%2BJ.%26aulast%3DMathias%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DM.%2BA.%26aulast%3DFuchs%26aufirst%3DP.%2BL.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%255B111In%255DDTPA-folate%2520for%2520use%2520as%2520a%2520tumor-targeted%2520radiopharmaceutical%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D673%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Cytotoxicity of folate-<i>Pseudomonas</i> exotoxin conjugates toward tumor cells. Contribution of translocation domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">24847</span><span class="NLM_x">â</span> <span class="NLM_lpage">24854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=24847-24854&author=C.+P.+Leamonauthor=I.+Pastanauthor=P.+S.+Low&title=Cytotoxicity+of+folate-Pseudomonas+exotoxin+conjugates+toward+tumor+cells.+Contribution+of+translocation+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DPastan%26aufirst%3DI.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCytotoxicity%2520of%2520folate-Pseudomonas%2520exotoxin%2520conjugates%2520toward%2520tumor%2520cells.%2520Contribution%2520of%2520translocation%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D24847%26epage%3D24854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Cytotoxicity of momordin-folate conjugates in cultured human cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">24966</span><span class="NLM_x">â</span> <span class="NLM_lpage">24971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=24966-24971&author=C.+P.+Leamonauthor=P.+S.+Low&title=Cytotoxicity+of+momordin-folate+conjugates+in+cultured+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCytotoxicity%2520of%2520momordin-folate%2520conjugates%2520in%2520cultured%2520human%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D24966%26epage%3D24971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mayor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabharanjak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxfield, F. R.</span><span> </span><span class="NLM_article-title">Cholesterol-dependent retention of GPI-anchored proteins in endosomes</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4626</span><span class="NLM_x">â</span> <span class="NLM_lpage">4638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1093%2Femboj%2F17.16.4626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=9707422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1cXlslOhsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=4626-4638&author=S.+Mayorauthor=S.+Sabharanjakauthor=F.+R.+Maxfield&title=Cholesterol-dependent+retention+of+GPI-anchored+proteins+in+endosomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol-dependent retention of GPI-anchored proteins in endosomes</span></div><div class="casAuthors">Mayor, Satyajit; Sabharanjak, Shefali; Maxfield, Frederick R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4626-4638</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Several cell surface eukaryotic proteins have a glycosylphosphatidylinositol (GPI) modification at the C-terminal end that serves as their sole means of membrane anchoring.  Using fluorescently labeled ligands and digital fluorescence microscopy, we show that contrary to the potocytosis model, GPI-anchored proteins are internalized into endosomes that contain markers for both receptor-mediated uptake (e.g. transferrin) and fluid phase endocytosis (e.g. dextrans).  This was confirmed by immunogold electron microscopy and the observation that a fluorescent folate deriv. bound to the GPI-anchored folate receptor is internalized into the same compartment as co-internalized horseradish peroxidase-transferrin; the folate fluorescence was quenched when cells subsequently were incubated with diaminobenzidine and H2O2.  Most of the GPI-anchored proteins are recycled back to the plasma membrane but at a rate that is at least 3-fold slower than C6-NBD-sphingomyelin or recycling receptors.  This endocytic retention is regulated by the level of cholesterol in cell membranes; GPI-anchored proteins are recycled back to the cell surface at the same rate as recycling transferrin receptors and C6-NBD-sphingomyelin in cholesterol-depleted cells.  Cholesterol-dependent endocytic sorting of GPI-anchored proteins is consistent with the involvement of specialized lipid domains or 'rafts' in endocytic sorting.  These results provide an alternative explanation for GPI-requiring functions of some GPI-anchored proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlM2pzgdrULVg90H21EOLACvtfcHk0ljr3qFOzh0WQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslOhsL0%253D&md5=f665f485114eddd34f174e2039031043</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.16.4626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.16.4626%26sid%3Dliteratum%253Aachs%26aulast%3DMayor%26aufirst%3DS.%26aulast%3DSabharanjak%26aufirst%3DS.%26aulast%3DMaxfield%26aufirst%3DF.%2BR.%26atitle%3DCholesterol-dependent%2520retention%2520of%2520GPI-anchored%2520proteins%2520in%2520endosomes%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D4626%26epage%3D4638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kamen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdevila, A.</span><span> </span><span class="NLM_article-title">Receptor-mediated folate accumulation is regulated by the cellular folate content</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">5983</span><span class="NLM_x">â</span> <span class="NLM_lpage">5987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=5983-5987&author=B.+A.+Kamenauthor=A.+Capdevila&title=Receptor-mediated+folate+accumulation+is+regulated+by+the+cellular+folate+content"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamen%26aufirst%3DB.%2BA.%26aulast%3DCapdevila%26aufirst%3DA.%26atitle%3DReceptor-mediated%2520folate%2520accumulation%2520is%2520regulated%2520by%2520the%2520cellular%2520folate%2520content%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1986%26volume%3D83%26spage%3D5983%26epage%3D5987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ladino, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourret, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedersha, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmacher, V. S.</span><span> </span><span class="NLM_article-title">Folate-maytansinoids: target-selective drugs of low molecular weight</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">â</span> <span class="NLM_lpage">864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C859%3A%3AAID-IJC16%3E3.0.CO%3B2-%23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=9399666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2sXnslOqsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1997&pages=859-864&author=C.+A.+Ladinoauthor=R.+V.+Chariauthor=L.+A.+Bourretauthor=N.+L.+Kedershaauthor=V.+S.+Goldmacher&title=Folate-maytansinoids%3A+target-selective+drugs+of+low+molecular+weight"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-maytansinoids: target-selective drugs of low molecular weight</span></div><div class="casAuthors">Ladino, Cynthia A.; Chari, Ravi V. J.; Bourret, Lizabeth A.; Kedersha, Nancy L.; Goldmacher, Victor S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">859-864</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Folate receptor is over-expressed in a variety of carcinomas.  To design a cytotoxic drug that would selectively target these carcinomas, we synthesized folate-maytansinoids.  These drugs showed high affinity toward folate receptor, appeared to enter cells exclusively via the folate receptor-mediated caveolar pathway and displayed high cytotoxic potency (in the range of 10-11 to 10-10M) and remarkable selectivity for folate receptor-expressing carcinoma cell lines.  Folate-maytansinoids represent a new class of tumor-specific agents in which the targeting and the cytotoxic function can be altered independently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxUw3TqJLHJbVg90H21EOLACvtfcHk0lg2YQB1x7wKOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnslOqsrg%253D&md5=67e0e0a918dae7616220a73876628a23</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C859%3A%3AAID-IJC16%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819971210%252973%253A6%253C859%253A%253AAID-IJC16%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DLadino%26aufirst%3DC.%2BA.%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DBourret%26aufirst%3DL.%2BA.%26aulast%3DKedersha%26aufirst%3DN.%2BL.%26aulast%3DGoldmacher%26aufirst%3DV.%2BS.%26atitle%3DFolate-maytansinoids%253A%2520target-selective%2520drugs%2520of%2520low%2520molecular%2520weight%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1997%26volume%3D73%26spage%3D859%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Measurement of endosome pH following folate receptor-mediated endocytosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">1312</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">â</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1312&publication_year=1996&pages=237-242&author=R.+J.+Leeauthor=S.+Wangauthor=P.+S.+Low&title=Measurement+of+endosome+pH+following+folate+receptor-mediated+endocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DMeasurement%2520of%2520endosome%2520pH%2520following%2520folate%2520receptor-mediated%2520endocytosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1996%26volume%3D1312%26spage%3D237%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, P. L.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of Taxol-folic acid conjugates as targeted antineoplastics</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">â</span> <span class="NLM_lpage">2414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2397-2414&author=J.+W.+Leeauthor=J.+Y.+Luauthor=P.+S.+Lowauthor=P.+L.+Fuchs&title=Synthesis+and+evaluation+of+Taxol-folic+acid+conjugates+as+targeted+antineoplastics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DJ.%2BY.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DFuchs%26aufirst%3DP.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520Taxol-folic%2520acid%2520conjugates%2520as%2520targeted%2520antineoplastics%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2397%26epage%3D2414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">â</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1124%2Fjpet.106.117648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17289839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=462-468&author=J.+Yangauthor=H.+Chenauthor=I.+R.+Vlahovauthor=J.+X.+Chengauthor=P.+S.+Low&title=Characterization+of+the+pH+of+folate+receptor-containing+endosomes+and+the+rate+of+hydrolysis+of+internalized+acid-labile+folate-drug+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates</span></div><div class="casAuthors">Yang, Jun; Chen, Hongtao; Vlahov, Iontcho R.; Cheng, Ji-Xin; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">462-468</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the widely accepted assumption that most endosomal compartments are acidic, evaluation of the efficiency of pH-dependent drug release from a ligand-targeted drug conjugate during receptor-mediated endocytosis is lacking.  Therefore, the authors have characterized the kinetics of pH-dependent drug release from a model folate-drug conjugate during folate receptor (FR)-mediated endosomal trafficking.  For this purpose, the authors synthesized an acid-labile folate-fluorescence resonance energy transfer reporter (ALFR) that emits green fluorescence (BODIPY FL, 6-((4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diazas-indacene-3-propionyl)amino) hexanoic acid) only after acid-catalyzed hydrolysis of the acyl hydrazone linker.  In a cell-free system, cleavage of ALFR was found to be efficient only at acidic pH values (t1/2 = 1.95, 4.63, and 75 h at pH 4, 5, and 6, resp.) and essentially resistant to hydrolysis at pH 7.  Curiously, when applied to folate receptor-expressing cancer cells, the acid-labile folate-linked probe exhibited little or no recovery of BODIPY FL fluorescence (green), even after 55 h of incubation, arguing very inefficient cleavage within the FR endocytic pathway.  To understand this unanticipated observation, the authors measured the pH of FR-contg. endosomes using ratiometric fluorescence microscopy and obsd. that most FR+ endosomes are only mildly acidic (av. â¼pH 6.5).  Taken together, these data argue that the FR-trafficking pathway does not involve acidic compartments and that acyl hydrazone linkers may constitute a poor option for FR-mediated drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_WR8Ij4-63bVg90H21EOLACvtfcHk0lh7w_ywTDuRYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehtLw%253D&md5=35f083bc26b11a1077bacb1f19d2476e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.117648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.117648%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCharacterization%2520of%2520the%2520pH%2520of%2520folate%2520receptor-containing%2520endosomes%2520and%2520the%2520rate%2520of%2520hydrolysis%2520of%2520internalized%2520acid-labile%2520folate-drug%2520conjugates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D462%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindl, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">â</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060145g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Kgt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1226-1232&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=P.+J.+Kleindlauthor=M.+Vetzelauthor=E.+Westrick&title=Synthesis+and+biological+evaluation+of+EC140%3A+a+novel+folate-targeted+vinca+alkaloid+conjugate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of EC140: A Novel Folate-Targeted Vinca Alkaloid Conjugate</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Kleindl, Paul J.; Vetzel, Marilynn; Westrick, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1226-1232</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel folate conjugate of desacetylvinblastine monohydrazide (DAVLBH), herein referred to as EC140, was designed and evaluated for biol. activity against folate receptor (FR)-pos. cells and tumors.  EC140 was produced by coupling a peptidic analog of the vitamin folic acid to DAVLBH via an acylhydrazone bond.  This water-sol. conjugate was found to retain high affinity for FR-pos. cells, and it produced specific, dose-responsive activity in vitro.  Initial in vivo tests confirmed EC140's activity in both syngeneic and xenograft models.  Hence, enduring complete responses were obsd. in animals bearing established, s.c. tumors prior to therapy using regimens that produced minor toxicity.  In contrast, treatment with the unconjugated DAVLBH drug produced nominal efficacy when dosed at its MTD.  Overall, EC140's performance in vitro and in vivo warrants further preclin. study before this novel targeted chemotherapeutic is considered for clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ7-32DTohULVg90H21EOLACvtfcHk0lh7w_ywTDuRYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Kgt7g%253D&md5=d5e26d02977f76ef9343b55a719dbdf3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbc060145g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060145g%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DKleindl%26aufirst%3DP.%2BJ.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DWestrick%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520EC140%253A%2520a%2520novel%2520folate-targeted%2520vinca%2520alkaloid%2520conjugate%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D1226%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleindl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4434</span><span class="NLM_x">â</span> <span class="NLM_lpage">4442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4434-4442&author=J.+A.+Reddyauthor=R.+Dortonauthor=E.+Westrickauthor=A.+Dawsonauthor=T.+Smithauthor=L.+C.+Xuauthor=M.+Vetzelauthor=P.+Kleindlauthor=I.+R.+Vlahovauthor=C.+P.+Leamon&title=Preclinical+evaluation+of+EC145%2C+a+folate-vinca+alkaloid+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DDorton%26aufirst%3DR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DDawson%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DKleindl%26aufirst%3DP.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DPreclinical%2520evaluation%2520of%2520EC145%252C%2520a%2520folate-vinca%2520alkaloid%2520conjugate%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4434%26epage%3D4442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Vlashi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1868</span><span class="NLM_x">â</span> <span class="NLM_lpage">1875</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp900158d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KntrbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1868-1875&author=E.+Vlashiauthor=J.+E.+Sturgisauthor=M.+Thomasauthor=P.+S.+Low&title=Real+time%2C+noninvasive+imaging+and+quantitation+of+the+accumulation+of+ligand-targeted+drugs+into+receptor-expressing+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Real Time, Noninvasive Imaging and Quantitation of the Accumulation of Ligand-Targeted Drugs into Receptor-Expressing Solid Tumors</span></div><div class="casAuthors">Vlashi, Erina; Sturgis, Jennifer E.; Thomas, Mini; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1868-1875</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted therapies are emerging as a preferred strategy for treatment of cancer and other diseases.  To evaluate the effect of high affinity receptors on the rate and extent of tumor penetration of receptor-targeted drugs, the authors have characterized the kinetics of folate-rhodamine uptake by folate receptor (FR)-expressing tumors in live mice.  Folate-rhodamine was selected to model receptor-targeted drugs, because (i) it has high affinity (Kd = 10-9 M) for FR-rich tumors, (ii) its uptake can be monitored in vivo by multiphoton microscopy, and (iii) five folate-targeted drugs of similar size are currently undergoing clin. trials.  The authors demonstrate that folate-rhodamine sats. tumor FR in <5 min, <30 min, and <100 min following i.v., paraorbital, and i.p. injection, resp.; complete clearance of folate-rhodamine from receptor-neg. tissues requires â¥50 min, and a "binding site barrier" may retard, but does not prevent, penetration of the ligand-targeted drug.  The authors conclude that low mol. wt. ligand-targeted drugs have appropriate pharmacokinetic properties for tumor-selective delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0ttlLS39mbVg90H21EOLACvtfcHk0ljwByJHuwSXsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KntrbJ&md5=feb728a1117b44790d3de6d7f8a769d2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fmp900158d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp900158d%26sid%3Dliteratum%253Aachs%26aulast%3DVlashi%26aufirst%3DE.%26aulast%3DSturgis%26aufirst%3DJ.%2BE.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DReal%2520time%252C%2520noninvasive%2520imaging%2520and%2520quantitation%2520of%2520the%2520accumulation%2520of%2520ligand-targeted%2520drugs%2520into%2520receptor-expressing%2520solid%2520tumors%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D1868%26epage%3D1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamineâfolate, a potential radiopharmaceutical for tumor imaging</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">â</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9500709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK28XivVarsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=56-62&author=S.+Wangauthor=R.+J.+Leeauthor=C.+J.+Mathiasauthor=M.+A.+Greenauthor=P.+S.+Low&title=Synthesis%2C+purification%2C+and+tumor+cell+uptake+of+67Ga-deferoxamine%E2%88%92folate%2C+a+potential+radiopharmaceutical+for+tumor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Purification, and Tumor Cell Uptake of 67Ga-Deferoxamine-Folate, a Potential Radiopharmaceutical for Tumor Imaging</span></div><div class="casAuthors">Wang, Susan; Lee, Robert J.; Mathias, Carla J.; Green, Mark A.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-62</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The vitamin folic acid was covalently linked to the chelating agent deferoxamine (DF) via an amide bond using a simple carbodiimide coupling reaction.  A mixt. of two isomers, DF-folate(Î±) and DF-folate(Î³), was produced involving the Î±- and Î³-carboxyl group of folic acid, resp.  These two isomers were sepd. by anion-exchange chromatog. using a NH4HCO3 gradient.  Competitive binding studies revealed that only the DF-folate(Î³) is recognized by the folate receptor on KB cells, interacting with an affinity comparable to unconjugated folic acid.  The DF-folate conjugates were radiolabeled with the Î³-emitting radionuclide 67Ga3+ and tested for uptake by cultured KB cells overexpressing the folate receptor.  The cellular accumulation of 67Ga-DF-folate(Î³) complex was found to be time-, temp.-, and concn.-dependent.  The 67Ga-DF-folate(Î³) tracer exhibited rapid uptake kinetics in cell culture with a t1/2 of â¼3 min.  The KB cell assocn. of 67Ga-DF-folate(Î³) was competitively blocked by free folic acid, indicating that uptake of the 67Ga-DF-folate(Î³) was specifically mediated by the folate receptor.  Since the folate receptor is overexpressed on the surfaces of many neoplastic cells, these results suggest that 67Ga-DF-folate(Î³) complex might be useful as a diagnostic agent for noninvasive imaging of folate receptor-positing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-l2E_I0vsmLVg90H21EOLACvtfcHk0ljwByJHuwSXsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVarsA%253D%253D&md5=20ebe8d7e80ab68c0bf5f53f71c3c3d9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fbc9500709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9500709%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DMathias%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DM.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%252C%2520purification%252C%2520and%2520tumor%2520cell%2520uptake%2520of%252067Ga-deferoxamine%25E2%2588%2592folate%252C%2520a%2520potential%2520radiopharmaceutical%2520for%2520tumor%2520imaging%26jtitle%3DBioconjugate%2520Chem.%26date%3D1996%26volume%3D7%26spage%3D56%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhapuram, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmacher, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">6376</span><span class="NLM_x">â</span> <span class="NLM_lpage">6382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6376-6382&author=J.+A.+Reddyauthor=E.+Westrickauthor=H.+K.+Santhapuramauthor=S.+J.+Howardauthor=M.+L.+Millerauthor=M.+Vetzelauthor=I.+Vlahovauthor=R.+V.+Chariauthor=V.+S.+Goldmacherauthor=C.+P.+Leamon&title=Folate+receptor-specific+antitumor+activity+of+EC131%2C+a+folate-maytansinoid+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DSanthapuram%26aufirst%3DH.%2BK.%26aulast%3DHoward%26aufirst%3DS.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BL.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DVlahov%26aufirst%3DI.%26aulast%3DChari%26aufirst%3DR.%2BV.%26aulast%3DGoldmacher%26aufirst%3DV.%2BS.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DFolate%2520receptor-specific%2520antitumor%2520activity%2520of%2520EC131%252C%2520a%2520folate-maytansinoid%2520conjugate%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6376%26epage%3D6382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I.</span><span> </span><span class="NLM_article-title">Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9839</span><span class="NLM_x">â</span> <span class="NLM_lpage">9844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1158%2F0008-5472.CAN-08-2341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19047164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtbnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9839-9844&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=M.+Vetzelauthor=R.+Dortonauthor=E.+Westrickauthor=N.+Parkerauthor=Y.+Wangauthor=I.+Vlahov&title=Folate+targeting+enables+durable+and+specific+antitumor+responses+from+a+therapeutically+null+tubulysin+B+analogue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vetzel, Marilynn; Dorton, Ryan; Westrick, Elaine; Parker, Nikki; Wang, Yu; Vlahov, Iontcho</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9839-9844</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The membrane-bound high-affinity folate receptor (FR) is highly expressed on a wide range of primary and metastatic human cancers, such as those originating in ovary, lung, breast, endometrium, kidney, and brain.  Because folate-linked conjugates bind to and become internalized within FR-expressing cells (similar to that of free folic acid), we explored the possibility of using the folate ligand to target a potent, semisynthetic analog of the microtubule inhibitor tubulysin B to FR-enriched tumors.  When tested in vitro, a novel folate conjugate, herein referred to as EC0305, was found to specifically inhibit the growth of a panel of FR-pos. cell lines (IC50 range, 1-10 nmol/L) in a dose-dependent manner, whereas cells lacking FR expression were unaffected.  The potency of EC0305 was also confirmed against a human KB xenograft-nu/nu mouse cancer model.  Here, a brief three times per wk, 2-wk regimen yielded remarkable antitumor activity (100% tumor-free animals) without causing significant wt. loss or major organ tissue degeneration.  In contrast, antitumor activity was completely abolished in EC0305-treated animals that were co-dosed with an excess of a nontoxic folate-contg. analog, thereby confirming that the antitumor effect of this agent was mediated by FRs.  The advantage provided by folate conjugation was further proved by the untargeted free drug, which was found to be completely inactive at both tolerable and highly toxic dose levels.  Collectively, these results show that this potent antiproliferative tubulysin compd. can be specifically delivered to FR-pos. tumors to provide substantial therapeutic benefit using well-tolerable dosing regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERb5UAdy0OLVg90H21EOLACvtfcHk0ljHNAPtTR5MMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtbnM&md5=bd1df729a17da7cd97983e3c65edc6ff</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2341%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DDorton%26aufirst%3DR.%26aulast%3DWestrick%26aufirst%3DE.%26aulast%3DParker%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVlahov%26aufirst%3DI.%26atitle%3DFolate%2520targeting%2520enables%2520durable%2520and%2520specific%2520antitumor%2520responses%2520from%2520a%2520therapeutically%2520null%2520tubulysin%2520B%2520analogue%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9839%26epage%3D9844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westrick, E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">â</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc049709b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFOmu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=803-811&author=C.+P.+Leamonauthor=J.+A.+Reddyauthor=I.+R.+Vlahovauthor=M.+Vetzelauthor=N.+Parkerauthor=J.+S.+Nicosonauthor=L.+C.+Xuauthor=E.+Westrick&title=Synthesis+and+biological+evaluation+of+EC72%3A+a+new+folate-targeted+chemotherapeutic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of EC72: A New Folate-Targeted Chemotherapeutic</span></div><div class="casAuthors">Leamon, Christopher P.; Reddy, Joseph A.; Vlahov, Iontcho R.; Vetzel, Marilynn; Parker, Nikki; Nicoson, Jeffrey S.; Xu, Le-Cun; Westrick, Elaine</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">803-811</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel folate conjugate of mitomycin C, herein referred to as EC72, was designed and evaluated for biol. activity against FR-pos. cells and tumors.  EC72 was produced by coupling folic acid-Î³-cysteine to 7-N-modified MMC via a disulfide bond.  This water sol. conjugate was found to retain high affinity for FR-pos. cells, and it produced dose responsive activity in vitro against a panel of folate receptor (FR)-pos. cell lines.  EC72's activity was considered to be targeted and specific for the FR since (i) excess folic acid blocked biol. activity, and (ii) FR-neg. cell lines were unresponsive to this drug.  Initial in vivo tests confirmed EC72's activity in both syngeneic and xenograft models, and this activity occurred in the apparent absence of gross or pathol. toxicity.  These results are significant, since daily dosing of EC72 for more than 30 consecutive days yielded no evidence of myelosuppression or toxicity to major organs, including the FR-pos. kidneys.  The latter observation supports published data, indicating that the apically oriented kidney proximal tubule FRs function to salvage folates prior to their excretion and to return these mols. back into systemic circulation.  Overall, EC72's performance in vitro and in vivo warrants further preclin. study before this novel targeted chemotherapeutic is considered for clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjrIFT4HT-2rVg90H21EOLACvtfcHk0ljHNAPtTR5MMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFOmu7g%253D&md5=53335ae1329fe478972c189eac23a337</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbc049709b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc049709b%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DVlahov%26aufirst%3DI.%2BR.%26aulast%3DVetzel%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DN.%26aulast%3DNicoson%26aufirst%3DJ.%2BS.%26aulast%3DXu%26aufirst%3DL.%2BC.%26aulast%3DWestrick%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520EC72%253A%2520a%2520new%2520folate-targeted%2520chemotherapeutic%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D803%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Henne, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doorneweerd, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenbrink, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Synthesis and activity of a folate peptide camptothecin prodrug</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5350</span><span class="NLM_x">â</span> <span class="NLM_lpage">5355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5350-5355&author=W.+A.+Henneauthor=D.+D.+Doorneweerdauthor=A.+R.+Hilgenbrinkauthor=S.+A.+Kularatneauthor=P.+S.+Low&title=Synthesis+and+activity+of+a+folate+peptide+camptothecin+prodrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenne%26aufirst%3DW.%2BA.%26aulast%3DDoorneweerd%26aufirst%3DD.%2BD.%26aulast%3DHilgenbrink%26aufirst%3DA.%2BR.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520a%2520folate%2520peptide%2520camptothecin%2520prodrug%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5350%26epage%3D5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Crippa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seregni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavoni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarfone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buraggi, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombardieri, E.</span><span> </span><span class="NLM_article-title">Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">31A</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">â</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31A&publication_year=1995&pages=686-690&author=F.+Crippaauthor=G.+Bolisauthor=E.+Seregniauthor=N.+Gavoniauthor=G.+Scarfoneauthor=C.+Ferrarisauthor=G.+L.+Buraggiauthor=E.+Bombardieri&title=Single-dose+intraperitoneal+radioimmunotherapy+with+the+murine+monoclonal+antibody+I-131+MOv18%3A+clinical+results+in+patients+with+minimal+residual+disease+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrippa%26aufirst%3DF.%26aulast%3DBolis%26aufirst%3DG.%26aulast%3DSeregni%26aufirst%3DE.%26aulast%3DGavoni%26aufirst%3DN.%26aulast%3DScarfone%26aufirst%3DG.%26aulast%3DFerraris%26aufirst%3DC.%26aulast%3DBuraggi%26aufirst%3DG.%2BL.%26aulast%3DBombardieri%26aufirst%3DE.%26atitle%3DSingle-dose%2520intraperitoneal%2520radioimmunotherapy%2520with%2520the%2520murine%2520monoclonal%2520antibody%2520I-131%2520MOv18%253A%2520clinical%2520results%2520in%2520patients%2520with%2520minimal%2520residual%2520disease%2520of%2520ovarian%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1995%26volume%3D31A%26spage%3D686%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arienti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolls, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Re, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggermont, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goey, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratama, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nooy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raspagliesi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravagnani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarfone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trimbos, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnaar, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolhuis, R. L.</span><span> </span><span class="NLM_article-title">Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody</span> <span class="citation_source-journal">J. Natl. Cancer. Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">â</span> <span class="NLM_lpage">1469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1093%2Fjnci%2F87.19.1463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=7674333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A280%3ADyaK2MvgsVKntQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1995&pages=1463-1469&author=S.+Canevariauthor=G.+Stoterauthor=F.+Arientiauthor=G.+Bollsauthor=M.+I.+Colnaghiauthor=E.+M.+Di+Reauthor=A.+M.+Eggermontauthor=S.+H.+Goeyauthor=J.+W.+Gratamaauthor=C.+H.+Lamersauthor=M.+A.+Nooyauthor=G.+Parmianiauthor=F.+Raspagliesiauthor=F.+Ravagnaniauthor=G.+Scarfoneauthor=J.+B.+Trimbosauthor=S.+O.+Warnaarauthor=R.+L.+Bolhuis&title=Regression+of+advanced+ovarian+carcinoma+by+intraperitoneal+treatment+with+autologous+T+lymphocytes+retargeted+by+a+bispecific+monoclonal+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody</span></div><div class="casAuthors">Canevari S; Stoter G; Arienti F; Bolis G; Colnaghi M I; Di Re E M; Eggermont A M; Goey S H; Gratama J W; Lamers C H; et al</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1463-9</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">BACKGROUND:  The high frequency of relapse after induction chemotherapy of advanced ovarian carcinoma calls for new therapeutic approaches.  Lysis of ovarian carcinoma cells can be achieved by retargeting of T lymphocytes using F(ab')2 fragments of the bispecific monoclonal antibody (MAb) OC/TR, which is directed to the CD3 molecule on T lymphocytes and to the folate receptor on ovarian carcinoma cells.  PURPOSE:  Our purpose was to assess in ovarian carcinoma patients the antitumor activity of in vitro-activated autologous peripheral blood T lymphocytes retargeted with OC/TR.  METHODS:  Patients with epithelial ovarian cancer (International Federation of Gynecology and Obstetrics stages III and IV) meeting specific criteria were eligible to enter a phase II immunotherapy trial.  Before immunotherapy, the 28 patients who entered the trial underwent laparotomy to reduce their tumor load and to allow measurement of all indicator lesions.  They then received two cycles of five daily intraperitoneal infusions of autologous in vitro activated peripheral blood T lymphocytes retargeted with OC/TR plus recombinant interleukin 2 (IL-2) with (n = 11) or without (n = 17) a second daily infusion of OC/TR F(ab')2 and IL-2.  Response to treatment could be assessed in 26 patients following explorative laparotomy; time to progression could be assessed in 27 patients.  RESULTS:  Seven patients had clinical evidence of progressive disease after treatment and therefore did not undergo laparotomy.  Of the 19 patients evaluated by surgery and histology, three showed complete response, one showed complete intraperitoneal response with progressive disease in retroperitoneal lymph nodes, three showed partial response, seven had stable disease, and five had progressive disease.  The overall intraperitoneal response rate was 27% (95% confidence interval [CI] = 10%-44%).  The complete responses seen in three patients lasted 26 months in one patient, 23 months in the second, and 18 months in the third.  Two patients were not assessable for response.  One of these patients had bowel perforation during catheter removal, which precluded further evaluation.  The second patient was positive only by cytologic examination before immunotherapy, was tumor free at laparotomy after immunotherapy, and remained so for the entire 21 months of follow-up, as determined by cytologic examination of random biopsy specimens.  The median time to disease progression in the 15 assessable patients plus those who had stable disease was 11 months (95% CI = 6-18 months).  Immunotherapy-related toxic effects included mild to moderate fever, nausea, emesis, and fatigue.  Anti-mouse antibodies were detectable by the end of the treatment in 21 of 25 patients tested.  CONCLUSIONS:  Locoregional immunotherapy of ovarian cancer with bispecific MAb-retargeted T lymphocytes can result in tumor regression.  Toxicity was mild to moderate and only transient.  IMPLICATIONS:  Improvement in systemic antitumor responses is needed before this approach can prove useful as adjunctive treatment following induction chemotherapy in patients with minimal residual disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRM_FUFogOCGZyxfu64m4ffW6udTcc2ebz4qZ7NZozNbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MvgsVKntQ%253D%253D&md5=48952650de6b77951092eaade2d7acc2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F87.19.1463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F87.19.1463%26sid%3Dliteratum%253Aachs%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DStoter%26aufirst%3DG.%26aulast%3DArienti%26aufirst%3DF.%26aulast%3DBolls%26aufirst%3DG.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26aulast%3DDi%2BRe%26aufirst%3DE.%2BM.%26aulast%3DEggermont%26aufirst%3DA.%2BM.%26aulast%3DGoey%26aufirst%3DS.%2BH.%26aulast%3DGratama%26aufirst%3DJ.%2BW.%26aulast%3DLamers%26aufirst%3DC.%2BH.%26aulast%3DNooy%26aufirst%3DM.%2BA.%26aulast%3DParmiani%26aufirst%3DG.%26aulast%3DRaspagliesi%26aufirst%3DF.%26aulast%3DRavagnani%26aufirst%3DF.%26aulast%3DScarfone%26aufirst%3DG.%26aulast%3DTrimbos%26aufirst%3DJ.%2BB.%26aulast%3DWarnaar%26aufirst%3DS.%2BO.%26aulast%3DBolhuis%26aufirst%3DR.%2BL.%26atitle%3DRegression%2520of%2520advanced%2520ovarian%2520carcinoma%2520by%2520intraperitoneal%2520treatment%2520with%2520autologous%2520T%2520lymphocytes%2520retargeted%2520by%2520a%2520bispecific%2520monoclonal%2520antibody%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D1995%26volume%3D87%26spage%3D1463%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Melani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicosia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luison, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casorati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshhar, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M. P.</span><span> </span><span class="NLM_article-title">Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4146</span><span class="NLM_x">â</span> <span class="NLM_lpage">4154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4146-4154&author=C.+Melaniauthor=M.+Figiniauthor=D.+Nicosiaauthor=E.+Luisonauthor=V.+Ramakrishnaauthor=G.+Casoratiauthor=G.+Parmianiauthor=Z.+Eshharauthor=S.+Canevariauthor=M.+P.+Colombo&title=Targeting+of+interleukin+2+to+human+ovarian+carcinoma+by+fusion+with+a+single-chain+Fv+of+antifolate+receptor+antibody"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelani%26aufirst%3DC.%26aulast%3DFigini%26aufirst%3DM.%26aulast%3DNicosia%26aufirst%3DD.%26aulast%3DLuison%26aufirst%3DE.%26aulast%3DRamakrishna%26aufirst%3DV.%26aulast%3DCasorati%26aufirst%3DG.%26aulast%3DParmiani%26aufirst%3DG.%26aulast%3DEshhar%26aufirst%3DZ.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520of%2520interleukin%25202%2520to%2520human%2520ovarian%2520carcinoma%2520by%2520fusion%2520with%2520a%2520single-chain%2520Fv%2520of%2520antifolate%2520receptor%2520antibody%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4146%26epage%3D4154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Spannuth, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sood, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. L.</span><span> </span><span class="NLM_article-title">Farletuzumab in epithelial ovarian carcinoma</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1517%2F14712591003592069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=20092424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=431-437&author=W.+A.+Spannuthauthor=A.+K.+Soodauthor=R.+L.+Coleman&title=Farletuzumab+in+epithelial+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Farletuzumab in epithelial ovarian carcinoma</span></div><div class="casAuthors">Spannuth, Whitney A.; Sood, Anil K.; Coleman, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">431-437</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Ovarian cancer is the leading cause of death from a gynecol. malignancy.  Recurrence is both common and lethal, necessitating the development of novel targeted therapies.  Farletuzumab (MORAb-003) is a humanized mAb with high affinity for folate receptor Î± (FRÎ±), a 38 kDa GPI-anchored protein that is overexpressed in 90% of epithelial ovarian cancers.Areas covered in this review: Preclin. and clin. trials, published or presented at national meetings from 2006 to the present, are presented in this review.What the reader will gain: Preclin. studies have demonstrated robust antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro, inhibition of tumor growth in ovarian tumor xenografts and a safe toxicol. profile in non-human primates.  Phase I and II studies have demonstrated single agent and combination therapy efficacy with minimal drug-specific toxicity.  The Phase III development plan in ovarian cancer patients includes combination chemotherapy studies in both platinum-sensitive (recently launched) and platinum-resistant (planned) recurrent disease.Take home message: FRÎ± is overexpressed in ovarian cancers but largely absent from normal tissue, making it an attractive therapeutic target.  Farletuzumab is a novel inhibitor of FRÎ± and has shown clin. efficacy in early phase trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0MP0Tnh8nJrVg90H21EOLACvtfcHk0lgpK5RxL82C4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsb8%253D&md5=71c0426b2f81493887249bc61923f157</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1517%2F14712591003592069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712591003592069%26sid%3Dliteratum%253Aachs%26aulast%3DSpannuth%26aufirst%3DW.%2BA.%26aulast%3DSood%26aufirst%3DA.%2BK.%26aulast%3DColeman%26aufirst%3DR.%2BL.%26atitle%3DFarletuzumab%2520in%2520epithelial%2520ovarian%2520carcinoma%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D431%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Kranz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinella, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, E. J.</span><span> </span><span class="NLM_article-title">Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">9057</span><span class="NLM_x">â</span> <span class="NLM_lpage">9061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=9057-9061&author=D.+M.+Kranzauthor=T.+A.+Patrickauthor=K.+E.+Brigleauthor=M.+J.+Spinellaauthor=E.+J.+Roy&title=Conjugates+of+folate+and+anti-T-cell-receptor+antibodies+specifically+target+folate-receptor-positive+tumor+cells+for+lysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKranz%26aufirst%3DD.%2BM.%26aulast%3DPatrick%26aufirst%3DT.%2BA.%26aulast%3DBrigle%26aufirst%3DK.%2BE.%26aulast%3DSpinella%26aufirst%3DM.%2BJ.%26aulast%3DRoy%26aufirst%3DE.%2BJ.%26atitle%3DConjugates%2520of%2520folate%2520and%2520anti-T-cell-receptor%2520antibodies%2520specifically%2520target%2520folate-receptor-positive%2520tumor%2520cells%2520for%2520lysis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D9057%26epage%3D9061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Cho, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranz, D. M.</span><span> </span><span class="NLM_article-title">Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">â</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9700244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2sXivF2htLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=338-346&author=B.+K.+Choauthor=E.+J.+Royauthor=T.+A.+Patrickauthor=D.+M.+Kranz&title=Single-chain+Fv%2Ffolate+conjugates+mediate+efficient+lysis+of+folate-receptor-positive+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Single-Chain Fv/Folate Conjugates Mediate Efficient Lysis of Folate-Receptor-Positive Tumor Cells</span></div><div class="casAuthors">Cho, Bryan K.; Roy, Edward J.; Patrick, Todd A.; Kranz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bispecific antibodies that bind to a tumor antigen and the T cell receptor (TCR) redirect cytotoxic T lymphocytes (CTL) to lyse tumor cells which have escaped normal immune recognition mechanisms.  One well-characterized tumor antigen, the folate receptor (FR), is expressed on most ovarian carcinomas and some types of brain cancer.  Recently, it was shown that conjugates of folate and anti-TCR antibodies are extremely potent bispecific agents that target tumor cells expressing the high-affinity folate receptor, but not normal cells expressing only the reduced folate carrier protein.  In this paper, it is shown that the size of these conjugates can be reduced to the smallest bispecific agent yet described (30 kDa) by attaching folate to a single-chain antibody, scFv, of the anti-TCR antibody KJ16.  The scFv/folate conjugates are as effective as IgG/folate conjugates in mediating lysis of FR+ tumor cells by CTL.  The optimal folate d. was in the range of 5-15 folate mols. per scFv or IgG mol., which yielded half-maximal lysis values (EC50) of approx. 40 pM (1.2 ng/mL for scFv).  Finally, the scFv/folate conjugates could efficiently target tumor cells even in the presence of free folic acid at concns. that are normally found in serum.  Compared to conventional bispecific antibodies, the small size of scFv/folate conjugates may prove advantageous in the ability to penetrate tumors and in reduced immunogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpSkfzcKlocLVg90H21EOLACvtfcHk0lgpK5RxL82C4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivF2htLc%253D&md5=c7e1c6b96b9097f1e7933dc2c3534f43</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbc9700244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9700244%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DB.%2BK.%26aulast%3DRoy%26aufirst%3DE.%2BJ.%26aulast%3DPatrick%26aufirst%3DT.%2BA.%26aulast%3DKranz%26aufirst%3DD.%2BM.%26atitle%3DSingle-chain%2520Fv%252Ffolate%2520conjugates%2520mediate%2520efficient%2520lysis%2520of%2520folate-receptor-positive%2520tumor%2520cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D338%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Rund, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holler, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranz, D. M.</span><span> </span><span class="NLM_article-title">Bispecific agents target endogenous murine T cells against human tumor xenografts</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">â</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2F%28SICI%291097-0215%2819990924%2983%3A1%3C141%3A%3AAID-IJC24%3E3.0.CO%3B2-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=10449621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1MXlvF2nt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=141-149&author=L.+A.+Rundauthor=B.+K.+Choauthor=T.+C.+Manningauthor=P.+D.+Hollerauthor=E.+J.+Royauthor=D.+M.+Kranz&title=Bispecific+agents+target+endogenous+murine+T+cells+against+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Bispecific agents target endogenous murine T cells against human tumor xenografts</span></div><div class="casAuthors">Rund, Laurie A.; Cho, Bryan K.; Manning, Thomas C.; Holler, Phillip D.; Roy, Edward J.; Kranz, David M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-149</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A variety of immunol. approaches to cancer treatment are currently being explored.  These include strategies designed to enhance or redirect the activity of T cells against tumors.  Bispecific antibodies comprise a class of agents capable of redirecting T cells by binding to a tumor antigen and the T-cell receptor (TCR).  In vivo pre-clin. testing of bispecific antibodies against human tumors has to date been limited to the use of immunodeficient mice that receive the bispecific agent, activated human effector T cells, and human tumor cells.  In this report, we show that TCR transgenic/RAG-I knockout mice (TCR/RAG) serve as a unique model allowing endogenous T cells to be redirected against transplanted human tumors.  The findings show that TCR/RAG mice (i) accepted transplants of human tumors, including the folate-receptor-pos. tumor line KB; (ii) contained endogenous cytotoxic T lymphocytes that could be activated in vivo with an antigenic peptide recognized by the transgenic TCR; (iii) rejected human tumors after treatment with the activating peptide and bispecific agents that contained folic acid covalently linked to an anti-TCR antibody.  Successful rejection was achieved with folate conjugates of Fab or scFv fragments.  Treatment with activating agents and bispecific conjugates resulted in the complete eradication of freshly transplanted tumors as well as significantly prolonging the survival of mice bearing established solid tumors.  Our results highlight the importance of including T-cell-activating modalities in combination with bispecific antibodies.  Addnl., we introduce a system that allows endogenous T cells to be redirected against human tumor xenografts and in which the T cells may be followed in vivo by use of a clonotypic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEvRidTOBqVrVg90H21EOLACvtfcHk0liItAvm0ILKYQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvF2nt7k%253D&md5=e145c77f666f5b9cd4b8da003cbb09c5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819990924%2983%3A1%3C141%3A%3AAID-IJC24%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819990924%252983%253A1%253C141%253A%253AAID-IJC24%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DRund%26aufirst%3DL.%2BA.%26aulast%3DCho%26aufirst%3DB.%2BK.%26aulast%3DManning%26aufirst%3DT.%2BC.%26aulast%3DHoller%26aufirst%3DP.%2BD.%26aulast%3DRoy%26aufirst%3DE.%2BJ.%26aulast%3DKranz%26aufirst%3DD.%2BM.%26atitle%3DBispecific%2520agents%2520target%2520endogenous%2520murine%2520T%2520cells%2520against%2520human%2520tumor%2520xenografts%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1999%26volume%3D83%26spage%3D141%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Knutson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krco, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelemen, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalli, K. R.</span><span> </span><span class="NLM_article-title">T-Cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4254</span><span class="NLM_x">â</span> <span class="NLM_lpage">4261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1200%2FJCO.2006.05.9311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16908932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGju7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=4254-4261&author=K.+L.+Knutsonauthor=C.+J.+Krcoauthor=C.+L.+Erskineauthor=K.+Goodmanauthor=L.+E.+Kelemenauthor=P.+J.+Wettsteinauthor=P.+S.+Lowauthor=L.+C.+Hartmannauthor=K.+R.+Kalli&title=T-Cell+immunity+to+the+folate+receptor+alpha+is+prevalent+in+women+with+breast+or+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">T-Cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer</span></div><div class="casAuthors">Knutson, Keith L.; Krco, Christopher J.; Erskine, Courtney L.; Goodman, Karin; Kelemen, Linda E.; Wettstein, Peter J.; Low, Philip S.; Hartmann, Lynn C.; Kalli, Kimberly R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4254-4261</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Studies have demonstrated that the generation of immunity to tumor antigens is assocd. with improved prognosis for many cancers.  A candidate antigen is the folate receptor alpha (FRÎ±), which is overexpressed in breast and ovarian cancers.  Our goal in this study was to attain a better understanding of the extent of endogenous FRÎ± immunity.  Methods: Using a CD4+ T cell epitope prediction algorithm, we predicted promiscuous epitopes of FRÎ±, and tested for immunity in 30 breast (n = 17) or ovarian (n = 13) cancer patients and 18 healthy donors using enzyme-linked immunospot anal.  Results: Fourteen peptides were predicted, seven each from the carboxy- and amino-terminus halves of the protein.  More than 70% of patients demonstrated immunity to at least one FRÎ± peptide.  Patients responded to an av. of 3 Â± 0.5 peptides, whereas healthy donors responded to 1 Â± 0.4 peptides (P = .004).  Five peptides were recognized by more than 25% of patients.  Responses to three peptides were higher (P < .05) in patients than in healthy donors, suggesting augmented immunity.  Compared with healthy individuals, patients developed higher immunity to the amino-terminus half of the receptor (P = .03).  There was no difference between each group in the responses to nonspecific (P = .2) and viral stimuli (P = .5).  Lastly, patients demonstrated elevated levels of FRÎ± antibodies consistent with a coordinated immune response.  Conclusion: These findings demonstrate that the FRÎ± is a target of the immune system in breast and ovarian cancer patients.  Understanding which antigens are targeted by the immune system may be important for prognosis or immune-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNdnWKnElStrVg90H21EOLACvtfcHk0liItAvm0ILKYQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGju7vF&md5=d7976f4a778bca6963073d98cca45b82</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.05.9311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.05.9311%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DK.%2BL.%26aulast%3DKrco%26aufirst%3DC.%2BJ.%26aulast%3DErskine%26aufirst%3DC.%2BL.%26aulast%3DGoodman%26aufirst%3DK.%26aulast%3DKelemen%26aufirst%3DL.%2BE.%26aulast%3DWettstein%26aufirst%3DP.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHartmann%26aufirst%3DL.%2BC.%26aulast%3DKalli%26aufirst%3DK.%2BR.%26atitle%3DT-Cell%2520immunity%2520to%2520the%2520folate%2520receptor%2520alpha%2520is%2520prevalent%2520in%2520women%2520with%2520breast%2520or%2520ovarian%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D4254%26epage%3D4261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0168-3659%2803%2900215-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12932634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVSktLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&pages=17-29&author=Y.+Luauthor=P.+S.+Low&title=Immunotherapy+of+folate+receptor-expressing+tumors%3A+review+of+recent+advances+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects</span></div><div class="casAuthors">Lu, Yingjuan; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The cell surface receptor for the vitamin folic acid (termed the folate receptor), is often elevated in cancers of the ovary, kidney, lung, mammary gland, brain, endometrium, and myeloid cells of hematopoietic origin.  Because the folate receptor (FR) is either absent from normal tissues or localized to the apical surfaces of polarized epithelia, where it is inaccessible to circulating drugs, folate-linked drugs do not normally accumulate in healthy tissues.  However, since the same receptor is fully accessible on cancer cells, it has frequently been exploited as a target for receptor-directed cancer therapies, including chemotherapies and immunotherapies.  In fact, most strategies for the immunotherapy of cancer have at some time been adapted to treat FR-expressing tumors.  In this article, recent progress in the retargeting of the immune system to folate receptor-expressing cancers is summarized and future strategies for redirecting natural killer cells, antibodies and cytotoxic T lymphocytes to this large class of malignancies are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrShPjiB9PSs7Vg90H21EOLACvtfcHk0lhQy0D9B6Hryg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVSktLw%253D&md5=a049999c82f8f567607bdeeec408790f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2803%2900215-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252803%252900215-3%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DImmunotherapy%2520of%2520folate%2520receptor-expressing%2520tumors%253A%2520review%2520of%2520recent%2520advances%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2003%26volume%3D91%26spage%3D17%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Yi, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Lopez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kularatne, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">â</span> <span class="NLM_lpage">1236</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp900070b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFWjtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1228-1236&author=Y.+S.+Yiauthor=W.+Ayala-Lopezauthor=S.+A.+Kularatneauthor=P.+S.+Low&title=Folate-targeted+hapten+immunotherapy+of+adjuvant-induced+arthritis%3A+comparison+of+hapten+potencies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Targeted Hapten Immunotherapy of Adjuvant-Induced Arthritis: Comparison of Hapten Potencies</span></div><div class="casAuthors">Yi, Young-Su; Ayala-Lopez, Wilfredo; Kularatne, Sumith A.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1228-1236</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously reported that disease symptoms can be greatly ameliorated in rodents with adjuvant-induced arthritis (AIA) by first immunizing the rodents against fluorescein and then treating the animals with folate-fluorescein.  In this targeted hapten therapy, folate-fluorescein was shown to decorate folate receptor (FR)-expressing activated macrophages with fluorescein (an immunogenic hapten), leading to binding of antifluorescein antibodies and the consequent elimination of the activated macrophages by Fc receptor-expressing immune cells.  In the current study, we compare the therapeutic potencies of a variety of FR-targeted haptens in treating the symptoms of AIA in rats.  Rats were immunized with either dinitrophenyl (DNP) or trinitrophenyl (TNP) conjugated to keyhole limpet hemocyanin followed by induction of AIA with heat-inactivated Mycobacterium butyricum.  Following development of arthritis, rats were treated with one of five folate-hapten conjugates (folate-DNP1, folate-DNP2, folate-DNP3, folate-FITC, or folate-TNP) at two different doses (30 nmol/kg or 200 nmol/kg) 5Ã/wk for 25 days.  Symptoms of AIA in treated rats, including paw swelling, arthritis score, splenomegaly, bone erosion, and FR+ activated macrophage d. in inflamed tissues, were quantitated over the course of therapy.  Although all folate-hapten conjugates promoted a redn. in disease symptoms, folate-TNP and folate-FITC proved to be more potent than any of the 3 folate-DNP conjugates.  We conclude that both folate-TNP and folate-FITC constitute promising haptens for use in FR-targeted immunotherapy of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRXVgay8kFe7Vg90H21EOLACvtfcHk0lhQy0D9B6Hryg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFWjtb8%253D&md5=a573c9e924c1a006a98f1b9a0b1df858</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fmp900070b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp900070b%26sid%3Dliteratum%253Aachs%26aulast%3DYi%26aufirst%3DY.%2BS.%26aulast%3DAyala-Lopez%26aufirst%3DW.%26aulast%3DKularatne%26aufirst%3DS.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate-targeted%2520hapten%2520immunotherapy%2520of%2520adjuvant-induced%2520arthritis%253A%2520comparison%2520of%2520hapten%2520potencies%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D1228%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Miotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupa, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regazzoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliabue, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span> </span><span class="NLM_article-title">Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fijc.2910390306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=2434438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaL2sXhslCgtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1987&pages=297-303&author=S.+Miottiauthor=S.+Canevariauthor=S.+Menardauthor=D.+Mezzanzanicaauthor=G.+Porroauthor=S.+M.+Pupaauthor=M.+Regazzoniauthor=E.+Tagliabueauthor=M.+I.+Colnaghi&title=Characterization+of+human+ovarian+carcinoma-associated+antigens+defined+by+novel+monoclonal+antibodies+with+tumor-restricted+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity</span></div><div class="casAuthors">Miotti, S.; Canevari, S.; Menard, S.; Mezzanzanica, D.; Porro, G.; Pupa, S. M.; Regazzoni, M.; Tagliabue, E.; Colnachi, M. I.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-303</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Three new monoclonal antibodies (MAbs) (MOv16, MOv18 and MOv19) were raised against human ovarian carcinoma.  To obtain more specific reagents, the following exptl. approach was adopted: (1) the selection of a poorly differentiated ovarian carcinoma which was unreactive with all the MAb previously selected in the authors' lab.; and (2) the application of a particular immunization protocol.  The reactivity of the selected MAbs was studied by solid-phase RIA on live and fixed cells from tumor cell lines and by immunofluorescence on frozen sections from surgical specimens.  The MAb MOv16 reacted with 60% of ovarian carcinomas as well as with a high percentage of other carcinomas and with some normal tissues.  In contrast, MOv18 and MOv19 appeared to have restricted specificities for ovarian carcinomas and cystadenomas.  Reactivity to other carcinomas was obsd. in a few cases and no reactivity was found to non-epithelial tumors or normal tissues.  Immunopptn. expts. indicated that MOv16 recognizes a 48-50 kilodalton (kDA) protein, whereas MOv18 and MOv19 both identify a 38-40 kDA glycoprotein band.  Cross-competition expts., together with a double-determinant immunoradiometric assay which uses MOv18 as catcher and MOv19 as tracer, suggested that they recognize different epitopes carried by the same mol.  Thus, MOv18 and MOv19 could be efficient tools for in vivo diagnosis and therapy of ovarian carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Lylmslvx9LVg90H21EOLACvtfcHk0lhQy0D9B6Hryg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhslCgtrs%253D&md5=8891a5cfda16ff233b9b870daa5cf9d1</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910390306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910390306%26sid%3Dliteratum%253Aachs%26aulast%3DMiotti%26aufirst%3DS.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DMenard%26aufirst%3DS.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DPorro%26aufirst%3DG.%26aulast%3DPupa%26aufirst%3DS.%2BM.%26aulast%3DRegazzoni%26aufirst%3DM.%26aulast%3DTagliabue%26aufirst%3DE.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26atitle%3DCharacterization%2520of%2520human%2520ovarian%2520carcinoma-associated%2520antigens%2520defined%2520by%2520novel%2520monoclonal%2520antibodies%2520with%2520tumor-restricted%2520specificity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1987%26volume%3D39%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Coney, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carayannopoulos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frasca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurawski, V. R.,  Jr.</span><span> </span><span class="NLM_article-title">Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6125</span><span class="NLM_x">â</span> <span class="NLM_lpage">6132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=6125-6132&author=L.+R.+Coneyauthor=A.+Tomassettiauthor=L.+Carayannopoulosauthor=V.+Frascaauthor=B.+A.+Kamenauthor=M.+I.+Colnaghiauthor=V.+R.+Zurawski&title=Cloning+of+a+tumor-associated+antigen%3A+MOv18+and+MOv19+antibodies+recognize+a+folate-binding+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConey%26aufirst%3DL.%2BR.%26aulast%3DTomassetti%26aufirst%3DA.%26aulast%3DCarayannopoulos%26aufirst%3DL.%26aulast%3DFrasca%26aufirst%3DV.%26aulast%3DKamen%26aufirst%3DB.%2BA.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26aulast%3DZurawski%26aufirst%3DV.%2BR.%26atitle%3DCloning%2520of%2520a%2520tumor-associated%2520antigen%253A%2520MOv18%2520and%2520MOv19%2520antibodies%2520recognize%2520a%2520folate-binding%2520protein%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D6125%26epage%3D6132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit-Taskar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâDonoghue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasquillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konner, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span> </span><span class="NLM_article-title">Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">â</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.nucmedbio.2007.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18355690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1KitLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=343-351&author=P.+M.+Smith-Jonesauthor=N.+Pandit-Taskarauthor=W.+Caoauthor=J.+O%E2%80%99Donoghueauthor=M.+D.+Philipsauthor=J.+Carrasquilloauthor=J.+A.+Konnerauthor=L.+J.+Oldauthor=S.+M.+Larson&title=Preclinical+radioimmunotargeting+of+folate+receptor+alpha+using+the+monoclonal+antibody+conjugate+DOTA-MORAb-003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003</span></div><div class="casAuthors">Smith-Jones, Peter M.; Pandit-Taskar, Neeta; Cao, Wei; O'Donoghue, Joseph; Philips, Martin D.; Carrasquillo, Jorge; Konner, Jason A.; Old, Lloyd J.; Larson, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-351</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: The in vitro and in vivo behavior of the radiolabeled monoclonal antibody MORAb-003 was investigated as a prelude to a clin. trial.  Methods: The cellular retention of 111In- and 131I-labeled MORAb-003 was investigated using IGROV1 and SW620 cells.  Biodistribution studies in tumor-bearing mice were performed with the more favorable agent.  Results: Five 1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid (DOTA) mols. were conjugated to MORAb-003 with no apparent loss of immunoreactivity.  Radiolabeled MORAb-003 had a high affinity for the folate receptor alpha (FRA) expressed by both IGROV1 and SW620 cells and was found to bind to around 8Ã105 and 7 Ã 105 sites/cell, resp.  Both cancer cell lines were found to internalize both 131I- and 111In-labeled MORAb-003, but 111In was retained and 131I was released as iodide.  In athymic mice, 111In-DOTA-MORAb-003 was cleared from the blood with a single exponential biol. clearance rate of 110 h.  The uptake in SW620 tumors was 32 Â± 5%ID/g after 4 days.  The clearance rate of activity from normal organs such as liver, kidney and spleen was similar to the blood clearance and was 5.36%ID/g, 4.03%ID/g and 4.36%ID/g at 1 day postinjection and 2.14%ID/g, 1.65%ID/g and 3.74%ID/g after 8 days, resp.  In a pilot clin. study, the biodistribution and tumor targeting of 111In-MORAb-003 was assessed in three patients undergoing treatment with cold MORAb-003.  Conclusion: MORAb-003 is an attractive antibody for radioimmunoscintigraphy and possibly radioimmunotherapy of FRA-expressing cancers in addn. to its potential direct therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFEvNdHveZ17Vg90H21EOLACvtfcHk0lit7xWIQTibmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1KitLo%253D&md5=c2c06179a574b98083f5d429c0a6e4fc</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DPandit-Taskar%26aufirst%3DN.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DJ.%26aulast%3DPhilips%26aufirst%3DM.%2BD.%26aulast%3DCarrasquillo%26aufirst%3DJ.%26aulast%3DKonner%26aufirst%3DJ.%2BA.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26atitle%3DPreclinical%2520radioimmunotargeting%2520of%2520folate%2520receptor%2520alpha%2520using%2520the%2520monoclonal%2520antibody%2520conjugate%2520DOTA-MORAb-003%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D343%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Coney, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanborn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casalini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colnaghi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurawski, V. R.,  Jr.</span><span> </span><span class="NLM_article-title">Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2448</span><span class="NLM_x">â</span> <span class="NLM_lpage">2455</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=2448-2455&author=L.+R.+Coneyauthor=D.+Mezzanzanicaauthor=D.+Sanbornauthor=P.+Casaliniauthor=M.+I.+Colnaghiauthor=V.+R.+Zurawski&title=Chimeric+murine-human+antibodies+directed+against+folate+binding+receptor+are+efficient+mediators+of+ovarian+carcinoma+cell+killing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConey%26aufirst%3DL.%2BR.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DSanborn%26aufirst%3DD.%26aulast%3DCasalini%26aufirst%3DP.%26aulast%3DColnaghi%26aufirst%3DM.%2BI.%26aulast%3DZurawski%26aufirst%3DV.%2BR.%26atitle%3DChimeric%2520murine-human%2520antibodies%2520directed%2520against%2520folate%2520binding%2520receptor%2520are%2520efficient%2520mediators%2520of%2520ovarian%2520carcinoma%2520cell%2520killing%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D2448%26epage%3D2455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Figini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, A. D.</span><span> </span><span class="NLM_article-title">In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">239</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">â</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=1994&pages=68-78&author=M.+Figiniauthor=J.+D.+Marksauthor=G.+Winterauthor=A.+D.+Griffiths&title=In+vitro+assembly+of+repertoires+of+antibody+chains+on+the+surface+of+phage+by+renaturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFigini%26aufirst%3DM.%26aulast%3DMarks%26aufirst%3DJ.%2BD.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DGriffiths%26aufirst%3DA.%2BD.%26atitle%3DIn%2520vitro%2520assembly%2520of%2520repertoires%2520of%2520antibody%2520chains%2520on%2520the%2520surface%2520of%2520phage%2520by%2520renaturation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1994%26volume%3D239%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Figini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luison, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripamonti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortarino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cioccio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurizi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span> </span><span class="NLM_article-title">Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor</span> <span class="citation_source-journal">Cancer Immunol. Immunother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">â</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1007%2Fs00262-008-0575-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18704410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Olsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=531-546&author=M.+Figiniauthor=F.+Martinauthor=R.+Ferriauthor=E.+Luisonauthor=E.+Ripamontiauthor=A.+Zacchettiauthor=M.+Mortarinoauthor=V.+Di+Cioccioauthor=G.+Mauriziauthor=M.+Allegrettiauthor=S.+Canevari&title=Conversion+of+murine+antibodies+to+human+antibodies+and+their+optimization+for+ovarian+cancer+therapy+targeted+to+the+folate+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor</span></div><div class="casAuthors">Figini, Mariangela; Martin, Franck; Ferri, Renata; Luison, Elena; Ripamonti, Elena; Zacchetti, Alberto; Mortarino, Mimosa; Cioccio, Vito; Maurizi, Giovanni; Allegretti, Marcello; Canevari, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-546</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We previously developed murine and chimeric antibodies against a specific epithelial ovarian carcinoma (EOC) marker, named folate receptor (FR), and promising results were obtained in phase II trials.  More recently, we successfully generated a completely human Fab fragment, C4, by conversion of one of the murine anti-FR antibodies to human antibody using phage display and guided selection.  However, subsequent efforts to obtain C4 in a dimer format, which seems esp. desirable for EOC locoregional treatment, resulted in a highly heterogeneous product upon natural dimerization and in a very poor prodn. yield upon chem. dimerization by a non-hydrolyzable linker to a di-Fab-maleimide (DFM).  We therefore designed, constructed and characterized a large Fab dual combinatorial human antibody phage display library obtained from EOC patients and potentially biased toward an anti-tumor response in an effort to obtain new anti-FR human antibodies suitable for therapy.  Using this library and guiding the selection on FR-expressing cells with murine/human antibody chains, we generated four new human anti-FR antibody (AFRA) Fab fragments, one of which was genetically and chem. manipulated to obtain a chem. dimer, designated AFRA-DFM5.3, with high yield prodn. and the capability for purifn. scaled-up to clin. grade.  Overall affinity of AFRA-DFM5.3 was in the 2-digit nanomolar range, and immunohistochem. indicated that the reagent recognized the FR expressed on EOC samples. 131I-AFRA-DFM5.3 showed high immunoreactivity, in vitro stability and integrity, and specifically accumulated only in FR-expressing tumors in s.c. preclin. in vivo models.  Overall, our studies demonstrate the successful conversion of murine to completely human anti-FR antibodies through the combined use of antibody phage display libraries biased toward an anti-tumor response, guided selection and chain shuffling, and point to the suitability of AFRA5.3 for future clin. application in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp77BCOtMmA7Vg90H21EOLACvtfcHk0lh2lkux2MOQkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Olsbc%253D&md5=21ad69dc44ff17f09748c583153d3776</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1007%2Fs00262-008-0575-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-008-0575-5%26sid%3Dliteratum%253Aachs%26aulast%3DFigini%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DF.%26aulast%3DFerri%26aufirst%3DR.%26aulast%3DLuison%26aufirst%3DE.%26aulast%3DRipamonti%26aufirst%3DE.%26aulast%3DZacchetti%26aufirst%3DA.%26aulast%3DMortarino%26aufirst%3DM.%26aulast%3DDi%2BCioccio%26aufirst%3DV.%26aulast%3DMaurizi%26aufirst%3DG.%26aulast%3DAllegretti%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DS.%26atitle%3DConversion%2520of%2520murine%2520antibodies%2520to%2520human%2520antibodies%2520and%2520their%2520optimization%2520for%2520ovarian%2520cancer%2520therapy%2520targeted%2520to%2520the%2520folate%2520receptor%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2009%26volume%3D58%26spage%3D531%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">â</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fijc.21126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15828051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXosVaqtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2005&pages=710-719&author=Y.+Luauthor=E.+Segaauthor=P.+S.+Low&title=Folate+receptor-targeted+immunotherapy%3A+induction+of+humoral+and+cellular+immunity+against+hapten-decorated+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-targeted immunotherapy: Induction of humoral and cellular immunity against hapten-decorated cancer cells</span></div><div class="casAuthors">Lu, Yingjuan; Sega, Emanuela; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">710-719</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We previously exploited the frequent overexpression of folate receptors on cancer cells to decorate malignant cell surfaces selectively with folate-hapten conjugates.  In antihapten-immunized hosts, this targeted localization of foreign haptens to tumor cells led to rapid accumulation of autologous antihapten IgG, which in turn yielded potent antitumor activity upon stimulation with cytokines (IL-2, IFN-Î±).  In an effort to understand the effector mechanisms responsible for tumor regression, we have now investigated the involvement of both humoral and cellular immune components in the tumor destruction process.  We report that the dependence of therapeutic efficacy on folate-hapten concn. is bimodal, suggesting that the conjugate must bridge between a cell surface FR and an antihapten IgG in order to mediate killing.  Studies with cancer cells in vitro further demonstrate that folate-fluorescein-marked tumor cells are killed primarily by antibody-dependent cellular cytotoxicity and phagocytosis, with no contribution from complement-dependent mechanisms.  Investigations of specific immune cell involvement also reveal that asialo-GMI+-natural killer cells, macrophages, CD4+ T cells and CD8+ T cells contribute significantly to recognition/removal of the cancer mass, and that elimination of these cell types markedly compromises the therapy.  Because the initial antibody-dependent stage of tumor cell killing is shown to lead to a long-term antibody-independent cellular immunity that involves both CD4+ and CD8+ T cells, we propose that Fc receptor-expressing immune cells not only initiate destruction of the IgG-marked tumor cells, but also participate in presentation of endogenous tumor antigens in a manner that leads to long-term cellular immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwssI7ou1kc7Vg90H21EOLACvtfcHk0lh2lkux2MOQkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXosVaqtLs%253D&md5=df153353c29643bc3adccd35e766e8ef</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1002%2Fijc.21126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21126%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSega%26aufirst%3DE.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate%2520receptor-targeted%2520immunotherapy%253A%2520induction%2520of%2520humoral%2520and%2520cellular%2520immunity%2520against%2520hapten-decorated%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D116%26spage%3D710%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Douglas, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curiel, D. T.</span><span> </span><span class="NLM_article-title">Targeted gene delivery by tropism-modified adenoviral vectors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1574</span><span class="NLM_x">â</span> <span class="NLM_lpage">1578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1996&pages=1574-1578&author=J.+T.+Douglasauthor=B.+E.+Rogersauthor=M.+E.+Rosenfeldauthor=S.+I.+Michaelauthor=M.+Fengauthor=D.+T.+Curiel&title=Targeted+gene+delivery+by+tropism-modified+adenoviral+vectors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DJ.%2BT.%26aulast%3DRogers%26aufirst%3DB.%2BE.%26aulast%3DRosenfeld%26aufirst%3DM.%2BE.%26aulast%3DMichael%26aufirst%3DS.%2BI.%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DCuriel%26aufirst%3DD.%2BT.%26atitle%3DTargeted%2520gene%2520delivery%2520by%2520tropism-modified%2520adenoviral%2520vectors%26jtitle%3DNat.%2520Biotechnol.%26date%3D1996%26volume%3D14%26spage%3D1574%26epage%3D1578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">El-Aneed, A.</span><span> </span><span class="NLM_article-title">An overview of current delivery systems in cancer gene therapy</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.jconrel.2003.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14684267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslCmu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=1-14&author=A.+El-Aneed&title=An+overview+of+current+delivery+systems+in+cancer+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of current delivery systems in cancer gene therapy</span></div><div class="casAuthors">El-Aneed, Anas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The main objective in gene therapy is the development of efficient, non-toxic gene carriers that can encapsulate and deliver foreign genetic materials into specific cell types such as cancerous cells.  During the past two decades, enormous research in the area of gene delivery has been conducted worldwide, in particular for cancer gene therapy application.  Viral vectors are biol. systems derived from naturally evolved viruses capable of transferring their genetic materials into the host cells.  Many viruses including retrovirus, adenovirus, herpes simplex virus (HSV), adeno-assocd. virus (AAV) and pox virus have been modified to eliminate their toxicity and maintain their high gene transfer capability.  The limitations assocd. with viral vectors, however, in terms of their safety, particularly immunogenicity, and in terms of their limited capacity of transgenic materials, have encouraged researchers to increasingly focus on non-viral vectors as an alternative to viral vectors.  Non-viral vectors are generally cationic in nature.  They include cationic polymers such as poly(ethylenimine) (PEI) and poly(l-lysine) (PLL), cationic peptides and cationic liposomes.  The newly described liposomal prepn. LPD (liposomes/protamine/DNA), for example, has shown superiority over conventional liposomes/DNA complexes (lipoplexes).  Although non-viral vectors are less efficient than viral ones, they have the advantages of safety, simplicity of prepn. and high gene encapsulation capability.  This article reviews the most recent studies highlighting the advantages and the limitations of various types of gene delivery systems used in cancer gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvZ_7RS8hEdLVg90H21EOLACvtfcHk0lgMiu4hv6eN0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslCmu70%253D&md5=2ac74d680875518c68d2dc89d7a92d85</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2003.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2003.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Aneed%26aufirst%3DA.%26atitle%3DAn%2520overview%2520of%2520current%2520delivery%2520systems%2520in%2520cancer%2520gene%2520therapy%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2004%26volume%3D94%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Gottschalk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiano, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S. L.</span><span> </span><span class="NLM_article-title">Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression</span> <span class="citation_source-journal">Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">â</span> <span class="NLM_lpage">191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=7584080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGitrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1994&pages=185-191&author=S.+Gottschalkauthor=R.+J.+Cristianoauthor=L.+C.+Smithauthor=S.+L.+Woo&title=Folate+receptor+mediated+DNA+delivery+into+tumor+cells%3A+potosomal+disruption+results+in+enhanced+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-mediated DNA delivery into tumor cells: Potosomal disruption results in enhanced gene expression</span></div><div class="casAuthors">Gottschalk, Stephen; Cristiano, Richard J.; Smith, Louis C.; Woo, Savio L. C.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Therapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">185-91</span>CODEN:
                <span class="NLM_cas:coden">GETHEC</span>;
        ISSN:<span class="NLM_cas:issn">0969-7128</span>.
    </div><div class="casAbstract">We have used a particular folate receptor, which is overexpressed in tumor cells, for targeted DNA delivery into these cell types.  This folate receptor internalizes folate through caveolae by a process named potocytosis, which is distinct from endocytosis, through clathrin-coated pits.  When folate conjugated to poly-L-lysine was used to deliver the E. coli Î²-galactosidase gene into tumor cells overexpressing the folate receptor, only low levels of Î²-galactosidase activity were detectable.  When a replication-defective adenovirus was coincubated with the DNA/folate complexes, 20 to 30% of the cells stained blue with X-gal and a 1000-fold increase of Î²-galactosidase activity was obsd.  Thus, for high efficient DNA delivery and gene expression via the caveolae system, a potosomal disruption agent is needed.  Furthermore, folate-mediated DNA delivery is restricted to tumor cells that highly overexpress the folate receptor, which will permit future development of tumor cell-specific delivery of toxic genes for cancer gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaYwwCPWEdArVg90H21EOLACvtfcHk0lgMiu4hv6eN0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGitrc%253D&md5=8be49f53dac6bdc1a02344767900f120</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGottschalk%26aufirst%3DS.%26aulast%3DCristiano%26aufirst%3DR.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BC.%26aulast%3DWoo%26aufirst%3DS.%2BL.%26atitle%3DFolate%2520receptor%2520mediated%2520DNA%2520delivery%2520into%2520tumor%2520cells%253A%2520potosomal%2520disruption%2520results%2520in%2520enhanced%2520gene%2520expression%26jtitle%3DGene%2520Ther.%26date%3D1994%26volume%3D1%26spage%3D185%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">1112</span><span class="NLM_x">â</span> <span class="NLM_lpage">1118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=1112-1118&author=J.+A.+Reddyauthor=D.+Deanauthor=M.+D.+Kennedyauthor=P.+S.+Low&title=Optimization+of+folate-conjugated+liposomal+vectors+for+folate+receptor-mediated+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DDean%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DM.%2BD.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DOptimization%2520of%2520folate-conjugated%2520liposomal%2520vectors%2520for%2520folate%2520receptor-mediated%2520gene%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D1112%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">â</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2000&pages=27-37&author=J.+A.+Reddyauthor=P.+S.+Low&title=Enhanced+folate+receptor+mediated+gene+therapy+using+a+novel+pH-sensitive+lipid+formulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DEnhanced%2520folate%2520receptor%2520mediated%2520gene%2520therapy%2520using%2520a%2520novel%2520pH-sensitive%2520lipid%2520formulation%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2000%26volume%3D64%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Lungwitz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breunig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blunk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopferich, A.</span><span> </span><span class="NLM_article-title">Polyethylenimine-based non-viral gene delivery systems</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ejpb.2004.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15939236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFCrsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2005&pages=247-266&author=U.+Lungwitzauthor=M.+Breunigauthor=T.+Blunkauthor=A.+Gopferich&title=Polyethylenimine-based+non-viral+gene+delivery+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Polyethylenimine-based non-viral gene delivery systems</span></div><div class="casAuthors">Lungwitz, U.; Breunig, M.; Blunk, T.; Goepferich, A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-266</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Gene therapy has become a promising strategy for the treatment of many inheritable or acquired diseases that are currently considered incurable.  Non-viral vectors have attracted great interest, as they are simple to prep., rather stable, easy to modify and relatively safe, compared to viral vectors.  Unfortunately, they also suffer from a lower transfection efficiency, requiring addnl. effort for their optimization.  The cationic polymer polyethylenimine (PEI) has been widely used for non-viral transfection in vitro and in vivo and has an advantage over other polycations in that it combines strong DNA compaction capacity with an intrinsic endosomolytic activity.  Here, we give some insight into strategies developed for PEI-based non-viral vectors to overcome intracellular obstacles, including the improvement of methods for polyplex prepn. and the incorporation of endosomolytic agents or nuclear localization signals.  In recent years, PEI-based non-viral vectors have been locally or systemically delivered, mostly to target gene delivery to tumor tissue, the lung or liver.  This requires strategies to efficiently shield transfection polyplexes against non-specific interaction with blood components, extracellular matrix and untargeted cells and the attachment of targeting moieties, which allow for the directed gene delivery to the desired cell or tissue.  In this context, materials, facilitating the design of novel PEI-based non-viral vectors are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJB9zklqR36rVg90H21EOLACvtfcHk0lgSZgXoTVO2Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFCrsrs%253D&md5=a736d2567d19d48826900c287c38c9fa</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2004.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2004.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLungwitz%26aufirst%3DU.%26aulast%3DBreunig%26aufirst%3DM.%26aulast%3DBlunk%26aufirst%3DT.%26aulast%3DGopferich%26aufirst%3DA.%26atitle%3DPolyethylenimine-based%2520non-viral%2520gene%2520delivery%2520systems%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2005%26volume%3D60%26spage%3D247%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Benns, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maheshwari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furgeson, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahato, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span> </span><span class="NLM_article-title">Folate-PEG-folate-graft-polyethylenimine-based gene delivery</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">â</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.3109%2F10611860108997923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=11697107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslKksr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=123-139&author=J.+M.+Bennsauthor=A.+Maheshwariauthor=D.+Y.+Furgesonauthor=R.+I.+Mahatoauthor=S.+W.+Kim&title=Folate-PEG-folate-graft-polyethylenimine-based+gene+delivery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-PEG-folate-graft-polyethylenimine-based gene delivery</span></div><div class="casAuthors">Benns, Jonathan M.; Maheshwari, Anurag; Furgeson, Darin Y.; Mahato, Ram I.; Kim, Sung Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-139, 176-178, Plate III, IV and V</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">Folate-polyethylene glycol-folate-grafted-polyethylenimine (FPF-g-PEI) was synthesized by linking folic acid to both ends of a mono-functional PEG and then grafting to PEI.  The graft ratio was detd. using Beer's law by measuring the UV absorbance at 363 nm.  The pH profile, diam. and shape of the carriers were detd.  Transfection efficiencies were optimized in normal smooth muscle cells (SMC) and CT-26 colon adenocarcinoma cells using plasmid DNA encoding luciferase reporter gene.  Free folic acid was shown to inhibit transfection with FPF-2.3g-PEI at neutral charge ratio.  Relative toxicity between PEI and the modified carrier was measured using MTT colorimetric assay.  Therapeutic potential of pmIFN-Î³ complexed with these polymeric carriers in terms of gene expression was detd. at protein and mRNA levels using ELISA and RT-PCR.  FPF-g-PEI was detd. to have 2.3 folate-PEG-folate (FPF) linear polymers grafted to each PEI mol.  The av. mol. wt. was measured to be â¼33,500 Mw and the pH profile was characteristic of endosomal disruption capacity.  At. Force Microscopy (AFM) and Dynamic Laser Light Scattering (DLLS) indicated FPF-2.3g-PEI and PEI (at 2 wt./wt. ratio) efficiently condensed plasmid DNA resulting in oblique spheroid polyplexes with a mean diam. of â¼150 nm.  FPF-2.3g-PEI was superior to PEI in terms of cytotoxicity and transfection efficiency in cancer cells.  Smooth muscle cells showed no specificity for folate tethered complexes, where PEI/pLuc complexes yielded higher efficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0pF6EjaU3xrVg90H21EOLACvtfcHk0lgSZgXoTVO2Cg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslKksr8%253D&md5=fd7a45a718a135d147371692a2fd4f5a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3109%2F10611860108997923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611860108997923%26sid%3Dliteratum%253Aachs%26aulast%3DBenns%26aufirst%3DJ.%2BM.%26aulast%3DMaheshwari%26aufirst%3DA.%26aulast%3DFurgeson%26aufirst%3DD.%2BY.%26aulast%3DMahato%26aufirst%3DR.%2BI.%26aulast%3DKim%26aufirst%3DS.%2BW.%26atitle%3DFolate-PEG-folate-graft-polyethylenimine-based%2520gene%2520delivery%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2001%26volume%3D9%26spage%3D123%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Hofland, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iginla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osetinsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessodes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wils, P.</span><span> </span><span class="NLM_article-title">Folate-targeted gene transfer in vivo</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">â</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1006%2Fmthe.2002.0604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12027558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFGjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=739-744&author=H.+E.+Hoflandauthor=C.+Massonauthor=S.+Iginlaauthor=I.+Osetinskyauthor=J.+A.+Reddyauthor=C.+P.+Leamonauthor=D.+Schermanauthor=M.+Bessodesauthor=P.+Wils&title=Folate-targeted+gene+transfer+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted gene transfer in vivo</span></div><div class="casAuthors">Hofland, Hans E. J.; Masson, Christophe; Iginla, Shaff; Osetinsky, Irina; Reddy, Joseph A.; Leamon, Christopher P.; Scherman, Daniel; Bessodes, Michel; Wils, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Nonviral systemic delivery is one of the most attractive approaches for cancer gene therapy.  To achieve this goal, various labs. have developed cationic liposomes.  However, when injected i.v., cationic lipid-DNA complexes accumulate mostly into and transfect lung tissue.  Here, we describe a method by which these complexes can be targeted to tumors using folic acid.  Adding polyethylene glycol (PEG)-lipids to the complexes dramatically reduced both lung accumulation and gene transfer to lungs and tumors after i.v. administration.  The presence of folic acid at the distal end of the PEG-lipid did not modify tumor accumulation of the complexes.  However, with folate-targeted complexes, gene transfer activity was restored in tumors while the activity in lungs was reduced by 50- to 100-fold compared with nontargeted lipid-DNA complexes.  This approach provides a first in vivo proof of concept to achieve targeted tumor gene delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTem_XQj6E67Vg90H21EOLACvtfcHk0lgBjrSpGyKqmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFGjtbY%253D&md5=edcf05ef071c79c4f1ec5b3c536fc0d4</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1006%2Fmthe.2002.0604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmthe.2002.0604%26sid%3Dliteratum%253Aachs%26aulast%3DHofland%26aufirst%3DH.%2BE.%26aulast%3DMasson%26aufirst%3DC.%26aulast%3DIginla%26aufirst%3DS.%26aulast%3DOsetinsky%26aufirst%3DI.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DScherman%26aufirst%3DD.%26aulast%3DBessodes%26aufirst%3DM.%26aulast%3DWils%26aufirst%3DP.%26atitle%3DFolate-targeted%2520gene%2520transfer%2520in%2520vivo%26jtitle%3DMol.%2520Ther.%26date%3D2002%26volume%3D5%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abburi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlahov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wils, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leamon, C. P.</span><span> </span><span class="NLM_article-title">Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors</span> <span class="citation_source-journal">Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1542</span><span class="NLM_x">â</span> <span class="NLM_lpage">1550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fsj.gt.3301833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12407426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1Knsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=1542-1550&author=J.+A.+Reddyauthor=C.+Abburiauthor=H.+Hoflandauthor=S.+J.+Howardauthor=I.+Vlahovauthor=P.+Wilsauthor=C.+P.+Leamon&title=Folate-targeted%2C+cationic+liposome-mediated+gene+transfer+into+disseminated+peritoneal+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors</span></div><div class="casAuthors">Reddy, J. A.; Abburi, C.; Hofland, H.; Howard, S. J.; Vlahov, I.; Wils, P.; Leamon, C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1542-1550</span>CODEN:
                <span class="NLM_cas:coden">GETHEC</span>;
        ISSN:<span class="NLM_cas:issn">0969-7128</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A folate-targeted, cationic lipid based transfection complex was developed and found to specifically transfect folate receptor-expressing cells and tumors.  These liposomal vectors were comprised of protamine-condensed plasmid DNA, a mixt. of cationic and neutral lipids, and a folic acid-cysteine-polyethyleneglycol-phosphatidylethanolamine (FA-Cys-PEG-PE) conjugate.  Pre-optimization studies revealed that inclusion of low amts. (0.01 to 0.03%) of FA-Cys-PEG-PE yielded the highest binding activity of dioleoylphosphatidylcholine/cholesterol liposomes to folate receptor-bearing cells.  In contrast, higher amts. (>0.5%) of FA-Cys-PEG-PE progressively decreased cellular binding of the liposomes.  In vitro studies with cationic lipid/dioleoylphosphatidylethanolamine formulations indicated that as little as 0.01 to 0.3% of FA-Cys-PEG-PE was needed to produce optimal targeted expression of plasmid DNA.  Similarly, using a disseminated i.p. L1210A tumor model, max. in vivo transfection activity occurred with i.p. administered formulations that contained low amts. (0.01 mol%) of the FA-Cys-PEG-PE targeting lipid.  Overall, folate-labeled formulations produced an eight- to 10-fold increase in tumor-assocd. luciferase expression, as compared with the corresponding non-targeted cationic lipid/DNA formulations.  These results collectively indicate that transfection of widespread i.p. cancers can be significantly enhanced using folate-targeted techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6nXisO8BVy7Vg90H21EOLACvtfcHk0lgBjrSpGyKqmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1Knsbo%253D&md5=8ed1a849bbaf44cf9b89f75419257d79</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fsj.gt.3301833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gt.3301833%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DAbburi%26aufirst%3DC.%26aulast%3DHofland%26aufirst%3DH.%26aulast%3DHoward%26aufirst%3DS.%2BJ.%26aulast%3DVlahov%26aufirst%3DI.%26aulast%3DWils%26aufirst%3DP.%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26atitle%3DFolate-targeted%252C%2520cationic%2520liposome-mediated%2520gene%2520transfer%2520into%2520disseminated%2520peritoneal%2520tumors%26jtitle%3DGene%2520Ther.%26date%3D2002%26volume%3D9%26spage%3D1542%26epage%3D1550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Bruckheimer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orthel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutzar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furstoss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anklesaria, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, R.</span><span> </span><span class="NLM_article-title">In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">â</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fsj.cgt.7700662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14671672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1yksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=128-134&author=E.+Bruckheimerauthor=P.+Harvieauthor=J.+Orthelauthor=B.+Dutzarauthor=K.+Furstossauthor=E.+Mebelauthor=P.+Anklesariaauthor=R.+Paul&title=In+vivo+efficacy+of+folate-targeted+lipid-protamine-DNA+%28LPD-PEG-folate%29+complexes+in+an+immunocompetent+syngeneic+model+for+breast+adenocarcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma</span></div><div class="casAuthors">Bruckheimer, Elizabeth; Harvie, Pierrot; Orthel, Jason; Dutzar, Benjamin; Furstoss, Kevin; Mebel, Elise; Anklesaria, Pervin; Paul, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene therapy utilizing lipid-based delivery systems holds tremendous promise for the treatment of cancer.  However, due to the potential adverse inflammatory and/or immune effects upon systemic administration, treatments thus far have been predominantly limited to intratumoral or regional treatment.  Previous studies from our group have demonstrated the antitumor efficacy of systemically administered, folate-targeted, lipid-protamine-DNA complexes (LPD-PEG-Folate) against breast cancer using an immunodeficient xenogenic murine model.  In the current study, the antitumor efficacy of LPD-PEG-Folate in a syngeneic, immune competent, murine model of breast cancer was examd.  In this model, the potential inflammatory or immune responses and their effects on systemic delivery can be addressed.  The 410.4 murine breast adenocarcinoma cell line was initially evaluated in vitro for its interactions with LPD-PEG-Folate and control LPD-PEG formulations.  Utilizing fluorescently labeled formulations and fluorscence-activated cell sorting (FACS) anal., a 1.6-fold enhancement of binding and internalization of LPD-PEG-Folate over LPD-PEG formulations was obsd., suggestive of specific receptor interaction.  Increased binding was manifested as 5-26-fold increases in luciferase gene expression in 410.4 cell transfection when comparing LPD-PEG-Folate to LPD-PEG.  Moreover, in vivo treatment of 410.4 breast tumors in BALB/c mice with i.v. injected LPD-PEG-Folate delivering the HSV-1 thymidine kinase (TK) gene, in combination with gancyclovir treatment, resulted in a significant redn. in mean tumor vol. (260.1 mm3) compared to the LPD-PEG-TK (914.1 mm3), as well as the vehicle (749.7 mm3) and untreated (825.3 mm3) control groups (day 25, P<.019).  In addn. to a reduced tumor vol., LPD-PEG-Folate-TK treatment also increased median survival from 25 days in the nontargeted LPD-PEG-TK groups to 31 days (P=.0011), which correlated with the termination of treatment.  Together, these results demonstrate that in the context of a fully functional immune system, LPD-PEG-Folate-TK treatment possesses significant specific antitumor efficacy and the potential for further preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEmYpbMVTQCLVg90H21EOLACvtfcHk0lgBjrSpGyKqmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1yksw%253D%253D&md5=a4743514f32111a293a6c128dd80eacf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700662%26sid%3Dliteratum%253Aachs%26aulast%3DBruckheimer%26aufirst%3DE.%26aulast%3DHarvie%26aufirst%3DP.%26aulast%3DOrthel%26aufirst%3DJ.%26aulast%3DDutzar%26aufirst%3DB.%26aulast%3DFurstoss%26aufirst%3DK.%26aulast%3DMebel%26aufirst%3DE.%26aulast%3DAnklesaria%26aufirst%3DP.%26aulast%3DPaul%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520folate-targeted%2520lipid-protamine-DNA%2520%2528LPD-PEG-folate%2529%2520complexes%2520in%2520an%2520immunocompetent%2520syngeneic%2520model%2520for%2520breast%2520adenocarcinoma%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2004%26volume%3D11%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Robbins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLachlan, I.</span><span> </span><span class="NLM_article-title">siRNA and innate immunity</span> <span class="citation_source-journal">Oligonucleotides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1089%2Foli.2009.0180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19441890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFersLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=89-102&author=M.+Robbinsauthor=A.+Judgeauthor=I.+MacLachlan&title=siRNA+and+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">siRNA and Innate Immunity</span></div><div class="casAuthors">Robbins, Marjorie; Judge, Adam; MacLachlan, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Oligonucleotides</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-102</span>CODEN:
                <span class="NLM_cas:coden">OLIGAJ</span>;
        ISSN:<span class="NLM_cas:issn">1545-4576</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Canonical small interfering RNA (siRNA) duplexes are potent activators of the mammalian innate immune system.  The induction of innate immunity by siRNA is dependent on siRNA structure and sequence, method of delivery, and cell type.  Synthetic siRNA in delivery vehicles that facilitate cellular uptake can induce high levels of inflammatory cytokines and interferons after systemic administration in mammals and in primary human blood cell cultures.  This activation is predominantly mediated by immune cells, normally via a Toll-like receptor (TLR) pathway.  The siRNA sequence dependency of these pathways varies with the type and location of the TLR involved.  Alternatively nonimmune cell activation may also occur, typically resulting from siRNA interaction with cytoplasmic RNA sensors such as RIG1.  As immune activation by siRNA-based drugs represents an undesirable side effect due to the considerable toxicities assocd. with excessive cytokine release in humans, understanding and abrogating this activity will be a crit. component in the development of safe and effective therapeutics.  This review describes the intracellular mechanisms of innate immune activation by siRNA, the design of appropriate sequences and chem. modification approaches, and suitable exptl. methods for studying their effects, with a view toward reducing siRNA-mediated off-target effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZg2Zc8zr8_bVg90H21EOLACvtfcHk0ljsW7o4iGdgQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFersLc%253D&md5=7031cc4cd08d03f522b21184d3e2fc4b</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1089%2Foli.2009.0180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Foli.2009.0180%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DM.%26aulast%3DJudge%26aufirst%3DA.%26aulast%3DMacLachlan%26aufirst%3DI.%26atitle%3DsiRNA%2520and%2520innate%2520immunity%26jtitle%3DOligonucleotides%26date%3D2009%26volume%3D19%26spage%3D89%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Behlke, M. A.</span><span> </span><span class="NLM_article-title">Progress towards in vivo use of siRNAs</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">â</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ymthe.2006.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16481219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFOktL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=644-670&author=M.+A.+Behlke&title=Progress+towards+in+vivo+use+of+siRNAs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Progress towards in Vivo Use of siRNAs</span></div><div class="casAuthors">Behlke, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">644-670</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  RNA interference (RNAi) has become the method of choice to suppress gene expression in vitro.  It is also emerging as a powerful tool for in vivo research with over 90 studies published using synthetic small interfering RNAs in mammals.  These reports demonstrate the potential for use of synthetic small interfering RNAs (siRNAs) as therapeutic agents, esp. in the areas of cancer and viral infection.  The no. of reports using siRNAs for functional genomics applications, for validation of targets for small-mol. drug development programs, and to address questions of basic biol. will rapidly grow as methods and protocols for use in animals become more established.  This review will first discuss aspects of RNAi biochem. and biol. that impact in vivo use, esp. as it relates to exptl. design, and will then provide an overview of published work with a focus on methodol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLVP7e1w-4I7Vg90H21EOLACvtfcHk0ljsW7o4iGdgQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFOktL8%253D&md5=c09bf54f5591b1d828a9ddb8331f2f6a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ymthe.2006.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymthe.2006.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBehlke%26aufirst%3DM.%2BA.%26atitle%3DProgress%2520towards%2520in%2520vivo%2520use%2520of%2520siRNAs%26jtitle%3DMol.%2520Ther.%26date%3D2006%26volume%3D13%26spage%3D644%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Targeted delivery systems for oligonucleotide therapeutics</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">â</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=195-203&author=B.+Yuauthor=X.+Zhaoauthor=L.+J.+Leeauthor=R.+J.+Lee&title=Targeted+delivery+systems+for+oligonucleotide+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DL.%2BJ.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DTargeted%2520delivery%2520systems%2520for%2520oligonucleotide%2520therapeutics%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Pirollo, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E. H.</span><span> </span><span class="NLM_article-title">Targeted delivery of small interfering RNA: approaching effective cancer therapies</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">â</span> <span class="NLM_lpage">1250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1247-1250&author=K.+F.+Pirolloauthor=E.+H.+Chang&title=Targeted+delivery+of+small+interfering+RNA%3A+approaching+effective+cancer+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPirollo%26aufirst%3DK.%2BF.%26aulast%3DChang%26aufirst%3DE.%2BH.%26atitle%3DTargeted%2520delivery%2520of%2520small%2520interfering%2520RNA%253A%2520approaching%2520effective%2520cancer%2520therapies%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1247%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Dominska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dykxhoorn, D. M.</span><span> </span><span class="NLM_article-title">Breaking down the barriers: siRNA delivery and endosome escape</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">â</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1242%2Fjcs.066399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=20356929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFeksL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=1183-1189&author=M.+Dominskaauthor=D.+M.+Dykxhoorn&title=Breaking+down+the+barriers%3A+siRNA+delivery+and+endosome+escape"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Breaking down the barriers: siRNA delivery and endosome escape</span></div><div class="casAuthors">Dominska, Monika; Dykxhoorn, Derek M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1183-1189</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  RNA interference (RNAi)-based technologies offer an attractive strategy for the sequence-specific silencing of disease-causing genes.  The application of small interfering (si)RNAs as potential therapeutic agents requires safe and effective methods for their delivery to the cytoplasm of the target cells and tissues.  Recent studies have shown significant progress in the development of targeting reagents that facilitate the recognition of and siRNA delivery to specific cell types.  However, most of these delivery approaches are not optimized to enable the intracellular trafficking of the siRNAs into the cytoplasm where they must assoc. with the RNA-induced silencing complex (RISC) to direct the cleavage of mRNAs bearing complementary binding sites.  In particular, the trafficking of siRNAs from endosomes into the cytoplasm represents a major rate-limiting step for many delivery approaches.  This Commentary focuses on novel strategies designed to enhance endosomal escape and thereby increase the efficacy of siRNA-mediated gene silencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkjWg97d22hbVg90H21EOLACvtfcHk0lirqgKFxCjaXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFeksL0%253D&md5=90bbc1e0b5d62a4a6f00656d4128e2c1</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1242%2Fjcs.066399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.066399%26sid%3Dliteratum%253Aachs%26aulast%3DDominska%26aufirst%3DM.%26aulast%3DDykxhoorn%26aufirst%3DD.%2BM.%26atitle%3DBreaking%2520down%2520the%2520barriers%253A%2520siRNA%2520delivery%2520and%2520endosome%2520escape%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26spage%3D1183%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions</span> <span class="citation_source-journal">RNA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">â</span> <span class="NLM_lpage">583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=577-583&author=K.+Zhangauthor=Q.+Wangauthor=Y.+Xieauthor=G.+Morauthor=E.+Segaauthor=P.+S.+Lowauthor=Y.+Huang&title=Receptor-mediated+delivery+of+siRNAs+by+tethered+nucleic+acid+base-paired+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DMor%26aufirst%3DG.%26aulast%3DSega%26aufirst%3DE.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DReceptor-mediated%2520delivery%2520of%2520siRNAs%2520by%2520tethered%2520nucleic%2520acid%2520base-paired%2520interactions%26jtitle%3DRNA%26date%3D2008%26volume%3D14%26spage%3D577%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Citro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczylik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginobbi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zupi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabretta, B.</span><span> </span><span class="NLM_article-title">Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells</span> <span class="citation_source-journal">Br. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fbjc.1994.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=8123474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGju7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1994&pages=463-467&author=G.+Citroauthor=C.+Szczylikauthor=P.+Ginobbiauthor=G.+Zupiauthor=B.+Calabretta&title=Inhibition+of+leukaemia+cell+proliferation+by+folic+acid-polylysine-mediated+introduction+of+c-myb+antisense+oligodeoxynucleotides+into+HL-60+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells</span></div><div class="casAuthors">Citro, G.; Szczylik, C.; Ginobbi, P.; Zupi, G.; Calabretta, B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-7</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The inhibitory effect of c-myb antisense oligodeoxynucleotides (ODNs) conjugated to folic acid (FA) on HL-60 cell proliferation was examd.  Folic acid was covalently linked to a polylysine chain and purified by gel chromatog.  Sterile FA-polylysine was complexed with c-myb sense and antisense.  Exposure of HL-60 cells to the FA-polylysine-c-myb antisense ODN complex resulted in a down-regulation of c-myb expression and a greater inhibition of proliferation than that obtained using free ODNs.  Moreover, Fa-polylysine conjugate alone or complexes to c-myb sense ODN was not toxic to cells.  The antigenic properties and uptake of the vitamin were not affected by the polylysine chain.  These data suggest that this strategy is potentially useful for the selective delivery of anti-oncogene-targeted ODNs into cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTx8fhfT_SgbVg90H21EOLACvtfcHk0lirqgKFxCjaXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGju7c%253D&md5=616a49aedb273a2d240df92b0a76b39d</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1994.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1994.84%26sid%3Dliteratum%253Aachs%26aulast%3DCitro%26aufirst%3DG.%26aulast%3DSzczylik%26aufirst%3DC.%26aulast%3DGinobbi%26aufirst%3DP.%26aulast%3DZupi%26aufirst%3DG.%26aulast%3DCalabretta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520leukaemia%2520cell%2520proliferation%2520by%2520folic%2520acid-polylysine-mediated%2520introduction%2520of%2520c-myb%2520antisense%2520oligodeoxynucleotides%2520into%2520HL-60%2520cells%26jtitle%3DBr.%2520J.%2520Cancer.%26date%3D1994%26volume%3D69%26spage%3D463%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group"> Jeong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. G.</span><span> </span><span class="NLM_article-title">Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine)</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2005&pages=223-232&author=S.+H.+Kimauthor=J.+H.++Jeongauthor=K.+C.+Choauthor=S.+W.+Kimauthor=T.+G.+Park&title=Target-specific+gene+silencing+by+siRNA+plasmid+DNA+complexed+with+folate-modified+poly%28ethylenimine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DJeong%26aufirst%3DJ.%2BH.%26aulast%3DCho%26aufirst%3DK.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DPark%26aufirst%3DT.%2BG.%26atitle%3DTarget-specific%2520gene%2520silencing%2520by%2520siRNA%2520plasmid%2520DNA%2520complexed%2520with%2520folate-modified%2520poly%2528ethylenimine%2529%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2005%26volume%3D104%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">York, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holley, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, C. L.</span><span> </span><span class="NLM_article-title">Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression</span> <span class="citation_source-journal">Biomacromolecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">â</span> <span class="NLM_lpage">943</span></span><div class="citationLinks">[<a href="/doi/10.1021/bm8014768" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=936-943&author=A.+W.+Yorkauthor=Y.+Zhangauthor=A.+C.+Holleyauthor=Y.+Guoauthor=F.+Huangauthor=C.+L.+McCormick&title=Facile+synthesis+of+multivalent+folate-block+copolymer+conjugates+via+aqueous+RAFT+polymerization%3A+targeted+delivery+of+siRNA+and+subsequent+gene+suppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fbm8014768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm8014768%26sid%3Dliteratum%253Aachs%26aulast%3DYork%26aufirst%3DA.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHolley%26aufirst%3DA.%2BC.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DMcCormick%26aufirst%3DC.%2BL.%26atitle%3DFacile%2520synthesis%2520of%2520multivalent%2520folate-block%2520copolymer%2520conjugates%2520via%2520aqueous%2520RAFT%2520polymerization%253A%2520targeted%2520delivery%2520of%2520siRNA%2520and%2520subsequent%2520gene%2520suppression%26jtitle%3DBiomacromolecules%26date%3D2009%26volume%3D10%26spage%3D936%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauchon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorenstein, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">3318</span><span class="NLM_x">â</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=3318-3322&author=S.+Wangauthor=R.+J.+Leeauthor=G.+Cauchonauthor=D.+G.+Gorensteinauthor=P.+S.+Low&title=Delivery+of+antisense+oligodeoxyribonucleotides+against+the+human+epidermal+growth+factor+receptor+into+cultured+KB+cells+with+liposomes+conjugated+to+folate+via+polyethylene+glycol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DCauchon%26aufirst%3DG.%26aulast%3DGorenstein%26aufirst%3DD.%2BG.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DDelivery%2520of%2520antisense%2520oligodeoxyribonucleotides%2520against%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor%2520into%2520cultured%2520KB%2520cells%2520with%2520liposomes%2520conjugated%2520to%2520folate%2520via%2520polyethylene%2520glycol%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D3318%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Rait, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirollo, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, E. H.</span><span> </span><span class="NLM_article-title">Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">â</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12435858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVWhsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=475-486&author=A.+S.+Raitauthor=K.+F.+Pirolloauthor=L.+Xiangauthor=D.+Ulickauthor=E.+H.+Chang&title=Tumor-targeting%2C+systemically+delivered+antisense+HER-2+chemosensitizes+human+breast+cancer+xenografts+irrespective+of+HER-2+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels</span></div><div class="casAuthors">Rait, Antonina S.; Pirollo, Kathleen F.; Xiang, Laiman; Ulick, David; Chang, Esther H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Baltimore, MD, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Johns Hopkins University Press</span>)
        </div><div class="casAbstract">Background: The failure to respond to chemotherapy is a major obstacle in the successful treatment of breast cancer.  The authors have previously shown that anti-HER-2 antisense oligonucleotide (AS HER-2 ODN) treatment was able to sensitize breast cancer cells to various chemotherapeutic agents in vitro irresp. of their HER-2 status, indicating that the use of AS HER-2 ODN therapy for breast cancer is not limited to tumors overexpressing the protein.  One of the main drawbacks to the use of antisense therapy in the clin. setting is the lack of an efficient, tumor-targeting, systemic delivery method.  The authors have developed a tumor-specific, ligand-targeting, cationic liposome delivery system designed for systemic gene therapy of cancer.  In this study the authors employ this ligand-liposome strategy to enhance the delivery of the AS Her-2 ODN to breast cancer cells, including those that do not overexpress HER-2, in vitro and in vivo.  Materials and Methods: A cationic liposome complex that includes folate as the targeting ligand was designed and optimized for more efficient delivery of AS HER-2 ODN to breast tumors cells in vitro, and more significantly, for systemic delivery with tumor-specific targeting in vivo.  Human breast cancer cell line MDA-MB-435, which does not overexpress HER-2, was used to compare the degree of chemosensitization to the taxanes of AS HER-2 ODN delivered via the optimized folate-liposome vs. com. Lipofectin.  MDA-MB-435 xenograft tumors were also used to evaluate the anti-tumor effect of the combination of systemically delivered folate-liposome-AS HER-2 ODN and docetaxel (Taxotere).  Results: The optimized folate-liposome-AS HER-2 ODN complex significantly increases the response of breast tumor cell lines to conventional chemotherapeutic agents in vitro as compared to AS HER-2 delivered via an unliganded com. available reagent, Lipofectin.  In vivo, the folate-liposome-AS HER-2 ODN complex has prolonged stability in blood and increased uptake in tumors.  More significantly, the combination of i.v. administered ligand-liposome-AS HER-2 ODN and docetaxel resulted in a marked inhibition of xenograft growth in an aggressive breast cancer model that does not overexpress HER-2, even after treatment ended.  Conclusions: Although there are other reports of liposomal delivery of AS ODNs, this is the first report of in vivo efficacy against human cancer cells using a tumor-targeting liposome delivery system for systemic AS therapy.  Moreover, the increased stability in circulation and anti-tumor efficacy obsd. were obtained without the need for continuous i.v. infusion.  HER-2 is an integral component within a network of cell growth pathways that can affect many different types of tumors where HER-2 may be a contributing factor, such as ovarian, esophageal, and GI malignancies including colon and pancreatic cancers.  Therefore, the effectiveness of this therapy with xenograft tumors that do not overexpress HER-2 has the potential to expand the clin. usefulness of this efficacious form of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryP5i681arc7Vg90H21EOLACvtfcHk0ljIZ3XoG_7YqA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVWhsr0%253D&md5=0f7327fc271777e437555341d44cefd2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRait%26aufirst%3DA.%2BS.%26aulast%3DPirollo%26aufirst%3DK.%2BF.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DUlick%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DE.%2BH.%26atitle%3DTumor-targeting%252C%2520systemically%2520delivered%2520antisense%2520HER-2%2520chemosensitizes%2520human%2520breast%2520cancer%2520xenografts%2520irrespective%2520of%2520HER-2%2520levels%26jtitle%3DMol.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D475%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Leamon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardee, G. E.</span><span> </span><span class="NLM_article-title">Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">â</span> <span class="NLM_lpage">747</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc020089t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2ksbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=738-747&author=C.+P.+Leamonauthor=S.+R.+Cooperauthor=G.+E.+Hardee&title=Folate-liposome-mediated+antisense+oligodeoxynucleotide+targeting+to+cancer+cells%3A+evaluation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Liposome-Mediated Antisense Oligodeoxynucleotide Targeting to Cancer Cells: Evaluation in Vitro and in Vivo</span></div><div class="casAuthors">Leamon, Christopher P.; Cooper, Scott R.; Hardee, Gregory E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">738-747</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The objective of this study was to investigate the use of folate-targeted liposomes for the delivery of encapsulated oligonucleotides to folate receptor (FR)-pos. tumor cells in vitro and in vivo.  This project involved the synthesis and biol. evaluation of many folate-PEG-lipid conjugates, where the chem. form of the folate moiety (pteroate) and the length of the PEG linker chain were varied widely. Folate-targeted oligonucleotide-contg. liposomes were prepd. using conventional methods, and the extent of cell uptake was evaluated using, among others, the FR pos. KB cell line. Oligonucleotide-loaded folate-targeted liposomes were found to rapidly assoc. with the KB cells, and satn. was typically reached within the first hour of incubation at 37 Â°C.  Nearly 100 000 liposomes per cell were bound or internalized at satn. Importantly, cell assocn. was blocked by a large excess folic acid, thus reflecting the FR-specific nature of the cell interaction.  Full targeting potential was achieved with PEG linkers as low as 1000 in mol. wt., and pteroates bearing glycine or Î³-aminobutyryl residues juxtaposed to the pteroic acid moiety were also effective for targeting, provided that a terminal cysteine moiety was present at the distal end of the PEG chain for added hydrophilicity.  When tested in vivo, folate-targeted liposomes were found to deliver â¼1.8-fold more oligonucleotide to the livers of nude mice (relative to the nontargeted PEG-contg. formulations); however, no improvement in KB tumor uptake was obsd.  We conclude from these results that folate liposomes can effectively deliver oligonucleotides into folate receptor-bearing cells in vitro, but addnl. barriers exist in vivo that prevent or decrease effective tumor uptake and retention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOOpDFh4gFMLVg90H21EOLACvtfcHk0lgdsULRVAI8Jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2ksbc%253D&md5=0e0475958da2a1a0d0a976c9c61cb301</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fbc020089t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc020089t%26sid%3Dliteratum%253Aachs%26aulast%3DLeamon%26aufirst%3DC.%2BP.%26aulast%3DCooper%26aufirst%3DS.%2BR.%26aulast%3DHardee%26aufirst%3DG.%2BE.%26atitle%3DFolate-liposome-mediated%2520antisense%2520oligodeoxynucleotide%2520targeting%2520to%2520cancer%2520cells%253A%2520evaluation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBioconjugate%2520Chem.%26date%3D2003%26volume%3D14%26spage%3D738%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Yoshizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakoshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitani, Y.</span><span> </span><span class="NLM_article-title">Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts</span> <span class="citation_source-journal">Eur. J. Pharm. Biopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">â</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ejpb.2008.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18647651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlags7fI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2008&pages=718-725&author=T.+Yoshizawaauthor=Y.+Hattoriauthor=M.+Hakoshimaauthor=K.+Kogaauthor=Y.+Maitani&title=Folate-linked+lipid-based+nanoparticles+for+synthetic+siRNA+delivery+in+KB+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts</span></div><div class="casAuthors">Yoshizawa, Takashi; Hattori, Yoshiyuki; Hakoshima, Motoki; Koga, Kimiko; Maitani, Yoshie</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">718-725</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RNA interference (RNAi) is a sequence-specific gene-silencing mechanism triggered by synthetic small interfering RNA (siRNA), and is utilized in a wide range of fields including cancer gene therapy by down-regulating a specific target protein.  In this study, for tumor-targeted siRNA delivery, the authors developed a folate-linked nanoparticle (NP-F), and evaluated the potential of NP-F-mediated tumor gene therapy in human nasopharyngeal KB cells, which overexpressed folate receptor (FR).  NP-F was composed of cholesteryl-3Î²-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol), Tween 80 and folate-poly(ethylene glycol)-distearoylphosphatidylethanolamine conjugate (f-PEG2000-DSPE), and NP-P was substituted f-PEG2000-DSPE in NP-F PEG2000-DSPE for a non-targeting nanoparticle.  The NP-F and siRNA complex (nanoplex) formed at a charge ratio (+/-) of 2/1 in the presence of 5 mM NaCl was injectable size and increased transfection efficiency in the cells.  NP-F showed a significantly higher intracellular amt. of siRNA and stronger localization of siRNA in the cytoplasm than NP-P.  When Her-2 siRNA was transfected into cells by NP-F and NP-P, NP-F significantly inhibited tumor growth, and selectively suppressed Her-2 protein expression more than NP-P.  In in vivo gene therapy, a NP-F nanoplex of Her-2 siRNA by intratumoral injection significantly inhibited tumor growth of KB xenografts compared with control siRNA, but a NP-P nanoplex did not.  These results of the expts. have provided optimal conditions to form folate-linked nanoparticle complexes with siRNA for folate-targeted gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJ3fiylKA-7Vg90H21EOLACvtfcHk0lgdsULRVAI8Jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlags7fI&md5=12de93cece4d7e8c1929ae0952527c8c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2008.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2008.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DYoshizawa%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DHakoshima%26aufirst%3DM.%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DMaitani%26aufirst%3DY.%26atitle%3DFolate-linked%2520lipid-based%2520nanoparticles%2520for%2520synthetic%2520siRNA%2520delivery%2520in%2520KB%2520tumor%2520xenografts%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2008%26volume%3D70%26spage%3D718%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Jeong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. G.</span><span> </span><span class="NLM_article-title">In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles</span> <span class="citation_source-journal">J. Biomater. Sci., Polym. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span><span class="NLM_x">â</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1163%2F156856205774472335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16370241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWlsLbF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1409-1419&author=J.+H.+Jeongauthor=S.+H.+Kimauthor=S.+W.+Kimauthor=T.+G.+Park&title=In+vivo+tumor+targeting+of+ODN-PEG-folic+acid%2FPEI+polyelectrolyte+complex+micelles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles</span></div><div class="casAuthors">Jeong, Ji Hoon; Kim, Sun Hwa; Kim, Sung Wan; Park, Tae Gwan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomaterials Science, Polymer Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1409-1419</span>CODEN:
                <span class="NLM_cas:coden">JBSEEA</span>;
        ISSN:<span class="NLM_cas:issn">0920-5063</span>.
    
            (<span class="NLM_cas:orgname">VSP</span>)
        </div><div class="casAbstract">A tumor-targeting antisense oligodeoxynucleotide (ODN) delivery system based on polyelectrolyte complex (PEC) micelles is demonstrated.  ODN-PEG-folic acid (ODN-PEG-FA) was synthesized using a heterofunctional PEG linker.  The PEC micelles for the targeted ODN delivery to tumor cells were produced by ionic interactions between the ODN-PEG-FA and polyethylenimine (PEI).  The in vivo targeting properties of the PEC micelles were assessed using a mouse tumor model.  The size of ODN-PEG-FA/PEI PEC micelles was 92.3 nm with a relatively narrow distribution.  Cellular uptake of the ODN-PEG-FA/PEI PEC micelles by folic acid receptor over-expressing cells (KB) was greatly enhanced compared to that of ODN-PEG/PEI PEC micelles.  When the ODN-PEG-FA/PEI PEC micelles were systemically administered to the mice bearing KB cell xenograft tumor, ODN was accumulated to the solid tumor in a target specific manner.  This study suggests that the PEC micelles with a receptor-recognizable targeting ligand on the surface have potential for passive and active targeted delivery of ODN drugs to cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jOvir3CyKLVg90H21EOLACvtfcHk0lgdsULRVAI8Jg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWlsLbF&md5=e4689f95e6b27f5e1c3a50b45c31b9ee</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1163%2F156856205774472335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1163%252F156856205774472335%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DPark%26aufirst%3DT.%2BG.%26atitle%3DIn%2520vivo%2520tumor%2520targeting%2520of%2520ODN-PEG-folic%2520acid%252FPEI%2520polyelectrolyte%2520complex%2520micelles%26jtitle%3DJ.%2520Biomater.%2520Sci.%252C%2520Polym.%2520Ed.%26date%3D2005%26volume%3D16%26spage%3D1409%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">van Vlerken, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amiji, M. M.</span><span> </span><span class="NLM_article-title">Multi-functional polymeric nanoparticles for tumour-targeted drug delivery</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">â</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=205-216&author=L.+E.+van+Vlerkenauthor=M.+M.+Amiji&title=Multi-functional+polymeric+nanoparticles+for+tumour-targeted+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BVlerken%26aufirst%3DL.%2BE.%26aulast%3DAmiji%26aufirst%3DM.%2BM.%26atitle%3DMulti-functional%2520polymeric%2520nanoparticles%2520for%2520tumour-targeted%2520drug%2520delivery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2006%26volume%3D3%26spage%3D205%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Hobbs, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsky, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torchilin, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">â</span> <span class="NLM_lpage">4612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.95.8.4607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=9539785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1cXis1OgsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=4607-4612&author=S.+K.+Hobbsauthor=W.+L.+Monskyauthor=F.+Yuanauthor=W.+G.+Robertsauthor=L.+Griffithauthor=V.+P.+Torchilinauthor=R.+K.+Jain&title=Regulation+of+transport+pathways+in+tumor+vessels%3A+role+of+tumor+type+and+microenvironment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment</span></div><div class="casAuthors">Hobbs, Susan K.; Monsky, Wayne L.; Yuan, Fan; Roberts, W. Gregory; Griffith, Linda; Torchilin, Vladimir P.; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4607-4612</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Novel anti-neoplastic agents such as gene targeting vectors and encapsulated carriers are quite large (approx. 100-300 nm in diam.).  An understanding of the functional size and physiol. regulation of transvascular pathways is necessary to optimize delivery of these agents.  Here we analyze the functional limits of transvascular transport and its modulation by the microenvironment.  One human and five murine tumors including mammary and colorectal carcinomas, hepatoma, glioma, and sarcoma were implanted in the dorsal skin-fold chamber or cranial window, and the pore cutoff size, a functional measure of transvascular gap size, was detd.  The microenvironment was modulated: (i) spatially, by growing tumors in s.c. or cranial locations and (ii) temporally, by inducing vascular regression in hormone-dependent tumors.  Tumors grown s.c. exhibited a characteristic pore cutoff size ranging from 200 nm to 1.2 Î¼m.  This pore cutoff size was reduced in tumors grown in the cranium or in regressing tumors after hormone withdrawal.  Vessels induced in basic fibroblast growth factor-contg. gels had a pore cutoff size of 200 nm.  Albumin permeability was independent of pore cutoff size.  These results have three major implications for the delivery of therapeutic agents: (i) delivery may be less efficient in cranial tumors than in s.c. tumors, (ii) delivery may be reduced during tumor regression induced by hormonal ablation, and (iii) permeability to a mol. is independent of pore cutoff size as long as the diam. of the mol. is much less than the pore diam.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88VvYDuUcTLVg90H21EOLACvtfcHk0lhxXGqGwlVQ3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1OgsLc%253D&md5=ac230a357069787fb819e23a043bd3f0</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.8.4607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.8.4607%26sid%3Dliteratum%253Aachs%26aulast%3DHobbs%26aufirst%3DS.%2BK.%26aulast%3DMonsky%26aufirst%3DW.%2BL.%26aulast%3DYuan%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DGriffith%26aufirst%3DL.%26aulast%3DTorchilin%26aufirst%3DV.%2BP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DRegulation%2520of%2520transport%2520pathways%2520in%2520tumor%2520vessels%253A%2520role%2520of%2520tumor%2520type%2520and%2520microenvironment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D4607%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Immordino, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattel, L.</span><span> </span><span class="NLM_article-title">Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.2217%2F17435889.1.3.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17717971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlantb7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=297-315&author=M.+L.+Immordinoauthor=F.+Dosioauthor=L.+Cattel&title=Stealth+liposomes%3A+review+of+the+basic+science%2C+rationale%2C+and+clinical+applications%2C+existing+and+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential</span></div><div class="casAuthors">Immordino, Maria Laura; Dosio, Franco; Cattel, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1176-9114</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Among several promising new drug-delivery systems, liposomes represent an advanced technol. to deliver active mols. to the site of action, and at present several formulations are in clin. use.  Research on liposome technol. has progressed from conventional vesicles ("first-generation liposomes") to "second-generation liposomes", in which long-circulating liposomes are obtained by modulating the lipid compn., size, and charge of the vesicle.  Liposomes with modified surfaces have also been developed using several mols., such as glycolipids or sialic acid.  A significant step in the development of long-circulating liposomes came with inclusion of the synthetic polymer poly-(ethylene glycol) (PEG) in liposome compn.  The presence of PEG on the surface of the liposomal carrier has been shown to extend blood-circulation time while reducing mononuclear phagocyte system uptake (stealth liposomes).  This technol. has resulted in a large no. of liposome formulations encapsulating active mols., with high target efficiency and activity.  Further, by synthetic modification of the terminal PEG mol., stealth liposomes can be actively targeted with monoclonal antibodies or ligands.  This review focuses on stealth technol. and summarizes pre-clin. and clin. data relating to the principal liposome formulations; it also discusses emerging trends of this promising technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL8BsakziX-bVg90H21EOLACvtfcHk0lhxXGqGwlVQ3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlantb7E&md5=0ecb6e03b94783f06b71f41dc2d1fe78</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.2217%2F17435889.1.3.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17435889.1.3.297%26sid%3Dliteratum%253Aachs%26aulast%3DImmordino%26aufirst%3DM.%2BL.%26aulast%3DDosio%26aufirst%3DF.%26aulast%3DCattel%26aufirst%3DL.%26atitle%3DStealth%2520liposomes%253A%2520review%2520of%2520the%2520basic%2520science%252C%2520rationale%252C%2520and%2520clinical%2520applications%252C%2520existing%2520and%2520potential%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2006%26volume%3D1%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1233</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">â</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1233&publication_year=1995&pages=134-144&author=R.+J.+Leeauthor=P.+S.+Low&title=Folate-mediated+tumor+cell+targeting+of+liposome-entrapped+doxorubicin+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DFolate-mediated%2520tumor%2520cell%2520targeting%2520of%2520liposome-entrapped%2520doxorubicin%2520in%2520vitro%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1995%26volume%3D1233%26spage%3D134%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliot, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. A.</span><span> </span><span class="NLM_article-title">Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">â</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=316-322&author=K.+E.+Andersonauthor=L.+A.+Eliotauthor=B.+R.+Stevensonauthor=J.+A.+Rogers&title=Formulation+and+evaluation+of+a+folic+acid+receptor-targeted+oral+vancomycin+liposomal+dosage+form"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DEliot%26aufirst%3DL.%2BA.%26aulast%3DStevenson%26aufirst%3DB.%2BR.%26aulast%3DRogers%26aufirst%3DJ.%2BA.%26atitle%3DFormulation%2520and%2520evaluation%2520of%2520a%2520folic%2520acid%2520receptor-targeted%2520oral%2520vancomycin%2520liposomal%2520dosage%2520form%26jtitle%3DPharm.%2520Res.%26date%3D2001%26volume%3D18%26spage%3D316%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Pan, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">594</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=594-602&author=X.+Q.+Panauthor=X.+Zhengauthor=G.+Shiauthor=H.+Wangauthor=M.+Ratnamauthor=R.+J.+Lee&title=Strategy+for+the+treatment+of+acute+myelogenous+leukemia+based+on+folate+receptor+beta-targeted+liposomal+doxorubicin+combined+with+receptor+induction+using+all-trans+retinoic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%2BQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRatnam%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DStrategy%2520for%2520the%2520treatment%2520of%2520acute%2520myelogenous%2520leukemia%2520based%2520on%2520folate%2520receptor%2520beta-targeted%2520liposomal%2520doxorubicin%2520combined%2520with%2520receptor%2520induction%2520using%2520all-trans%2520retinoic%2520acid%26jtitle%3DBlood%26date%3D2002%26volume%3D100%26spage%3D594%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Gabizon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmeeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalipsky, S.</span><span> </span><span class="NLM_article-title">Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1177</span><span class="NLM_x">â</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2004.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15094214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1177-1192&author=A.+Gabizonauthor=H.+Shmeedaauthor=A.+T.+Horowitzauthor=S.+Zalipsky&title=Tumor+cell+targeting+of+liposome-entrapped+drugs+with+phospholipid-anchored+folic+acid-PEG+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates</span></div><div class="casAuthors">Gabizon, Alberto; Shmeeda, Hilary; Horowitz, Aviva T.; Zalipsky, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1177-1192</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Targeting of liposomes with phospholipid-anchored folate conjugates is an attractive approach to deliver chemotherapeutic agents to folate receptor (FR) expressing tumors.  The use of polyethylene glycol (PEG)-coated liposomes with folate attached to the outer end of a small fraction of phospholipid-anchored PEG mols. appears to be the most appropriate way to combine long-circulating properties crit. for liposome deposition in tumors and binding of liposomes to FR on tumor cells.  Although a no. of important formulation parameters remain to be optimized, there are indications, at least in one ascitic tumor model, that folate targeting shifts intra-tumor distribution of liposomes to the cellular compartment.  In vitro, folate targeting enhances the cytotoxicity of liposomal drugs against FR-expressing tumor cells.  In vivo, the therapeutic data are still fragmentary and appear to be formulation- and tumor model-dependent.  Further studies are required to det. whether folate targeting can confer a clear advantage in efficacy and/or toxicity to liposomal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXmcjmN9RMbVg90H21EOLACvtfcHk0lj7On4414XBvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtF2rtLs%253D&md5=b6948331c4bc8ab98a988af1434b5016</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2004.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2004.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DGabizon%26aufirst%3DA.%26aulast%3DShmeeda%26aufirst%3DH.%26aulast%3DHorowitz%26aufirst%3DA.%2BT.%26aulast%3DZalipsky%26aufirst%3DS.%26atitle%3DTumor%2520cell%2520targeting%2520of%2520liposome-entrapped%2520drugs%2520with%2520phospholipid-anchored%2520folic%2520acid-PEG%2520conjugates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D1177%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Gabizon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzemach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmeeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalipsky, S.</span><span> </span><span class="NLM_article-title">In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">6551</span><span class="NLM_x">â</span> <span class="NLM_lpage">6559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14695160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSqurnF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=6551-6559&author=A.+Gabizonauthor=A.+T.+Horowitzauthor=D.+Gorenauthor=D.+Tzemachauthor=H.+Shmeedaauthor=S.+Zalipsky&title=In+vivo+fate+of+folate-targeted+polyethylene-glycol+liposomes+in+tumor-bearing+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice</span></div><div class="casAuthors">Gabizon, Alberto; Horowitz, Aviva T.; Goren, Dorit; Tzemach, Dina; Shmeeda, Hilary; Zalipsky, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6551-6559</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To compare the in vivo tissue distribution of folate-targeted liposomes (FTLs) injected i.v. in mice bearing folate receptor (FR)-over-expressing tumors (mouse M109 and human KB carcinomas, and mouse J6456 lymphoma) to that of nontargeted liposomes (NTLs) of similar compn.  A small fraction of a folate-polyethylene-glycol (PEG)-distearoyl-phosphatidylethanolamine conjugate was incorporated in FTLs.  Both FTLs and NTLs were PEGylated with a PEG-distearoyl-phosphatidylethanolamine conjugate to prolong circulation time.  Liposomes were labeled with [3H]cholesterol hexadecyl ether with or without doxorubicin loading.  Liposome levels in plasma, tissues, or ascites were assessed by the no. of [3H] counts.  For doxorubicin-loaded formulations, the authors also detd. the tissue doxorubicin levels by fluorometry.  To est. the amt. of liposomes directly assocd. with tumor cells in vivo, we detd. the [3H]radiolabel counts in washed pellets of ascitic tumor cells using the ascitic J6456 lymphoma. RESULTS: FTLs retained the folate ligand in vivo, as demonstrated by their ability to bind ex vivo to FR-expressing cells after prolonged circulation and extravasation into malignant ascitic fluid.  In comparison with NTLs, FTLs were cleared faster from circulation as a result of greater liver uptake.  Despite the lower plasma levels, tumor levels of FTL-injected mice were not significantly different from those of NTL-injected mice.  When NTLs and FTLs were loaded with doxorubicin, liver uptake decreased because of liver blockade, and uptake by spleen and tumor increased.  When tumor-to-tissue liposome uptake ratios were analyzed, the targeting profile of FTLs was characterized by higher tumor:skin, and tumor:kidney ratios but lower tumor:liver ratio than NTLs.  After a concomitant dose of free folic acid, FTLs (but not NTLs) plasma clearance and liver uptake were inhibited, indicating that accelerated clearance was mediated by the folate ligand.  Surprisingly tumor uptake was not significantly affected by a codose of folic acid.  In the J6456 ascitic tumor model, tumor cell-assocd. liposome levels were significantly greater for FTL-injected mice than for NTL-injected mice, despite slightly higher levels of the latter in whole ascites.  Whereas folate targeting does not enhance overall liposome deposition in tumors, the targeting profile of tumor vs. other tissues is substantially different and intratumor liposome distribution in ascitic tumors is affected favorably with a selective shift toward liposome assocn. with FR-expressing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquYwuKaHHaXrVg90H21EOLACvtfcHk0lg7onT_Us493Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSqurnF&md5=54bbb0802d87648c071098b28e8196d1</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabizon%26aufirst%3DA.%26aulast%3DHorowitz%26aufirst%3DA.%2BT.%26aulast%3DGoren%26aufirst%3DD.%26aulast%3DTzemach%26aufirst%3DD.%26aulast%3DShmeeda%26aufirst%3DH.%26aulast%3DZalipsky%26aufirst%3DS.%26atitle%3DIn%2520vivo%2520fate%2520of%2520folate-targeted%2520polyethylene-glycol%2520liposomes%2520in%2520tumor-bearing%2520mice%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D6551%26epage%3D6559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Ni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Folate receptor targeted delivery of liposomal daunorubicin into tumor cells</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2131</span><span class="NLM_x">â</span> <span class="NLM_lpage">2135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12174894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2ltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2131-2135&author=S.+Niauthor=S.+M.+Stephensonauthor=R.+J.+Lee&title=Folate+receptor+targeted+delivery+of+liposomal+daunorubicin+into+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor targeted delivery of liposomal daunorubicin into tumor cells</span></div><div class="casAuthors">Ni, Sandy; Stephenson, Stacy M.; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2131-2135</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">The folate receptor (FR) is amplified in a wide variety of human tumors.  Thus, targeting cytotoxic therapies to FR is a promising strategy for chemotherapy.  FR-targeted liposomal daunorubicin (f-L-DNR) was compared to non-targeted liposomal DNR (L-DNR) for cellular uptake and cytotoxicity in FR-expressing cells.  Liposomal DNR retention was evaluated for liposomes loaded with either sodium citrate or ammonium sulfate as the trapping agent.  The cellular uptake of liposomal DNR was detd. by flow cytometry and fluorometry measurements while cytotoxicity was detd. by the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.  Liposomal DNR retention was superior for liposomes prepd. using ammonium sulfate.  Cellular uptake of f-L-DNR in KB oral carcinoma cells, Chinese hamster ovary (CHO-FR-Î²), and KG-1 human acute myelogenous leukemia cells were 9.4, 40, and 4.6-fold higher than non-targeted L-DNR, resp.  The cytotoxicity of f-L-DNR in KB and CHO-FR-Î² cells was 18 times and 49 times higher than L-DNR, resp.  Both cellular uptake and cytotoxicity of f-L-DNR could be inhibited by 1 mM folic acid.  FR-mediated delivery of liposomal DNR to FR-expressing cells increases DNR cellular uptake and cytotoxicity.  Therefore, therapeutic evaluation in relevant animal models is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUMCSJ43Nb6bVg90H21EOLACvtfcHk0lg7onT_Us493Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2ltrY%253D&md5=d48ef6f27006bfb6e13978bbc4303ae6</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DStephenson%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DFolate%2520receptor%2520targeted%2520delivery%2520of%2520liposomal%2520daunorubicin%2520into%2520tumor%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2002%26volume%3D22%26spage%3D2131%26epage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Saul, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annapragada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamkonda, R. V.</span><span> </span><span class="NLM_article-title">Controlled targeting of liposomal doxorubicin via the folate receptor in vitro</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0168-3659%2803%2900295-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=14499185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1SntLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=49-67&author=J.+M.+Saulauthor=A.+Annapragadaauthor=J.+V.+Natarajanauthor=R.+V.+Bellamkonda&title=Controlled+targeting+of+liposomal+doxorubicin+via+the+folate+receptor+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled targeting of liposomal doxorubicin via the folate receptor in vitro</span></div><div class="casAuthors">Saul, Justin M.; Annapragada, Ananth; Natarajan, Jayaganesh V.; Bellamkonda, Ravi V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">49-67</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Differential expression of folate receptor has been exploited to target liposomes to tumors.  Astrogliomas express low folate receptor levels and are typically surrounded by normal cells expressing little or no folate receptors.  While targeting cells with high over-expression of folate receptor (KB and HeLa) has been demonstrated, it is unclear whether targeting tumors expressing low levels of folate receptor is possible.  In this study, it was demonstrated that optimizing the no. of targeting ligands (folic acid) enables differential liposomal doxorubicin uptake in C6 glioma while sparing healthy cortical cells.  By micellization of folate conjugates and their controlled insertion into pre-formed liposomes, tight control over the no. of targeting ligands per liposome was demonstrated.  Doxorubicin uptake in KB and C6 cells was dependent on the no. of targeting ligands, while cortical cells showed increasing non-specific uptake with ligand no.  Co-culture of C6 glioma with cortical cells confirmed preferential uptake in C6 glioma relative to cortical cells.  A cell kill expt. showed that folate-targeted liposomal doxorubicin is cytotoxic and slows proliferation of KB and C6 cells with minimal effect on cortical cells.  Therefore modulation of targeting ligand no. enables significant differential uptake of doxorubicin in cells with low levels of folate receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD5V0hn8bmprVg90H21EOLACvtfcHk0lg7onT_Us493Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1SntLg%253D&md5=e678e4a0b840f749773eea501e6d6d28</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2803%2900295-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252803%252900295-5%26sid%3Dliteratum%253Aachs%26aulast%3DSaul%26aufirst%3DJ.%2BM.%26aulast%3DAnnapragada%26aufirst%3DA.%26aulast%3DNatarajan%26aufirst%3DJ.%2BV.%26aulast%3DBellamkonda%26aufirst%3DR.%2BV.%26atitle%3DControlled%2520targeting%2520of%2520liposomal%2520doxorubicin%2520via%2520the%2520folate%2520receptor%2520in%2520vitro%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2003%26volume%3D92%26spage%3D49%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Shi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">â</span> <span class="NLM_lpage">319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=309-319&author=G.+Shiauthor=W.+Guoauthor=S.+M.+Stephensonauthor=R.+J.+Lee&title=Efficient+intracellular+drug+and+gene+delivery+using+folate+receptor-targeted+pH-sensitive+liposomes+composed+of+cationic%2Fanionic+lipid+combinations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DStephenson%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DEfficient%2520intracellular%2520drug%2520and%2520gene%2520delivery%2520using%2520folate%2520receptor-targeted%2520pH-sensitive%2520liposomes%2520composed%2520of%2520cationic%252Fanionic%2520lipid%2520combinations%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2002%26volume%3D80%26spage%3D309%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Pan, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1629</span><span class="NLM_x">â</span> <span class="NLM_lpage">1633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12168846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsFWksLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=1629-1633&author=X.+Q.+Panauthor=H.+Wangauthor=R.+J.+Lee&title=Boron+delivery+to+a+murine+lung+carcinoma+using+folate+receptor-targeted+liposomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes</span></div><div class="casAuthors">Pan, Xing Q.; Wang, Huaqing; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1629-1633</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Folate receptor (FR) is amplified in a variety of human tumors.  Folate-derived liposomes have been shown to selectively deliver entrapped agents into tumor cells via receptor-mediated endocytosis.  In this preliminary study, the biodistribution of FR-targeted liposomes were evaluated as a potential delivery agent for Na3 (B20H17NH3) for boron neutron capture therapy (BNCT) of FR(+) tumors.  Na3 (B20H17NH3) was incorporated into liposomes by passive entrapment, following which they were administered i.v. into BALB/c mice bearing s.c. implants of FR(+) M109 murine lung carcinoma.  Tumor and normal tissue boron content was measured by d.c. plasma at. emission spectroscopy.  Mice that received FR-targeted and non-targeted control liposomes showed indistinguishable levels of tumor boron uptake (up to 85 Î¼g/g tumor), which reached a max. at the 24 h time point, while the tumor-to-blood (T/B) ratio continued to rise until the 72 h time point.  High-level boron delivery is possible using liposomes as a delivery agent.  FR targeting does not significantly enhance overall tumor localization but may improve boron delivery at the cellular and subcellular levels, which warrant further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2YT3Wi3pE7Vg90H21EOLACvtfcHk0li8Tj_M-NfDDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsFWksLw%253D&md5=ea6c020204b2b3f57995b2000458ef3b</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DX.%2BQ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DBoron%2520delivery%2520to%2520a%2520murine%2520lung%2520carcinoma%2520using%2520folate%2520receptor-targeted%2520liposomes%26jtitle%3DAnticancer%2520Res.%26date%3D2002%26volume%3D22%26spage%3D1629%26epage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Stephenson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjarks, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">â</span> <span class="NLM_lpage">3345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12926073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVCgsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3341-3345&author=S.+M.+Stephensonauthor=W.+Yangauthor=P.+J.+Stevensauthor=W.+Tjarksauthor=R.+F.+Barthauthor=R.+J.+Lee&title=Folate+receptor-targeted+liposomes+as+possible+delivery+vehicles+for+boron+neutron+capture+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy</span></div><div class="casAuthors">Stephenson, Stacy M.; Yang, Weilian; Stevens, Phillip J.; Tjarks, Werner; Barth, Rolf F.; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">3341-3345</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: The folate receptor is amplified in a variety of human tumors including over 90% of ovarian carcinoma.  FR-targeted liposomes have previously been used by us to selectively deliver entrapped boron-contg. compds. to tumor cells for neutron capture therapy (NCT).  In the present study we have evaluated the delivery of Na3(B20H17NH3), which has been loaded into FR-targeted liposomes, in mice bearing xenograft implants of FR (+) KB s.c. tumor.  Materials and Methods: Na3(B20H17NH3) was passively entrapped into FR-targeted liposomes, which were administered i.v. into nude mice bearing s.c. implants of the FR(+) human oral carcinoma KB cell line.  Normal and tumor boron content was measured by d.c. plasma-at. emission spectroscopy.  Results: Mice that received FR-targeted liposomes contg. boron showed the highest tumor boron levels at 24 h (6.1 Î¼g/g) and tumor/blood boron ratios continued to rise for up to 120 h.  Conclusion: Boron delivery via FR-targeted liposomes is feasible and potentially can improve tumor uptake compared to non-targeted liposomes, and may improve cellular and subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonC_eqV7gfzbVg90H21EOLACvtfcHk0li8Tj_M-NfDDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVCgsL4%253D&md5=2f9779aa3e670687bd27f8dabaaa3b4c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStephenson%26aufirst%3DS.%2BM.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DStevens%26aufirst%3DP.%2BJ.%26aulast%3DTjarks%26aufirst%3DW.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DFolate%2520receptor-targeted%2520liposomes%2520as%2520possible%2520delivery%2520vehicles%2520for%2520boron%2520neutron%2520capture%2520therapy%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3341%26epage%3D3345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Thirumamagal, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandyopadhyaya, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naranyanasamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnsamuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golightly, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jehning, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjarks, W.</span><span> </span><span class="NLM_article-title">Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT)</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">â</span> <span class="NLM_lpage">1150</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060075d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1141-1150&author=B.+T.+Thirumamagalauthor=X.+B.+Zhaoauthor=A.+K.+Bandyopadhyayaauthor=S.+Naranyanasamyauthor=J.+Johnsamuelauthor=R.+Tiwariauthor=D.+W.+Golightlyauthor=V.+Patelauthor=B.+T.+Jehningauthor=M.+V.+Backerauthor=R.+F.+Barthauthor=R.+J.+Leeauthor=J.+M.+Backerauthor=W.+Tjarks&title=Receptor-targeted+liposomal+delivery+of+boron-containing+cholesterol+mimics+for+boron+neutron+capture+therapy+%28BNCT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)</span></div><div class="casAuthors">Thirumamagal, B. T. S.; Zhao, Xiaobin B.; Bandyopadhyaya, Achintya K.; Narayanasamy, Sureshbabu; Johnsamuel, Jayaseharan; Tiwari, Rohit; Golightly, Danold W.; Patel, Vimalkumar; Jehning, Brian T.; Backer, Marina V.; Barth, Rolf F.; Lee, Robert J.; Backer, Joseph M.; Tjarks, Werner</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1141-1150</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liposomes have been a main focus of tumor-selective boron delivery strategies in boron neutron capture therapy (BNCT), a binary method for the treatment of cancer that is based on the nuclear reaction between boron atoms and low-energy thermal neutrons.  Three novel carboranyl cholesterol derivs. were prepd. as lipid bilayer components for the construction of nontargeted and receptor-targeted boronated liposomes for BNCT.  A major structural feature of these novel boronated cholesterol mimics is the replacement of the B and the C ring of cholesterol with a carborane cluster.  Computational analyses indicated that all three boronated compds. have structural features and physicochem. properties that are very similar to those of cholesterol.  One of the synthesized boronated cholesterol mimics was stably incorporated into non-, folate receptor (FR)-, and vascular endothelial growth factor receptor-2 (VEGFR-2)-targeted liposomes.  No major differences were found in appearance, size distribution, and lamellarity between conventional dipalmitoylphosphatidylcholine (DPPC)/cholesterol liposomes, nontargeted, and FR-targeted liposomal formulations of this carboranyl cholesterol deriv.  FR-targeted boronated liposomes were taken up extensively in FR overexpressing KB cells in vitro, and the uptake was effectively blocked in the presence of free folate.  In contrast, a boronated cholesterol mimic incorporated into nontargeted liposomes showed significantly lower cellular uptake.  There was no apparent in vitro cytotoxicity in FR overexpressing KB cells and VEGFR-2 overexpressing 293/KDR cells when these were incubated with boronated FR- and (VEGFR-2)-targeted liposomes, resp., although the former accumulated extensively in KB cells and the latter effectively interacted with VEGFR-2 by causing autophosphorylation and protecting 293/KDR cells from SLT (Shiga-like toxin)-VEGF cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeLUOoPO0-LVg90H21EOLACvtfcHk0lj7OKUSk_wXEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D&md5=4a6a65107118389c48d5ee8233e563f8</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fbc060075d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060075d%26sid%3Dliteratum%253Aachs%26aulast%3DThirumamagal%26aufirst%3DB.%2BT.%26aulast%3DZhao%26aufirst%3DX.%2BB.%26aulast%3DBandyopadhyaya%26aufirst%3DA.%2BK.%26aulast%3DNaranyanasamy%26aufirst%3DS.%26aulast%3DJohnsamuel%26aufirst%3DJ.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DGolightly%26aufirst%3DD.%2BW.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DJehning%26aufirst%3DB.%2BT.%26aulast%3DBacker%26aufirst%3DM.%2BV.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DBacker%26aufirst%3DJ.%2BM.%26aulast%3DTjarks%26aufirst%3DW.%26atitle%3DReceptor-targeted%2520liposomal%2520delivery%2520of%2520boron-containing%2520cholesterol%2520mimics%2520for%2520boron%2520neutron%2520capture%2520therapy%2520%2528BNCT%2529%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D1141%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Henriksen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoultz, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelsen, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruland, O. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, R. H.</span><span> </span><span class="NLM_article-title">Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">â</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.nucmedbio.2003.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15093814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Sit7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=441-449&author=G.+Henriksenauthor=B.+W.+Schoultzauthor=T.+E.+Michaelsenauthor=O.+S.+Brulandauthor=R.+H.+Larsen&title=Sterically+stabilized+liposomes+as+a+carrier+for+alpha-emitting+radium+and+actinium+radionuclides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Sterically stabilized liposomes as a carrier for Î±-emitting radium and actinium radionuclides</span></div><div class="casAuthors">Henriksen, Gjermund; Schoultz, B. W.; Michaelsen, T. E.; Bruland, O. S.; Larsen, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-449</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The Î±-particle emitting radionuclides 223Ra (t12 = 11.4 d), 224Ra (t1/2 = 3.6 d), and 225Ac(t1/2 = 10.0 d) may have a broad application in targeted radiotherapy provided that they could be linked to vehicles with tumor affinity.  The potential usefulness of liposomes as carriers was studied in the present work.  Radium and actinium radionuclides could be loaded in good yields into sterically stabilized lipsomes.  Subsequent coating of the lipsomes with a folate-F(ab')2 construct yielded a product with affinity towards tumor cells expressing folate receptors.  Radionuclide loaded liposomes showed excellent stability in serum in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUjtCDuUGfLVg90H21EOLACvtfcHk0lj7OKUSk_wXEw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Sit7k%253D&md5=58c47b8a4d9df93b15d8f6fe91025e52</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2003.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2003.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DG.%26aulast%3DSchoultz%26aufirst%3DB.%2BW.%26aulast%3DMichaelsen%26aufirst%3DT.%2BE.%26aulast%3DBruland%26aufirst%3DO.%2BS.%26aulast%3DLarsen%26aufirst%3DR.%2BH.%26atitle%3DSterically%2520stabilized%2520liposomes%2520as%2520a%2520carrier%2520for%2520alpha-emitting%2520radium%2520and%2520actinium%2520radionuclides%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2004%26volume%3D31%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">3198</span><span class="NLM_x">â</span> <span class="NLM_lpage">3204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=8106354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK2cXhsVeqsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=3198-3204&author=R.+J.+Leeauthor=P.+S.+Low&title=Delivery+of+liposomes+into+cultured+KB+cells+via+folate+receptor-mediated+endocytosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis</span></div><div class="casAuthors">Lee, Robert J.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3198-204</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Folic acid was covalently conjugated to 66-nm liposomes via spacers of various lengths in an attempt to target the liposomes to KB cells expressing folate receptors.  Spacers of short and intermediate lengths were unable to mediate assocn. of folate-conjugated liposomes with receptor-bearing cells, however, use of a 250 Ã polyethylene glycol spacer (PEG, Mr â¼3350) permitted avid uptake of the liposomes at â¼2.5 Ã 105 sites/cell.  The binding of folate-PEG liposomes to KB cells could be competitively inhibited by excess free folate or by anti-serum against the folate receptor, demonstrating the interaction is mediated by the cell surface folate-binding protein.  Following binding, cell-assocd. folate-PEG liposomes were internalized by folate-receptor-mediated endocytosis at 37Â° but not at 4Â°.  These folate-PEG liposomes show potential for delivering large quantities of low mol. wt. compds. non-destructively into folate receptor-bearing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3o2kccFYlLVg90H21EOLACvtfcHk0liKiKSz892Mww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsVeqsbk%253D&md5=1b269b76044c296a71134dc583404b37</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DDelivery%2520of%2520liposomes%2520into%2520cultured%2520KB%2520cells%2520via%2520folate%2520receptor-mediated%2520endocytosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D3198%26epage%3D3204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Gabizon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzemach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelbaum-Shavit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qazen, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalipsky, S.</span><span> </span><span class="NLM_article-title">Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">â</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9801124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK1MXnsF2ntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=289-298&author=A.+Gabizonauthor=A.+T.+Horowitzauthor=D.+Gorenauthor=D.+Tzemachauthor=F.+Mandelbaum-Shavitauthor=M.+M.+Qazenauthor=S.+Zalipsky&title=Targeting+folate+receptor+with+folate+linked+to+extremities+of+poly%28ethylene+glycol%29-grafted+liposomes%3A+in+vitro+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Folate Receptor with Folate Linked to Extremities of Poly(ethylene glycol)-Grafted Liposomes: In Vitro Studies</span></div><div class="casAuthors">Gabizon, Alberto; Horowitz, Aviva T.; Goren, Dorit; Tzemach, Dinah; Mandelbaum-Shavit, Frederika; Qazen, Masoud M.; Zalipsky, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugates of 3 components, folic acid-polyethylene glycol-distearoylphosphatidylethanolamine (FA-PEG-DSPE), derived from PEG with mol. wts. of 2000 and 3350 Da were synthesized by a carbodiimide-mediated coupling of FA to H2N-PEG-DSPE.  The conjugates were characterized by 1H NMR, MALDI-TOF, and HPLC anal. of enzymic cleavage with carboxypeptidase G.  As a prototype of a folate receptor (FR)-targeted system, the conjugates were formulated at 0.5 mol% phospholipid in hydrogenated phosphatidylcholine/cholesterol liposomes with or without addnl. methoxyPEG2000-DSPE.  In vitro binding studies were performed with sublines of M109 (murine lung carcinoma) and KB (human epidermal carcinoma) cells each contg. high and low densities of FR. FA-PEG-DSPE significantly enhanced liposome binding to tumor cells.  The best binding was obsd. when FA-PEG liposomes contained no addnl. mPEG-lipid.  The presence of mPEG on liposomal surfaces significantly inhibited FA-PEG-liposome binding to FR.  Increasing the mol. wt. of the PEG tether from 2000 to 3350 Da improved the FR binding, particularly in the case of mPEG-coated liposomes.  The FA-PEG liposomes bound to M109-HiFR cells very avidly as demonstrated by the inability of free FA (used in a 700-fold excess either at the beginning or at the end of the incubation) to prevent the cell binding.  This is in contrast to the 5-10-fold lower cell binding activity of mPEG-FA compared to that of free FA, and likely to be related to the multivalent nature of the liposome-bound FA.  Only 22% of FA-PEG3350 and 32% of FA-PEG3350/mPEG cell-assocd. liposomes could be removed by exposure to pH 3, conditions that dissoc. FA-FR, suggesting that more than two-thirds of the bound liposomes were internalized during incubation for 24 h at 37Â°.  FA-targeted liposomes also show enhanced nonspecific binding to extracellular tissue culture components, a phenomenon esp. relevant in short incubation time expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcCEu1Kbj71LVg90H21EOLACvtfcHk0liKiKSz892Mww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsF2ntw%253D%253D&md5=90ecb245128b81bb59c834bcc3ba37de</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fbc9801124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9801124%26sid%3Dliteratum%253Aachs%26aulast%3DGabizon%26aufirst%3DA.%26aulast%3DHorowitz%26aufirst%3DA.%2BT.%26aulast%3DGoren%26aufirst%3DD.%26aulast%3DTzemach%26aufirst%3DD.%26aulast%3DMandelbaum-Shavit%26aufirst%3DF.%26aulast%3DQazen%26aufirst%3DM.%2BM.%26aulast%3DZalipsky%26aufirst%3DS.%26atitle%3DTargeting%2520folate%2520receptor%2520with%2520folate%2520linked%2520to%2520extremities%2520of%2520poly%2528ethylene%2520glycol%2529-grafted%2520liposomes%253A%2520in%2520vitro%2520studies%26jtitle%3DBioconjugate%2520Chem.%26date%3D1999%26volume%3D10%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Yamada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitani, Y.</span><span> </span><span class="NLM_article-title">Design of folate-linked liposomal doxorubicin to its antitumor effect in mice</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8161</span><span class="NLM_x">â</span> <span class="NLM_lpage">8168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1158%2F1078-0432.CCR-08-0159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19088031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=8161-8168&author=A.+Yamadaauthor=Y.+Taniguchiauthor=K.+Kawanoauthor=T.+Hondaauthor=Y.+Hattoriauthor=Y.+Maitani&title=Design+of+folate-linked+liposomal+doxorubicin+to+its+antitumor+effect+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice</span></div><div class="casAuthors">Yamada, Atsushi; Taniguchi, Yukimi; Kawano, Kumi; Honda, Takashi; Hattori, Yoshiyuki; Maitani, Yoshie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8161-8168</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Tumor cell targeting is a promising strategy for enhancing the therapeutic potential of chemotherapy agents.  Polyethylene glycol (PEG)-coated (sterically stabilized) liposomes show enhanced accumulation on the surface of tumors, but steric hindrance by PEGylation reduces the assocn. of the liposome-bound ligand with its receptor.  To increase folate receptor (FR) targeting, we optimized the concn. and PEG spacer length of folate-PEG-lipid in liposomes.  Exptl. Design: Three types of folate-linked liposomal doxorubicin were designed and prepd. by optimizing the concn. and PEG spacer length of folate-PEG-lipid in PEGylated or non-PEGylated liposomes and by masking folate-linked liposomes where the folate ligand is "masked" by adjacent PEG spacers.  The liposome targeting efficacy was evaluated in vitro and in vivo.  RESULTS: In human oral carcinoma KB cells, which overexpress FR, modification with sufficiently long PEG spacer and a high concn. of folate ligand to non-PEGylated liposomes increased the FR-mediated assocn. and cytotoxicity more than with PEGylated and masked folate-linked liposomes.  On the contrary, in mice bearing murine lung carcinoma M109, modification with the folate ligand in PEGylated and masked folate-linked liposomes showed significantly higher antitumor effect than with non-PEGylated liposomes irresp. of the length of time in the circulation after i.v. injection.  CONCLUSIONS: The results of this study will be beneficial for the design and prepn. of ligand-targeting carriers for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4ecs3n74xLVg90H21EOLACvtfcHk0liKiKSz892Mww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2it7vJ&md5=6fa8be912557ebcb5d029db920dd1f72</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0159%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DA.%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DMaitani%26aufirst%3DY.%26atitle%3DDesign%2520of%2520folate-linked%2520liposomal%2520doxorubicin%2520to%2520its%2520antitumor%2520effect%2520in%2520mice%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2008%26volume%3D14%26spage%3D8161%26epage%3D8168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Zhao, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthusamy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">2424</span><span class="NLM_x">â</span> <span class="NLM_lpage">2435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2424-2435&author=X.+B.+Zhaoauthor=N.+Muthusamyauthor=J.+C.+Byrdauthor=R.+J.+Lee&title=Cholesterol+as+a+bilayer+anchor+for+PEGylation+and+targeting+ligand+in+folate-receptor-targeted+liposomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BB.%26aulast%3DMuthusamy%26aufirst%3DN.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DCholesterol%2520as%2520a%2520bilayer%2520anchor%2520for%2520PEGylation%2520and%2520targeting%2520ligand%2520in%2520folate-receptor-targeted%2520liposomes%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2424%26epage%3D2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Xiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ijpharm.2007.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18258394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFCks74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2008&pages=29-36&author=G.+Xiangauthor=J.+Wuauthor=Y.+Luauthor=Z.+Liuauthor=R.+J.+Lee&title=Synthesis+and+evaluation+of+a+novel+ligand+for+folate-mediated+targeting+liposomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes</span></div><div class="casAuthors">Xiang, Guangya; Wu, Jun; Lu, Yanhui; Liu, Zhilan; Lee, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Folate receptors (FRs) have been identified as cellular surface markers for cancer and leukemia.  Liposomes contg. lipophilic derivs. of folate have been shown to effectively target FR-expressing cells.  Here, the authors report the synthesis of a novel lipophilic folate deriv., folate-polyethylene glycol-cholesterol hemisuccinate (F-PEG-CHEMS), and its evaluation as a targeting ligand for liposomal doxorubicin (L-DOX) in FR-expressing cells.  Liposomes contg. F-PEG-CHEMS, with a mean diam. of 120Â±20 nm, were synthesized by polycarbonate membrane extrusion and were shown to have excellent colloidal stability.  The liposomes were taken up selectively by KB cells, which overexpress FR-Î±.  Compared to folate-PEG-cholesterol (F-PEG-Chol), which contains a carbamate linkage, F-PEG-CHEMS better retained its FR-targeting activity during prolonged storage.  In addn., F-PEG-CHEMS contg. liposomes loaded with DOX (F-L-DOX) showed greater cytotoxicity (IC50 = 10.0 Î¼M) than nontargeted control L-DOX (IC50 = 57.5 Î¼M) in KB cells.  In ICR mice, both targeted and nontargeted liposomes exhibited long circulation properties, although F-L-DOX (t 1/2 = 12.34 h) showed more rapid plasma clearance than L-DOX (t 1/2 = 17.10 h).  These results suggest that F-PEG-CHEMS is effective as a novel ligand for the synthesis of FR-targeted liposomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWYXc8r5W7z7Vg90H21EOLACvtfcHk0lg9ib-gr-B6ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFCks74%253D&md5=839eb82aa5c367f4b8cbbd868fef857c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2007.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2007.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520ligand%2520for%2520folate-mediated%2520targeting%2520liposomes%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2008%26volume%3D356%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Vogel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Peptide-mediated release of folate-targeted liposome contents from endosomal compartments</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">â</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja952725m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=1581-1586&author=K.+Vogelauthor=S.+Wangauthor=R.+J.+Leeauthor=J.+Chmielewskiauthor=P.+S.+Low&title=Peptide-mediated+release+of+folate-targeted+liposome+contents+from+endosomal+compartments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fja952725m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja952725m%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DChmielewski%26aufirst%3DJ.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DPeptide-mediated%2520release%2520of%2520folate-targeted%2520liposome%2520contents%2520from%2520endosomal%2520compartments%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D1581%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Turk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielewski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1559</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1559&publication_year=2002&pages=56-68&author=M.+J.+Turkauthor=J.+A.+Reddyauthor=J.+A.+Chmielewskiauthor=P.+S.+Low&title=Characterization+of+a+novel+pH-sensitive+peptide+that+enhances+drug+release+from+folate-targeted+liposomes+at+endosomal+pHs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DM.%2BJ.%26aulast%3DReddy%26aufirst%3DJ.%2BA.%26aulast%3DChmielewski%26aufirst%3DJ.%2BA.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520novel%2520pH-sensitive%2520peptide%2520that%2520enhances%2520drug%2520release%2520from%2520folate-targeted%2520liposomes%2520at%2520endosomal%2520pHs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1559%26spage%3D56%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Rui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. H.</span><span> </span><span class="NLM_article-title">Diplasmenylcholine-folate liposomes: an efficient vehicle for intracellular drug delivery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">11213</span><span class="NLM_x">â</span> <span class="NLM_lpage">11218</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9742949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=11213-11218&author=Y.+Ruiauthor=S.+Wangauthor=P.+S.+Lowauthor=D.+H.+Thompson&title=Diplasmenylcholine-folate+liposomes%3A+an+efficient+vehicle+for+intracellular+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fja9742949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9742949%26sid%3Dliteratum%253Aachs%26aulast%3DRui%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DD.%2BH.%26atitle%3DDiplasmenylcholine-folate%2520liposomes%253A%2520an%2520efficient%2520vehicle%2520for%2520intracellular%2520drug%2520delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D11213%26epage%3D11218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Sudimack, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjarks, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. J.</span><span> </span><span class="NLM_article-title">A novel pH-sensitive liposome formulation containing oleyl alcohol</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1564</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">â</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1564&publication_year=2002&pages=31-37&author=J.+J.+Sudimackauthor=W.+Guoauthor=W.+Tjarksauthor=R.+J.+Lee&title=A+novel+pH-sensitive+liposome+formulation+containing+oleyl+alcohol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudimack%26aufirst%3DJ.%2BJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DTjarks%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26atitle%3DA%2520novel%2520pH-sensitive%2520liposome%2520formulation%2520containing%2520oleyl%2520alcohol%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1564%26spage%3D31%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Liggins, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, H. M.</span><span> </span><span class="NLM_article-title">Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations</span> <span class="citation_source-journal">Adv. Drug. Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0169-409X%2802%2900016-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=11897145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVWnsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=191-202&author=R.+T.+Ligginsauthor=H.+M.+Burt&title=Polyether-polyester+diblock+copolymers+for+the+preparation+of+paclitaxel+loaded+polymeric+micelle+formulations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations</span></div><div class="casAuthors">Liggins, R. T.; Burt, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-202</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  A no. of hypersensitivity reactions have been attributed to the presence of Cremophor EL in the current formulation for paclitaxel.  This has led to the development of formulations for paclitaxel employing polyether-polyester diblock copolymers as micelle forming carriers.  Diblock copolymers of methoxypolyethylene glycol-block-poly(d,l-lactide) (MePEG:PDLLA) were synthesized from monomers of d,l-lactide and MePEG by a ring opening bulk polymn. in the presence of stannous octoate.  Up to 25% paclitaxel could be loaded into matrixes of MePEG:PDLLA (60:40, MePEG mol. wt. of 2000) using the soln. casting method.  Dissoln. of paclitaxel/copolymer matrixes in aq. media resulted in complete solubilization of paclitaxel within the hydrophobic PDLLA core of the micelles.  This review article describes the synthetic reaction conditions influencing the degree of conversion of monomer to copolymer, thermal properties, crit. micelle concns. of copolymers, methods of incorporation of paclitaxel into copolymer matrixes and subsequent constitution in aq. media and biol. evaluations of micellar paclitaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBDTjhuysbILVg90H21EOLACvtfcHk0lh0KOdp-WygQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVWnsr4%253D&md5=f0288c0317a8793e4a4e4d59bcca3e5b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900016-9%26sid%3Dliteratum%253Aachs%26aulast%3DLiggins%26aufirst%3DR.%2BT.%26aulast%3DBurt%26aufirst%3DH.%2BM.%26atitle%3DPolyether-polyester%2520diblock%2520copolymers%2520for%2520the%2520preparation%2520of%2520paclitaxel%2520loaded%2520polymeric%2520micelle%2520formulations%26jtitle%3DAdv.%2520Drug.%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span> </span><span class="NLM_article-title">Preparation of micelle-forming polymerâdrug conjugates</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">â</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc00016a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADyaK38XksFGktbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1992&pages=295-301&author=M.+Yokoyamaauthor=G.+S.+Kwonauthor=T.+Okanoauthor=Y.+Sakuraiauthor=T.+Setoauthor=K.+Kataoka&title=Preparation+of+micelle-forming+polymer%E2%88%92drug+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of micelle-forming polymer-drug conjugates</span></div><div class="casAuthors">Yokoyama, Masayuki; Kwon, Glenn S.; Okano, Teruo; Sakurai, Yasuhisa; Seto, Takashi; Kataoka, Kazunori</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-301</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    </div><div class="casAbstract">Adriamycin, a hydrophobic anticancer drug, was conjugated with poly(ethylene oxide)-poly(aspartic acid) block copolymers composed of various lengths of each block copolymer segment ranging from 1000 to 12 000 in mol. wt. and from 10 to 80 units, resp.  Conjugation was achieved without pptn. by adjusting the ratio of adriamycin to aspartic acid residues of the block copolymer and the quantity of DMF used for the reaction.  The conjugates showed high water soly. irresp. of a large amt. of the conjugated adriamycin.  Furthermore, these conjugates form micellar structures with a hydrophobic inner core and a hydrophilic outer shell.  This micellar architecture may be utilized for effective drug targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVj5MFFU862LVg90H21EOLACvtfcHk0lh0KOdp-WygQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XksFGktbc%253D&md5=cf145162a9079cf81c4446f99ef916be</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fbc00016a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc00016a007%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DKwon%26aufirst%3DG.%2BS.%26aulast%3DOkano%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DSeto%26aufirst%3DT.%26aulast%3DKataoka%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520micelle-forming%2520polymer%25E2%2588%2592drug%2520conjugates%26jtitle%3DBioconjugate%2520Chem.%26date%3D1992%26volume%3D3%26spage%3D295%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Yoo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. G.</span><span> </span><span class="NLM_article-title">Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">â</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=17-27&author=H.+S.+Yooauthor=E.+A.+Leeauthor=T.+G.+Park&title=Doxorubicin-conjugated+biodegradable+polymeric+micelles+having+acid-cleavable+linkages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DE.%2BA.%26aulast%3DPark%26aufirst%3DT.%2BG.%26atitle%3DDoxorubicin-conjugated%2520biodegradable%2520polymeric%2520micelles%2520having%2520acid-cleavable%2520linkages%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2002%26volume%3D82%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Kwon, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, T.</span><span> </span><span class="NLM_article-title">Soluble self-assembled block copolymers for drug delivery</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">â</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=597-600&author=G.+S.+Kwonauthor=T.+Okano&title=Soluble+self-assembled+block+copolymers+for+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DG.%2BS.%26aulast%3DOkano%26aufirst%3DT.%26atitle%3DSoluble%2520self-assembled%2520block%2520copolymers%2520for%2520drug%2520delivery%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D597%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. H.</span><span> </span><span class="NLM_article-title">Polymeric micelle for tumor pH and folate-mediated targeting</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">â</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2FS0168-3659%2803%2900239-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=12932642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVSkur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&pages=103-113&author=E.+S.+Leeauthor=K.+Naauthor=Y.+H.+Bae&title=Polymeric+micelle+for+tumor+pH+and+folate-mediated+targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Polymeric micelle for tumor pH and folate-mediated targeting</span></div><div class="casAuthors">Lee, Eun Seong; Na, Kun; Bae, You Han</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Novel pH-sensitive polymeric mixed micelles composed of poly(l-histidine) (polyHis; Mw 5000)/PEG (Mn 2000) and poly(l-lactic acid) (PLLA) (Mn 3000)/PEG (Mn 2000) block copolymers with or without folate conjugation were prepd. by diafiltration.  The micelles were investigated for pH-dependent drug release, folate receptor-mediated internalization and cytotoxicity using MCF-7 cells in vitro.  The polyHis/PEG micelles showed accelerated adriamycin release as the pH decreased from 8.0.  When the cumulative release for 24 h was plotted as a function of pH, the gradual transition in release rate appeared in a pH range from 8.0 to 6.8.  In order to tailor the triggering pH of the polymeric micelles to the more acidic extracellular pH of tumors, while improving the micelle stability at pH 7.4, the PLLA/PEG block copolymer was blended with polyHis/PEG to form mixed micelles.  Blending shifted the triggering pH to a lower value.  Depending on the amt. of PLLA/PEG, the mixed micelles were destabilized in the pH range of 7.2-6.6 (triggering pH for adriamycin release).  When the mixed micelles were conjugated with folic acid, the in vitro results demonstrated that the micelles were more effective in tumor cell kill due to accelerated drug release and folate receptor-mediated tumor uptake.  In addn., after internalization polyHis was found to be effective for cytosolic ADR delivery by virtue of fusogenic activity.  This approach is expected to be useful for treatment of solid tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEjbof8z6xm7Vg90H21EOLACvtfcHk0li8L0fY4tcDVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVSkur4%253D&md5=9ac80e60647cfb9cccfc8e859afddb27</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2FS0168-3659%2803%2900239-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-3659%252803%252900239-6%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DNa%26aufirst%3DK.%26aulast%3DBae%26aufirst%3DY.%2BH.%26atitle%3DPolymeric%2520micelle%2520for%2520tumor%2520pH%2520and%2520folate-mediated%2520targeting%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2003%26volume%3D91%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. H.</span><span> </span><span class="NLM_article-title">Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">â</span> <span class="NLM_lpage">418</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.jconrel.2004.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15763623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitV2hsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2005&pages=405-418&author=E.+S.+Leeauthor=K.+Naauthor=Y.+H.+Bae&title=Doxorubicin+loaded+pH-sensitive+polymeric+micelles+for+reversal+of+resistant+MCF-7+tumor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor</span></div><div class="casAuthors">Lee, Eun Seong; Na, Kun; Bae, You Han</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-418</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to overcome multidrug resistance in solid tumors, doxorubicin (DOX) loaded pH-sensitive micelles of which surface was decorated with folate (PHSM/f) were evaluated both in vitro and in vivo expts.  PHSM/f were fabricated from a mixt. of two block copolymers of poly(-histidine) (Mn: 5K)-b-PEG (Mn: 2K)-folate (polyHis/PEG-folate) (75%) and poly(-lactic acid) (Mn: 3K)-b-PEG (Mn: 2K)-folate (PLLA/PEG-folate) (25%).  The PHSM/f showed more than 90% cytotoxicity of DOX resistant MCF-7 (MCF-7/DOXR) when cultured with PHSM/f at a concn. of 10 Î¼g/mL DOX.  The result was interpreted by a sequential event of active internalization of PHSM/f via folate-receptor mediated endocytosis and ionization of His residues which result in micelle destabilization and probably disturbance of endosomal membranes.  This potential mechanism may endow the drug carriers to bypass Pgp efflux pump and sequestration of DOX in acidic intracellular compartments, yielding high cytotoxicity.  Exptl. evaluation of tumor regression was carried out in a small animal model bearing s.c.  MCF-7 or MCF-7/DOXR xenografts.  The tumor (MCF-7/DOXR) vols. of mice treated with PHSM/f were significantly less than control groups treated with free DOX or similar micelles but without folate (PHSM).  In the MCF-7/DOXR xenograft model, the accumulated DOX level of PHSM/f in solid tumors was 20 times higher than free DOX group, and 3 times higher than PHSM group.  The results demonstrate that PHSM/f is a viable means for treating drug resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowgQ6vR9ReyLVg90H21EOLACvtfcHk0li8L0fY4tcDVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitV2hsbY%253D&md5=0b50c93ce8f43324d6d8b4d36172c36c</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2004.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2004.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DNa%26aufirst%3DK.%26aulast%3DBae%26aufirst%3DY.%2BH.%26atitle%3DDoxorubicin%2520loaded%2520pH-sensitive%2520polymeric%2520micelles%2520for%2520reversal%2520of%2520resistant%2520MCF-7%2520tumor%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2005%26volume%3D103%26spage%3D405%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span> </span><span class="NLM_article-title">Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging</span> <span class="citation_source-journal">Langmuir</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5213</span><span class="NLM_x">â</span> <span class="NLM_lpage">5217</span></span><div class="citationLinks">[<a href="/doi/10.1021/la703570m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1emt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2008&pages=5213-5217&author=H.+Chenauthor=S.+Kimauthor=W.+Heauthor=H.+Wangauthor=P.+S.+Lowauthor=K.+Parkauthor=J.+X.+Cheng&title=Fast+release+of+lipophilic+agents+from+circulating+PEG-PDLLA+micelles+revealed+by+in+vivo+Forster+resonance+energy+transfer+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Release of Lipophilic Agents from Circulating PEG-PDLLA Micelles Revealed by in Vivo Foerster Resonance Energy Transfer Imaging</span></div><div class="casAuthors">Chen, Hongtao; Kim, Sungwon; He, Wei; Wang, Haifeng; Low, Philip S.; Park, Kinam; Cheng, Ji-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Langmuir</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5213-5217</span>CODEN:
                <span class="NLM_cas:coden">LANGD5</span>;
        ISSN:<span class="NLM_cas:issn">0743-7463</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the in vivo behavior of nanoparticles is crit. for the translation of nanomedicine from lab. research to clin. trials.  In this work, in vivo Forster resonance energy transfer (FRET) imaging was employed to monitor the release of hydrophobic mols. from circulating poly(ethylene glycol)-poly(D,L-lactic acid) (PEG-PDLLA) micelles.  A lipophilic FRET pair (DiIC18 and DiOC18) was phys. entrapped into micelle cores by mimicking the loading of hydrophobic drugs.  The FRET efficiency was found significantly reduced within 15 min after i.v. injection, implying that DiIC18 and DiOC18 quickly escaped from the circulating micelles.  FRET spectroscopy studies further demonstrated that Î±- and Î²-globulins were major factors for the obsd. fast release, while Î³-globulins, albumin, and red blood cells played minor roles.  These results provide useful information for developing blood-stable micelles to deliver hydrophobic drugs to the target site via prolonged circulation and extravasation from the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUPY59sUkK67Vg90H21EOLACvtfcHk0lhfGCL5QXXrrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1emt7Y%253D&md5=009eaa2532346849e723c7bf4277064b</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fla703570m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fla703570m%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLow%26aufirst%3DP.%2BS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26atitle%3DFast%2520release%2520of%2520lipophilic%2520agents%2520from%2520circulating%2520PEG-PDLLA%2520micelles%2520revealed%2520by%2520in%2520vivo%2520Forster%2520resonance%2520energy%2520transfer%2520imaging%26jtitle%3DLangmuir%26date%3D2008%26volume%3D24%26spage%3D5213%26epage%3D5217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span> </span><span class="NLM_article-title">Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">6596</span><span class="NLM_x">â</span> <span class="NLM_lpage">6601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.0707046105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18445654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVOgtr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=6596-6601&author=H.+Chenauthor=S.+Kimauthor=L.+Liauthor=S.+Wangauthor=K.+Parkauthor=J.+X.+Cheng&title=Release+of+hydrophobic+molecules+from+polymer+micelles+into+cell+membranes+revealed+by+Forster+resonance+energy+transfer+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging</span></div><div class="casAuthors">Chen, Hongtao; Kim, Sungwon; Li, Li; Wang, Shuyi; Park, Kinam; Cheng, Ji-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6596-6601,</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">It is generally assumed that polymeric micelles, upon administration into the blood stream, carry drug mols. until they are taken up into cells followed by intracellular release.  The current work revisits this conventional wisdom.  The study using dual-labeled micelles contg. fluorescently labeled copolymers and hydrophobic fluorescent probes entrapped in the polymeric micelle core showed that cellular uptake of hydrophobic probes was much faster than that of labeled copolymers.  This result implies that the hydrophobic probes in the core are released from micelles in the extracellular space.  Forster resonance energy transfer (FRET) imaging and spectroscopy were used to monitor this process in real time.  A FRET pair, DiIC18(3) and DiOC18(3), was loaded into monomethoxy poly(ethylene glycol)-block-poly(D,L-lactic acid) micelles.  By monitoring the FRET efficiency, release of the core-loaded probes to model membranes was demonstrated.  During administration of polymeric micelles to tumor cells, a decrease of FRET was obsd. both on the cell membrane and inside of cells, indicating the release of core-loaded probes to the cell membrane before internalization.  The decrease of FRET on the plasma membrane was also obsd. during administration of paclitaxel-loaded micelles.  Taken together, our results suggest a membrane-mediated pathway for cellular uptake of hydrophobic mols. preloaded in polymeric micelles.  The plasma membrane provides a temporal residence for micelle-released hydrophobic mols. before their delivery to target intracellular destinations.  A putative role of the PEG shell in the mol. transport from micelle to membrane is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSnLzySl0dybVg90H21EOLACvtfcHk0lhfGCL5QXXrrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVOgtr0%253D&md5=7b15b05760ca3954ca7991a4e02c4636</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0707046105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0707046105%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26atitle%3DRelease%2520of%2520hydrophobic%2520molecules%2520from%2520polymer%2520micelles%2520into%2520cell%2520membranes%2520revealed%2520by%2520Forster%2520resonance%2520energy%2520transfer%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D6596%26epage%3D6601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Konda, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiener, E. C.</span><span> </span><span class="NLM_article-title">Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts</span> <span class="citation_source-journal">Invest. Radiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=199-204&author=S.+D.+Kondaauthor=S.+Wangauthor=M.+Brechbielauthor=E.+C.+Wiener&title=Biodistribution+of+a+153+Gd-folate+dendrimer%2C+generation+%3D+4%2C+in+mice+with+folate-receptor+positive+and+negative+ovarian+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonda%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBrechbiel%26aufirst%3DM.%26aulast%3DWiener%26aufirst%3DE.%2BC.%26atitle%3DBiodistribution%2520of%2520a%2520153%2520Gd-folate%2520dendrimer%252C%2520generation%2520%253D%25204%252C%2520in%2520mice%2520with%2520folate-receptor%2520positive%2520and%2520negative%2520ovarian%2520tumor%2520xenografts%26jtitle%3DInvest.%2520Radiol.%26date%3D2002%26volume%3D37%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Quintana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raczka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piehler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myc, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majoros, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patri, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mule, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1310</span><span class="NLM_x">â</span> <span class="NLM_lpage">1316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2002&pages=1310-1316&author=A.+Quintanaauthor=E.+Raczkaauthor=L.+Piehlerauthor=I.+Leeauthor=A.+Mycauthor=I.+Majorosauthor=A.+K.+Patriauthor=T.+Thomasauthor=J.+Muleauthor=J.+R.+Baker&title=Design+and+function+of+a+dendrimer-based+therapeutic+nanodevice+targeted+to+tumor+cells+through+the+folate+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana%26aufirst%3DA.%26aulast%3DRaczka%26aufirst%3DE.%26aulast%3DPiehler%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DMyc%26aufirst%3DA.%26aulast%3DMajoros%26aufirst%3DI.%26aulast%3DPatri%26aufirst%3DA.%2BK.%26aulast%3DThomas%26aufirst%3DT.%26aulast%3DMule%26aufirst%3DJ.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DDesign%2520and%2520function%2520of%2520a%2520dendrimer-based%2520therapeutic%2520nanodevice%2520targeted%2520to%2520tumor%2520cells%2520through%2520the%2520folate%2520receptor%26jtitle%3DPharm.%2520Res.%26date%3D2002%26volume%3D19%26spage%3D1310%26epage%3D1316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Kukowska-Latallo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candido, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigavekar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majoros, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balogh, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">5317</span><span class="NLM_x">â</span> <span class="NLM_lpage">5324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=5317-5324&author=J.+F.+Kukowska-Latalloauthor=K.+A.+Candidoauthor=Z.+Caoauthor=S.+S.+Nigavekarauthor=I.+J.+Majorosauthor=T.+P.+Thomasauthor=L.+P.+Baloghauthor=M.+K.+Khanauthor=J.+R.+Baker&title=Nanoparticle+targeting+of+anticancer+drug+improves+therapeutic+response+in+animal+model+of+human+epithelial+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukowska-Latallo%26aufirst%3DJ.%2BF.%26aulast%3DCandido%26aufirst%3DK.%2BA.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DNigavekar%26aufirst%3DS.%2BS.%26aulast%3DMajoros%26aufirst%3DI.%2BJ.%26aulast%3DThomas%26aufirst%3DT.%2BP.%26aulast%3DBalogh%26aufirst%3DL.%2BP.%26aulast%3DKhan%26aufirst%3DM.%2BK.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DNanoparticle%2520targeting%2520of%2520anticancer%2520drug%2520improves%2520therapeutic%2520response%2520in%2520animal%2520model%2520of%2520human%2520epithelial%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D5317%26epage%3D5324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Patri, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukowska-Latallo, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. R.,  Jr.</span><span> </span><span class="NLM_article-title">Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">â</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.addr.2005.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16290254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12ksbrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=2203-2214&author=A.+K.+Patriauthor=J.+F.+Kukowska-Latalloauthor=J.+R.+Baker&title=Targeted+drug+delivery+with+dendrimers%3A+comparison+of+the+release+kinetics+of+covalently+conjugated+drug+and+non-covalent+drug+inclusion+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex</span></div><div class="casAuthors">Patri, Anil K.; Kukowska-Latallo, Jolanta F.; Baker, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2203-2214</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dendrimers have unique characteristics including monodispersity and modifiable surface functionality, along with highly defined size and structure.  This makes these polymers attractive candidates as carriers in drug delivery applications.  Drug delivery can be achieved by coupling a drug to polymer through one of two approaches.  Hydrophobic drugs can be complexed within the hydrophobic dendrimer interior to make them water-sol. or drugs can be covalently coupled onto the surface of the dendrimer.  Using both methods we compared the efficacy of generation 5 PAMAM dendrimers in the targeted drug delivery of methotrexate coupled to the polymer.  The amine-terminated dendrimers bind to neg. charged membranes of cells in a non-specific manner and can cause toxicity in vitro and in vivo.  To reduce toxicity and to increase aq. soly., modifications were made to the surface hydroxyl groups of the dendrimers.  For targeted drug delivery, the dendrimer was modified to have a neutral terminal functionality for use with surface-conjugated folic acid as the targeting agent.  The complexation of methotrexate within a dendrimer changes the water insol. drug into a stable and readily water-sol. compd.  When this dendrimer complexed drug, however, was placed in a soln. of phosphate buffered saline, the methotrexate was immediately released and displayed diffusion characteristics identical to free methotrexate.  Covalently coupled methotrexate dendrimer conjugates were stable under identical conditions in water and buffered saline.  Cytotoxicity tests showed that methotrexate as the dendrimer inclusion complex had an activity identical to the free drug in vitro.  In contrast, folic acid targeted dendrimer with covalently conjugated methotrexate specifically killed receptor-expressing cells by intracellular delivery of the drug through receptor-mediated endocytosis.  This study demonstrates that while drug as a dendrimer inclusion complex is readily released and active in vitro, covalently conjugated drug to dendrimer is better suited for specifically targeted drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGossybNL6K9gLVg90H21EOLACvtfcHk0ljPszFD-p_wWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12ksbrM&md5=1f91bba62e990c8de2ccb054a74eafcd</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2005.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2005.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DPatri%26aufirst%3DA.%2BK.%26aulast%3DKukowska-Latallo%26aufirst%3DJ.%2BF.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DTargeted%2520drug%2520delivery%2520with%2520dendrimers%253A%2520comparison%2520of%2520the%2520release%2520kinetics%2520of%2520covalently%2520conjugated%2520drug%2520and%2520non-covalent%2520drug%2520inclusion%2520complex%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D2203%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Sonvico, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mornet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasseur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubernet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaillard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrouard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebeke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duguet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvreur, P.</span><span> </span><span class="NLM_article-title">Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1181</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc050050z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleqsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=1181-1188&author=F.+Sonvicoauthor=S.+Mornetauthor=S.+Vasseurauthor=C.+Dubernetauthor=D.+Jaillardauthor=J.+Degrouardauthor=J.+Hoebekeauthor=E.+Duguetauthor=P.+Colomboauthor=P.+Couvreur&title=Folate-conjugated+iron+oxide+nanoparticles+for+solid+tumor+targeting+as+potential+specific+magnetic+hyperthermia+mediators%3A+synthesis%2C+physicochemical+characterization%2C+and+in+vitro+experiments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Conjugated Iron Oxide Nanoparticles for Solid Tumor Targeting as Potential Specific Magnetic Hyperthermia Mediators: Synthesis, Physicochemical Characterization, and in Vitro Experiments</span></div><div class="casAuthors">Sonvico, Fabio; Mornet, Stephane; Vasseur, Sebastien; Dubernet, Catherine; Jaillard, Danielle; Degrouard, Jeril; Hoebeke, Johan; Duguet, Etienne; Colombo, Paolo; Couvreur, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1181-1188</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New folate-conjugated superparamagnetic maghemite nanoparticles have been synthesized for the intracellular hyperthermia treatment of solid tumors.  These ultradispersed nanosystems have been characterized for their physicochem. properties and tumor cell targeting ability, facilitated by surface modification with folic acid.  Preliminary expts. of nanoparticles heating under the influence of an alternating magnetic field at 108 kHz have been also performed.  The nanoparticle size, surface charge, and colloidal stability have been assessed in various conditions of ionic strength and pH.  The ability of these folate "decorated" maghemite nanoparticles to recognize the folate receptor has been investigated both by surface plasmon resonance and in folate receptor expressing cell lines, using radiolabeled folic acid in competitive binding expts.  The specificity of nanoparticle cellular uptake has been further investigated by transmission electron microscopy after incubation of these nanoparticles in the presence of three cell lines with differing folate receptor expression levels.  Qual. and quant. detns. of both folate nanoparticles and nontargeted control nanoparticles demonstrated a specific cell internalization of the folate superparamagnetic nanoparticles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkulGEiwuaZ7Vg90H21EOLACvtfcHk0lhj6mcezAM0IQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleqsrs%253D&md5=95288a7b68e44b62a3151cf73f89ef68</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fbc050050z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc050050z%26sid%3Dliteratum%253Aachs%26aulast%3DSonvico%26aufirst%3DF.%26aulast%3DMornet%26aufirst%3DS.%26aulast%3DVasseur%26aufirst%3DS.%26aulast%3DDubernet%26aufirst%3DC.%26aulast%3DJaillard%26aufirst%3DD.%26aulast%3DDegrouard%26aufirst%3DJ.%26aulast%3DHoebeke%26aufirst%3DJ.%26aulast%3DDuguet%26aufirst%3DE.%26aulast%3DColombo%26aufirst%3DP.%26aulast%3DCouvreur%26aufirst%3DP.%26atitle%3DFolate-conjugated%2520iron%2520oxide%2520nanoparticles%2520for%2520solid%2520tumor%2520targeting%2520as%2520potential%2520specific%2520magnetic%2520hyperthermia%2520mediators%253A%2520synthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520in%2520vitro%2520experiments%26jtitle%3DBioconjugate%2520Chem.%26date%3D2005%26volume%3D16%26spage%3D1181%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Kohler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells</span> <span class="citation_source-journal">Langmuir</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">8858</span><span class="NLM_x">â</span> <span class="NLM_lpage">8864</span></span><div class="citationLinks">[<a href="/doi/10.1021/la0503451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=8858-8864&author=N.+Kohlerauthor=C.+Sunauthor=J.+Wangauthor=M.+Zhang&title=Methotrexate-modified+superparamagnetic+nanoparticles+and+their+intracellular+uptake+into+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fla0503451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fla0503451%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DMethotrexate-modified%2520superparamagnetic%2520nanoparticles%2520and%2520their%2520intracellular%2520uptake%2520into%2520human%2520cancer%2520cells%26jtitle%3DLangmuir%26date%3D2005%26volume%3D21%26spage%3D8858%26epage%3D8864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span> </span><span class="NLM_article-title">Gold nanorods mediate tumor cell death by compromising membrane integrity</span> <span class="citation_source-journal">Adv. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3136</span><span class="NLM_x">â</span> <span class="NLM_lpage">3141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1002%2Fadma.200701974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19020672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jt73J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=3136-3141&author=L.+Tongauthor=Y.+Zhaoauthor=T.+B.+Huffauthor=M.+N.+Hansenauthor=A.+Weiauthor=J.+X.+Cheng&title=Gold+nanorods+mediate+tumor+cell+death+by+compromising+membrane+integrity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Gold nanorods mediate tumor cell death by compromising membrane integrity</span></div><div class="casAuthors">Tong, Ling; Zhao, Yan; Huff, Terry B.; Hansen, Matthew N.; Wei, Alexander; Cheng, Ji-Xin</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Materials (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3136-3141</span>CODEN:
                <span class="NLM_cas:coden">ADVMEW</span>;
        ISSN:<span class="NLM_cas:issn">0935-9648</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Folate-conjugated gold nanorods targeted to tumor cell surfaces produced severe membrane damage upon near-IR irradn.  Photoinduced injury to the plasma membrane resulted in a rapid increase in intracellular calcium with subsequent disruption of the actin network, featured prominently by the formation of membrane blebs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo425_eiGtB07Vg90H21EOLACvtfcHk0lhj6mcezAM0IQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jt73J&md5=30d2a5b35633ea13c81eb6284b56f0b2</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fadma.200701974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadma.200701974%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHuff%26aufirst%3DT.%2BB.%26aulast%3DHansen%26aufirst%3DM.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26atitle%3DGold%2520nanorods%2520mediate%2520tumor%2520cell%2520death%2520by%2520compromising%2520membrane%2520integrity%26jtitle%3DAdv.%2520Mater.%26date%3D2007%26volume%3D19%26spage%3D3136%26epage%3D3141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Huff, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span> </span><span class="NLM_article-title">Hyperthermic effects of gold nanorods on tumor cells</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">â</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.2217%2F17435889.2.1.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17716198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvF2it74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=125-132&author=T.+B.+Huffauthor=L.+Tongauthor=Y.+Zhaoauthor=M.+N.+Hansenauthor=J.+X.+Chengauthor=A.+Wei&title=Hyperthermic+effects+of+gold+nanorods+on+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperthermic effects of gold nanorods on tumor cells</span></div><div class="casAuthors">Huff, Terry B.; Tong, Ling; Zhao, Yan; Hansen, Matthew N.; Cheng, Ji-Xin; Wei, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1743-5889</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Plasmon-resonant gold nanorods, which have large absorption cross sections at near-IR frequencies, are excellent candidates as multifunctional agents for image-guided therapies based on localized hyperthermia.  The controlled modification of the surface chem. of the nanorods is of crit. importance, as issues of cell-specific targeting and nonspecific uptake must be addressed prior to clin. evaluation.  Nanorods coated with cetyltrimethylammonium bromide (a cationic surfactant used in nanorod synthesis) are internalized within hours into KB cells by a nonspecific uptake pathway, whereas the careful removal of cetyltrimethylammonium bromide from nanorods functionalized with folate results in their accumulation on the cell surface over the same time interval.  In either case, the nanorods render the tumor cells highly susceptible to photothermal damage when irradiated at the nanorods' longitudinal plasmon resonance, generating extensive blebbing of the cell membrane at laser fluences as low as 30 J/cm2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhLB5c4NMMbVg90H21EOLACvtfcHk0lhj6mcezAM0IQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvF2it74%253D&md5=e33b3d6bfb71dd422e80e171f26efd3e</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.2217%2F17435889.2.1.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17435889.2.1.125%26sid%3Dliteratum%253Aachs%26aulast%3DHuff%26aufirst%3DT.%2BB.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHansen%26aufirst%3DM.%2BN.%26aulast%3DCheng%26aufirst%3DJ.%2BX.%26aulast%3DWei%26aufirst%3DA.%26atitle%3DHyperthermic%2520effects%2520of%2520gold%2520nanorods%2520on%2520tumor%2520cells%26jtitle%3DNanomedicine%26date%3D2007%26volume%3D2%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, R. D.</span><span> </span><span class="NLM_article-title">On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles</span> <span class="citation_source-journal">Acta Biomater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">â</span> <span class="NLM_lpage">48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=40-48&author=J.+Zhangauthor=S.+Ranaauthor=R.+S.+Srivastavaauthor=R.+D.+Misra&title=On+the+chemical+synthesis+and+drug+delivery+response+of+folate+receptor-activated%2C+polyethylene+glycol-functionalized+magnetite+nanoparticles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DR.%2BS.%26aulast%3DMisra%26aufirst%3DR.%2BD.%26atitle%3DOn%2520the%2520chemical%2520synthesis%2520and%2520drug%2520delivery%2520response%2520of%2520folate%2520receptor-activated%252C%2520polyethylene%2520glycol-functionalized%2520magnetite%2520nanoparticles%26jtitle%3DActa%2520Biomater.%26date%3D2008%26volume%3D4%26spage%3D40%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Kam, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisdom, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span> </span><span class="NLM_article-title">Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">11600</span><span class="NLM_x">â</span> <span class="NLM_lpage">11605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1073%2Fpnas.0502680102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=16087878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGgsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=11600-11605&author=N.+W.+Kamauthor=M.+O%E2%80%99Connellauthor=J.+A.+Wisdomauthor=H.+Dai&title=Carbon+nanotubes+as+multifunctional+biological+transporters+and+near-infrared+agents+for+selective+cancer+cell+destruction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction</span></div><div class="casAuthors">Kam, Nadine Wong Shi; O'Connell, Michael; Wisdom, Jeffrey A.; Dai, Hongjie</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11600-11605</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Biol. systems are known to be highly transparent to 700 to 1,100 nm near-IR (NIR) light.  It is shown here that the strong optical absorbance of single-walled carbon nanotubes (SWNTs) in this special spectral window, an intrinsic property of SWNTs, can be used for optical stimulation of nanotubes inside living cells to afford multifunctional nanotube biol. transporters.  For oligonucleotides transported inside living cells by nanotubes, the oligos can translocate into cell nucleus upon endosomal rupture triggered by NIR laser pulses.  Continuous NIR radiation can cause cell death because of excessive local heating of SWNT in vitro.  Selective cancer cell destruction can be achieved by functionalization of SWNT with a folate moiety, selective internalization of SWNTs inside cells labeled with folate receptor tumor markers, and NIR-triggered cell death, without harming receptor-free normal cells.  Thus, the transporting capabilities of carbon nanotubes combined with suitable functionalization chem. and their intrinsic optical properties can lead to new classes of novel nanomaterials for drug delivery and cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogrLCeiVQ0vLVg90H21EOLACvtfcHk0liXGOyMgOJWgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGgsbs%253D&md5=e0bb2015153d9fb4698237130666d82a</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502680102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502680102%26sid%3Dliteratum%253Aachs%26aulast%3DKam%26aufirst%3DN.%2BW.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DM.%26aulast%3DWisdom%26aufirst%3DJ.%2BA.%26aulast%3DDai%26aufirst%3DH.%26atitle%3DCarbon%2520nanotubes%2520as%2520multifunctional%2520biological%2520transporters%2520and%2520near-infrared%2520agents%2520for%2520selective%2520cancer%2520cell%2520destruction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D11600%26epage%3D11605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resasco, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. R.</span><span> </span><span class="NLM_article-title">Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes</span> <span class="citation_source-journal">J. Biomed. Opt.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">021009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1117%2F1.3078803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19405722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKms7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=021009&author=F.+Zhouauthor=D.+Xingauthor=Z.+Ouauthor=B.+Wuauthor=D.+E.+Resascoauthor=W.+R.+Chen&title=Cancer+photothermal+therapy+in+the+near-infrared+region+by+using+single-walled+carbon+nanotubes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes</span></div><div class="casAuthors">Zhou, Feifan; Xing, Da; Ou, Zhongmin; Wu, Baoyan; Resasco, Daniel E.; Chen, Wei R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Optics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">021009/1-021009/7</span>CODEN:
                <span class="NLM_cas:coden">JBOPFO</span>;
        ISSN:<span class="NLM_cas:issn">1083-3668</span>.
    
            (<span class="NLM_cas:orgname">Society of Photo-Optical Instrumentation Engineers</span>)
        </div><div class="casAbstract">Single-walled carbon nanotubes (SWNTs) have a high optical absorbance in the near-IR (NIR) region.  In this special optical window, biol. systems are known to be highly transparent.  The optical properties of SWNTs provide an opportunity for selective photothermal therapy for cancer treatment.  Specifically, CoMoCAT nanotubes with a uniform size (about 0.81 nm) and a narrow absorption peak at 980 nm are ideal candidates for such a novel approach.  Here, CoMoCAT SWNTs are conjugated to folate, which can bind specifically to the surface of the folate receptor tumor markers.  Folate-SWNT (FA-SWNT) targeted tumor cells were irradiated by a 980-nm laser.  In our in vitro and in vivo expts., FA-SWNT effectively enhanced the photothermal destruction on tumor cells and noticeably spared the photothermal destruction for nontargeted normal cells.  Thus, SWNTs, combined with suitable tumor markers, can be used as novel nanomaterials for selective photothermal therapy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5lLuSAUnGsrVg90H21EOLACvtfcHk0liXGOyMgOJWgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKms7o%253D&md5=df9e0964257b4f324dd022e6176cd74e</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1117%2F1.3078803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1117%252F1.3078803%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DOu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DResasco%26aufirst%3DD.%2BE.%26aulast%3DChen%26aufirst%3DW.%2BR.%26atitle%3DCancer%2520photothermal%2520therapy%2520in%2520the%2520near-infrared%2520region%2520by%2520using%2520single-walled%2520carbon%2520nanotubes%26jtitle%3DJ.%2520Biomed.%2520Opt.%26date%3D2009%26volume%3D14%26spage%3D021009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Zheng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickson, J. D.</span><span> </span><span class="NLM_article-title">Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17757</span><span class="NLM_x">â</span> <span class="NLM_lpage">17762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17757-17762&author=G.+Zhengauthor=J.+Chenauthor=H.+Liauthor=J.+D.+Glickson&title=Rerouting+lipoprotein+nanoparticles+to+selected+alternate+receptors+for+the+targeted+delivery+of+cancer+diagnostic+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGlickson%26aufirst%3DJ.%2BD.%26atitle%3DRerouting%2520lipoprotein%2520nanoparticles%2520to%2520selected%2520alternate%2520receptors%2520for%2520the%2520targeted%2520delivery%2520of%2520cancer%2520diagnostic%2520and%2520therapeutic%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D17757%26epage%3D17762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Glickson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund-Katz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chance, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, G.</span><span> </span><span class="NLM_article-title">Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents</span> <span class="citation_source-journal">Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">â</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=18706292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Wmu7%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=101-110&author=J.+D.+Glicksonauthor=S.+Lund-Katzauthor=R.+Zhouauthor=H.+Choiauthor=I.+W.+Chenauthor=H.+Liauthor=I.+Corbinauthor=A.+V.+Popovauthor=W.+Caoauthor=L.+Songauthor=C.+Qiauthor=D.+Marottaauthor=D.+S.+Nelsonauthor=J.+Chenauthor=B.+Chanceauthor=G.+Zheng&title=Lipoprotein+nanoplatform+for+targeted+delivery+of+diagnostic+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents</span></div><div class="casAuthors">Glickson, Jerry D.; Lund-Katz, Sissel; Zhou, Rong; Choi, Hoon; Chen, I.-Wei; Li, Hui; Corbin, Ian; Popov, Anatoliy V.; Cao, Weiguo; Song, Liping; Qi, Chenze; Marotta, Diane; Nelson, David S.; Chen, Juan; Chance, Britton; Zheng, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">MIOMBP</span>;
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    
            (<span class="NLM_cas:orgname">BC Decker Inc.</span>)
        </div><div class="casAbstract">A review.  Low-d. lipoprotein (LDL) provides a highly versatile natural nanoplatform for delivery of visible or near-IR fluorescent optical and magnetic resonance imaging (MRI) contrast agents and photodynamic therapy and chemotherapeutic agents to normal and neoplastic cells that overexpress low-d. lipoprotein receptors (LDLRs).  Extension to other lipoproteins ranging in diam. from about 10 nm (high-d. lipoprotein [HDL]) to over a micron (chylomicrons) is feasible.  Loading of contrast or therapeutic agents onto or into these particles has been achieved by protein loading (covalent attachment to protein side chains), surface loading (intercalation into the phospholipid monolayer), and core loading (extn. and reconstitution of the triglyceride/cholesterol ester core).  Core and surface loading of LDL have been used for delivery of optical imaging agents to tumor cells in vivo and in culture.  Surface loading was used for delivery of gadolinium-bis-stearylamide contrast agents for in vivo MRI detection in tumor-bearing mice.  Chlorin and phthalocyanine near-IR photodynamic therapy agents (â¤ 400/LDL) have been attached by core loading.  Protein loading was used to reroute the LDL from its natural receptor (LDLR) to folate receptors and could be used to target other receptors.  A semisynthetic nanoparticle has been constructed by coating magnetite iron oxide nanoparticles with carboxylated cholesterol and overlaying a monolayer of phospholipid to which apolipoprotein A1 or E was adsorbed for targeting HDL or adsorbing synthetic amphipathic helical peptides Itargeting LDL or folate receptors.  These particles can be used for in situ loading of magnetite into cells for MRI-monitored cell tracking or gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonTC2hmeUW7Vg90H21EOLACvtfcHk0liqLm3Tyr76fQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Wmu7%252FE&md5=34e75605118bb849bf46cb575b659716</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlickson%26aufirst%3DJ.%2BD.%26aulast%3DLund-Katz%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DI.%2BW.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DCorbin%26aufirst%3DI.%26aulast%3DPopov%26aufirst%3DA.%2BV.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DC.%26aulast%3DMarotta%26aufirst%3DD.%26aulast%3DNelson%26aufirst%3DD.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChance%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DLipoprotein%2520nanoplatform%2520for%2520targeted%2520delivery%2520of%2520diagnostic%2520and%2520therapeutic%2520agents%26jtitle%3DMol.%2520Imaging%26date%3D2008%26volume%3D7%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Nayak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, L. A.</span><span> </span><span class="NLM_article-title">Folate-mediated cell targeting and cytotoxicity using thermoresponsive microgels</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">10258</span><span class="NLM_x">â</span> <span class="NLM_lpage">10259</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0474143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=10258-10259&author=S.+Nayakauthor=H.+Leeauthor=J.+Chmielewskiauthor=L.+A.+Lyon&title=Folate-mediated+cell+targeting+and+cytotoxicity+using+thermoresponsive+microgels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Fja0474143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0474143%26sid%3Dliteratum%253Aachs%26aulast%3DNayak%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DChmielewski%26aufirst%3DJ.%26aulast%3DLyon%26aufirst%3DL.%2BA.%26atitle%3DFolate-mediated%2520cell%2520targeting%2520and%2520cytotoxicity%2520using%2520thermoresponsive%2520microgels%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D10258%26epage%3D10259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span> </span><span class="NLM_article-title">Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">â</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.ijpharm.2004.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=15541922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXps1Oqtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2004&pages=155-162&author=L.+Zhangauthor=S.+Houauthor=S.+Maoauthor=D.+Weiauthor=X.+Songauthor=Y.+Lu&title=Uptake+of+folate-conjugated+albumin+nanoparticles+to+the+SKOV3+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells</span></div><div class="casAuthors">Zhang, Liangke; Hou, Shixiang; Mao, Shengjun; Wei, Dapeng; Song, Xiangrong; Lu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">155-162</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bovine serum albumin nanoparticles (BSANPs) were prepd. by a coacervation method and chem. crosslinking with glutaraldehyde.  Furthermore, the BSANPs were reacted with the activated folic acid to conjugate folate via amino groups of the BSANPs, to improve their intracellular uptake to target cells.  The nanoparticles were apparently spherical with diams. less than 150 nm and their av. diam. was 70 nm by a transmission electron microscope (TEM) and a laser light scattering particle analyzer, resp.  An extent of folate conjugation with the BSANPs was 169 Î¼mol/g BSA by spectrophotometric anal.  Cell uptake studies were carried out in SKOV3 cells (human ovarian cancer cell line) using fluorescein isothiocyanate labeled nanoparticles.  The extent of BSANPs taken up by the cells was measured with a fluorescence spectrophotometer.  The nanoparticles were taken up to the cells and levels of binding and uptake were increased with the time of incubation until 4 h.  The levels of folate-conjugated BSANPs were higher than those of BSANPs and saturable.  The assocn. of folate-conjugated BSANPs to SKOV3 cells was inhibited by an excess amt. of folic acid, suggesting that the binding and/or uptake were mediated by the folate receptor.  These results implied that the folate-conjugated BSANPs might be useful as a drug carrier system to deliver drugs into the cells expressing folate receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-VnVL4-HDLLVg90H21EOLACvtfcHk0ljQH1LvAeJ5eQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXps1Oqtbw%253D&md5=cdd983a9386e2201a71fef72c6fc7b54</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2004.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2004.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DUptake%2520of%2520folate-conjugated%2520albumin%2520nanoparticles%2520to%2520the%2520SKOV3%2520cells%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2004%26volume%3D287%26spage%3D155%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, L. Y.</span><span> </span><span class="NLM_article-title">Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">836</span><span class="NLM_x">â</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc060361p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjslWht70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=836-843&author=Y.+Renauthor=S.+M.+Wongauthor=L.+Y.+Lim&title=Folic+acid-conjugated+protein+cages+of+a+plant+virus%3A+a+novel+delivery+platform+for+doxorubicin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin</span></div><div class="casAuthors">Ren, Yupeng; Wong, Sek Man; Lim, Lee-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">836-843</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein cage of a plant virus may provide a template for monodispersed nanosized systems for drug delivery.  Using the Hibiscus chlorotic ringspot virus (HCRSV) as a model plant virus, we have prepd. nanosized protein cages (30 nm) capable of encapsulating the anticancer drug, doxorubicin.  The technique utilized the simultaneous encapsulation of a polyprotic acid of mw 200 kDa to produce an encapsulation efficiency for doxorubicin of about 7.5%.  Folic acid was conjugated onto the capsids to impart cancer-targeting capability.  The resultant nanosized systems improved the uptake and cytotoxicity of doxorubicin in the ovarian cancer cells, OVCAR-3, with statistical significance.  Plant virus capsids may therefore provide viable templates for targeted drug delivery in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbnAw0nh0R1rVg90H21EOLACvtfcHk0ljQH1LvAeJ5eQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjslWht70%253D&md5=08e224dd6f3502f22404a9dd99bdd5ac</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fbc060361p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060361p%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DS.%2BM.%26aulast%3DLim%26aufirst%3DL.%2BY.%26atitle%3DFolic%2520acid-conjugated%2520protein%2520cages%2520of%2520a%2520plant%2520virus%253A%2520a%2520novel%2520delivery%2520platform%2520for%2520doxorubicin%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D836%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Destito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, M.</span><span> </span><span class="NLM_article-title">Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">â</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.chembiol.2007.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17961827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amt77P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=1152-1162&author=G.+Destitoauthor=R.+Yehauthor=C.+S.+Raeauthor=M.+G.+Finnauthor=M.+Manchester&title=Folic+acid-mediated+targeting+of+cowpea+mosaic+virus+particles+to+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Folic Acid-Mediated Targeting of Cowpea Mosaic Virus Particles to Tumor Cells</span></div><div class="casAuthors">Destito, Giuseppe; Yeh, Robert; Rae, Chris S.; Finn, M. G.; Manchester, Marianne</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1152-1162</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cowpea mosaic virus (CPMV) is a well-characterized nanoparticle that has been used for a variety of nanobiotechnol. applications.  CPMV interacts with several mammalian cell lines and tissues in vivo.  To overcome natural CPMV targeting and redirect CPMV particles to cells of interest, we attached a folic acid-PEG conjugate by using the copper-catalyzed azide-alkyne cycloaddn. reaction.  PEGylation of CPMV completely eliminated background binding of the virus to tumor cells.  The PEG-folate moiety allowed CPMV-specific recognition of tumor cells bearing the folate receptor.  In addn., by testing CPMV formulations with different amts. of the PEG-FA moiety displayed on the surface, we show that higher-d. loading of targeting ligands on CPMV may not be necessary for efficient targeting to tumor cells.  These studies help to define the requirements for efficiently targeting nanoparticles and protein cages to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv3X6Aa3BAqLVg90H21EOLACvtfcHk0ljQH1LvAeJ5eQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amt77P&md5=7643b83dc78dd293e03802ad1bf6cd37</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DDestito%26aufirst%3DG.%26aulast%3DYeh%26aufirst%3DR.%26aulast%3DRae%26aufirst%3DC.%2BS.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DManchester%26aufirst%3DM.%26atitle%3DFolic%2520acid-mediated%2520targeting%2520of%2520cowpea%2520mosaic%2520virus%2520particles%2520to%2520tumor%2520cells%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D1152%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Liu, S. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiradharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y. Y.</span><span> </span><span class="NLM_article-title">Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">â</span> <span class="NLM_lpage">1433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1016%2Fj.biomaterials.2006.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=17141308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlClsrbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1423-1433&author=S.+Q.+Liuauthor=N.+Wiradharmaauthor=S.+J.+Gaoauthor=Y.+W.+Tongauthor=Y.+Y.+Yang&title=Bio-functional+micelles+self-assembled+from+a+folate-conjugated+block+copolymer+for+targeted+intracellular+delivery+of+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs</span></div><div class="casAuthors">Liu, Shao-Qiong; Wiradharma, Nikken; Gao, Shu-Jun; Tong, Yen Wah; Yang, Yi-Yan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1423-1433</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study, a block copolymer, poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide-co-2-aminoethyl methacrylate)-b-poly(10-undecenoic acid) (P(NIPAAm-co-DMAAm-co-AMA)-b-PUA) was synthesized, and folic acid was conjugated to the hydrophilic block through the amine group in AMA.  This polymer was self-assembled into micelles, which exhibited pH-induced temp. sensitivity.  They were smaller in size, and possessed a better-defined core-shell structure as well as more stable hydrophobic core than the random copolymer P(NIPAAm-co-DMAAm-co-UA), and provided a shell with folate mols.  An anti-cancer drug, doxorubicin (DOX) was encapsulated into the micelles.  The mean diam. of the blank and DOX-loaded micelles was less than 100 nm.  DOX release was pH-dependent, being faster at low pH (endosomes/lysosomes).  Therefore, DOX was readily released from the micelles into the nucleus after being taken up.  More importantly, IC50 of DOX-loaded micelles with folate against folate receptor-expressing 4T1 and KB cells was much lower than that of the DOX-loaded micelles without folate (3.8 vs. 7.6 mg/L for 4T1 cells and 1.2 vs. 3.0 mg/L for KB cells).  In vivo expts. conducted in a 4T1 mouse breast cancer model demonstrated that DOX-loaded micelles had a longer blood circulation time than free DOX (t 1/2: 30 min and 140 min, resp.).  In addn., the micelles delivered an increased amt. of DOX to the tumor when compared to free DOX.  These bio-functional micelles may make a promising carrier to transport anticancer drugs specifically to tumor cells and release the drug mols. inside the cells to the cytosols for improved chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQG4zLELhdbVg90H21EOLACvtfcHk0lgE3rzw1mm-PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlClsrbL&md5=a1b83819956a86bbad3ef9c74f8a1d4b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2006.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2006.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%2BQ.%26aulast%3DWiradharma%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DS.%2BJ.%26aulast%3DTong%26aufirst%3DY.%2BW.%26aulast%3DYang%26aufirst%3DY.%2BY.%26atitle%3DBio-functional%2520micelles%2520self-assembled%2520from%2520a%2520folate-conjugated%2520block%2520copolymer%2520for%2520targeted%2520intracellular%2520delivery%2520of%2520anticancer%2520drugs%26jtitle%3DBiomaterials%26date%3D2007%26volume%3D28%26spage%3D1423%26epage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Perentes, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiew, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padera, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, Y.</span><span> </span><span class="NLM_article-title">In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">â</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm100509v&amp;key=10.1038%2Fnmeth.1295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm100509v&amp;key=19151720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm100509v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFGksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=143-145&author=J.+Y.+Perentesauthor=T.+D.+McKeeauthor=C.+D.+Leyauthor=H.+Mathiewauthor=M.+Dawsonauthor=T.+P.+Paderaauthor=L.+L.+Munnauthor=R.+K.+Jainauthor=Y.+Boucher&title=In+vivo+imaging+of+extracellular+matrix+remodeling+by+tumor-associated+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts</span></div><div class="casAuthors">Perentes, Jean Y.; McKee, Trevor D.; Ley, Carsten D.; Mathiew, Hannah; Dawson, Michelle; Padera, Timothy P.; Munn, Lance L.; Jain, Rakesh K.; Boucher, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-145</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we integrated multiphoton laser scanning microscopy and the registration of second harmonic generation images of collagen fibers to overcome difficulties in tracking stromal cell-matrix interactions for several days in live mice.  We show that the matrix-modifying hormone relaxin increased tumor-assocd. fibroblast (TAF) interaction with collagen fibers by stimulating Î²1-integrin activity, which is necessary for fiber remodeling by matrix metalloproteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr07EJpIjJbxbVg90H21EOLACvtfcHk0lgE3rzw1mm-PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFGksg%253D%253D&md5=ca1737a6476120136556ec7cd15245a1</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.1295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.1295%26sid%3Dliteratum%253Aachs%26aulast%3DPerentes%26aufirst%3DJ.%2BY.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLey%26aufirst%3DC.%2BD.%26aulast%3DMathiew%26aufirst%3DH.%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DPadera%26aufirst%3DT.%2BP.%26aulast%3DMunn%26aufirst%3DL.%2BL.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DBoucher%26aufirst%3DY.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520extracellular%2520matrix%2520remodeling%2520by%2520tumor-associated%2520fibroblasts%26jtitle%3DNat.%2520Methods%26date%3D2009%26volume%3D6%26spage%3D143%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100509v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm100509v%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100509v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ad6d6de08223c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
